UI	LS
-	:
95333264	CD

TI	LS
-	:
The	DT
peri-kappa	NN
B	NN
site	NN
mediates	VBZ
human	JJ
immunodeficiency	NN
virus	NN
type	NN
2	CD
enhancer	NN
activation	NN
in	IN
monocytes	NNS
but	CC
not	RB
in	IN
T	NN
cells	NNS
.	.

AB	LS
-	:
Human	JJ
immunodeficiency	NN
virus	NN
type	NN
2	CD
(	(
HIV-2	NN
)	)
,	,
like	IN
HIV-1	NN
,	,
causes	VBZ
AIDS	NN
and	CC
is	VBZ
associated	VBN
with	IN
AIDS	NN
cases	NNS
primarily	RB
in	IN
West	NNP
Africa	NNP
.	.

HIV-1	NN
and	CC
HIV-2	NN
display	VBP
significant	JJ
differences	NNS
in	IN
nucleic	JJ
acid	NN
sequence	NN
and	CC
in	IN
the	DT
natural	JJ
history	NN
of	IN
clinical	JJ
disease	NN
.	.

Consistent	JJ
with	IN
these	DT
differences	NNS
,	,
we	PRP
have	VBP
previously	RB
demonstrated	VBN
that	IN
the	DT
enhancer/promoter	NN
region	NN
of	IN
HIV-2	NN
functions	VBZ
quite	RB
differently	RB
from	IN
that	DT
of	IN
HIV-1	NN
.	.

Whereas	IN
activation	NN
of	IN
the	DT
HIV-1	NN
enhancer	NN
following	VBG
T-cell	NN
stimulation	NN
is	VBZ
mediated	VBN
largely	RB
through	IN
binding	NN
of	IN
the	DT
transcription	NN
factor	NN
NF-kappa	NN
B	NN
to	TO
two	CD
adjacent	JJ
kappa	NN
B	NN
sites	NNS
in	IN
the	DT
HIV-1	NN
long	JJ
terminal	JJ
repeat	NN
,	,
activation	NN
of	IN
the	DT
HIV-2	NN
enhancer	NN
in	IN
monocytes	NNS
and	CC
T	NN
cells	NNS
is	VBZ
dependent	JJ
on	IN
four	CD
cis-acting	JJ
elements	NNS
:	:
a	DT
single	JJ
kappa	NN
B	NN
site	NN
,	,
two	CD
purine-rich	JJ
binding	VBG
sites	NNS
,	,
PuB1	NN
and	CC
PuB2	NN
,	,
and	CC
a	DT
pets	NN
site	NN
.	.

We	PRP
have	VBP
now	RB
identified	VBN
a	DT
novel	JJ
cis-acting	JJ
element	NN
within	IN
the	DT
HIV-2	NN
enhancer	NN
,	,
immediately	RB
upstream	JJ
of	IN
the	DT
kappa	NN
B	NN
site	NN
,	,
designated	VBN
peri-kappa	NN
B	NN
.	.

This	DT
site	NN
is	VBZ
conserved	VBN
among	IN
isolates	NNS
of	IN
HIV-2	NN
and	CC
the	DT
closely	RB
related	JJ
simian	JJ
immunodeficiency	NN
virus	NN
,	,
and	CC
transfection	NN
assays	NNS
show	VBP
this	DT
site	NN
to	TO
mediate	VB
HIV-2	NN
enhancer	NN
activation	NN
following	VBG
stimulation	NN
of	IN
monocytic	JJ
but	CC
not	RB
T-cell	NN
lines	NNS
.	.

This	DT
is	VBZ
the	DT
first	JJ
description	NN
of	IN
an	DT
HIV-2	NN
enhancer	NN
element	NN
which	WDT
displays	VBZ
such	JJ
monocyte	NN
specificity	NN
,	,
and	CC
no	DT
comparable	JJ
enhancer	NN
element	NN
has	VBZ
been	VBN
clearly	RB
defined	VBN
for	IN
HIV-1	NN
.	.

While	IN
a	DT
nuclear	JJ
factor	NN
(	(
s	NNS
)	)
from	IN
both	CC
peripheral	JJ
blood	NN
monocytes	NNS
and	CC
T	NN
cells	NNS
binds	VBZ
the	DT
peri-kappa	NN
B	NN
site	NN
,	,
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
suggest	VBP
that	IN
either	CC
a	DT
different	JJ
protein	NN
binds	VBZ
to	TO
this	DT
site	NN
in	IN
monocytes	NNS
versus	CC
T	NN
cells	NNS
or	CC
that	IN
the	DT
protein	NN
recognizing	VBG
this	DT
enhancer	NN
element	NN
undergoes	VBZ
differential	JJ
modification	NN
in	IN
monocytes	NNS
and	CC
T	NN
cells	NNS
,	,
thus	RB
supporting	VBG
the	DT
transfection	NN
data	NNS
.	.

Further	RB
,	,
while	IN
specific	JJ
constitutive	JJ
binding	NN
to	TO
the	DT
peri-kappa	NN
B	NN
site	NN
is	VBZ
seen	VBN
in	IN
monocytes	NNS
,	,
stimulation	NN
with	IN
phorbol	NN
esters	NNS
induces	VBZ
additional	JJ
,	,
specific	JJ
binding	NN
.	.

Understanding	VBG
the	DT
monocyte-specific	JJ
function	NN
of	IN
the	DT
peri-kappa	NN
B	NN
factor	NN
may	MD
ultimately	RB
provide	VB
insight	NN
into	IN
the	DT
different	JJ
role	NN
monocytes	NNS
and	CC
T	NN
cells	NNS
play	VBP
in	IN
HIV	NN
pathogenesis	NN
.	.

UI	LS
-	:
95347379	CD

TI	LS
-	:
Distinct	JJ
signaling	NN
properties	NNS
identify	VBP
functionally	RB
different	JJ
CD4	NN
epitopes	NNS
.	.

AB	LS
-	:
The	DT
CD4	NN
coreceptor	NN
interacts	VBZ
with	IN
non-polymorphic	JJ
regions	NNS
of	IN
major	JJ
histocompatibility	NN
complex	NN
class	NN
II	CD
molecules	NNS
on	IN
antigen-presenting	JJ
cells	NNS
and	CC
contributes	VBZ
to	TO
T	NN
cell	NN
activation	NN
.	.

We	PRP
have	VBP
investigated	VBN
the	DT
effect	NN
of	IN
CD4	NN
triggering	NN
on	IN
T	NN
cell	NN
activating	NN
signals	NNS
in	IN
a	DT
lymphoma	NN
model	NN
using	VBG
monoclonal	JJ
antibodies	NNS
(	(
mAb	NN
)	)
which	WDT
recognize	VBP
different	JJ
CD4	NN
epitopes	NNS
.	.

We	PRP
demonstrate	VBP
that	IN
CD4	NN
triggering	NN
delivers	VBZ
signals	NNS
capable	JJ
of	IN
activating	VBG
the	DT
NF-AT	NN
transcription	NN
factor	NN
which	WDT
is	VBZ
required	VBN
for	IN
interleukin-2	NN
gene	NN
expression	NN
.	.

Whereas	IN
different	JJ
anti-CD4	JJ
mAb	NN
or	CC
HIV-1	NN
gp120	NN
could	MD
all	DT
trigger	VB
activation	NN
of	IN
the	DT
protein	NN
tyrosine	NN
kinases	NNS
p56lck	NN
and	CC
p59fyn	NN
and	CC
phosphorylation	NN
of	IN
the	DT
Shc	NN
adaptor	NN
protein	NN
,	,
which	WDT
mediates	VBZ
signals	NNS
to	TO
Ras	NN
,	,
they	PRP
differed	VBD
significantly	RB
in	IN
their	PRP$
ability	NN
to	TO
activate	VB
NF-AT	NN
.	.

Lack	NN
of	IN
full	JJ
activation	NN
of	IN
NF-AT	NN
could	MD
be	VB
correlated	VBN
to	TO
a	DT
dramatically	RB
reduced	VBN
capacity	NN
to	TO
induce	VB
calcium	NN
flux	NN
and	CC
could	MD
be	VB
complemented	VBN
with	IN
a	DT
calcium	NN
ionophore	NN
.	.

The	DT
results	NNS
identify	VBP
functionally	RB
distinct	JJ
epitopes	NNS
on	IN
the	DT
CD4	NN
coreceptor	NN
involved	VBN
in	IN
activation	NN
of	IN
the	DT
Ras/protein	NN
kinase	NN
C	NN
and	CC
calcium	NN
pathways	NNS
.	.

UI	LS
-	:
95338146	CD

TI	LS
-	:
Hematopoietic	JJ
lineage	NN
commitment	NN
:	:
role	NN
of	IN
transcription	NN
factors	NNS
.	.

AB	LS
-	:
This	DT
review	NN
focuses	VBZ
on	IN
the	DT
roles	NNS
of	IN
transcription	NN
factors	NNS
in	IN
hematopoietic	JJ
lineage	NN
commitment	NN
.	.

A	DT
brief	JJ
introduction	NN
to	TO
lineage	NN
commitment	NN
and	CC
asymmetric	JJ
cell	NN
division	NN
is	VBZ
followed	VBN
by	IN
a	DT
discussion	NN
of	IN
several	JJ
methods	NNS
used	VBN
to	TO
identify	VB
transcription	NN
factors	NNS
important	JJ
in	IN
specifying	VBG
hematopoietic	JJ
cell	NN
types	NNS
.	.

Next	RB
is	VBZ
presented	VBN
a	DT
discussion	NN
of	IN
the	DT
use	NN
of	IN
embryonic	JJ
stem	NN
cells	NNS
in	IN
the	DT
analysis	NN
of	IN
hematopoietic	JJ
gene	NN
expression	NN
and	CC
the	DT
use	NN
of	IN
targeted	VBN
gene	NN
disruption	NN
to	TO
analyze	VB
the	DT
role	NN
of	IN
transcription	NN
factors	NNS
in	IN
hematopoiesis	NN
.	.

Finally	RB
,	,
the	DT
status	NN
of	IN
our	PRP$
current	JJ
knowledge	NN
concerning	VBG
the	DT
roles	NNS
of	IN
transcription	NN
factors	NNS
in	IN
the	DT
commitment	NN
to	TO
erythroid	JJ
,	,
myeloid	JJ
and	CC
lymphoid	JJ
cell	NN
types	NNS
is	VBZ
summarized	VBN
.	.

UI	LS
-	:
95362365	CD

TI	LS
-	:
RB	NN
and	CC
a	DT
novel	JJ
E2F-1	NN
binding	NN
protein	NN
in	IN
MHC	NN
class	NN
II	CD
deficient	JJ
B-cell	NN
lines	NNS
and	CC
normal	JJ
IFN-gamma	NN
induction	NN
of	IN
the	DT
class	NN
IL	NN
transactivator	NN
CIITA	NN
in	IN
class	NN
II	CD
non-inducible	JJ
RB-defective	JJ
tumor	NN
lines	NNS
.	.

AB	LS
-	:
The	DT
major	JJ
histocompatibility	NN
(	(
MHC	NN
)	)
class	NN
II	CD
genes	NNS
encode	VBP
cell	NN
surface	NN
proteins	NNS
that	WDT
bind	VBP
antigenic	JJ
peptide	NN
for	IN
presentation	NN
to	TO
T-cells	NNS
.	.

The	DT
class	NN
II	CD
proteins	NNS
are	VBP
expressed	VBN
constitutively	RB
on	IN
B-cells	NNS
and	CC
EBV-	NN
transformed	JJ
B-cells	NNS
,	,
and	CC
are	VBP
inducible	JJ
by	IN
IFN-gamma	NN
on	IN
a	DT
wide	JJ
variety	NN
of	IN
cell	NN
types	NNS
.	.

Retinoblastoma	NN
protein	NN
(	(
RB	NN
)	)
is	VBZ
a	DT
tumor	NN
suppressor	NN
and	CC
functions	VBZ
as	IN
a	DT
transcriptional	JJ
repressor	NN
by	IN
binding	VBG
and	CC
inactivating	VBG
the	DT
transactivator	NN
E2F-I	NN
.	.

RB-defective	JJ
tumor	NN
lines	NNS
are	VBP
non-inducible	JJ
for	IN
MHC	NN
class	NN
II	CD
by	IN
IFN-gamma	NN
,	,
or	CC
very	RB
weakly	RB
inducible	JJ
,	,
but	CC
transfection	NN
of	IN
2	CD
different	JJ
lines	NNS
with	IN
RB	NN
expression	NN
vectors	NNS
re-establishes	VBZ
or	CC
substantially	RB
enhances	VBZ
class	NN
II	CD
inducibility	NN
.	.

Therefore	RB
,	,
we	PRP
examined	VBD
the	DT
RB	NN
status	NN
of	IN
a	DT
series	NN
of	IN
B-cell	NN
mutants	NNS
that	WDT
are	VBP
defective	JJ
in	IN
class	NN
II	CD
expression	NN
,	,
generated	VBN
either	CC
in	FW
vitro	FW
or	CC
derived	VBN
from	IN
Bare	NN
Lymphocyte	NN
Syndrome	NN
(	(
BLS	NN
)	)
patients	NNS
.	.

Nuclear	JJ
matrix-bound	JJ
RB	NN
was	VBD
detectable	JJ
in	IN
all	DT
cases	NNS
,	,
indicating	VBG
that	IN
loss	NN
of	IN
RB	NN
is	VBZ
not	RB
responsible	JJ
for	IN
decreased	VBN
class	NN
II	CD
expression	NN
in	IN
these	DT
lines	NNS
.	.

A	DT
second	JJ
E2F-I	NN
binding	NN
protein	NN
,	,
most	RBS
likely	RB
DP-I	NN
,	,
was	VBD
also	RB
apparently	RB
normal	JJ
in	IN
both	CC
class	NN
II-positive	JJ
and	CC
-negative	JJ
B-cell	NN
lines	NNS
.	.

We	PRP
also	RB
examined	VBD
the	DT
IFN-gamma	NN
induction	NN
of	IN
CIITA	NN
in	IN
RB-defective	JJ
lines	NNS
.	.

CIITA	NN
is	VBZ
a	DT
class	NN
II	CD
gene	NN
transactivator	NN
known	VBN
to	TO
be	VB
defective	JJ
in	IN
one	CD
form	NN
of	IN
BLS	NN
and	CC
to	TO
be	VB
required	VBN
for	IN
the	DT
induction	NN
of	IN
MHC	NN
class	NN
II	CD
by	IN
IFN-gamma	NN
.	.

CIITA	NN
mRNA	NN
is	VBZ
normally	RB
inducible	JJ
by	IN
IFN-gamma	NN
in	IN
class	NN
II	CD
non-inducible	JJ
,	,
RB-defective	JJ
lines	NNS
,	,
and	CC
in	IN
one	CD
line	NN
,	,
re-expression	NN
of	IN
RB	NN
has	VBZ
no	DT
effect	NN
on	IN
CIITA	NN
mRNA	NN
induction	NN
levels	NNS
.	.

Thus	RB
,	,
the	DT
block	NN
in	IN
MHC	NN
class	NN
II	CD
inducibility	NN
in	IN
RB-defective	JJ
cells	NNS
is	VBZ
not	RB
due	JJ
to	TO
a	DT
block	NN
in	IN
CIITA	NN
inducibility	NN
.	.

UI	LS
-	:
95221892	CD

TI	LS
-	:
cDNA	NN
cloning	NN
of	IN
a	DT
NGFI-B/nur77-related	JJ
transcription	NN
factor	NN
from	IN
an	DT
apoptotic	JJ
human	JJ
T	NN
cell	NN
line	NN
.	.

AB	LS
-	:
A	DT
human	JJ
T	NN
lymphoid	JJ
cell	NN
line	NN
,	,
PEER	NN
,	,
dies	VBZ
by	IN
apoptosis	NN
in	IN
the	DT
presence	NN
of	IN
PMA	NN
and	CC
calcium	NN
ionophore	NN
.	.

A	DT
new	JJ
gene	NN
,	,
TINUR	NN
,	,
was	VBD
cloned	VBN
from	IN
apoptotic	JJ
PEER	NN
cells	NNS
.	.

The	DT
expression	NN
of	IN
the	DT
TINUR	NN
gene	NN
is	VBZ
induced	VBN
within	IN
1	CD
h	NN
after	IN
the	DT
cross-linking	NN
of	IN
the	DT
T	NN
cell	NN
Ag	NN
receptor	NN
complex	NN
.	.

TINUR	NN
belongs	VBZ
to	TO
the	DT
NGFI-B/nur77	NN
family	NN
of	IN
the	DT
steroid	NN
receptor	NN
superfamily	NN
and	CC
is	VBZ
an	DT
orphan	NN
receptor	NN
.	.

TINUR	NN
binds	VBZ
to	TO
the	DT
same	JJ
DNA	NN
sequence	NN
as	IN
NGFI-B/nur77	NN
.	.

We	PRP
also	RB
propose	VBP
that	IN
the	DT
NGFI-B/nur77	NN
family	NN
can	MD
be	VB
classified	VBN
into	IN
two	CD
subtypes	NNS
.	.

UI	LS
-	:
95279882	CD

TI	LS
-	:
GM-CSF	NN
and	CC
IL-2	NN
share	VBP
common	JJ
control	NN
mechanisms	NNS
in	IN
response	NN
to	TO
costimulatory	JJ
signals	NNS
in	IN
T	NN
cells	NNS
.	.

AB	LS
-	:
Antigen	NN
complexed	VBN
with	IN
major	JJ
histocompatibility	NN
complex	NN
class	NN
I	CD
or	CC
II	CD
molecules	NNS
on	IN
the	DT
surface	NN
of	IN
antigen	NN
presenting	NN
cells	NNS
interacts	VBZ
with	IN
the	DT
T	NN
cell	NN
receptor	NN
(	(
TCR	NN
)	)
on	IN
the	DT
surface	NN
of	IN
T	NN
cells	NNS
and	CC
initiates	VBZ
an	DT
activation	NN
cascade	NN
.	.

So	RB
called	VBN
costimulatory	JJ
signals	NNS
,	,
mediated	VBN
by	IN
other	JJ
cell	NN
surface	NN
interactions	NNS
or	CC
soluble	JJ
cytokines	NNS
produced	VBN
by	IN
antigen	NN
presenting	NN
cells	NNS
,	,
are	VBP
also	RB
required	VBN
for	IN
complete	JJ
T	NN
cell	NN
activation	NN
.	.

High	JJ
levels	NNS
of	IN
cytokine	NN
gene	NN
expression	NN
in	IN
T	NN
cells	NNS
also	RB
required	VBD
both	CC
TCR	NN
and	CC
costimulatory	JJ
signals	NNS
.	.

The	DT
granulocyte-macrophage	JJ
colony-stimulating	JJ
factor	NN
requires	VBZ
sequences	NNS
in	IN
the	DT
promoter	NN
as	RB
well	RB
as	IN
a	DT
powerful	JJ
enhancer	NN
located	JJ
3kb	RB
upstream	RB
to	TO
respond	VB
to	TO
TCR-like	JJ
signals	NNS
.	.

These	DT
promoter	NN
and	CC
enhancer	NN
regions	NNS
are	VBP
mainly	RB
activated	VBN
by	IN
the	DT
transcription	NN
factor	NN
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
(	(
NFAT	NN
)	)
.	.

The	DT
activation	NN
of	IN
NFAT	NN
by	IN
TCR	NN
signals	NNS
has	VBZ
been	VBN
well	RB
described	VBN
for	IN
interleukin-2	NN
(	(
IL-2	NN
)	)
and	CC
IL-4	NN
gene	NN
transcription	NN
in	IN
T	NN
cells	NNS
.	.

Costimulatory	JJ
signals	NNS
,	,
such	JJ
as	IN
activation	NN
of	IN
the	DT
CD28	NN
cell	NN
surface	NN
molecule	NN
on	IN
T	NN
cells	NNS
,	,
lead	VBP
to	TO
activation	NN
through	IN
a	DT
distinct	JJ
region	NN
of	IN
the	DT
granulocyte-macrophage	JJ
colony-stimulating	JJ
factor	NN
(	(
GM-CSF	NN
)	)
promoter	NN
.	.

This	DT
region	NN
is	VBZ
termed	VBN
the	DT
CK-1	NN
or	CC
CD28RE	NN
and	CC
appears	VBZ
to	TO
bind	VB
specific	JJ
members	NNS
of	IN
the	DT
NF-kappa	NN
B	NN
family	NN
of	IN
transcription	NN
factors	NNS
.	.

Human	JJ
T	NN
leukemia	NN
virus	NN
type	NN
1	CD
(	(
HTLV-1	NN
)	)
infects	VBZ
T	NN
cells	NNS
and	CC
can	MD
lead	VB
to	TO
increase	VB
GM-CSF	NN
expression	NN
.	.

We	PRP
have	VBP
found	VBN
that	IN
the	DT
HTLV-1	NN
transactivator	NN
protein	NN
,	,
tax	NN
,	,
acts	VBZ
as	IN
a	DT
costimulatory	JJ
signal	NN
for	IN
GM-CSF	NN
and	CC
IL-2	NN
gene	NN
transcription	NN
,	,
in	IN
that	IN
it	PRP
can	MD
cooperate	VB
with	IN
TCR	NN
signals	NNS
to	TO
mediate	VB
high	JJ
level	NN
gene	NN
expression	NN
.	.

Tax	NN
activates	VBZ
the	DT
GM-CSF	NN
promoter	NN
through	IN
the	DT
CK-1/CD28RE	NN
region	NN
and	CC
also	RB
activates	VBZ
nuclear	JJ
factor-kappa	NN
B	NN
binding	VBG
to	TO
this	DT
region	NN
.	.

However	RB
,	,
other	JJ
transcription	NN
factors	NNS
or	CC
coactivators	NNS
of	IN
NF-kappa	NN
B	NN
are	VBP
required	VBN
for	IN
tax	NN
activation	NN
but	CC
these	DT
remain	VBP
to	TO
be	VB
identified	VBN
.	.

The	DT
CK-1/CD28RE	NN
of	IN
GM-CSF	NN
shows	VBZ
a	DT
high	JJ
degree	NN
of	IN
similarity	NN
to	TO
the	DT
IL-2	NN
CD28RE	NN
and	CC
the	DT
IL-3	NN
gene	NN
also	RB
contains	VBZ
a	DT
related	JJ
region	NN
.	.

This	DT
observation	NN
,	,
together	RB
with	IN
the	DT
fact	NN
that	IN
both	CC
GM-CSF	NN
and	CC
IL-2	NN
respond	VBP
to	TO
TCR	NN
signals	NNS
via	IN
NFAT	NN
,	,
implies	VBZ
a	DT
high	JJ
degree	NN
of	IN
conservation	NN
in	IN
the	DT
regulation	NN
of	IN
cytokine	NN
gene	NN
expression	NN
in	IN
T	NN
cells	NNS
.	.

UI	LS
-	:
95221870	CD

TI	LS
-	:
Functional	JJ
characterization	NN
of	IN
novel	JJ
IL-2	NN
transcriptional	JJ
inhibitors	NNS
.	.

AB	LS
-	:
IL-2-mediated	JJ
T	NN
cell	NN
proliferation	NN
is	VBZ
a	DT
critical	JJ
early	JJ
event	NN
in	IN
the	DT
inflammatory	JJ
process	NN
.	.

Formation	NN
of	IN
the	DT
NFAT-1	NN
transcriptional	JJ
complex	NN
on	IN
the	DT
IL-2	NN
promoter	NN
is	VBZ
essential	JJ
for	IN
IL-2	NN
transcription	NN
.	.

Using	VBG
a	DT
cell	NN
line	NN
that	WDT
is	VBZ
stably	RB
transfected	VBN
with	IN
a	DT
trimer	NN
of	IN
the	DT
NFAT-1	NN
regulatory	JJ
element	NN
linked	VBN
to	TO
a	DT
lac-Z	NN
reporter	NN
gene	NN
,	,
we	PRP
screened	VBD
for	IN
inhibitors	NNS
of	IN
NFAT-1-mediated	JJ
beta-galactosidase	NN
activity	NN
.	.

WIN	NN
61058	CD
and	CC
WIN	NN
53071	CD
were	VBD
identified	VBN
as	IN
microM	NN
inhibitors	NNS
.	.

These	DT
compounds	NNS
also	RB
inhibited	VBD
beta-galactosidase	NN
mRNA	NN
levels	NNS
.	.

Similar	JJ
inhibition	NN
of	IN
NFAT-1-mediated	JJ
gene	NN
expression	NN
was	VBD
observed	VBN
in	IN
a	DT
second	JJ
cell	NN
line	NN
,	,
which	WDT
is	VBZ
stably	RB
transfected	VBN
with	IN
NFAT-1	NN
regulatory	JJ
elements	NNS
linked	VBN
to	TO
the	DT
reporter	NN
gene	NN
for	IN
sCD8	NN
.	.

At	IN
10	CD
microM	NN
,	,
both	DT
compounds	NNS
inhibited	VBD
IL-2	NN
mRNA	NN
and	CC
protein	NN
levels	NNS
in	IN
the	DT
NFAT-1-linked	JJ
lac-Z	NN
transfectants	NNS
,	,
and	CC
in	IN
human	JJ
lymphocytes	NNS
.	.

Both	DT
compounds	NNS
inhibited	VBD
the	DT
mixed	JJ
lymphocyte	NN
reaction	NN
,	,
and	CC
this	DT
inhibition	NN
was	VBD
reversed	VBN
by	IN
exogenous	JJ
IL-2	NN
.	.

WIN	NN
53071	CD
inhibited	VBD
IL-2	NN
production	NN
induced	VBN
in	IN
the	DT
calcium-dependent	JJ
PMA	NN
and	CC
ionomycin	NN
pathway	NN
.	.

Conversely	RB
,	,
calcium-independent	JJ
anti-CD28	JJ
Ab	NN
and	CC
PMA-induced	JJ
IL-2	NN
production	NN
was	VBD
resistant	JJ
.	.

Both	DT
compounds	NNS
altered	VBD
the	DT
NFAT-1	NN
transcriptional	JJ
complex	NN
,	,
causing	VBG
its	PRP$
retarded	VBN
mobility	NN
on	IN
gels	NNS
.	.

By	IN
these	DT
functional	JJ
criteria	NNS
,	,
we	PRP
believe	VBP
we	PRP
have	VBP
identified	VBN
two	CD
structurally	RB
distinct	JJ
,	,
novel	JJ
inhibitors	NNS
of	IN
NFAT-1-mediated	JJ
transcription	NN
.	.

UI	LS
-	:
95394020	CD

TI	LS
-	:
Interleukin-2	NN
promoter	NN
activity	NN
in	IN
Epstein-Barr	JJ
virus-transformed	JJ
B	NN
lymphocytes	NNS
is	VBZ
controlled	VBN
by	IN
nuclear	JJ
factor-chi	NN
B	NN
.	.

AB	LS
-	:
The	DT
regulation	NN
of	IN
interleukin	NN
(	(
IL	NN
)	)
-2	CD
gene	NN
expression	NN
has	VBZ
been	VBN
investigated	VBN
mainly	RB
in	IN
T	NN
lymphocytes	NNS
,	,
the	DT
predominant	JJ
producers	NNS
of	IN
IL-2	NN
.	.

However	RB
,	,
B	NN
cells	NNS
can	MD
also	RB
synthesize	VB
IL-2	NN
.	.

In	IN
the	DT
present	JJ
study	NN
we	PRP
analyzed	VBD
the	DT
control	NN
of	IN
IL-2	NN
promoter	NN
activity	NN
in	IN
Epstein-Barr	JJ
virus	NN
(	(
EBV	NN
)	)
-transformed	JJ
B	NN
cell	NN
clones	NNS
which	WDT
are	VBP
capable	JJ
of	IN
secreting	VBG
IL-2	NN
at	IN
a	DT
low	JJ
level	NN
after	IN
stimulation	NN
with	IN
phorbol	NN
12-myristate	NN
13-acetate	NN
and	CC
the	DT
Ca2+	NN
ionophore	NN
ionomycin	NN
.	.

Transient	JJ
transfections	NNS
using	VBG
reporter	NN
constructs	NNS
with	IN
multiples	NNS
of	IN
transcription	NN
factor	NN
binding	NN
sites	NNS
from	IN
the	DT
IL-2	NN
promoter	NN
[	(
distal	JJ
nuclear	JJ
factor	NN
(	(
NF	NN
)	)
-AT	NN
,	,
proximal	JJ
NF-AT	NN
,	,
AP-1/Octamer	NN
(	(
UPS	NN
)	)
or	CC
NF-chi	NN
B	NN
(	(
TCEd	NN
)	)
sites	NNS
]	)
were	VBD
performed	VBN
.	.

In	IN
EBV-transformed	JJ
B	NN
clones	NNS
,	,
the	DT
chi	NN
B	NN
site	NN
exerted	VBD
the	DT
strongest	JJS
inducible	JJ
activity	NN
;	:
the	DT
NF-AT	NN
binding	NN
sites	NNS
showed	VBD
either	CC
no	DT
or	CC
only	RB
weak	JJ
activity	NN
compared	VBN
to	TO
Jurkat	NN
T	NN
cells	NNS
.	.

An	DT
IL-2	NN
promoter	NN
bearing	VBG
a	DT
defective	JJ
NF-chi	NN
B	NN
site	NN
was	VBD
completely	RB
inactive	JJ
in	IN
EBV-transformed	NN
B	NN
cells	NNS
,	,
while	IN
it	PRP
still	RB
had	VBD
activity	NN
in	IN
Jurkat	NN
T	NN
cells	NNS
.	.

In	IN
seven	CD
EBV-B	NN
cell	NN
clones	NNS
or	CC
lines	NNS
differing	VBG
in	IN
their	PRP$
capacity	NN
to	TO
secrete	VB
IL-2	NN
,	,
the	DT
activity	NN
of	IN
the	DT
IL-2	NN
promoter	NN
correlated	VBD
well	RB
with	IN
the	DT
status	NN
of	IN
IL-2	NN
secretion	NN
.	.

Similarly	RB
,	,
a	DT
human	JJ
immunodeficiency	NN
virus	NN
promoter	NN
,	,
whose	WP$
activity	NN
is	VBZ
controlled	VBN
through	IN
chi	NN
B	NN
factors	NNS
,	,
was	VBD
found	VBN
to	TO
be	VB
active	JJ
in	IN
the	DT
IL-2	NN
producing	NN
EBV-B	NN
cells	NNS
,	,
but	CC
inactive	JJ
in	IN
the	DT
non-IL-2-producing	JJ
cells	NNS
.	.

Electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
using	VBG
protein	NN
extracts	NNS
from	IN
EBV-B	NN
cells	NNS
and	CC
the	DT
IL-2	NN
NF-chi	NN
B	NN
probe	NN
revealed	VBD
the	DT
constitutive	JJ
generation	NN
of	IN
chi	NN
B	NN
complexes	NNS
in	IN
IL-2-secreting	NN
cells	NNS
consisting	VBG
mainly	RB
of	IN
heterodimeric	JJ
p50/p65	NN
complexes	NNS
.	.

A	DT
weaker	JJR
chi	NN
B	NN
complex	JJ
formation	NN
and	CC
faster-migrating	JJ
complexes	NNS
were	VBD
detected	VBN
in	IN
non-IL-2-secreting	JJ
cells	NNS
.	.

These	DT
results	NNS
demonstrate	VBP
that	IN
the	DT
IL-2	NN
NF-chi	NN
B	NN
site	NN
is	VBZ
indispensable	JJ
for	IN
the	DT
activity	NN
of	IN
the	DT
IL-2	NN
promoter	NN
in	IN
EBV-transformed	JJ
B	NN
cells	NNS
,	,
whereas	IN
other	JJ
transcription	NN
factors	NNS
appear	VBP
to	TO
be	VB
less	RBR
important	JJ
for	IN
IL-2	NN
expression	NN
in	IN
these	DT
cells	NNS
.	.

UI	LS
-	:
95355533	CD

TI	LS
-	:
Does	VBZ
thyroidectomy	NN
,	,
radioactive	JJ
iodine	NN
therapy	NN
,	,
or	CC
antithyroid	JJ
drug	NN
treatment	NN
alter	VB
reactivity	NN
of	IN
patients	NNS
'	POS
T	NN
cells	NNS
to	TO
epitopes	NNS
of	IN
thyrotropin	NN
receptor	NN
in	IN
autoimmune	JJ
thyroid	NN
diseases	NNS
?	.

AB	LS
-	:
The	DT
effect	NN
of	IN
treatment	NN
on	IN
thyroid	NN
antibody	NN
production	NN
and	CC
T	NN
cell	NN
reactivity	NN
to	TO
thyroid	NN
antigens	NNS
was	VBD
studied	VBN
in	IN
15	CD
patients	NNS
with	IN
Graves	NN
'	POS
disease	NN
(	(
GD	NN
)	)
before	IN
and	CC
after	IN
thyroidectomy	NN
,	,
19	CD
patients	NNS
with	IN
GD	NN
before	IN
and	CC
after	IN
radioactive	JJ
iodine	NN
(	(
RAI	NN
)	)
therapy	NN
,	,
and	CC
9	CD
patients	NNS
maintained	VBD
euthyroid	JJ
on	IN
antithyroid	JJ
drugs	NNS
(	(
ATD	NN
)	)
.	.

Twenty	CD
subjects	NNS
matched	JJ
for	IN
age	NN
and	CC
sex	NN
without	IN
known	JJ
thyroid	NN
disease	NN
served	VBD
as	IN
controls	NNS
.	.

In	IN
GD	NN
patients	NNS
,	,
the	DT
responses	NNS
of	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
(	(
PBMC	NN
)	)
and	CC
TSH	NN
receptor	NN
(	(
TSHR	NN
)	)
-specific	JJ
T	NN
cell	NN
lines	NNS
to	TO
recombinant	JJ
human	JJ
TSHR	NN
extracellular	JJ
domain	NN
,	,
thyroglobulin	NN
,	,
and	CC
TSHR	NN
peptides	NNS
were	VBD
examined	VBN
on	IN
the	DT
day	NN
of	IN
surgery	NN
or	CC
RAI	NN
therapy	NN
(	(
day	NN
0	CD
)	)
and	CC
also	RB
6-8	CD
weeks	NNS
and	CC
3-6	CD
months	NNS
thereafter	RB
.	.

Reactivity	NN
to	TO
TSHR	NN
peptides	NNS
before	IN
surgery	NN
was	VBD
heterogeneous	JJ
and	CC
spanned	VBD
the	DT
entire	JJ
extracellular	JJ
domain	NN
.	.

Six	CD
to	TO
8	CD
weeks	NNS
after	IN
subtotal	JJ
thyroidectomy	NN
,	,
the	DT
number	NN
of	IN
patients	NNS
'	POS
PBMC	NN
responding	VBG
to	TO
any	DT
peptide	NN
and	CC
the	DT
average	JJ
number	NN
of	IN
recognized	VBN
peptides	NNS
decreased	VBD
.	.

A	DT
further	JJ
decrease	NN
in	IN
the	DT
T	NN
cell	NN
reactivity	NN
to	TO
TSHR	NN
peptides	NNS
was	VBD
observed	VBN
3-6	CD
months	NNS
after	IN
surgery	NN
.	.

The	DT
responses	NNS
of	IN
PBMC	NN
from	IN
Graves	NN
'	POS
patients	NNS
before	IN
RAI	NN
therapy	NN
were	VBD
less	JJR
than	IN
those	DT
in	IN
the	DT
presurgical	JJ
group	NN
.	.

Six	CD
to	TO
8	CD
weeks	NNS
after	IN
RAI	NN
therapy	NN
,	,
the	DT
number	NN
of	IN
patients	NNS
responding	VBG
to	TO
any	DT
peptide	NN
and	CC
the	DT
average	JJ
number	NN
of	IN
recognized	VBN
peptides	NNS
increased	VBD
.	.

Three	CD
to	TO
6	CD
months	NNS
after	IN
RAI	NN
,	,
T	NN
cell	NN
responses	NNS
to	TO
TSHR	NN
peptides	NNS
were	VBD
less	JJR
than	IN
those	DT
6-8	CD
weeks	NNS
after	IN
RAI	NN
therapy	NN
,	,
but	CC
still	RB
higher	JJR
than	IN
the	DT
values	NNS
on	IN
day	NN
0	CD
.	.

Responses	NNS
of	IN
PBMC	NN
from	IN
patients	NNS
with	IN
GD	NN
,	,
maintained	VBD
euthyroid	JJ
on	IN
ATD	NN
,	,
were	VBD
lower	JJR
than	IN
those	DT
before	IN
surgery	NN
or	CC
RAI	NN
therapy	NN
.	.

The	DT
reactivity	NN
of	IN
T	NN
cell	NN
lines	NNS
in	IN
different	JJ
groups	NNS
reflected	VBD
a	DT
pattern	NN
similar	JJ
to	TO
PBMC	NN
after	IN
treatment	NN
.	.

TSHR	NN
antibody	NN
and	CC
microsomal	JJ
antibody	NN
levels	NNS
decreased	VBD
after	IN
surgery	NN
,	,
but	CC
increased	VBD
after	IN
RAI	NN
therapy	NN
.	.

The	DT
difference	NN
in	IN
the	DT
number	NN
of	IN
recognized	VBN
peptides	NNS
by	IN
patients	NNS
'	POS
PBMC	NN
before	IN
RAI	NN
and	CC
surgery	NN
may	MD
reflect	VB
the	DT
effect	NN
of	IN
long	JJ
term	NN
therapy	NN
with	IN
ATD	NN
in	IN
the	DT
patients	NNS
before	IN
RAI	NN
vs.	CC
the	DT
shorter	JJR
period	NN
in	IN
patients	NNS
before	IN
surgery	NN
.	.

The	DT
decreased	VBN
T	NN
cell	NN
reactivity	NN
to	TO
thyroid	NN
antigens	NNS
after	IN
thyroidectomy	NN
could	MD
be	VB
the	DT
result	NN
of	IN
removal	NN
of	IN
a	DT
major	JJ
part	NN
of	IN
the	DT
thyroid	NN
gland	NN
or	CC
redistribution	NN
of	IN
suppressor-inducer	JJ
T	NN
cells	NNS
.	.

The	DT
increased	VBN
T	NN
cell	NN
response	NN
after	IN
RAI	NN
therapy	NN
is	VBZ
probably	RB
epitope	NN
specific	JJ
,	,
rather	RB
than	IN
a	DT
response	NN
to	TO
the	DT
whole	JJ
TSHR	NN
molecule	NN
.	.

Synchronous	JJ
recognition	NN
of	IN
peptides	NNS
158-176	CD
and	CC
248-263	CD
is	VBZ
important	JJ
for	IN
the	DT
development	NN
of	IN
GD	NN
,	,
and	CC
the	DT
loss	NN
of	IN
recognition	NN
of	IN
one	CD
of	IN
these	DT
epitopes	NNS
may	MD
be	VB
an	DT
early	JJ
sign	NN
of	IN
immune	JJ
remission	NN
and	CC
a	DT
predictor	NN
of	IN
euthyroidism	NN
.	.

UI	LS
-	:
95286632	CD

TI	LS
-	:
The	DT
transcription	NN
factor	NN
,	,
Nm23H2	NN
,	,
binds	VBZ
to	TO
and	CC
activates	VBZ
the	DT
translocated	VBN
c-myc	NN
allele	NN
in	IN
Burkitt	NN
's	POS
lymphoma	NN
.	.

AB	LS
-	:
We	PRP
have	VBP
identified	VBN
an	DT
in	FW
vivo	FW
footprint	NN
over	IN
the	DT
PuF	NN
site	NN
on	IN
the	DT
translocated	VBN
c-myc	NN
allele	NN
in	IN
Burkitt	NN
's	POS
lymphoma	NN
cells	NNS
.	.

The	DT
PuF	NN
site	NN
on	IN
the	DT
silent	JJ
normal	JJ
c-myc	NN
allele	NN
was	VBD
unoccupied	JJ
.	.

We	PRP
demonstrated	VBD
by	IN
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
,	,
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
with	IN
antibody	NN
,	,
UV	NN
cross-linking	NN
followed	VBN
by	IN
SDS-gel	NN
electrophoresis	NN
,	,
and	CC
Western	NN
analysis	NN
that	IN
Nm23H2	NN
in	IN
B	NN
cell	NN
nuclear	JJ
extracts	NNS
bound	VBD
to	TO
the	DT
c-myc	NN
PuF	NN
site	NN
.	.

Transfection	NN
experiments	NNS
with	IN
c-myc	NN
promoter	NN
constructs	NNS
in	IN
both	CC
DHL-9	NN
and	CC
Raji	NN
cells	NNS
revealed	VBD
that	IN
the	DT
PuF	NN
site	NN
functioned	VBD
as	IN
a	DT
positive	JJ
regulatory	JJ
element	NN
in	IN
B	NN
cells	NNS
with	IN
a	DT
drop	NN
in	IN
activity	NN
with	IN
mutation	NN
of	IN
this	DT
site	NN
.	.

Access	NN
to	TO
this	DT
site	NN
is	VBZ
blocked	VBN
in	IN
the	DT
normal	JJ
silent	JJ
c-myc	NN
allele	NN
;	:
these	DT
data	NNS
suggest	VBP
that	IN
the	DT
Nm23H2	NN
protein	NN
is	VBZ
involved	VBN
in	IN
deregulation	NN
of	IN
the	DT
translocated	VBN
c-myc	NN
allele	NN
in	IN
Burkitt	NN
's	POS
lymphoma	NN
cells	NNS
.	.

UI	LS
-	:
95257963	CD

TI	LS
-	:
Coupling	NN
of	IN
a	DT
signal	NN
response	NN
domain	NN
in	IN
I	NN
kappa	NN
B	NN
alpha	NN
to	TO
multiple	JJ
pathways	NNS
for	IN
NF-kappa	NN
B	NN
activation	NN
.	.

AB	LS
-	:
The	DT
eukaryotic	JJ
transcription	NN
factor	NN
NF-kappa	NN
B	NN
plays	VBZ
a	DT
central	JJ
role	NN
in	IN
the	DT
induced	VBN
expression	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
and	CC
in	IN
many	JJ
aspects	NNS
of	IN
the	DT
genetic	JJ
program	NN
mediating	VBG
normal	JJ
T-cell	NN
activation	NN
and	CC
growth	NN
.	.

The	DT
nuclear	JJ
activity	NN
of	IN
NF-kappa	NN
B	NN
is	VBZ
tightly	RB
regulated	VBN
from	IN
the	DT
cytoplasmic	JJ
compartment	NN
by	IN
an	DT
inhibitory	JJ
subunit	NN
called	VBN
I	NN
kappa	NN
B	NN
alpha	NN
.	.

This	DT
cytoplasmic	JJ
inhibitor	NN
is	VBZ
rapidly	RB
phosphorylated	VBN
and	CC
degraded	VBN
in	IN
response	NN
to	TO
a	DT
diverse	JJ
set	NN
of	IN
NF-kappa	NN
B-inducing	JJ
agents	NNS
,	,
including	VBG
T-cell	NN
mitogens	NNS
,	,
proinflammatory	JJ
cytokines	NNS
,	,
and	CC
viral	JJ
transactivators	NNS
such	JJ
as	IN
the	DT
Tax	NN
protein	NN
of	IN
human	JJ
T-cell	NN
leukemia	NN
virus	NN
type	NN
1	CD
.	.

To	TO
explore	VB
these	DT
I	NN
kappa	NN
B	NN
alpha-dependent	JJ
mechanisms	NNS
for	IN
NF-kappa	NN
B	NN
induction	NN
,	,
we	PRP
identified	VBD
novel	JJ
mutants	NNS
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
that	WDT
uncouple	VBP
its	PRP$
inhibitory	JJ
and	CC
signal-transducing	JJ
functions	NNS
in	IN
human	JJ
T	NN
lymphocytes	NNS
.	.

Specifically	RB
,	,
removal	NN
of	IN
the	DT
N-terminal	JJ
36	CD
amino	NN
acids	NNS
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
failed	VBD
to	TO
disrupt	VB
its	PRP$
ability	NN
to	TO
form	VB
latent	JJ
complexes	NNS
with	IN
NF-kappa	NN
B	NN
in	IN
the	DT
cytoplasm	NN
.	.

However	RB
,	,
this	DT
deletion	NN
mutation	NN
prevented	VBD
the	DT
induced	VBN
phosphorylation	NN
,	,
degradative	JJ
loss	NN
,	,
and	CC
functional	JJ
release	NN
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
from	IN
NF-kappa	NN
B	NN
in	IN
Tax-expressing	JJ
cells	NNS
.	.

Alanine	NN
substitutions	NNS
introduced	VBN
at	IN
two	CD
serine	NN
residues	NNS
positioned	JJ
within	IN
this	DT
N-terminal	JJ
regulatory	JJ
region	NN
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
also	RB
yielded	VBD
constitutive	JJ
repressors	NNS
that	WDT
escaped	VBD
from	IN
Tax-induced	JJ
turnover	NN
and	CC
that	WDT
potently	RB
inhibited	VBD
immune	JJ
activation	NN
pathways	NNS
for	IN
NF-kappa	NN
B	NN
induction	NN
,	,
including	VBG
those	DT
initiated	VBN
from	IN
antigen	NN
and	CC
cytokine	NN
receptors	NNS
.	.

In	IN
contrast	NN
,	,
introduction	NN
of	IN
a	DT
phosphoserine	NN
mimetic	JJ
at	IN
these	DT
sites	NNS
rectified	VBD
this	DT
functional	JJ
defect	NN
,	,
a	DT
finding	NN
consistent	JJ
with	IN
a	DT
causal	JJ
linkage	NN
between	IN
the	DT
phosphorylation	NN
status	NN
and	CC
proteolytic	JJ
stability	NN
of	IN
this	DT
cytoplasmic	JJ
inhibitor	NN
.	.

Together	RB
,	,
these	DT
in	FW
vivo	FW
studies	NNS
define	VBP
a	DT
critical	JJ
signal	NN
response	NN
domain	NN
in	IN
I	NN
kappa	NN
B	NN
alpha	NN
that	WDT
coordinately	RB
controls	VBZ
the	DT
biologic	JJ
activities	NNS
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
and	CC
NF-kappa	NN
B	NN
in	IN
response	NN
to	TO
viral	JJ
and	CC
immune	JJ
stimuli	NNS
.	.

UI	LS
-	:
95325614	CD

TI	LS
-	:
The	DT
activation	NN
of	IN
the	DT
Jak-STAT	JJ
1	CD
signaling	NN
pathway	NN
by	IN
IL-5	NN
in	IN
eosinophils	NNS
.	.

AB	LS
-	:
The	DT
intracellular	JJ
signal	NN
transduction	NN
of	IN
IL-5	NN
in	IN
eosinophils	NNS
is	VBZ
unknown	JJ
.	.

The	DT
objective	NN
of	IN
this	DT
study	NN
was	VBD
to	TO
investigate	VB
the	DT
involvement	NN
of	IN
the	DT
newly	RB
discovered	VBN
Jak-STAT	JJ
pathway	NN
in	IN
the	DT
IL-5	NN
signal	NN
transduction	NN
mechanism	NN
.	.

Eosinophils	NNS
were	VBD
purified	VBN
from	IN
peripheral	JJ
blood	NN
by	IN
discontinuous	JJ
Percoll	NN
gradients	NNS
and	CC
stimulated	VBN
with	IN
IL-5	NN
.	.

The	DT
involvement	NN
of	IN
Jak	NN
2	CD
was	VBD
investigated	VBN
by	IN
immunoprecipitation	NN
followed	VBN
by	IN
immunoblotting	VBG
for	IN
tyrosine	NN
phosphorylation	NN
.	.

The	DT
activation	NN
of	IN
Jak	NN
2	CD
was	VBD
studied	VBN
by	IN
autophosphorylation	NN
of	IN
the	DT
immunoprecipitated	VBN
kinase	NN
.	.

Jak	NN
2	CD
was	VBD
tyrosine	NN
phosphorylated	JJ
within	IN
1	CD
to	TO
3	CD
min	NN
after	IN
stimulation	NN
of	IN
eosinophils	NNS
with	IN
IL-5	NN
.	.

Further	RB
,	,
the	DT
immunoprecipitated	VBN
Jak	NN
2	CD
obtained	VBN
from	IN
IL-5-stimulated	JJ
cells	NNS
underwent	VBD
autophosphorylation	NN
.	.

Jak	NN
2	CD
coprecipitated	VBD
with	IN
the	DT
beta-subunit	NN
of	IN
the	DT
IL-5	NN
receptor	NN
,	,
suggesting	VBG
a	DT
physical	JJ
association	NN
of	IN
the	DT
kinase	NN
with	IN
the	DT
receptor	NN
.	.

The	DT
nuclear	JJ
factor	NN
STAT-1	NN
(	(
p91	NN
)	)
was	VBD
investigated	VBN
by	IN
immunoprecipitation	NN
followed	VBN
by	IN
immunoblotting	VBG
for	IN
tyrosine	NN
phosphorylation	NN
.	.

STAT-1	NN
was	VBD
tyrosine	NN
phosphorylated	JJ
within	IN
15	CD
min	NN
of	IN
IL-5	NN
stimulation	NN
.	.

The	DT
presence	NN
of	IN
STAT-1	NN
in	IN
the	DT
nuclear	JJ
extract	NN
was	VBD
studied	VBN
by	IN
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
.	.

IL-5	NN
induced	VBD
two	CD
proteins	NNS
that	WDT
bound	VBD
to	TO
the	DT
gamma-activating	JJ
sequence	NN
.	.

In	IN
the	DT
presence	NN
of	IN
an	DT
anti-STAT-1	JJ
Ab	NN
,	,
the	DT
band	NN
was	VBD
supershifted	VBN
.	.

Thus	RB
,	,
we	PRP
demonstrated	VBD
that	IN
IL-5	NN
activated	VBD
the	DT
Jak	NN
2-STAT	NN
1	CD
signaling	NN
pathway	NN
in	IN
eosinophils	NNS
.	.

We	PRP
speculate	VBP
that	IN
the	DT
Jak	NN
2-STAT	NN
1	CD
pathway	NN
may	MD
be	VB
involved	VBN
in	IN
the	DT
activation	NN
of	IN
IL-5-inducible	JJ
genes	NNS
in	IN
eosinophils	NNS
.	.

UI	LS
-	:
95074873	CD

TI	LS
-	:
Epstein-Barr	JJ
virus	NN
nuclear	JJ
protein	NN
2	CD
transactivation	NN
of	IN
the	DT
latent	JJ
membrane	NN
protein	NN
1	CD
promoter	NN
is	VBZ
mediated	VBN
by	IN
J	NN
kappa	NN
and	CC
PU.1	NN
.	.

AB	LS
-	:
Expression	NN
of	IN
the	DT
Epstein-Barr	JJ
virus	NN
(	(
EBV	NN
)	)
latent	JJ
membrane	NN
protein	NN
1	CD
(	(
LMP-1	NN
)	)
oncogene	NN
is	VBZ
regulated	VBN
by	IN
the	DT
EBV	NN
nuclear	JJ
protein	NN
2	CD
(	(
EBNA-2	NN
)	)
transactivator	NN
.	.

EBNA-2	NN
is	VBZ
known	VBN
to	TO
interact	VB
with	IN
the	DT
cellular	JJ
DNA-binding	JJ
protein	NN
J	NN
kappa	NN
and	CC
is	VBZ
recruited	VBN
to	TO
promoters	NNS
containing	VBG
the	DT
GTGGGAA	NN
J	NN
kappa	NN
recognition	NN
sequence	NN
.	.

The	DT
minimal	JJ
EBNA-2-responsive	JJ
LMP-1	NN
promoter	NN
includes	VBZ
one	CD
J	NN
kappa-binding	JJ
site	NN
,	,
and	CC
we	PRP
now	RB
show	VBP
that	IN
mutation	NN
of	IN
that	DT
site	NN
,	,
such	JJ
that	IN
J	NN
kappa	NN
can	MD
not	RB
bind	VB
,	,
reduces	VBZ
EBNA-2	NN
responsiveness	NN
by	IN
60	CD
%	NN
.	.

To	TO
identify	VB
other	JJ
factors	NNS
which	WDT
interact	VBP
with	IN
the	DT
LMP-1	NN
EBNA-2	NN
response	NN
element	NN
(	(
E2RE	NN
)	)
,	,
a	DT
-236/-145	JJ
minimal	JJ
E2RE	NN
was	VBD
used	VBN
as	IN
a	DT
probe	NN
in	IN
an	DT
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
.	.

The	DT
previously	RB
characterized	VBN
factors	NNS
J	NN
kappa	NN
,	,
PU.1	NN
,	,
and	CC
AML1	NN
bind	VBP
to	TO
the	DT
LMP-1	NN
E2RE	NN
,	,
along	IN
with	IN
six	CD
other	JJ
unidentified	JJ
factors	NNS
(	(
LBF2	NN
to	TO
LBF7	NN
)	)
.	.

Binding	VBG
sites	NNS
were	VBD
mapped	VBN
for	IN
each	DT
factor	NN
.	.

LBF4	NN
is	VBZ
B-	NN
and	CC
T-cell	NN
specific	JJ
and	CC
recognizes	VBZ
the	DT
PU.1	NN
GGAA	NN
core	NN
sequence	NN
as	IN
shown	VBN
by	IN
methylation	NN
interference	NN
.	.

LBF4	NN
has	VBZ
a	DT
molecular	JJ
mass	NN
of	IN
105	CD
kDa	NN
and	CC
is	VBZ
probably	RB
unrelated	JJ
to	TO
PU.1	NN
.	.

LBF2	NN
was	VBD
found	VBN
only	RB
in	IN
epithelial	JJ
cell	NN
lines	NNS
,	,
whereas	IN
LBF3	NN
,	,
LBF5	NN
,	,
LBF6	NN
,	,
and	CC
LBF7	NN
were	VBD
not	RB
cell	NN
type	NN
specific	JJ
.	.

Mutations	NNS
of	IN
the	DT
AML1-	NN
or	CC
LBF4-binding	JJ
sites	NNS
had	VBD
no	DT
effect	NN
on	IN
EBNA-2	NN
transactivation	NN
,	,
whereas	IN
mutation	NN
of	IN
the	DT
PU.1-binding	JJ
site	NN
completely	RB
eliminated	VBD
EBNA-2	NN
responses	NNS
.	.

A	DT
gst-EBNA-2	NN
fusion	NN
protein	NN
specifically	RB
depleted	VBD
PU.1	NN
from	IN
nuclear	JJ
extracts	NNS
and	CC
bound	VBD
in	FW
vitro	FW
translated	VBN
PU.1	NN
,	,
providing	VBG
biochemical	JJ
evidence	NN
for	IN
a	DT
direct	JJ
EBNA-2-PU.1	JJ
interaction	NN
.	.

Thus	RB
,	,
EBNA-2	NN
transactivation	NN
of	IN
the	DT
LMP-1	NN
promoter	NN
is	VBZ
dependent	JJ
on	IN
interaction	NN
with	IN
at	IN
least	JJS
two	CD
distinct	JJ
sequence-specific	JJ
DNA-binding	JJ
proteins	NNS
,	,
J	NN
kappa	NN
and	CC
PU.1	NN
.	.

LBF3	NN
,	,
LBF5	NN
,	,
LBF6	NN
,	,
or	CC
LBF7	NN
may	MD
also	RB
be	VB
involved	VBN
,	,
since	IN
their	PRP$
binding	VBG
sites	NNS
also	RB
contribute	VBP
to	TO
EBNA-2	NN
responsiveness	NN
.	.

UI	LS
-	:
95053891	CD

TI	LS
-	:
DNA-binding	JJ
studies	NNS
of	IN
the	DT
Epstein-Barr	JJ
virus	NN
nuclear	JJ
antigen	NN
2	CD
(	(
EBNA-2	NN
)	)
:	:
evidence	NN
for	IN
complex	JJ
formation	NN
by	IN
latent	JJ
membrane	NN
protein	NN
gene	NN
promoter-binding	JJ
proteins	NNS
in	IN
EBNA-2-positive	JJ
cell	NN
lines	NNS
.	.

AB	LS
-	:
The	DT
Epstein-Barr	JJ
virus	NN
(	(
EBV	NN
)	)
nuclear	JJ
antigen	NN
2	CD
(	(
EBNA-2	NN
)	)
protein	NN
is	VBZ
essential	JJ
for	IN
the	DT
immortalization	NN
of	IN
human	JJ
primary	JJ
B	NN
cells	NNS
by	IN
EBV	NN
.	.

EBNA-2	NN
trans-activates	VBZ
cellular	JJ
and	CC
viral	JJ
genes	NNS
like	IN
CD23	NN
,	,
c-fgr	NN
,	,
latent	JJ
membrane	NN
protein	NN
1	CD
(	(
LMP1	NN
)	)
and	CC
terminal	JJ
protein	NN
1	CD
(	(
TP1	NN
)	)
.	.

Trans-activation	NN
of	IN
the	DT
TP1	NN
promoter	NN
and	CC
of	IN
the	DT
BamHI	NN
C	NN
promoter	NN
has	VBZ
already	RB
been	VBN
investigated	VBN
in	IN
detail	NN
and	CC
appears	VBZ
to	TO
be	VB
mediated	VBN
via	IN
protein-protein	JJ
interactions	NNS
and	CC
not	RB
by	IN
direct	JJ
binding	NN
of	IN
EBNA-2	NN
type	NN
A	NN
(	(
of	IN
EBV	NN
type	NN
1	CD
)	)
to	TO
the	DT
DNA	NN
.	.

EBNA-2	NN
is	VBZ
able	JJ
to	TO
trans-activate	VB
the	DT
expression	NN
of	IN
the	DT
LMP	NN
gene	NN
in	IN
several	JJ
cell	NN
lines	NNS
.	.

Various	JJ
reports	NNS
have	VBP
delineated	VBN
the	DT
cis-acting	JJ
elements	NNS
of	IN
the	DT
LMP	NN
promoter	NN
through	IN
which	WDT
EBNA-2	NN
mediates	VBZ
trans-activation	NN
.	.

To	TO
determine	VB
whether	IN
EBNA-2	NN
also	RB
trans-activates	VBZ
the	DT
LMP	NN
promoter	NN
by	IN
protein-protein	JJ
interactions	NNS
,	,
we	PRP
performed	VBD
a	DT
series	NN
of	IN
gel	NN
retardation	NN
assays	NNS
and	CC
competition	NN
experiments	NNS
with	IN
LMP	NN
promoter	NN
fragments	NNS
of	IN
different	JJ
sizes	NNS
.	.

We	PRP
determined	VBD
that	IN
the	DT
protein-binding	JJ
region	NN
on	IN
the	DT
LMP	NN
promoter	NN
was	VBD
within	IN
a	DT
42	CD
bp	NN
fragment	NN
encompassing	VBG
nucleotides	NNS
-135	CD
to	TO
-176	CD
relative	JJ
to	TO
the	DT
LMP	NN
transcriptional	JJ
start	NN
site	NN
.	.

None	NN
of	IN
the	DT
DNA	NN
fragments	NNS
investigated	VBN
indicated	VBD
interaction	NN
of	IN
EBNA-2	NN
with	IN
the	DT
DNA	NN
via	IN
protein-protein	JJ
interactions	NNS
.	.

No	DT
significant	JJ
differences	NNS
between	IN
EBNA-2-positive	JJ
and	CC
EBNA-2-negative	JJ
nuclear	JJ
extracts	NNS
could	MD
be	VB
seen	VBN
in	IN
the	DT
gel	NN
retardation	NN
assay	NN
under	IN
conditions	NNS
that	WDT
clearly	RB
showed	VBD
binding	NN
of	IN
EBNA-2A	NN
to	TO
the	DT
TP1	NN
promoter	NN
.	.

However	RB
,	,
analysis	NN
of	IN
sucrose	NN
gradient	NN
fractions	NNS
in	IN
the	DT
gel	NN
retardation	NN
assay	NN
provided	VBD
evidence	NN
that	IN
the	DT
LMP	NN
promoter-binding	JJ
proteins	NNS
form	VBP
a	DT
complex	NN
of	IN
higher	JJR
M(r)	NN
in	IN
EBNA-2-positive	JJ
cell	NN
extracts	NNS
.	.

These	DT
complexes	NNS
were	VBD
destroyed	VBN
by	IN
detergent	NN
.	.

We	PRP
deduce	VBP
from	IN
these	DT
results	NNS
that	IN
EBNA-2-positive	JJ
cells	NNS
might	MD
indeed	RB
contain	VB
specific	JJ
complexes	NNS
bound	VBN
to	TO
the	DT
LMP	NN
promoter	NN
which	WDT
are	VBP
,	,
however	RB
,	,
too	RB
labile	JJ
to	TO
be	VB
detected	VBN
in	IN
a	DT
standard	JJ
gel	NN
retardation	NN
assay	NN
.	.

UI	LS
-	:
95015835	CD

TI	LS
-	:
Simultaneous	JJ
activation	NN
of	IN
Ig	NN
and	CC
Oct-2	NN
synthesis	NN
and	CC
reduction	NN
of	IN
surface	NN
MHC	NN
class	NN
II	CD
expression	NN
by	IN
IL-6	NN
.	.

AB	LS
-	:
Terminal	JJ
differentiation	NN
of	IN
B	NN
cells	NNS
to	TO
plasma	NN
cells	NNS
in	FW
vivo	FW
is	VBZ
characterized	VBN
by	IN
secretion	NN
of	IN
Ig	NN
and	CC
extinction	NN
of	IN
MHC	NN
class	NN
II	CD
expression	NN
on	IN
the	DT
cell	NN
surface	NN
.	.

We	PRP
show	VBP
that	IN
IL-6	NN
signaling	NN
leads	VBZ
to	TO
marked	JJ
increases	NNS
in	IN
the	DT
synthesis	NN
and	CC
secretion	NN
of	IN
Ig	NN
in	IN
clonal	JJ
human	JJ
B	NN
cell	NN
lines	NNS
and	CC
newly	RB
isolated	VBN
polyclonal	JJ
B	NN
lymphocytes	NNS
in	FW
vitro	FW
.	.

The	DT
IL-6-induced	JJ
cells	NNS
resemble	VBP
plasma	NN
cells	NNS
in	IN
ultrastructure	NN
and	CC
in	IN
reduced	VBN
expression	NN
of	IN
surface	NN
MHC	NN
class	NN
II	CD
.	.

Enhanced	VBN
Ig	NN
synthesis	NN
is	VBZ
a	DT
result	NN
of	IN
coordinated	VBN
transcriptional	JJ
activation	NN
of	IN
Ig	NN
genes	NNS
without	IN
promoter	NN
or	CC
isotype	NN
specificity	NN
,	,
and	CC
differential	JJ
accumulation	NN
of	IN
the	DT
mRNA	NN
encoding	VBG
the	DT
secreted	VBN
form	NN
of	IN
Ig	NN
heavy	JJ
chain	NN
.	.

It	PRP
is	VBZ
saturable	JJ
and	CC
subject	JJ
to	TO
negative	JJ
control	NN
when	WRB
IL-6	NN
stimulation	NN
is	VBZ
prolonged	JJ
.	.

Coordinate	JJ
with	IN
temporal	JJ
changes	NNS
in	IN
Ig	NN
synthesis	NN
,	,
the	DT
DNA-binding	JJ
activity	NN
and	CC
the	DT
synthesis	NN
of	IN
the	DT
B	NN
cell-enriched	JJ
transcription	NN
factor	NN
Oct-2	NN
are	VBP
regulated	VBN
.	.

Thus	RB
,	,
differentiation	NN
of	IN
B	NN
cells	NNS
with	IN
IL-6	NN
in	FW
vitro	FW
recapitulates	VBZ
the	DT
hallmarks	NNS
of	IN
terminal	JJ
B	NN
differentiation	NN
in	FW
vivo	FW
;	:
Oct-2	NN
may	MD
have	VB
a	DT
role	NN
in	IN
this	DT
process	NN
.	.

UI	LS
-	:
96126094	CD

TI	LS
-	:
The	DT
number	NN
of	IN
glucocorticoid	NN
receptors	NNS
in	IN
peripheral	JJ
human	JJ
lymphocytes	NNS
is	VBZ
elevated	VBN
by	IN
a	DT
zinc	NN
containing	VBG
trace	NN
element	NN
preparation	NN
.	.

AB	LS
-	:
A	DT
trace	NN
element	NN
preparation	NN
(	(
Beres	NN
Drops	NN
Plus	NN
,	,
BDP	NN
)	)
elevates	VBZ
the	DT
number	NN
of	IN
glucocorticoid	NN
receptors	NNS
(	(
gcR	NN
)	)
in	IN
peripheral	JJ
lymphocytes	NNS
isolated	VBN
both	CC
from	IN
healthy	JJ
blood	NN
donors	NNS
and	CC
rheumatoid	JJ
arthritis	NN
patients	NNS
.	.

This	DT
enhancement	NN
by	IN
BDP	NN
was	VBD
found	VBN
either	CC
for	IN
constitutive	JJ
expression	NN
of	IN
gcRs	NNS
or	CC
in	IN
experiments	NNS
when	WRB
the	DT
lymphocytes	NNS
were	VBD
stimulated	VBN
by	IN
interleukin	NN
(	(
IL	NN
)	)
-6	CD
.	.

There	EX
was	VBD
no	DT
significant	JJ
effect	NN
of	IN
BDP	NN
on	IN
IL-1	NN
and	CC
tumour	NN
necrosis	NN
factor	NN
alpha	NN
(	(
TNF	NN
alpha	NN
)	)
-induced	JJ
changes	NNS
of	IN
gcRs	NNS
.	.

The	DT
effect	NN
of	IN
BDP	NN
was	VBD
greatly	RB
dependent	JJ
on	IN
the	DT
presence	NN
of	IN
Zn++	NN
ions	NNS
in	IN
the	DT
preparation	NN
,	,
since	IN
the	DT
augmenting	VBG
effect	NN
was	VBD
abolished	VBN
if	IN
BDP	NN
did	VBD
not	RB
contain	VB
zinc	NN
.	.

UI	LS
-	:
95199654	CD

TI	LS
-	:
[	(
Regulation	NN
of	IN
transcription	NN
of	IN
the	DT
interleukin-2	NN
gene	NN
in	IN
B-lymphocytes	NNS
]	)

AB	LS
-	:
Since	IN
most	JJS
B	NN
cell	NN
clones	NNS
immortalized	VBN
with	IN
EBV	NN
virus	NN
can	MD
be	VB
induced	VBN
to	TO
produce	VB
interleukin-2	NN
,	,
a	DT
typical	JJ
T	NN
cell	NN
cytokine	NN
,	,
we	PRP
studied	VBD
the	DT
role	NN
of	IN
different	JJ
elements	NNS
of	IN
the	DT
IL-2	NN
promoter	NN
in	IN
such	JJ
clones	NNS
by	IN
transfection	NN
.	.

It	PRP
was	VBD
found	VBN
,	,
in	IN
particular	JJ
,	,
that	IN
the	DT
element	NN
TCEd	NN
,	,
which	WDT
binds	VBZ
the	DT
transcription	NN
factor	NN
NF-kB	NN
,	,
is	VBZ
very	RB
active	JJ
in	IN
all	DT
three	CD
B	NN
clones	NNS
tested	VBN
.	.

This	DT
element	NN
has	VBZ
no	DT
activity	NN
in	IN
T	NN
cells	NNS
of	IN
the	DT
Jurkat	NN
line	NN
.	.

The	DT
NFATd	NN
element	NN
,	,
which	WDT
binds	VBZ
the	DT
transcription	NN
factor	NN
NFAT-1	NN
and	CC
is	VBZ
very	RB
active	JJ
in	IN
T	NN
cells	NNS
,	,
is	VBZ
only	RB
weakly	RB
active	JJ
in	IN
one	CD
B	NN
clone	NN
and	CC
not	RB
at	IN
all	DT
in	IN
another	DT
.	.

Different	JJ
elements	NNS
thus	RB
contribute	VBP
to	TO
IL-2	NN
promoter	NN
activity	NN
in	IN
different	JJ
cells	NNS
.	.

UI	LS
-	:
95166259	CD

TI	LS
-	:
Transcription-independent	JJ
turnover	NN
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
during	IN
monocyte	NN
adherence	NN
:	:
implications	NNS
for	IN
a	DT
translational	JJ
component	NN
regulating	VBG
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
levels	NNS
.	.

AB	LS
-	:
We	PRP
identified	VBD
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
as	IN
an	DT
immediate-early	JJ
gene	NN
in	IN
human	JJ
monocytes	NNS
that	WDT
is	VBZ
expressed	VBN
in	IN
response	NN
to	TO
a	DT
variety	NN
of	IN
signals	NNS
,	,
including	VBG
adhesion	NN
,	,
lipopolysaccharide	NN
,	,
and	CC
phorbol	NN
myristate	NN
acetate	NN
.	.

Within	IN
5	CD
min	NN
of	IN
monocyte	NN
adhesion	NN
,	,
the	DT
level	NN
of	IN
the	DT
I	NN
kappa	NN
B	NN
alpha	NN
protein	NN
is	VBZ
markedly	RB
diminished	VBN
but	CC
is	VBZ
rapidly	RB
replaced	VBN
in	IN
a	DT
cycloheximide-sensitive	JJ
manner	NN
within	IN
20	CD
min	NN
.	.

Accompanying	VBG
the	DT
rapid	JJ
turnover	NN
of	IN
the	DT
I	NN
kappa	NN
B	NN
alpha	NN
protein	NN
is	VBZ
simultaneous	JJ
translocation	NN
of	IN
NF-kappa	NN
B-related	JJ
transcription	NN
factors	NNS
to	TO
nuclei	NNS
of	IN
adhered	JJ
monocytes	NNS
.	.

The	DT
demonstration	NN
that	IN
NF-kappa	NN
B	NN
can	MD
regulate	VB
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
gene	NN
transcription	NN
in	IN
other	JJ
cell	NN
types	NNS
suggested	VBD
that	IN
the	DT
rapid	JJ
increase	NN
in	IN
steady-state	JJ
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
levels	NNS
we	PRP
observed	VBD
within	IN
30	CD
min	NN
of	IN
monocyte	NN
adherence	NN
would	MD
result	VB
from	IN
NF-kappa	NN
B-dependent	JJ
transcriptional	JJ
stimulation	NN
of	IN
the	DT
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
gene	NN
.	.

Nuclear	JJ
run-on	JJ
analyses	NNS
indicated	VBD
that	IN
,	,
instead	RB
,	,
while	IN
several	JJ
immediate-early	JJ
cytokine	NN
genes	NNS
,	,
such	JJ
as	IN
the	DT
interleukin	NN
1	CD
beta	NN
(	(
IL-1	NN
beta	NN
)	)
gene	NN
,	,
were	VBD
transcriptionally	RB
activated	VBN
during	IN
monocyte	NN
adhesion	NN
,	,
the	DT
rate	NN
of	IN
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
gene	NN
transcription	NN
remained	VBD
constant	JJ
.	.

The	DT
adherence-dependent	JJ
increase	NN
in	IN
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
levels	NNS
was	VBD
also	RB
not	RB
a	DT
consequence	NN
of	IN
mRNA	NN
stabilization	NN
events	NNS
.	.

Interestingly	RB
,	,
while	IN
increases	NNS
in	IN
both	CC
IL-1	NN
beta	NN
and	CC
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
levels	NNS
were	VBD
detected	VBN
in	IN
nuclei	NNS
of	IN
adherent	JJ
monocytes	NNS
,	,
cytoplasmic	JJ
levels	NNS
of	IN
IL-1	NN
beta	NN
mRNA	NN
increased	VBN
during	IN
adherence	NN
whereas	IN
those	DT
of	IN
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
did	VBD
not	RB
.	.

Taken	VBN
together	RB
,	,
our	PRP$
data	NNS
suggest	VBP
that	IN
two	CD
interactive	JJ
mechanisms	NNS
regulate	VBP
monocytic	JJ
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
levels	NNS
.	.

We	PRP
propose	VBP
that	IN
adherent	JJ
monocytes	NNS
regulate	VBP
nuclear	JJ
processing	NN
(	(
or	CC
decay	NN
)	)
of	IN
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
,	,
thereby	RB
increasing	VBG
mRNA	NN
levels	NNS
without	IN
stimulating	VBG
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
gene	NN
transcription	NN
.	.

Moreover	RB
,	,
since	IN
inhibition	NN
of	IN
protein	NN
synthesis	NN
leads	VBZ
to	TO
accumulation	NN
of	IN
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
without	IN
stimulating	VBG
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
gene	NN
transcription	NN
,	,
we	PRP
suggest	VBP
that	IN
low	JJ
cytoplasmic	JJ
levels	NNS
of	IN
I	NN
kappa	NN
B	NN
alpha/MAD-3	NN
mRNA	NN
are	VBP
maintained	VBN
by	IN
a	DT
translation-dependent	JJ
degradation	NN
mechanism	NN
.	.

UI	LS
-	:
95124333	CD

TI	LS
-	:
Distinct	JJ
roles	NNS
of	IN
the	DT
molecular	JJ
chaperone	NN
hsp90	NN
in	IN
modulating	VBG
dioxin	NN
receptor	NN
function	NN
via	IN
the	DT
basic	JJ
helix-loop-helix	JJ
and	CC
PAS	NN
domains	NNS
.	.

AB	LS
-	:
The	DT
intracellular	JJ
dioxin	NN
receptor	NN
mediates	VBZ
signal	NN
transduction	NN
by	IN
dioxin	NN
and	CC
functions	VBZ
as	IN
a	DT
ligand-activated	JJ
transcription	NN
factor	NN
.	.

It	PRP
contains	VBZ
a	DT
basic	JJ
helix-loop-helix	JJ
(	(
bHLH	JJ
)	)
motif	NN
contiguous	JJ
with	IN
a	DT
Per-Arnt-Sim	NN
(	(
PAS	NN
)	)
homology	NN
region	NN
.	.

In	IN
extracts	NNS
from	IN
nonstimulated	JJ
cells	NNS
the	DT
receptor	NN
is	VBZ
recovered	VBN
in	IN
an	DT
inducible	JJ
cytoplasmic	JJ
form	NN
associated	VBN
with	IN
the	DT
90-kDa	JJ
heat	NN
shock	NN
protein	NN
(	(
hsp90	NN
)	)
,	,
a	DT
molecular	JJ
chaperone	NN
.	.

We	PRP
have	VBP
reconstituted	VBN
ligand-dependent	JJ
activation	NN
of	IN
the	DT
receptor	NN
to	TO
a	DT
DNA-binding	JJ
form	NN
by	IN
using	VBG
the	DT
dioxin	NN
receptor	NN
and	CC
its	PRP$
bHLH-PAS	JJ
partner	NN
factor	NN
Arnt	NN
expressed	VBN
by	IN
in	FW
vitro	FW
translation	NN
in	IN
reticulocyte	JJ
lysate	NN
.	.

Deletion	NN
of	IN
the	DT
PAS	NN
domain	NN
of	IN
the	DT
receptor	NN
resulted	VBD
in	IN
constitutive	JJ
dimerization	NN
with	IN
Arnt	NN
.	.

In	IN
contrast	NN
,	,
this	DT
receptor	NN
mutant	NN
showed	VBD
low	JJ
levels	NNS
of	IN
xenobiotic	JJ
response	NN
element-binding	JJ
activity	NN
,	,
indicating	VBG
that	IN
the	DT
PAS	NN
domain	NN
may	MD
be	VB
important	JJ
for	IN
DNA-binding	JJ
affinity	NN
and/or	CC
specificity	NN
of	IN
the	DT
receptor	NN
.	.

It	PRP
was	VBD
not	RB
possible	JJ
to	TO
reconstitute	VB
dioxin	NN
receptor	NN
function	NN
with	IN
proteins	NNS
expressed	VBN
in	IN
wheat	NN
germ	NN
lysate	NN
.	.

In	IN
line	NN
with	IN
these	DT
observations	NNS
,	,
reticulocyte	NN
lysate	NN
but	CC
not	RB
wheat	NN
germ	NN
lysate	NN
promoted	VBD
the	DT
association	NN
of	IN
de	FW
novo	FW
synthesized	VBN
dioxin	NN
receptor	NN
with	IN
hsp90	NN
.	.

At	IN
least	JJS
two	CD
distinct	JJ
domains	NNS
of	IN
the	DT
receptor	NN
mediated	VBD
interaction	NN
with	IN
hsp90	NN
:	:
the	DT
ligand-binding	JJ
domain	NN
located	JJ
within	IN
the	DT
PAS	NN
region	NN
and	CC
,	,
surprisingly	RB
,	,
the	DT
bHLH	JJ
domain	NN
.	.

Whereas	IN
ligand-binding	JJ
activity	NN
correlated	VBD
with	IN
association	NN
with	IN
hsp90	NN
,	,
bHLH-hsp90	JJ
interaction	NN
appeared	VBD
to	TO
be	VB
important	JJ
for	IN
DNA-binding	JJ
activity	NN
but	CC
not	RB
for	IN
dimerization	NN
of	IN
the	DT
receptor	NN
.	.

Several	JJ
distinct	JJ
roles	NNS
for	IN
hsp90	NN
in	IN
modulating	VBG
dioxin	NN
receptor	NN
function	NN
are	VBP
therefore	RB
likely	JJ
:	:
correct	JJ
folding	NN
of	IN
the	DT
ligand-binding	JJ
domain	NN
,	,
interference	NN
with	IN
Arnt	NN
heterodimerization	NN
,	,
and	CC
folding	NN
of	IN
a	DT
DNA-binding	JJ
conformation	NN
of	IN
the	DT
bHLH	JJ
domain	NN
.	.

Thus	RB
,	,
the	DT
dioxin	NN
receptor	NN
system	NN
provides	VBZ
a	DT
complex	JJ
and	CC
interesting	JJ
model	NN
of	IN
the	DT
regulation	NN
of	IN
transcription	NN
factors	NNS
by	IN
hsp90	NN
.	.

UI	LS
-	:
95110353	CD

TI	LS
-	:
The	DT
C-terminus	NN
of	IN
the	DT
B	NN
cell	NN
activator	NN
Oct-2	NN
functions	VBZ
as	IN
an	DT
activation	NN
domain	NN
in	IN
yeast	NN
.	.

AB	LS
-	:
Oct-1	NN
and	CC
Oct-2	NN
are	VBP
human	JJ
transcriptional	JJ
activators	NNS
that	WDT
bind	VBP
to	TO
the	DT
same	JJ
DNA	NN
element	NN
but	CC
activate	VBP
distinct	JJ
sets	NNS
of	IN
genes	NNS
.	.

We	PRP
expressed	VBD
these	DT
factors	NNS
in	IN
S.cerevisiae	FW
and	CC
observed	VBD
greater	JJR
than	IN
5-fold	JJ
stimulation	NN
of	IN
a	DT
lacZ	NN
reporter	NN
gene	NN
only	RB
with	IN
Oct-2	NN
.	.

Transfer	NN
of	IN
the	DT
Oct-2	NN
C-terminal	JJ
domain	NN
onto	IN
either	CC
Oct-1	NN
(	(
Oct1.2	NN
)	)
or	CC
a	DT
nonactivating	JJ
DNA-binding	JJ
domain	NN
from	IN
GAL4	NN
created	VBD
activators	NNS
capable	JJ
of	IN
greater	JJR
than	IN
15	CD
and	CC
10-fold	JJ
stimulation	NN
of	IN
activity	NN
,	,
respectively	RB
.	.

Thus	RB
,	,
the	DT
C-terminus	NN
of	IN
Oct-2	NN
is	VBZ
sufficient	JJ
to	TO
confer	VB
activation	NN
potential	NN
to	TO
nonactive	JJ
DNA-binding	JJ
fragments	NNS
in	IN
yeast	NN
.	.

UI	LS
-	:
95072469	CD

TI	LS
-	:
Glucocorticoid-induced	JJ
apoptosis	NN
of	IN
lymphoid	JJ
cells	NNS
.	.

AB	LS
-	:
The	DT
induction	NN
of	IN
cell	NN
death	NN
in	IN
lymphoid	JJ
cells	NNS
by	IN
glucocorticoids	NNS
is	VBZ
one	CD
of	IN
the	DT
earliest	JJS
and	CC
most	JJS
thoroughly	RB
studied	VBN
models	NNS
of	IN
apoptosis	NN
.	.

Although	IN
the	DT
exact	JJ
mechanism	NN
by	IN
which	WDT
apoptosis	NN
occurs	VBZ
in	IN
lymphocytes	NNS
is	VBZ
unknown	JJ
many	JJ
biochemical	JJ
and	CC
molecular	JJ
changes	NNS
have	VBP
been	VBN
shown	VBN
to	TO
occur	VB
in	IN
these	DT
cells	NNS
in	IN
response	NN
to	TO
glucocorticoids	NNS
.	.

The	DT
role	NN
of	IN
chromatin	NN
degradation	NN
and	CC
endonucleases	NNS
in	IN
the	DT
apoptotic	JJ
process	NN
has	VBZ
been	VBN
closely	RB
studied	VBN
,	,
as	RB
well	RB
as	IN
the	DT
involvement	NN
of	IN
several	JJ
oncogenes	NNS
in	IN
glucocorticoid-induced	JJ
cell	NN
lysis	NN
.	.

In	IN
addition	NN
,	,
the	DT
clinical	JJ
importance	NN
of	IN
glucocorticoid-induced	JJ
apoptosis	NN
in	IN
the	DT
treatment	NN
of	IN
lymphoid	JJ
neoplasms	NNS
has	VBZ
recently	RB
received	VBN
increased	VBN
attention	NN
.	.

UI	LS
-	:
95021266	CD

TI	LS
-	:
Human	JJ
T-cell	NN
leukemia	NN
virus	NN
type	NN
I	CD
Tax	NN
activation	NN
of	IN
NF-kappa	NN
B/Rel	NN
involves	VBZ
phosphorylation	NN
and	CC
degradation	NN
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
and	CC
RelA	NN
(	(
p65	NN
)	)
-mediated	JJ
induction	NN
of	IN
the	DT
c-rel	JJ
gene	NN
.	.

AB	LS
-	:
The	DT
tax	NN
gene	NN
product	NN
of	IN
human	JJ
T-cell	NN
leukemia	NN
virus	NN
type	NN
I	CD
(	(
HTLV-I	NN
)	)
is	VBZ
a	DT
potent	JJ
transcriptional	JJ
activator	NN
that	WDT
both	CC
stimulates	VBZ
viral	JJ
gene	NN
expression	NN
and	CC
activates	VBZ
an	DT
array	NN
of	IN
cellular	JJ
genes	NNS
involved	VBN
in	IN
T-cell	NN
growth	NN
.	.

Tax	NN
acts	VBZ
indirectly	RB
by	IN
inducing	VBG
or	CC
modifying	VBG
the	DT
action	NN
of	IN
various	JJ
host	NN
transcription	NN
factors	NNS
,	,
including	VBG
members	NNS
of	IN
the	DT
NF-kappa	NN
B/Rel	NN
family	NN
of	IN
enhancer-binding	JJ
proteins	NNS
.	.

In	IN
resting	VBG
T	NN
cells	NNS
,	,
many	JJ
of	IN
these	DT
NF-kappa	NN
B/Rel	NN
factors	NNS
are	VBP
sequestered	VBN
in	IN
the	DT
cytoplasm	NN
by	IN
various	JJ
ankyrin-rich	JJ
inhibitory	JJ
proteins	NNS
,	,
including	VBG
I	NN
kappa	NN
B	NN
alpha	NN
.	.

HTLV-I	NN
Tax	NN
expression	NN
leads	VBZ
to	TO
the	DT
constitutive	JJ
nuclear	JJ
expression	NN
of	IN
biologically	RB
active	JJ
NF-kappa	NN
B	NN
and	CC
c-Rel	NN
complexes	NNS
;	:
however	RB
,	,
the	DT
biochemical	JJ
mechanism	NN
(	(
s	NNS
)	)
underlying	VBG
this	DT
response	NN
remains	VBZ
poorly	RB
understood	VBN
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
demonstrate	VBP
that	IN
Tax-stimulated	JJ
nuclear	JJ
expression	NN
of	IN
NF-kappa	NN
B	NN
in	IN
both	CC
HTLV-I-infected	JJ
and	CC
Tax-transfected	JJ
human	JJ
T	NN
cells	NNS
is	VBZ
associated	VBN
with	IN
the	DT
phosphorylation	NN
and	CC
rapid	JJ
proteolytic	JJ
degradation	NN
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
.	.

In	IN
contrast	NN
to	TO
prior	JJ
in	FW
vitro	FW
studies	NNS
,	,
at	IN
least	JJS
a	DT
fraction	NN
of	IN
the	DT
phosphorylated	JJ
form	NN
of	IN
I	NN
kappa	NN
B	NN
alpha	NN
remains	VBZ
physically	RB
associated	VBN
with	IN
the	DT
NF-kappa	NN
B	NN
complex	NN
in	FW
vivo	FW
but	CC
is	VBZ
subject	JJ
to	TO
rapid	JJ
degradation	NN
,	,
thereby	RB
promoting	VBG
the	DT
nuclear	JJ
translocation	NN
of	IN
the	DT
active	JJ
NF-kappa	NN
B	NN
complex	NN
.	.

We	PRP
further	RB
demonstrate	VBP
that	IN
Tax	NN
induction	NN
of	IN
nuclear	JJ
c-Rel	NN
expression	NN
is	VBZ
activated	VBN
by	IN
the	DT
RelA	NN
(	(
p65	NN
)	)
subunit	NN
of	IN
NF-kappa	NN
B	NN
,	,
which	WDT
activates	VBZ
transcription	NN
of	IN
the	DT
c-rel	JJ
gene	NN
through	IN
an	DT
intrinsic	JJ
kappa	NN
B	NN
enhancer	NN
element	NN
.	.

In	IN
normal	JJ
cells	NNS
,	,
the	DT
subsequent	JJ
accumulation	NN
of	IN
nuclear	JJ
c-Rel	NN
acts	VBZ
to	TO
inhibit	VB
its	PRP$
own	JJ
continued	JJ
production	NN
,	,
indicating	VBG
the	DT
presence	NN
of	IN
an	DT
autoregulatory	JJ
loop	NN
.	.

(	(
ABSTRACT	NN
TRUNCATED	VBN
AT	IN
250	CD
WORDS	NNS
)	)

UI	LS
-	:
95311627	CD

TI	LS
-	:
Physiological	JJ
concentration	NN
of	IN
estradiol	NN
inhibits	VBZ
polymorphonuclear	JJ
leukocyte	NN
chemotaxis	NN
via	IN
a	DT
receptor	NN
mediated	JJ
system	NN
.	.

AB	LS
-	:
Estrogen	NN
exhibits	VBZ
a	DT
variety	NN
of	IN
actions	NNS
,	,
including	VBG
immuno-modulatory	JJ
effects	NNS
,	,
in	FW
vivo	FW
and	CC
in	FW
vitro	FW
.	.

The	DT
mechanism	NN
by	IN
which	WDT
estrogen	NN
exerts	VBZ
its	PRP$
anti-inflammatory	JJ
effect	NN
is	VBZ
not	RB
yet	RB
understood	VBN
.	.

We	PRP
investigated	VBD
the	DT
possible	JJ
mechanisms	NNS
of	IN
estradiol	NN
acting	VBG
via	IN
the	DT
polymorphonuclear	JJ
leukocytes	NNS
(	(
PMNs	NNS
)	)
,	,
which	WDT
are	VBP
important	JJ
in	IN
the	DT
immune	JJ
response	NN
.	.

The	DT
agent	NN
,	,
17	CD
beta-estradiol	NN
,	,
but	CC
not	RB
17	CD
alpha-estradiol	NN
,	,
significantly	RB
reduced	VBD
PMNs	NNS
chemotaxis	NN
to	TO
FMLP	NN
in	IN
a	DT
dose-dependent	JJ
manner	NN
(	(
control	NN
vs	CC
estrogen	NN
10(-10)-(-6)	CD
M	NN
,	,
P	NN
<	JJR
0.05	CD
)	)
.	.

Physiological	JJ
concentrations	NNS
of	IN
estradiol	NN
significantly	RB
reduced	VBD
the	DT
chemotaxis	NN
of	IN
PMNs	NNS
(	(
10(-10)	CD
mol	NN
)	)
.	.

Pre-incubation	NN
with	IN
clomiphene	NN
or	CC
tamoxifen	NN
which	WDT
are	VBP
estrogen	NN
receptor	NN
antagonists	NNS
,	,
eliminated	VBD
the	DT
inhibitory	JJ
effect	NN
of	IN
17	CD
beta-estradiol	NN
on	IN
the	DT
chemotaxis	NN
of	IN
PMNs	NNS
,	,
restoring	VBG
it	PRP
to	TO
the	DT
control	JJ
level	NN
.	.

These	DT
observations	NNS
suggest	VBP
that	IN
17	CD
beta-estradiol	NN
suppressed	VBD
the	DT
chemotaxis	NN
of	IN
PMNs	NNS
by	IN
a	DT
receptor-dependent	JJ
mechanism	NN
.	.

In	IN
addition	NN
,	,
the	DT
level	NN
of	IN
estradiol	NN
in	IN
human	JJ
plasma	NN
,	,
which	WDT
PMNs	NNS
were	VBD
drawn	VBN
,	,
showed	VBD
a	DT
close	JJ
,	,
inverse	JJ
correlation	NN
with	IN
the	DT
PMNs	NNS
chemotaxis	NN
to	TO
FMLP	NN
(	(
r	NN
=	JJ
-0.821	CD
p	NN
<	JJR
0.001	CD
)	)
.	.

Estrogen	NN
may	MD
modify	VB
the	DT
activity	NN
of	IN
neutrophils	NNS
during	IN
the	DT
normal	JJ
menstrual	JJ
cycle	NN
,	,
not	RB
only	RB
during	IN
pregnancy	NN
,	,
and	CC
influence	NN
inflammation	NN
.	.

UI	LS
-	:
95173590	CD

TI	LS
-	:
Calcium/calmodulin-dependent	JJ
protein	NN
kinase	NN
II	CD
downregulates	VBZ
both	CC
calcineurin	NN
and	CC
protein	NN
kinase	NN
C-mediated	JJ
pathways	NNS
for	IN
cytokine	NN
gene	NN
transcription	NN
in	IN
human	JJ
T	NN
cells	NNS
.	.

AB	LS
-	:
Engagement	NN
of	IN
the	DT
T	NN
cell	NN
receptor	NN
for	IN
antigen	NN
activates	VBZ
phospholipase	NN
C	NN
resulting	VBG
in	IN
an	DT
increase	NN
in	IN
intracellular	JJ
free	JJ
calcium	NN
concentration	NN
(	(
[Ca2+]i	NN
)	)
and	CC
activation	NN
of	IN
protein	NN
kinase	NN
C	NN
(	(
PKC	NN
)	)
.	.

Increased	VBN
[Ca2+]i	NN
activates	VBZ
Ca2+/calmodulin-dependent	JJ
kinases	NNS
including	VBG
the	DT
multifunctional	JJ
Ca2+/calmodulin-dependent	JJ
protein	NN
kinase	NN
II	CD
(	(
CaM-K	NN
II	CD
)	)
,	,
as	RB
well	RB
as	IN
calcineurin	NN
,	,
a	DT
type	NN
2B	NN
protein	NN
phosphatase	NN
.	.

Recent	JJ
studies	NNS
have	VBP
identified	VBN
calcineurin	NN
as	IN
a	DT
key	JJ
enzyme	NN
for	IN
interleukin	NN
(	(
IL	NN
)	)
-2	CD
and	CC
IL-4	NN
promoter	NN
activation	NN
.	.

However	RB
,	,
the	DT
role	NN
of	IN
CaM-K	NN
II	CD
remains	VBZ
unknown	JJ
.	.

We	PRP
have	VBP
used	VBN
mutants	NNS
of	IN
these	DT
kinases	NNS
and	CC
phosphatases	NNS
(	(
gamma	NN
B*CaM-K	NN
and	CC
delta	NN
CaM-AI	NN
,	,
respectively	RB
)	)
to	TO
explore	VB
their	PRP$
relative	JJ
role	NN
in	IN
cytokine	NN
gene	NN
transcription	NN
and	CC
their	PRP$
interactions	NNS
with	IN
PKC-dependent	JJ
signaling	NN
systems	NNS
.	.

gamma	NN
B*CaM-K	NN
and	CC
delta	NN
CaM-AI	NN
,	,
known	VBN
to	TO
exhibit	VB
constitutive	JJ
Ca(2+)-independent	JJ
activity	NN
,	,
were	VBD
cotransfected	VBN
(	(
alone	RB
or	CC
in	IN
combination	NN
)	)
in	IN
Jurkat	NN
T	NN
cells	NNS
with	IN
a	DT
plasmid	NN
containing	VBG
the	DT
intact	JJ
IL-2	NN
promoter	NN
driving	VBG
the	DT
expression	NN
of	IN
the	DT
chloramphenicol	NN
acetyltransferase	NN
reporter	NN
gene	NN
.	.

Cotransfection	NN
of	IN
gamma	NN
B*CaM-K	NN
with	IN
the	DT
IL-2	NN
promoter	NN
construct	NN
downregulated	VBD
its	PRP$
transcription	NN
in	IN
response	NN
to	TO
stimulation	NN
with	IN
ionomycin	NN
and	CC
phorbol	NN
myristate	NN
acetate	NN
(	(
PMA	NN
)	)
.	.

The	DT
inhibitory	JJ
effect	NN
of	IN
CaM-K	NN
II	CD
on	IN
IL-2	NN
promoter	NN
was	VBD
associated	VBN
with	IN
decreased	VBN
transcription	NN
of	IN
its	PRP$
AP-1	NN
and	CC
NF-AT	NN
transactivating	NN
pathways	NNS
.	.

Under	IN
the	DT
same	JJ
conditions	NNS
,	,
delta	NN
CaM-AI	NN
superinduced	VBD
IL-2	NN
promoter	NN
activity	NN
(	(
approximately	RB
twofold	JJ
increase	NN
)	)
.	.

When	WRB
both	DT
mutants	NNS
were	VBD
used	VBN
in	IN
combination	NN
,	,
gamma	NN
B*CaM-K	NN
inhibited	VBD
the	DT
induction	NN
of	IN
the	DT
IL-2	NN
promoter	NN
by	IN
delta	NN
CaM-AI	NN
.	.

Similar	JJ
results	NNS
were	VBD
obtained	VBN
when	WRB
a	DT
construct	NN
containing	VBG
the	DT
IL-4	NN
promoter	NN
also	RB
was	VBD
used	VBN
.	.

gamma	NN
B*CaM-K	NN
also	RB
downregulated	VBD
the	DT
activation	NN
of	IN
AP-1	NN
in	IN
response	NN
to	TO
transfection	NN
with	IN
a	DT
constitutively	RB
active	JJ
mutant	NN
of	IN
PKC	NN
or	CC
stimulation	NN
with	IN
PMA	NN
.	.

These	DT
results	NNS
suggest	VBP
that	IN
CaM-K	NN
II	CD
may	MD
exert	VB
negative	JJ
influences	NNS
on	IN
cytokine	NN
gene	NN
transcription	NN
in	IN
human	JJ
T	NN
cells	NNS
,	,
and	CC
provide	VBP
preliminary	JJ
evidence	NN
for	IN
negative	JJ
cross-talk	NN
with	IN
the	DT
calcineurin-	NN
and	CC
PKC-dependent	JJ
signaling	NN
systems	NNS
.	.

UI	LS
-	:
95166264	CD

TI	LS
-	:
Regulation	NN
of	IN
cell-type-specific	JJ
interleukin-2	NN
receptor	NN
alpha-chain	NN
gene	NN
expression	NN
:	:
potential	JJ
role	NN
of	IN
physical	JJ
interactions	NNS
between	IN
Elf-1	NN
,	,
HMG-I(Y)	NN
,	,
and	CC
NF-kappa	NN
B	NN
family	NN
proteins	NNS
.	.

AB	LS
-	:
The	DT
interleukin	NN
2	CD
receptor	NN
alpha-chain	NN
(	(
IL-2R	NN
alpha	NN
)	)
gene	NN
is	VBZ
rapidly	RB
and	CC
potently	RB
induced	VBN
in	IN
T	NN
cells	NNS
in	IN
response	NN
to	TO
mitogenic	JJ
stimuli	NNS
.	.

Previously	RB
,	,
an	DT
inducible	JJ
enhancer	NN
between	IN
nucleotides	NNS
-299	CD
and	CC
-228	CD
that	WDT
contains	VBZ
NF-kappa	NN
B	NN
and	CC
CArG	NN
motifs	NNS
was	VBD
identified	VBN
.	.

We	PRP
now	RB
report	VBP
the	DT
characterization	NN
of	IN
a	DT
second	JJ
essential	JJ
positive	JJ
regulatory	JJ
element	NN
located	JJ
between	IN
nucleotides	NNS
-137	CD
and	CC
-64	CD
that	WDT
binds	VBZ
Elf-1	NN
and	CC
HMG-I(Y)	NN
.	.

This	DT
element	NN
had	VBD
maximal	JJ
activity	NN
in	IN
lymphoid	JJ
cells	NNS
,	,
paralleling	VBG
the	DT
cell	NN
type	NN
specificity	NN
of	IN
Elf-1	NN
expression	NN
.	.

Transcription	NN
from	IN
the	DT
IL-2R	NN
alpha	NN
promoter	NN
was	VBD
inhibited	VBN
when	WRB
either	CC
the	DT
Elf-1	NN
or	CC
the	DT
HMG-I(Y)	NN
binding	NN
site	NN
was	VBD
mutated	VBN
.	.

Coexpression	NN
of	IN
both	DT
proteins	NNS
activated	VBD
transcription	NN
of	IN
the	DT
-137	CD
to	TO
-64	CD
element	NN
in	IN
COS-7	NN
cells	NNS
.	.

Elf-1	NN
physically	RB
associated	VBD
with	IN
HMG-I	NN
and	CC
with	IN
NF-kappa	NN
B	NN
p50	NN
and	CC
c-Rel	NN
in	FW
vitro	FW
,	,
suggesting	VBG
that	IN
protein-protein	JJ
interactions	NNS
might	MD
functionally	RB
coordinate	VB
the	DT
actions	NNS
of	IN
the	DT
upstream	JJ
and	CC
downstream	JJ
positive	JJ
regulatory	JJ
elements	NNS
.	.

This	DT
is	VBZ
the	DT
first	JJ
report	NN
of	IN
a	DT
physical	JJ
interaction	NN
between	IN
an	DT
Ets	NN
family	NN
member	NN
and	CC
NF-kappa	NN
B	NN
family	NN
proteins	NNS
.	.

These	DT
findings	NNS
provide	VBP
significant	JJ
new	JJ
insights	NNS
into	IN
the	DT
protein-protein	JJ
and	CC
protein-DNA	JJ
interactions	NNS
that	WDT
regulate	VBP
cell-type-specific	JJ
and	CC
inducible	JJ
IL-2R	NN
alpha	NN
gene	NN
expression	NN
and	CC
also	RB
have	VBP
implications	NNS
for	IN
other	JJ
genes	NNS
regulated	VBN
by	IN
Elf-1	NN
and	CC
NF-kappa	NN
B	NN
family	NN
proteins	NNS
.	.

UI	LS
-	:
95053740	CD

TI	LS
-	:
One	CD
gene	NN
,	,
two	CD
transcripts	NNS
:	:
isolation	NN
of	IN
an	DT
alternative	JJ
transcript	NN
encoding	VBG
for	IN
the	DT
autoantigen	NN
La/SS-B	NN
from	IN
a	DT
cDNA	NN
library	NN
of	IN
a	DT
patient	NN
with	IN
primary	JJ
Sjogrens	NN
'	POS
syndrome	NN
.	.

AB	LS
-	:
A	DT
cDNA	NN
library	NN
was	VBD
prepared	VBN
from	IN
peripheral	JJ
blood	NN
lymphocytes	NNS
of	IN
an	DT
autoimmune	JJ
patient	NN
with	IN
primary	JJ
Sjogrens	NN
'	POS
syndrome	NN
.	.

The	DT
cDNA	NN
library	NN
was	VBD
screened	VBN
with	IN
the	DT
patients	NNS
own	JJ
autoimmune	JJ
serum	NN
being	VBG
monospecific	JJ
for	IN
the	DT
nuclear	JJ
autoantigen	NN
La/SS-B	NN
.	.

Thereby	RB
an	DT
alternative	JJ
type	NN
of	IN
La	NN
mRNA	NN
was	VBD
identified	VBN
that	WDT
differed	VBD
from	IN
the	DT
known	JJ
La	NN
mRNA	NN
due	JJ
to	TO
an	DT
exchange	NN
of	IN
the	DT
exon	NN
1	CD
.	.

Sequencing	NN
of	IN
the	DT
genomic	JJ
region	NN
between	IN
the	DT
exons	NNS
1	CD
and	CC
2	CD
showed	VBD
that	IN
the	DT
alternative	JJ
5'-end	NN
is	VBZ
a	DT
part	NN
of	IN
the	DT
intron	NN
.	.

In	IN
addition	NN
,	,
the	DT
presence	NN
of	IN
an	DT
alternative	JJ
promoter	NN
site	NN
,	,
which	WDT
exists	VBZ
within	IN
the	DT
intron	NN
downstream	JJ
of	IN
the	DT
exon	NN
1	CD
,	,
became	VBD
evident	JJ
.	.

In	IN
consequence	NN
,	,
the	DT
alternative	JJ
La	NN
mRNA	NN
is	VBZ
the	DT
result	NN
of	IN
a	DT
promoter	NN
switching	NN
combined	VBN
with	IN
an	DT
alternative	JJ
splicing	NN
mechanism	NN
.	.

In	IN
the	DT
intron	NN
,	,
further	JJ
transcription	NN
factor	NN
binding	NN
sites	NNS
,	,
including	VBG
a	DT
NF-kappa	NN
B	NN
element	NN
,	,
were	VBD
identified	VBN
leading	VBG
to	TO
the	DT
suggestion	NN
that	IN
the	DT
expression	NN
of	IN
the	DT
gene	NN
encoding	VBG
for	IN
the	DT
nuclear	JJ
autoantigen	NN
La/SS-B	NN
alters	VBZ
in	IN
dependence	NN
on	IN
disease	NN
conditions	NNS
.	.

UI	LS
-	:
95152321	CD

TI	LS
-	:
1,25-Dihydroxyvitamin	NN
D3	NN
receptors	NNS
in	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
from	IN
patients	NNS
with	IN
primary	JJ
and	CC
secondary	JJ
hyperparathyroidism	NN
.	.

AB	LS
-	:
A	DT
decreased	VBN
number	NN
of	IN
calcitriol	NN
(	(
1,25(OH)2D3	NN
)	)
receptors	NNS
has	VBZ
been	VBN
observed	VBN
in	IN
parathyroid	JJ
glands	NNS
of	IN
uremic	JJ
animals	NNS
.	.

In	IN
humans	NNS
,	,
studies	NNS
carried	VBN
out	RP
in	IN
surgically	RB
removed	VBN
parathyroid	JJ
glands	NNS
have	VBP
shown	VBN
that	IN
calcitriol	NN
binding	NN
is	VBZ
higher	JJR
in	IN
primary	JJ
than	IN
in	IN
secondary	JJ
hyperparathyroidism	NN
.	.

Since	IN
specific	JJ
receptors	NNS
for	IN
calcitriol	NN
have	VBP
been	VBN
described	VBN
in	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
(	(
PBMC	NN
)	)
,	,
we	PRP
have	VBP
investigated	VBN
the	DT
specific	JJ
uptake	NN
of	IN
3H-labelled	JJ
1,25(OH)2D3	NN
in	IN
PBMC	NN
of	IN
12	CD
women	NNS
with	IN
primary	JJ
hyperparathyroidism	NN
(	(
PHP	NN
)	)
,	,
8	CD
women	NNS
with	IN
hyperparathyroidism	NN
secondary	JJ
to	TO
chronic	JJ
renal	JJ
failure	NN
(	(
SH	NN
)	)
,	,
9	CD
women	NNS
with	IN
renal	JJ
transplant	NN
(	(
RT	NN
)	)
,	,
and	CC
23	CD
healthy	JJ
women	NNS
.	.

The	DT
median	JJ
dissociation	NN
constant	NN
(	(
Kd	NN
)	)
was	VBD
similar	JJ
in	IN
all	DT
three	CD
groups	NNS
of	IN
patients	NNS
and	CC
in	IN
healthy	JJ
women	NNS
(	(
mean	NN
+/-	CC
S.D.	NN
(	(
range	NN
)	)
:	:
PHP	NN
,	,
1.2	CD
+/-	CC
1.0	CD
(	(
0.2-4	CD
)	)
x	CC
10(-10)	CD
M	NN
;	:
SH	NN
,	,
0.6	CD
+/-	CC
0.4	CD
(	(
0.2-1.2	CD
)	)
x	CC
10(-10)	CD
M	NN
;	:
RT	NN
,	,
1.1	CD
+/-	CC
0.5	CD
(	(
0.4-1.9	CD
)	)
x	CC
10(-10)	CD
M	NN
;	:
controls	NNS
,	,
1.0	CD
+/-	CC
0.6	CD
(	(
0.3-2.6	CD
)	)
x	CC
10(-10)	CD
M	NN
)	)
.	.
However	RB
,	,
the	DT
maximal	JJ
binding	NN
capacity	NN
(	(
Nmax	NN
)	)
was	VBD
significantly	RB
enhanced	VBN
in	IN
PHP	NN
(	(
3.9	CD
+/-	CC
1.9	CD
(	(
1.3-7.6	CD
)	)
fmol/10(7)	NN
cells	NNS
vs.	CC
2.3	CD
+/-	CC
0.9	CD
(	(
1.1-4.4	CD
)	)
fmol/10(7)	NN
cells	NNS
in	IN
controls	NNS
;	:
P	NN
=	JJ
0.0006	CD
)	)
and	CC
decreased	VBN
in	IN
SH	NN
(	(
0.8	CD
+/-	CC
0.5	CD
(	(
0.2-1.6	CD
)	)
fmol/10(7)	NN
cells	NNS
vs.	CC
2.3	CD
+/-	CC
0.9	CD
(	(
1.1-4.4	CD
)	)
fmol/10(7)	NN
cells	NNS
in	IN
controls	NNS
;	:
P	NN
=	JJ
0.0001	CD
)	)
,	,
whereas	IN
no	DT
changes	NNS
were	VBD
seen	VBN
in	IN
RT	NN
(	(
2.3	CD
+/-	CC
0.7	CD
(	(
1.2-3.3	CD
)	)
fmol/10(7)	NN
cells	NNS
vs.	CC
2.3	CD
+/-	CC
0.9	CD
(	(
1.1-4.4	CD
)	)
fmol/10(7)	NN
cells	NNS
in	IN
controls	NNS
)	)
.	.

In	IN
three	CD
patients	NNS
with	IN
PHP	NN
who	WP
were	VBD
subjected	VBN
to	TO
parathyroidectomy	NN
,	,
the	DT
calcitriol	NN
number	NN
came	VBD
down	RB
to	TO
normal	JJ
.	.

Changes	NNS
of	IN
calcitriol	NN
receptors	NNS
in	IN
primary	JJ
and	CC
secondary	JJ
hyperparathyroidism	NN
could	MD
magnify	VB
the	DT
consequences	NNS
of	IN
disturbances	NNS
in	IN
serum	NN
concentration	NN
of	IN
calcitriol	NN
itself	PRP
and	CC
might	MD
play	VB
an	DT
important	JJ
role	NN
in	IN
the	DT
development	NN
of	IN
secondary	JJ
hyperparathyroidism	NN
in	IN
uremia	NN
.	.

UI	LS
-	:
94365323	CD

TI	LS
-	:
Signals	NNS
and	CC
nuclear	JJ
factors	NNS
that	WDT
regulate	VBP
the	DT
expression	NN
of	IN
interleukin-4	NN
and	CC
interleukin-5	NN
genes	NNS
in	IN
helper	NN
T	NN
cells	NNS
.	.

AB	LS
-	:
Mouse	NN
thymoma	NN
line	NN
EL-4	NN
cells	NNS
produce	VBP
cytokines	NNS
such	JJ
as	IN
interleukin	NN
(	(
IL	NN
)	)
-2	CD
,	,
IL-3	NN
,	,
IL-4	NN
,	,
IL-10	NN
,	,
and	CC
granulocyte-macrophage	JJ
colony-stimulating	JJ
factor	NN
in	IN
response	NN
to	TO
phorbol	NN
12-myristate	NN
13-acetate	NN
(	(
PMA	NN
)	)
.	.

EL-4	NN
cells	NNS
also	RB
produce	VBP
low	JJ
levels	NNS
of	IN
IL-5	NN
when	WRB
stimulated	VBN
by	IN
PMA	NN
alone	RB
;	:
however	RB
,	,
cAMP	NN
greatly	RB
augments	VBZ
PMA-dependent	JJ
IL-5	NN
production	NN
.	.

A	DT
transient	JJ
transfection	NN
assay	NN
revealed	VBD
that	IN
two	CD
signals	NNS
,	,
PMA	NN
and	CC
cAMP	NN
,	,
are	VBP
required	VBN
for	IN
optimal	JJ
activation	NN
of	IN
the	DT
IL-5	NN
promoter	NN
.	.

In	IN
contrast	NN
,	,
cAMP	NN
almost	RB
completely	RB
inhibited	VBD
the	DT
PMA-dependent	JJ
activation	NN
of	IN
the	DT
endogenous	JJ
IL-2	NN
gene	NN
,	,
as	RB
well	RB
as	IN
the	DT
transfected	VBN
IL-2	NN
promoter	NN
.	.

These	DT
results	NNS
indicate	VBP
that	IN
the	DT
IL-5	NN
gene	NN
is	VBZ
positively	RB
regulated	VBN
by	IN
cAMP	NN
in	IN
a	DT
manner	NN
opposite	JJ
to	TO
that	DT
for	IN
the	DT
IL-2	NN
gene	NN
.	.

One	CD
of	IN
the	DT
nuclear	JJ
factors	NNS
(	(
NFs	NNS
)	)
that	WDT
regulates	VBZ
the	DT
response	NN
of	IN
the	DT
IL-5	NN
promoter	NN
to	TO
cAMP	NN
and	CC
PMA	NN
has	VBZ
properties	NNS
similar	JJ
to	TO
NF	NN
for	IN
activated	VBN
t	NN
cell	NN
.	.

The	DT
P	NN
sequence	NN
of	IN
the	DT
IL-4	NN
gene	NN
,	,
defined	VBN
as	IN
a	DT
responsive	JJ
element	NN
for	IN
PMA	NN
and	CC
calcium	NN
ionophore	NN
(	(
A23187	NN
)	)
,	,
shares	VBZ
sequence	NN
similarity	NN
with	IN
the	DT
NF	NN
kappa	NN
B	NN
and	CC
the	DT
NF-activated	JJ
T	NN
cell	NN
binding	NN
sites	NNS
.	.

We	PRP
attempted	VBD
to	TO
determine	VB
whether	IN
NF(P)	NN
,	,
a	DT
nuclear	JJ
factor	NN
specific	JJ
for	IN
the	DT
P	NN
sequence	NN
,	,
is	VBZ
related	JJ
to	TO
NF-kappa	NN
B	NN
and	CC
nuclear	JJ
factor	NN
for	IN
activated	VBN
T	NN
cell	NN
(	(
NF-AT	NN
)	)
.	.

In	IN
electromobility	NN
shift	NN
assays	NNS
both	CC
NF-kappa	NN
B	NN
(	(
P65	NN
or	CC
P65/P50	NN
heterodimer	NN
)	)
and	CC
NF-AT	NN
bound	VBD
to	TO
the	DT
P	NN
sequence	NN
.	.

However	RB
,	,
sequence	NN
specificity	NN
of	IN
NF-AT	NN
was	VBD
more	RBR
similar	JJ
to	TO
that	DT
of	IN
NF(P)	NN
,	,
and	CC
only	RB
a	DT
small	JJ
amount	NN
of	IN
P65	NN
was	VBD
detected	VBN
in	IN
NF(P)	NN
.	.

These	DT
results	NNS
indicate	VBP
that	IN
a	DT
component	NN
or	CC
components	NNS
of	IN
NF-AT	NN
have	VBP
the	DT
potential	NN
to	TO
reconstitute	VB
NF(P)	NN
,	,
whereas	IN
NF-kappa	NN
B	NN
alone	RB
does	VBZ
not	RB
account	VB
for	IN
NF(P)	NN
in	IN
Jurkat	NN
crude	JJ
extract	NN
.	.

Taken	VBN
together	RB
,	,
these	DT
results	NNS
suggest	VBP
that	IN
NF-AT-like	JJ
factors	NNS
are	VBP
involved	VBN
in	IN
the	DT
regulation	NN
of	IN
IL-4	NN
and	CC
IL-5	NN
genes	NNS
.	.

UI	LS
-	:
94183209	CD

TI	LS
-	:
Characterization	NN
of	IN
NF(P)	NN
,	,
the	DT
nuclear	JJ
factor	NN
that	WDT
interacts	VBZ
with	IN
the	DT
regulatory	JJ
P	NN
sequence	NN
(	(
5'-CGAAAATTTCC-3'	NN
)	)
of	IN
the	DT
human	JJ
interleukin-4	NN
gene	NN
:	:
relationship	NN
to	TO
NF-kappa	NN
B	NN
and	CC
NF-AT	NN
.	.

AB	LS
-	:
The	DT
P	NN
sequence	NN
of	IN
the	DT
human	JJ
interleukin-4	NN
(	(
IL-4	NN
)	)
gene	NN
,	,
which	WDT
was	VBD
defined	VBN
as	IN
a	DT
responsive	JJ
element	NN
for	IN
phorbol	NN
12-myristate	NN
13-acetate	NN
and	CC
calcium	NN
ionophore	NN
(	(
A23187	NN
)	)
in	IN
Jurkat	NN
T	NN
cells	NNS
,	,
shares	VBZ
sequence	NN
similarity	NN
with	IN
the	DT
NF-kappa	NN
B	NN
and	CC
the	DT
NF-AT	NN
binding	NN
sites	NNS
.	.

We	PRP
examined	VBD
whether	IN
NF(P)	NN
,	,
a	DT
nuclear	JJ
factor	NN
specific	JJ
for	IN
the	DT
P	NN
sequence	NN
,	,
is	VBZ
related	JJ
to	TO
NF-kappa	NN
B	NN
and	CC
NF-AT	NN
.	.

NF-kappa	NN
B	NN
(	(
P65	NN
or	CC
P65/P50	NN
heterodimer	NN
)	)
bound	VBD
to	TO
the	DT
P	NN
sequence	NN
in	IN
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
(	(
EMSA	NN
)	)
and	CC
activated	VBD
transcription	NN
through	IN
the	DT
P	NN
sequence	NN
when	WRB
expression	NN
plasmids	NNS
were	VBD
cotransfected	VBN
with	IN
P	NN
sequence-driven	JJ
reporter	NN
plasmids	NNS
in	IN
Jurkat	NN
T	NN
cells	NNS
.	.

In	IN
EMSAs	NNS
,	,
NF(P)	NN
binding	NN
was	VBD
inhibited	VBN
by	IN
the	DT
unlabeled	JJ
NF-AT	NN
binding	NN
site	NN
but	CC
not	RB
by	IN
the	DT
unlabeled	JJ
AP1	NN
binding	NN
site	NN
and	CC
purified	VBN
NF-AT	NN
contained	VBD
an	DT
activity	NN
that	WDT
bound	VBD
to	TO
the	DT
P	NN
sequence	NN
.	.

Both	CC
mobility	NN
shift	NN
and	CC
sequence	NN
specificity	NN
of	IN
NF-AT	NN
were	VBD
similar	JJ
to	TO
those	DT
of	IN
NF(P)	NN
and	CC
only	RB
a	DT
small	JJ
amount	NN
of	IN
P65	NN
was	VBD
detected	VBN
in	IN
NF(P)	NN
in	IN
crude	JJ
nuclear	JJ
extracts	NNS
.	.

These	DT
results	NNS
indicate	VBP
that	IN
the	DT
component	NN
(	(
s	NNS
)	)
of	IN
NF-AT	NN
has	VBZ
the	DT
potential	NN
to	TO
reconstitute	VB
NF(P)	NN
whereas	IN
NF-kappa	NN
B	NN
alone	RB
can	MD
not	RB
account	VB
for	IN
NF(P)	NN
in	IN
crude	JJ
extracts	NNS
.	.

Unlike	IN
NF-AT	NN
,	,
NF(P)	NN
does	VBZ
not	RB
contain	VB
AP1	NN
as	IN
its	PRP$
DNA	NN
binding	NN
component	NN
.	.

UI	LS
-	:
94259822	CD

TI	LS
-	:
Prenatal	JJ
immune	JJ
challenge	NN
alters	VBZ
the	DT
hypothalamic-pituitary-adrenocortical	JJ
axis	NN
in	IN
adult	JJ
rats	NNS
.	.

AB	LS
-	:
We	PRP
investigated	VBD
whether	IN
non-abortive	JJ
maternal	JJ
infections	NNS
would	MD
compromise	VB
fetal	JJ
brain	NN
development	NN
and	CC
alter	VB
hypothalamic-pituitary-adrenocortical	JJ
(	(
HPA	NN
)	)
axis	NN
functioning	VBG
when	WRB
adult	JJ
.	.

To	TO
study	VB
putative	JJ
teratogenic	JJ
effects	NNS
of	IN
a	DT
T	NN
cell-mediated	JJ
immune	JJ
response	NN
versus	CC
an	DT
endotoxic	JJ
challenge	NN
,	,
10-d-pregnant	JJ
rats	NNS
received	VBD
a	DT
single	JJ
intraperitoneal	JJ
injection	NN
of	IN
5	CD
x	NN
10	CD
(	(
8	CD
)	)
human	JJ
red	JJ
blood	NN
cells	NNS
(	(
HRBC	NN
)	)
or	CC
gram-negative	JJ
bacterial	JJ
endotoxin	NN
(	(
Escherichia	FW
coli	FW
LPS	NN
:	:
30	CD
micrograms/kg	NNS
)	)
.	.

The	DT
adult	JJ
male	JJ
progeny	NN
(	(
3	CD
mo	NN
old	JJ
)	)
of	IN
both	DT
experimental	JJ
groups	NNS
showed	VBD
increased	VBN
basal	JJ
plasma	NN
corticosterone	NN
levels	NNS
.	.

In	IN
addition	NN
,	,
after	IN
novelty	NN
stress	NN
the	DT
HRBC	NN
group	NN
,	,
but	CC
not	RB
the	DT
LPS	NN
group	NN
,	,
showed	VBD
increased	VBN
ACTH	NN
and	CC
corticosterone	NN
levels	NNS
.	.

Both	DT
groups	NNS
showed	VBD
substantial	JJ
decreases	NNS
in	IN
mineralocorticoid	NN
(	(
MR	NN
)	)
and	CC
glucocorticoid	NN
receptor	NN
(	(
GR	NN
)	)
levels	NNS
in	IN
the	DT
hippocampus	NN
,	,
a	DT
limbic	JJ
brain	NN
structure	NN
critical	JJ
for	IN
HPA	NN
axis	NN
regulation	NN
,	,
whereas	IN
GR	NN
concentrations	NNS
in	IN
the	DT
hypothalamus	NN
were	VBD
unchanged	JJ
and	CC
in	IN
anterior	JJ
pituitary	NN
were	VBD
slightly	RB
increased	VBN
.	.

HRBC	NN
and	CC
LPS	NN
indeed	RB
stimulated	VBD
the	DT
maternal	JJ
immune	JJ
system	NN
as	IN
revealed	VBN
by	IN
specific	JJ
anti-HRBC	JJ
antibody	NN
production	NN
and	CC
enhanced	VBD
IL-1	NN
beta	NN
mRNA	NN
expression	NN
in	IN
splenocytes	NNS
,	,
respectively	RB
.	.

This	DT
study	NN
demonstrates	VBZ
that	IN
a	DT
T	NN
cell-mediated	JJ
immune	JJ
response	NN
as	RB
well	RB
as	IN
an	DT
endotoxic	JJ
challenge	NN
during	IN
pregnancy	NN
can	MD
induce	VB
anomalies	NNS
in	IN
HPA	NN
axis	NN
function	NN
in	IN
adulthood	NN
.	.

Clinically	RB
,	,
it	PRP
may	MD
be	VB
postulated	VBN
that	IN
disturbed	JJ
fetal	JJ
brain	NN
development	NN
due	JJ
to	TO
prenatal	JJ
immune	JJ
challenge	NN
increases	VBZ
the	DT
vulnerability	NN
to	TO
develop	VB
mental	JJ
illness	NN
involving	VBG
inadequate	JJ
responses	NNS
to	TO
stress	NN
.	.

UI	LS
-	:
94344108	CD

TI	LS
-	:
DNA-binding	JJ
and	CC
transcriptional	JJ
regulatory	JJ
properties	NNS
of	IN
hepatic	JJ
leukemia	NN
factor	NN
(	(
HLF	NN
)	)
and	CC
the	DT
t(17;19)	NN
acute	JJ
lymphoblastic	JJ
leukemia	NN
chimera	NN
E2A-HLF	JJ
.	.

AB	LS
-	:
The	DT
t(17;19)	NN
translocation	NN
in	IN
acute	JJ
lymphoblastic	JJ
leukemias	NNS
results	VBZ
in	IN
creation	NN
of	IN
E2A-hepatic	JJ
leukemia	NN
factor	NN
(	(
HLF	NN
)	)
chimeric	JJ
proteins	NNS
that	WDT
contain	VBP
the	DT
DNA-binding	JJ
and	CC
protein	NN
dimerization	NN
domains	NNS
of	IN
the	DT
basic	JJ
leucine	NN
zipper	NN
(	(
bZIP	NN
)	)
protein	NN
HLF	NN
fused	VBN
to	TO
a	DT
portion	NN
of	IN
E2A	NN
proteins	NNS
with	IN
transcriptional	JJ
activation	NN
properties	NNS
.	.

An	DT
in	FW
vitro	FW
binding	VBG
site	NN
selection	NN
procedure	NN
was	VBD
used	VBN
to	TO
determine	VB
DNA	NN
sequences	NNS
preferentially	RB
bound	VBN
by	IN
wild-type	JJ
HLF	NN
and	CC
chimeric	JJ
E2A-HLF	JJ
proteins	NNS
isolated	VBN
from	IN
various	JJ
t(17;19)-bearing	JJ
leukemias	NNS
.	.

All	DT
were	VBD
found	VBN
to	TO
selectively	RB
bind	VB
the	DT
consensus	NN
sequence	NN
5'-GTTACGTAAT-3'	NN
with	IN
high	JJ
affinity	NN
.	.

Wild-type	JJ
and	CC
chimeric	JJ
HLF	NN
proteins	NNS
also	RB
bound	VBD
closely	RB
related	JJ
sites	NNS
identified	VBN
previously	RB
for	IN
bZIP	NN
proteins	NNS
of	IN
both	CC
the	DT
proline-	NN
and	CC
acidic	JJ
amino	NN
acid-rich	JJ
(	(
PAR	NN
)	)
and	CC
C/EBP	NN
subfamilies	NNS
;	:
however	RB
,	,
E2A-HLF	JJ
proteins	NNS
were	VBD
significantly	RB
less	JJR
tolerant	JJ
of	IN
certain	JJ
deviations	NNS
from	IN
the	DT
HLF	NN
consensus	NN
binding	NN
site	NN
.	.

These	DT
differences	NNS
were	VBD
directly	RB
attributable	JJ
to	TO
loss	NN
of	IN
an	DT
HLF	NN
ancillary	NN
DNA-binding	JJ
domain	NN
in	IN
all	DT
E2A-HLF	JJ
chimeras	NNS
and	CC
were	VBD
further	RB
exacerbated	JJ
by	IN
a	DT
zipper	NN
mutation	NN
in	IN
one	CD
isolate	NN
.	.

Both	CC
wild-type	JJ
and	CC
chimeric	JJ
HLF	NN
proteins	NNS
displayed	VBD
transcriptional	JJ
activator	NN
properties	NNS
in	IN
lymphoid	JJ
and	CC
nonlymphoid	JJ
cells	NNS
on	IN
reporter	NN
genes	NNS
containing	VBG
HLF	NN
or	CC
C/EBP	NN
consensus	NN
binding	NN
sites	NNS
.	.

But	CC
on	IN
reporter	NN
genes	NNS
with	IN
nonoptimal	JJ
binding	VBG
sites	NNS
,	,
their	PRP$
transcriptional	JJ
properties	NNS
diverged	VBD
and	CC
E2A-HLF	JJ
competitively	RB
inhibited	VBD
activation	NN
by	IN
wild-type	JJ
PAR	NN
proteins	NNS
.	.

These	DT
findings	NNS
establish	VBP
a	DT
spectrum	NN
of	IN
binding	VBG
site-specific	JJ
transcriptional	JJ
properties	NNS
for	IN
E2A-HLF	JJ
which	WDT
may	MD
preferentially	RB
activate	VB
expression	NN
of	IN
select	JJ
subordinate	JJ
genes	NNS
as	IN
a	DT
homodimer	NN
and	CC
potentially	RB
antagonize	VB
expression	NN
of	IN
others	NNS
through	IN
heteromeric	JJ
interactions	NNS
.	.

UI	LS
-	:
94240138	CD

TI	LS
-	:
Alternative	JJ
splicing	NN
of	IN
RNA	NN
transcripts	NNS
encoded	VBN
by	IN
the	DT
murine	NN
p105	NN
NF-kappa	NN
B	NN
gene	NN
generates	VBZ
I	NN
kappa	NN
B	NN
gamma	NN
isoforms	NNS
with	IN
different	JJ
inhibitory	JJ
activities	NNS
.	.

AB	LS
-	:
The	DT
gene	NN
encoding	VBG
the	DT
105-kDa	JJ
protein	NN
(	(
p105	NN
)	)
precursor	NN
of	IN
the	DT
p50	NN
subunit	NN
of	IN
transcription	NN
factor	NN
NF-kappa	NN
B	NN
also	RB
encodes	VBZ
a	DT
p70	NN
I	NN
kappa	NN
B	NN
protein	NN
,	,
I	NN
kappa	NN
B	NN
gamma	NN
,	,
which	WDT
is	VBZ
identical	JJ
to	TO
the	DT
C-terminal	JJ
607	CD
amino	NN
acids	NNS
of	IN
p105	NN
.	.

Here	RB
we	PRP
show	VBP
that	IN
alternative	JJ
RNA	NN
splicing	NN
generates	VBZ
I	NN
kappa	NN
B	NN
gamma	NN
isoforms	NNS
with	IN
properties	NNS
different	JJ
from	IN
those	DT
of	IN
p70	NN
.	.

One	CD
63-kDa	JJ
isoform	NN
,	,
termed	VBN
I	NN
kappa	NN
B	NN
gamma-1	NN
,	,
which	WDT
lacks	VBZ
59	CD
amino	NN
acids	NNS
C-terminal	JJ
to	TO
ankyrin	NN
repeat	NN
7	CD
,	,
has	VBZ
a	DT
novel	JJ
35-amino	NN
acid	NN
C	NN
terminus	NN
encoded	VBN
by	IN
an	DT
alternative	JJ
reading	NN
frame	NN
of	IN
the	DT
p105	NN
gene	NN
.	.

A	DT
55-kDa	JJ
isoform	NN
,	,
I	NN
kappa	NN
B	NN
gamma-2	NN
,	,
lacks	VBZ
the	DT
190	CD
C-terminal	JJ
amino	NN
acids	NNS
of	IN
p70I	NN
kappa	NN
B	NN
gamma	NN
.	.

In	IN
contrast	NN
to	TO
p70Ikappa	NN
B	NN
gamma	NN
,	,
which	WDT
is	VBZ
a	DT
cytoplasmic	JJ
protein	NN
,	,
I	NN
kappa	NN
B	NN
gamma-1	NN
is	VBZ
found	VBN
in	IN
both	CC
the	DT
cytoplasm	NN
and	CC
nucleus	NN
,	,
whereas	IN
I	NN
kappa	NN
B	NN
gamma-2	NN
is	VBZ
predominantly	RB
nuclear	JJ
.	.

The	DT
I	NN
kappa	NN
B	NN
gamma	NN
isoforms	NNS
also	RB
display	VBP
differences	NNS
in	IN
specificity	NN
and	CC
affinity	NN
for	IN
Rel/NF-kappa	NN
B	NN
proteins	NNS
.	.

While	IN
p70I	NN
kappa	NN
B	NN
gamma	NN
inhibits	VBZ
p50-	NN
,	,
p65-	NN
,	,
and	CC
c-Rel-mediated	JJ
transactivation	NN
and/or	CC
DNA	NN
binding	NN
,	,
both	CC
I	NN
kappa	NN
B	NN
gamma-1	NN
and	CC
I	NN
kappa	NN
B	NN
gamma-2	NN
are	VBP
specific	JJ
for	IN
p50	NN
and	CC
have	VBP
different	JJ
affinities	NNS
for	IN
this	DT
subunit	NN
.	.

The	DT
absence	NN
in	IN
I	NN
kappa	NN
B	NN
gamma-1	NN
and	CC
I	NN
kappa	NN
B	NN
gamma-2	NN
of	IN
a	DT
protein	NN
kinase	NN
A	NN
site	NN
whose	WP$
phosphorylation	NN
modulates	VBZ
p70I	NN
kappa	NN
B	NN
gamma	NN
inhibitory	JJ
activity	NN
suggests	VBZ
that	IN
alternative	JJ
RNA	NN
splicing	NN
may	MD
be	VB
used	VBN
to	TO
generate	VB
I	NN
kappa	NN
B	NN
gamma	NN
isoforms	NNS
that	WDT
respond	VBP
differently	RB
to	TO
intracellular	JJ
signals	NNS
.	.

UI	LS
-	:
94242719	CD

TI	LS
-	:
Some	DT
antioxidants	NNS
inhibit	VBP
,	,
in	IN
a	DT
co-ordinate	JJ
fashion	NN
,	,
the	DT
production	NN
of	IN
tumor	NN
necrosis	NN
factor-alpha	NN
,	,
IL-beta	NN
,	,
and	CC
IL-6	NN
by	IN
human	JJ
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
.	.

AB	LS
-	:
Some	DT
antioxidants	NNS
,	,
including	VBG
butylated	VBN
hydroxyanisole	NN
(	(
BHA	NN
)	)
,	,
tetrahydropapaveroline	NN
(	(
THP	NN
)	)
,	,
nordihydroguiauretic	JJ
acid	NN
,	,
and	CC
10,11-dihydroxyaporphine	NN
(	(
DHA	NN
)	)
,	,
were	VBD
found	VBN
to	TO
be	VB
potent	JJ
inhibitors	NNS
of	IN
the	DT
production	NN
of	IN
tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
-alpha	NN
,	,
IL-1	NN
beta	NN
,	,
and	CC
IL-6	NN
by	IN
human	JJ
peripheral	JJ
blood	NN
mononuclear	NN
cells	NNS
(	(
PBMC	NN
)	)
stimulated	VBN
by	IN
lipopolysaccharide	NN
(	(
LPS	NN
)	)
(	(
IC50s	NN
in	IN
the	DT
low	JJ
micromolar	JJ
range	NN
)	)
.	.

Inhibition	NN
of	IN
cytokine	NN
production	NN
was	VBD
gene	NN
selective	JJ
and	CC
not	RB
due	JJ
to	TO
general	JJ
effects	NNS
on	IN
protein	NN
synthesis	NN
.	.

Inhibition	NN
of	IN
cytokine	NN
production	NN
by	IN
PBMC	NN
was	VBD
observed	VBN
also	RB
when	WRB
other	JJ
inducers	NNS
were	VBD
used	VBN
(	(
staphylococci	NNS
,	,
silica	NN
,	,
zymosan	NN
)	)
.	.

Much	RB
higher	JJR
concentrations	NNS
of	IN
other	JJ
antioxidants	NNS
--	:
including	VBG
ascorbic	JJ
acid	NN
,	,
trolox	NN
,	,
alpha-tocopherol	NN
,	,
butylated	VBN
hydroxytoluene	NN
,	,
and	CC
the	DT
5-lipoxygenase	JJ
inhibitor	NN
zileuton	NN
--	:
did	VBD
not	RB
affect	VB
the	DT
production	NN
of	IN
these	DT
cytokines	NNS
.	.

The	DT
active	JJ
compounds	NNS
did	VBD
not	RB
inhibit	VB
IL-1-induced	JJ
production	NN
of	IN
IL-6	NN
in	IN
fibroblasts	NNS
,	,
showing	VBG
the	DT
cell	NN
selectivity	NN
of	IN
the	DT
effect	NN
.	.

Antioxidant-mediated	JJ
inhibition	NN
of	IN
cytokine	NN
production	NN
was	VBD
correlated	JJ
with	IN
low	JJ
levels	NNS
of	IN
the	DT
corresponding	JJ
messenger	NN
RNAs	NNS
.	.

Nuclear	JJ
run-on	JJ
experiments	NNS
showed	VBD
that	IN
THP	NN
inhibited	VBD
transcription	NN
of	IN
the	DT
IL-1	NN
beta	NN
gene	NN
.	.

THP	NN
decreased	VBD
the	DT
concentration	NN
of	IN
the	DT
transcription	NN
factors	NNS
NF-kappa	NN
B	NN
and	CC
AP-1	NN
detected	VBN
in	IN
nuclear	JJ
extracts	NNS
of	IN
PBMC	NN
cultured	VBN
in	IN
the	DT
presence	NN
or	CC
absence	NN
of	IN
LPS	NN
.	.

THP	NN
and	CC
DHA	NN
markedly	RB
decreased	VBD
the	DT
levels	NNS
of	IN
TNF-alpha	NN
and	CC
IL-1	NN
beta	NN
in	IN
the	DT
circulation	NN
of	IN
mice	NNS
following	VBG
LPS	NN
injection	NN
.	.

Thus	RB
antioxidants	NNS
vary	VBP
widely	RB
in	IN
potency	NN
as	IN
inhibitors	NNS
of	IN
the	DT
activation	NN
of	IN
transcription	NN
factors	NNS
and	CC
of	IN
the	DT
transcription	NN
of	IN
genes	NNS
for	IN
pro-inflammatory	JJ
cytokines	NNS
.	.

Coordinate	JJ
inhibition	NN
of	IN
the	DT
transcription	NN
of	IN
genes	NNS
for	IN
inflammatory	JJ
cytokines	NNS
could	MD
provide	VB
a	DT
strategy	NN
for	IN
therapy	NN
of	IN
diseases	NNS
with	IN
inflammatory	JJ
pathogenesis	NN
and	CC
for	IN
septic	JJ
shock	NN
.	.

UI	LS
-	:
95134788	CD

TI	LS
-	:
Evaluation	NN
of	IN
the	DT
respiratory	JJ
epithelium	NN
of	IN
normals	NNS
and	CC
individuals	NNS
with	IN
cystic	JJ
fibrosis	NN
for	IN
the	DT
presence	NN
of	IN
adenovirus	NN
E1a	NN
sequences	NNS
relevant	JJ
to	TO
the	DT
use	NN
of	IN
E1a-adenovirus	NN
vectors	NNS
for	IN
gene	NN
therapy	NN
for	IN
the	DT
respiratory	JJ
manifestations	NNS
of	IN
cystic	JJ
fibrosis	NN
.	.

AB	LS
-	:
Lung	NN
disease	NN
associated	VBN
with	IN
disorders	NNS
such	JJ
as	IN
cystic	JJ
fibrosis	NN
(	(
CF	NN
)	)
may	MD
be	VB
amenable	JJ
to	TO
somatic	JJ
gene	NN
therapy	NN
in	IN
which	WDT
there	EX
is	VBZ
delivery	NN
of	IN
the	DT
normal	JJ
gene	NN
directly	RB
to	TO
the	DT
respiratory	JJ
epithelium	NN
using	VBG
E1a-adenovirus	NN
(	(
Ad	NN
)	)
type	NN
2-	CD
or	CC
5-based	JJ
vectors	NNS
.	.

For	IN
safety	NN
reasons	NNS
,	,
the	DT
Ad	NN
vectors	NNS
are	VBP
rendered	VBN
replication	NN
deficient	JJ
by	IN
deletion	NN
of	IN
the	DT
E1a	NN
region	NN
.	.

Because	IN
there	EX
is	VBZ
the	DT
theoretical	JJ
possibility	NN
of	IN
an	DT
E1a-replication-deficient	JJ
vector	NN
replicating	VBG
as	IN
a	DT
result	NN
of	IN
recombination	NN
or	CC
complementation	NN
with	IN
Ad	NN
2/5	CD
E1a	NN
sequences	NNS
present	JJ
in	IN
the	DT
target	NN
cell	NN
,	,
this	DT
study	NN
is	VBZ
directed	VBN
toward	IN
evaluating	VBG
respiratory	NN
epithelium	NN
of	IN
normals	NNS
and	CC
individuals	NNS
with	IN
CF	NN
for	IN
the	DT
presence	NN
of	IN
E1a	NN
sequences	NNS
.	.

Using	VBG
Ad	NN
2/5	CD
E1a-specific	JJ
primers	NNS
and	CC
the	DT
polymerase	NN
chain	NN
reaction	NN
to	TO
evaluate	VB
DNA	NN
recovered	VBN
from	IN
freshly	RB
isolated	VBN
nasal	NN
and	CC
bronchial	JJ
epithelium	NN
recovered	VBN
by	IN
brushing	NN
,	,
E1a	NN
sequences	NNS
were	VBD
detected	VBN
in	IN
respiratory	JJ
epithelium	NN
of	IN
19	CD
of	IN
91	CD
normals	NNS
(	(
21	CD
%	NN
)	)
.	.

In	IN
the	DT
E1a-positive	JJ
samples	NNS
,	,
the	DT
average	NN
of	IN
E1a	NN
copy	NN
number	NN
was	VBD
55	CD
+/-	CC
18/10(3)	CD
recovered	VBN
cells	NNS
.	.

In	IN
CF	NN
individuals	NNS
,	,
7	CD
of	IN
52	CD
(	(
13	CD
%	NN
)	)
had	VBD
detectable	JJ
E1a	NN
sequences	NNS
in	IN
the	DT
respiratory	JJ
epithelium	NN
,	,
with	IN
E1a	NN
copy	NN
number	NN
in	IN
the	DT
positive	JJ
samples	NNS
of	IN
80	CD
+/-	CC
21/10(3)	CD
recovered	VBN
cells	NNS
.	.

These	DT
results	NNS
demonstrate	VBP
that	IN
there	EX
are	VBP
detectable	JJ
Ad	NN
2/5	CD
E1a	NN
sequences	NNS
in	IN
the	DT
respiratory	JJ
epithelium	NN
of	IN
a	DT
small	JJ
percentage	NN
of	IN
normals	NNS
and	CC
individuals	NNS
with	IN
CF	NN
.	.

Because	IN
of	IN
the	DT
theoretical	JJ
potential	NN
of	IN
such	JJ
sequences	NNS
supporting	VBG
replication	NN
of	IN
E1a-Ad	NN
vectors	NNS
,	,
human	JJ
gene	NN
therapy	NN
protocols	NNS
for	IN
CF	NN
utilizing	VBG
such	JJ
vectors	NNS
should	MD
consider	VB
evaluating	VBG
study	NN
individuals	NNS
for	IN
the	DT
presence	NN
of	IN
Ad	NN
2/5	CD
E1a	NN
sequences	NNS
in	IN
the	DT
respiratory	JJ
epithelium	NN
.	.

UI	LS
-	:
94289707	CD

TI	LS
-	:
HLA-DR-	JJ
,	,
CD33+	JJ
,	,
CD56+	JJ
,	,
CD16-	JJ
myeloid/natural	JJ
killer	NN
cell	NN
acute	JJ
leukemia	NN
:	:
a	DT
previously	RB
unrecognized	JJ
form	NN
of	IN
acute	JJ
leukemia	NN
potentially	RB
misdiagnosed	JJ
as	IN
French-American-British	JJ
acute	JJ
myeloid	JJ
leukemia-M3	NN
[	(
see	VB
comments	NNS
]	)

AB	LS
-	:
We	PRP
have	VBP
identified	VBN
and	CC
characterized	VBN
a	DT
previously	RB
unrecognized	JJ
form	NN
of	IN
acute	JJ
leukemia	NN
that	WDT
shares	VBZ
features	NNS
of	IN
both	CC
myeloid	JJ
and	CC
natural	JJ
killer	NN
(	(
NK	NN
)	)
cells	NNS
.	.

From	IN
a	DT
consecutive	JJ
series	NN
of	IN
350	CD
cases	NNS
of	IN
adult	JJ
de	FW
novo	FW
acute	JJ
myeloid	JJ
leukemia	NN
(	(
AML	NN
)	)
,	,
we	PRP
identified	VBD
20	CD
cases	NNS
(	(
6	CD
%	NN
)	)
with	IN
a	DT
unique	JJ
immunophenotype	NN
:	:
CD33+	JJ
,	,
CD56+	JJ
,	,
CD11a+	JJ
,	,
CD13lo	JJ
,	,
CD15lo	JJ
,	,
CD34+/-	JJ
,	,
HLA-DR-	JJ
,	,
CD16-	JJ
.	.

Multicolor	JJ
flow	NN
cytometric	JJ
assays	NNS
confirmed	VBD
the	DT
coexpression	NN
of	IN
myeloid	JJ
(	(
CD33	NN
,	,
CD13	NN
,	,
CD15	NN
)	)
and	CC
NK	NN
cell-associated	JJ
(	(
CD56	NN
)	)
antigens	NNS
in	IN
each	DT
case	NN
,	,
whereas	IN
reverse	NN
transcription	NN
polymerase	NN
chain	NN
reaction	NN
(	(
RT-PCR	NN
)	)
assays	NNS
confirmed	VBD
the	DT
identity	NN
of	IN
CD56	NN
(	(
neural	JJ
cell	NN
adhesion	NN
molecule	NN
)	)
in	IN
leukemic	JJ
blasts	NNS
.	.

Although	IN
two	CD
cases	NNS
expressed	VBD
CD4	NN
,	,
no	DT
case	NN
expressed	VBD
CD2	NN
,	,
CD3	NN
,	,
or	CC
CD8	NN
and	CC
no	DT
case	NN
showed	VBD
clonal	JJ
rearrangement	NN
of	IN
genes	NNS
encoding	VBG
the	DT
T-cell	NN
receptor	NN
(	(
TCR	NN
beta	NN
,	,
gamma	NN
,	,
delta	NN
)	)
.	.

Leukemic	JJ
blasts	NNS
in	IN
the	DT
majority	NN
of	IN
cases	NNS
shared	VBD
unique	JJ
morphologic	JJ
features	NNS
(	(
deeply	RB
invaginated	JJ
nuclear	JJ
membranes	NNS
,	,
scant	JJ
cytoplasm	NN
with	IN
fine	JJ
azurophilic	JJ
granularity	NN
,	,
and	CC
finely	RB
granular	JJ
Sudan	NN
black	JJ
B	NN
and	CC
myeloperoxidase	NN
cytochemical	JJ
reactivity	NN
)	)
that	WDT
were	VBD
remarkably	RB
similar	JJ
to	TO
those	DT
of	IN
acute	JJ
promyelocytic	JJ
leukemia	NN
(	(
APL	NN
)	)
;	:
particularly	RB
the	DT
microgranular	JJ
variant	NN
(	(
FAB	NN
AML-M3v	NN
)	)
.	.

However	RB
,	,
all	DT
20	CD
cases	NNS
lacked	VBD
the	DT
t(15;17)	NN
and	CC
17	CD
cases	NNS
tested	VBN
lacked	VBD
the	DT
promyelocytic/retinoic	JJ
acid	NN
receptor	NN
alpha	NN
(	(
RAR	NN
alpha	NN
)	)
fusion	NN
transcript	NN
in	IN
RT-PCR	NN
assays	NNS
;	:
12	CD
cases	NNS
had	VBD
46,XX	NN
or	CC
46,XY	NN
karyotypes	NNS
,	,
whereas	IN
2	CD
cases	NNS
had	VBD
abnormalities	NNS
of	IN
chromosome	NN
17q	NN
:	:
1	CD
with	IN
del(17)(q25)	NN
and	CC
the	DT
other	JJ
with	IN
t(11;17)(q23;q21)	NN
and	CC
the	DT
promyelocytic	JJ
leukemia	NN
zinc	NN
finger/RAR	NN
alpha	NN
fusion	NN
transcript	NN
.	.

All	DT
cases	NNS
tested	VBN
(	(
6/20	CD
)	)
,	,
including	VBG
the	DT
case	NN
with	IN
t(11;17)	NN
,	,
failed	VBD
to	TO
differentiate	VB
in	FW
vitro	FW
in	IN
response	NN
to	TO
all-trans	JJ
retinoic	JJ
acid	NN
(	(
ATRA	NN
)	)
,	,
suggesting	VBG
that	IN
these	DT
cases	NNS
may	MD
account	VB
for	IN
some	DT
APLs	NNS
that	WDT
have	VBP
not	RB
shown	VBN
a	DT
clinical	JJ
response	NN
to	TO
ATRA	NN
.	.

Four	CD
of	IN
6	CD
cases	NNS
tested	VBN
showed	VBD
functional	JJ
NK	NN
cell-mediated	JJ
cytotoxicity	NN
,	,
suggesting	VBG
a	DT
relationship	NN
between	IN
these	DT
unique	JJ
CD33+	JJ
,	,
CD56+	JJ
,	,
CD16-	JJ
acute	JJ
leukemias	NNS
and	CC
normal	JJ
CD56+	JJ
,	,
CD16-	JJ
NK	NN
precursor	NN
cells	NNS
.	.

Using	VBG
a	DT
combination	NN
of	IN
panning	NN
and	CC
multiparameter	NN
flow	NN
cytometric	JJ
sorting	NN
,	,
we	PRP
identified	VBD
a	DT
normal	JJ
CD56+	JJ
,	,
CD33+	JJ
,	,
CD16-	JJ
counterpart	NN
cell	NN
at	IN
a	DT
frequency	NN
of	IN
1	CD
%	NN
to	TO
2	CD
%	NN
in	IN
the	DT
peripheral	JJ
blood	NN
of	IN
healthy	JJ
individuals	NNS
.	.

Our	PRP$
studies	NNS
suggest	VBP
that	IN
this	DT
form	NN
of	IN
acute	JJ
leukemia	NN
may	MD
arise	VB
from	IN
transformation	NN
of	IN
a	DT
precursor	NN
cell	NN
common	JJ
to	TO
both	CC
the	DT
myeloid	JJ
and	CC
NK	NN
cell	NN
lineages	NNS
;	:
thus	RB
we	PRP
propose	VBP
the	DT
designation	NN
myeloid/NK	JJ
acute	JJ
leukemia	NN
.	.

Recognition	NN
of	IN
this	DT
new	JJ
leukemic	JJ
entity	NN
will	MD
be	VB
important	JJ
in	IN
distinguishing	VBG
these	DT
ATRA-nonresponsive	JJ
cases	NNS
from	IN
ATRA-responsive	JJ
true	JJ
APL	NN
.	.

UI	LS
-	:
94278430	CD

TI	LS
-	:
Analysis	NN
of	IN
Oct2-isoform	JJ
expression	NN
in	IN
lipopolysaccharide-stimulated	JJ
B	NN
lymphocytes	NNS
.	.

AB	LS
-	:
Oct2-isoform	JJ
expression	NN
in	IN
splenic	JJ
B	NN
cells	NNS
stimulated	VBN
with	IN
lipopolysaccharide	NN
or	CC
lipopolysaccharide	NN
plus	CC
phorbol-di-butyrate	NN
was	VBD
analysed	VBN
by	IN
cDNA	NN
cloning	NN
.	.

The	DT
frequency	NN
of	IN
Oct2-positive	JJ
clones	NNS
was	VBD
1/15,000	CD
in	IN
both	DT
libraries	NNS
.	.

Two	CD
new	JJ
isoforms	NNS
were	VBD
found	VBN
that	WDT
generate	VBP
novel	JJ
amino-	NN
or	CC
carboxy-terminal	JJ
sequences	NNS
.	.

An	DT
isoform	NN
lacking	VBG
exon	NN
11	CD
destroyed	VBD
the	DT
carboxy-terminal	JJ
leucin-zipper	NN
region	NN
and	CC
introduced	VBD
a	DT
frame	NN
shift	NN
creating	VBG
a	DT
novel	JJ
,	,
proline-rich	JJ
carboxy	NN
terminus	NN
.	.

A	DT
new	JJ
exon	NN
containing	VBG
a	DT
highly	RB
basic	JJ
region	NN
(	(
4c	NN
)	)
was	VBD
characterized	VBN
,	,
between	IN
exons	NNS
4	CD
and	CC
5	CD
.	.

This	DT
exon	NN
was	VBD
inserted	VBN
between	IN
glutamine-rich	JJ
regions	NNS
2	CD
and	CC
3	CD
,	,
carboxy	JJ
terminal	NN
of	IN
a	DT
tentative	JJ
leucine-zipper	NN
structure	NN
.	.

In	IN
addition	NN
,	,
a	DT
new	JJ
combination	NN
isoform	NN
containing	VBG
Oct2a	NN
's	POS
amino	NN
terminal	JJ
insert	NN
(	(
exon	NN
7a	NN
)	)
and	CC
Oct2b	NN
's	POS
carboxy	NN
terminal	JJ
insert	NN
(	(
exon	NN
13	CD
)	)
was	VBD
found	VBN
that	WDT
created	VBD
a	DT
novel	JJ
large	JJ
isoform	NN
,	,
Oct2ab	NN
.	.

More	RBR
frequent	JJ
use	NN
of	IN
the	DT
classical	JJ
Oct2a	NN
and	CC
Oct2b	NN
isoforms	NNS
was	VBD
observed	VBN
in	IN
the	DT
lipopolysaccharide-stimulated	JJ
B	NN
cells	NNS
,	,
while	IN
a	DT
preference	NN
for	IN
the	DT
Oct2ab	NN
and	CC
Oct2ba	NN
isoforms	NNS
was	VBD
observed	VBN
in	IN
lipopolysaccharide	NN
plus	CC
phorbol-di-butyrate-treated	JJ
cells	NNS
.	.

UI	LS
-	:
94314370	CD

TI	LS
-	:
Evidence	NN
for	IN
a	DT
trans-acting	JJ
activator	NN
function	NN
regulating	VBG
the	DT
expression	NN
of	IN
the	DT
human	JJ
CD5	NN
antigen	NN
.	.

AB	LS
-	:
Interspecies	JJ
somatic	JJ
cell	NN
hybrids	NNS
were	VBD
generated	VBN
by	IN
fusing	VBG
the	DT
mouse	NN
T-lymphoma	NN
cell	NN
line	NN
,	,
BW5147	NN
,	,
with	IN
normal	JJ
human	JJ
T	NN
lymphocytes	NNS
at	IN
different	JJ
stages	NNS
of	IN
differentiation	NN
.	.

Thymocytes	NNS
,	,
activated	VBN
peripheral	JJ
T	NN
lymphocytes	NNS
,	,
or	CC
an	DT
activated	VBN
T-cell	NN
clone	NN
were	VBD
used	VBN
as	IN
human	JJ
partners	NNS
,	,
respectively	RB
,	,
in	IN
three	CD
independent	JJ
fusions	NNS
.	.

Irrespective	JJ
of	IN
the	DT
human	JJ
cell	NN
partner	NN
used	VBN
for	IN
fusion	NN
,	,
a	DT
certain	JJ
number	NN
of	IN
hybrids	NNS
lost	VBD
CD5	NN
surface	NN
expression	NN
over	IN
a	DT
period	NN
of	IN
time	NN
in	IN
culture	NN
.	.

Analysis	NN
at	IN
the	DT
phenotype	NN
and	CC
genetic	JJ
level	NN
showed	VBD
that	IN
lack	NN
of	IN
CD5	NN
expression	NN
was	VBD
due	JJ
neither	CC
to	TO
segregation	NN
of	IN
human	JJ
autosome	NN
11	CD
,	,
on	IN
which	WDT
the	DT
CD5	NN
gene	NN
has	VBZ
been	VBN
mapped	VBN
,	,
nor	CC
to	TO
deletion	NN
of	IN
the	DT
CD5	NN
structural	JJ
gene	NN
.	.

Furthermore	RB
,	,
loss	NN
of	IN
CD5	NN
surface	NN
expression	NN
correlated	VBD
with	IN
the	DT
absence	NN
of	IN
specific	JJ
mRNA	NN
.	.

Since	IN
these	DT
hybrids	NNS
preferentially	RB
segregate	VBP
human	JJ
chromosomes	NNS
,	,
these	DT
results	NNS
indicate	VBP
the	DT
existence	NN
of	IN
a	DT
non-syntenic	JJ
trans-active	JJ
locus	NN
,	,
or	CC
loci	NNS
,	,
positively	RB
controlling	VBG
the	DT
expression	NN
of	IN
the	DT
human	JJ
CD5	NN
gene	NN
.	.

UI	LS
-	:
96063079	CD

TI	LS
-	:
BCL-6	NN
and	CC
the	DT
molecular	JJ
pathogenesis	NN
of	IN
B-cell	NN
lymphoma	NN
.	.

AB	LS
-	:
The	DT
results	NNS
presented	VBN
identify	VBP
the	DT
first	JJ
genetic	JJ
lesion	NN
associated	VBN
with	IN
DLCL	NN
,	,
the	DT
most	RBS
clinically	RB
relevant	JJ
form	NN
of	IN
NHL	NN
.	.

Although	IN
no	DT
proof	NN
yet	RB
exists	VBZ
of	IN
a	DT
role	NN
for	IN
these	DT
lesions	NNS
in	IN
DLCL	NN
pathogenesis	NN
,	,
the	DT
feature	NN
of	IN
the	DT
BCL-6	NN
gene	NN
product	NN
,	,
its	PRP$
specific	JJ
pattern	NN
of	IN
expression	NN
in	IN
B	NN
cells	NNS
,	,
and	CC
the	DT
clustering	NN
of	IN
lesions	NNS
disrupting	VBG
its	PRP$
regulatory	JJ
domain	NN
strongly	RB
suggest	VBP
that	IN
deregulation	NN
of	IN
BCL-6	NN
expression	NN
may	MD
contribute	VB
to	TO
DLCL	NN
development	NN
.	.

A	DT
more	RBR
precise	JJ
definition	NN
of	IN
the	DT
role	NN
of	IN
BCL-6	NN
in	IN
normal	JJ
and	CC
neoplastic	JJ
B-cell	NN
development	NN
is	VBZ
the	DT
goal	NN
of	IN
ongoing	JJ
study	NN
of	IN
transgenic	JJ
mice	NNS
engineered	VBN
either	CC
to	TO
express	VB
BCL-6	NN
under	IN
heterologous	JJ
promoters	NNS
or	CC
lacking	VBG
BCL-6	NN
function	NN
due	JJ
to	TO
targeted	VBN
deletions	NNS
.	.

In	IN
addition	NN
to	TO
contributing	VBG
to	TO
the	DT
understanding	NN
of	IN
DLCL	NN
pathogenesis	NN
,	,
the	DT
identification	NN
of	IN
BCL-6	NN
lesions	NNS
may	MD
have	VB
relevant	JJ
clinical	JJ
implications	NNS
.	.

DLCL	NN
represent	VBP
a	DT
heterogeneous	JJ
group	NN
of	IN
neoplasms	NNS
which	WDT
are	VBP
treated	VBN
homogeneously	RB
despite	IN
the	DT
fact	NN
that	IN
only	RB
50	CD
%	NN
of	IN
patients	NNS
experience	VBP
long-term	JJ
disease-free	JJ
survival	NN
(	(
Schneider	NNP
et	FW
al.	FW
1990	CD
)	)
.	.

The	DT
fact	NN
that	IN
BCL-6	NN
rearrangements	NNS
identify	VBP
biologically	RB
and	CC
clinically	RB
distinct	JJ
subsets	NNS
of	IN
DLCL	NN
suggests	VBZ
that	IN
these	DT
lesions	NNS
may	MD
be	VB
useful	JJ
as	IN
markers	NNS
in	IN
selection	NN
of	IN
differential	JJ
therapeutic	JJ
strategies	NNS
based	VBN
on	IN
different	JJ
risk	NN
groups	NNS
.	.

Furthermore	RB
,	,
the	DT
BCL-6	NN
rearrangements	NNS
can	MD
be	VB
used	VBN
to	TO
identify	VB
and	CC
monitor	VB
the	DT
malignant	JJ
clone	NN
with	IN
sensitive	JJ
PCR-based	JJ
techniques	NNS
.	.

Since	IN
clinical	JJ
remission	NN
has	VBZ
been	VBN
observed	VBN
in	IN
a	DT
significant	JJ
fraction	NN
of	IN
DLCL	NN
cases	NNS
,	,
these	DT
markers	NNS
may	MD
serve	VB
as	IN
critical	JJ
tools	NNS
for	IN
sensitive	JJ
monitoring	NN
of	IN
minimal	JJ
residual	JJ
disease	NN
and	CC
early	JJ
diagnosis	NN
of	IN
relapse	NN
(	(
Gribben	NNP
et	FW
al.	FW
1993	CD
)	)
.	.

UI	LS
-	:
94118533	CD

TI	LS
-	:
The	DT
SCL	NN
protein	NN
displays	VBZ
cell-specific	JJ
heterogeneity	NN
in	IN
size	NN
.	.

AB	LS
-	:
SCL	NN
protein	NN
production	NN
was	VBD
examined	VBN
in	IN
a	DT
variety	NN
of	IN
hemopoietic	JJ
cell	NN
lines	NNS
by	IN
immunoblotting	VBG
using	VBG
specific	JJ
polyclonal	JJ
antisera	NNS
.	.

SCL	NN
protein	NN
was	VBD
detected	VBN
in	IN
erythroid	JJ
,	,
megakaryocyte	NN
,	,
mast	NN
and	CC
early	JJ
myeloid	JJ
cell	NN
lines	NNS
,	,
as	RB
well	RB
as	IN
in	IN
several	JJ
lymphoid	JJ
leukemia	NN
cell	NN
lines	NNS
which	WDT
are	VBP
known	VBN
to	TO
harbor	VB
SCL	NN
gene	NN
rearrangements	NNS
.	.

In	IN
most	JJS
cell	NN
lines	NNS
,	,
proteins	NNS
of	IN
molecular	JJ
weight	NN
49	CD
and	CC
44	CD
kDa	NN
were	VBD
found	VBN
,	,
however	RB
two	CD
myeloid	JJ
cell	NN
lines	NNS
expressed	VBD
only	RB
lower	JJR
molecular	JJ
weight	NN
species	NNS
of	IN
24	CD
and	CC
22	CD
kDa	NN
.	.

This	DT
size	NN
discrepancy	NN
appeared	VBD
to	TO
be	VB
due	JJ
to	TO
cell-specific	JJ
translational	JJ
regulation	NN
,	,
since	IN
overexpression	NN
of	IN
a	DT
retrovirally	RB
transfected	VBN
SCL	NN
gene	NN
yielded	VBD
the	DT
higher	JJR
molecular	JJ
weight	NN
forms	NNS
in	IN
most	JJS
cell	NN
lines	NNS
(	(
GP+E-86	NN
,	,
AT2.5	NN
,	,
M1	NN
)	)
but	CC
only	RB
the	DT
22	CD
kDa	NN
form	NN
in	IN
the	DT
myeloid	JJ
cell	NN
line	NN
,	,
WEHI-3B/D+	NN
.	.

Overexpression	NN
of	IN
full-length	JJ
SCL	NN
protein	NN
in	IN
the	DT
lymphoid	JJ
cell	NN
lines	NNS
,	,
SupT1	NN
and	CC
Raji	NN
,	,
did	VBD
not	RB
alter	VB
cell	NN
phenotype	NN
and	CC
there	EX
was	VBD
no	DT
evidence	NN
for	IN
autoregulation	NN
of	IN
SCL	NN
transcription	NN
.	.

The	DT
restricted	JJ
pattern	NN
of	IN
SCL	NN
protein	NN
synthesis	NN
is	VBZ
consistent	JJ
with	IN
the	DT
restricted	JJ
expression	NN
of	IN
SCL	NN
mRNA	NN
documented	VBN
previously	RB
.	.

In	IN
addition	NN
,	,
the	DT
present	JJ
results	NNS
indicate	VBP
that	IN
SCL	NN
protein	NN
size	NN
was	VBD
determined	VBN
by	IN
regulation	NN
of	IN
translation	NN
in	IN
a	DT
cell-specific	JJ
manner	NN
.	.

UI	LS
-	:
97047773	CD

TI	LS
-	:
Apoptosis	NN
signaling	NN
pathways	NNS
in	IN
normal	JJ
T	NN
cells	NNS
:	:
differential	JJ
activity	NN
of	IN
Bcl-2	NN
and	CC
IL-1beta-converting	JJ
enzyme	NN
family	NN
protease	NN
inhibitors	NNS
on	IN
glucocorticoid-	NN
and	CC
Fas-mediated	JJ
cytotoxicity	NN
.	.

AB	LS
-	:
Fas-mediated	JJ
apoptosis	NN
plays	VBZ
an	DT
important	JJ
role	NN
in	IN
regulating	VBG
the	DT
immune	JJ
response	NN
in	IN
peripheral	JJ
T	NN
cells	NNS
.	.

Restimulation	NN
of	IN
T	NN
cell	NN
blasts	NNS
up-regulates	VBZ
Fas	NN
and	CC
Fas	NN
ligand	NN
expression	NN
,	,
with	IN
subsequent	JJ
interaction	NN
leading	VBG
to	TO
cell	NN
death	NN
.	.

Overexpression	NN
of	IN
Bcl-2	NN
in	IN
tumor	NN
cells	NNS
blocks	VBZ
apoptosis	NN
induced	VBN
by	IN
many	JJ
stimuli	NNS
,	,
but	CC
inhibition	NN
of	IN
Fas-mediated	JJ
killing	NN
has	VBZ
not	RB
been	VBN
consistently	RB
observed	VBN
.	.

To	TO
examine	VB
the	DT
behavior	NN
of	IN
Bcl-2	NN
in	IN
normal	JJ
cells	NNS
,	,
T	NN
cell	NN
blasts	NNS
were	VBD
transiently	RB
transfected	VBN
with	IN
Bcl-2	NN
and	CC
related	JJ
gene	NN
products	NNS
to	TO
determine	VB
the	DT
effect	NN
on	IN
apoptotic	JJ
signaling	NN
.	.

Transient	JJ
overexpression	NN
of	IN
Bcl-2	NN
in	IN
mouse	NN
and	CC
human	JJ
T	NN
cell	NN
blasts	NNS
did	VBD
not	RB
block	VB
Fas-mediated	JJ
apoptosis	NN
,	,
whereas	IN
etoposide-	NN
and	CC
glucocorticoid-induced	JJ
cytotoxicity	NN
was	VBD
potently	RB
inhibited	VBN
.	.

Expression	NN
of	IN
Bcl-xL	NN
and	CC
adenovirus	NN
E1B	NN
19K	NN
did	VBD
not	RB
interfere	VB
with	IN
anti-Fas	JJ
killing	NN
.	.

In	IN
contrast	NN
,	,
interleukin-1beta-converting	JJ
enzyme	NN
family	NN
protease	NN
inhibitors	NNS
Ac-DEVD-CHO	NN
and	CC
CrmA	NN
blocked	VBD
Fas-mediated	JJ
apoptosis	NN
.	.

These	DT
results	NNS
suggest	VBP
that	IN
peripheral	JJ
T	NN
cells	NNS
use	VBP
distinct	JJ
apoptosis	NN
signaling	NN
pathways	NNS
with	IN
differential	JJ
sensitivity	NN
to	TO
Bcl-2	NN
and	CC
interleukin-1beta-converting	JJ
enzyme	NN
family	NN
protease	NN
inhibitors	NNS
.	.

Since	IN
T	NN
cells	NNS
normally	RB
express	VBP
Bcl-2	NN
and	CC
Bcl-xL	NN
following	VBG
activation	NN
,	,
their	PRP$
inability	NN
to	TO
block	VB
Fas-mediated	JJ
apoptosis	NN
may	MD
allow	VB
for	IN
the	DT
elimination	NN
of	IN
self-reactive	JJ
cells	NNS
and	CC
the	DT
appropriate	JJ
regulation	NN
of	IN
immune	JJ
responses	NNS
.	.

UI	LS
-	:
94280766	CD

TI	LS
-	:
Function	NN
and	CC
activation	NN
of	IN
NF-kappa	NN
B	NN
in	IN
the	DT
immune	JJ
system	NN
.	.

AB	LS
-	:
NF-kappa	NN
B	NN
is	VBZ
a	DT
ubiquitous	JJ
transcription	NN
factor	NN
.	.

Nevertheless	RB
,	,
its	PRP$
properties	NNS
seem	VBP
to	TO
be	VB
most	RBS
extensively	RB
exploited	VBN
in	IN
cells	NNS
of	IN
the	DT
immune	JJ
system	NN
.	.

Among	IN
these	DT
properties	NNS
are	VBP
NF-kappa	NN
B	NN
's	POS
rapid	JJ
posttranslational	JJ
activation	NN
in	IN
response	NN
to	TO
many	JJ
pathogenic	JJ
signals	NNS
,	,
its	PRP$
direct	JJ
participation	NN
in	IN
cytoplasmic/nuclear	JJ
signaling	NN
,	,
and	CC
its	PRP$
potency	NN
to	TO
activate	VB
transcription	NN
of	IN
a	DT
great	JJ
variety	NN
of	IN
genes	NNS
encoding	VBG
immunologically	RB
relevant	JJ
proteins	NNS
.	.

In	IN
vertebrates	NNS
,	,
five	CD
distinct	JJ
DNA	NN
binding	NN
subunits	NNS
are	VBP
currently	RB
known	VBN
which	WDT
might	MD
extensively	RB
heterodimerize	VB
,	,
thereby	RB
forming	VBG
complexes	NNS
with	IN
distinct	JJ
transcriptional	JJ
activity	NN
,	,
DNA	NN
sequence	NN
specificity	NN
,	,
and	CC
cell	NN
type-	NN
and	CC
cell	NN
stage-specific	JJ
distribution	NN
.	.

The	DT
activity	NN
of	IN
DNA	NN
binding	NN
NF-kappa	NN
B	NN
dimers	NNS
is	VBZ
tightly	RB
controlled	VBN
by	IN
accessory	NN
proteins	NNS
called	VBN
I	NN
kappa	NN
B	NN
subunits	NNS
of	IN
which	WDT
there	EX
are	VBP
also	RB
five	CD
different	JJ
species	NNS
currently	RB
known	VBN
in	IN
vertebrates	NNS
.	.

I	NN
kappa	NN
B	NN
proteins	NNS
inhibit	VBP
DNA	NN
binding	NN
and	CC
prevent	VBP
nuclear	JJ
uptake	NN
of	IN
NF-kappa	NN
B	NN
complexes	NNS
.	.

An	DT
exception	NN
is	VBZ
the	DT
Bcl-3	NN
protein	NN
which	WDT
in	IN
addition	NN
can	MD
function	VB
as	IN
a	DT
transcription	NN
activating	NN
subunit	NN
in	IN
th	DT
nucleus	NN
.	.

Other	JJ
I	NN
kappa	NN
B	NN
proteins	NNS
are	VBP
rather	RB
involved	VBN
in	IN
terminating	VBG
NF-kappa	NN
B	NN
's	POS
activity	NN
in	IN
the	DT
nucleus	NN
.	.

The	DT
intracellular	JJ
events	NNS
that	WDT
lead	VBP
to	TO
the	DT
inactivation	NN
of	IN
I	NN
kappa	NN
B	NN
,	,
i.e.	FW
the	DT
activation	NN
of	IN
NF-kappa	NN
B	NN
,	,
are	VBP
complex	JJ
.	.

They	PRP
involve	VBP
phosphorylation	NN
and	CC
proteolytic	JJ
reactions	NNS
and	CC
seem	VBP
to	TO
be	VB
controlled	VBN
by	IN
the	DT
cells	NNS
'	POS
redox	NN
status	NN
.	.

Interference	NN
with	IN
the	DT
activation	NN
or	CC
activity	NN
of	IN
NF-kappa	NN
B	NN
may	MD
be	VB
beneficial	JJ
in	IN
suppressing	VBG
toxic/septic	JJ
shock	NN
,	,
graft-vs-host	JJ
reactions	NNS
,	,
acute	JJ
inflammatory	JJ
reactions	NNS
,	,
acute	JJ
phase	NN
response	NN
,	,
and	CC
radiation	NN
damage	NN
.	.

The	DT
inhibition	NN
of	IN
NF-kappa	NN
B	NN
activation	NN
by	IN
antioxidants	NNS
and	CC
specific	JJ
protease	NN
inhibitors	NNS
may	MD
provide	VB
a	DT
pharmacological	JJ
basis	NN
for	IN
interfering	VBG
with	IN
these	DT
acute	JJ
processes	NNS
.	.

UI	LS
-	:
94281402	CD

TI	LS
-	:
Pentoxifylline	NN
for	IN
the	DT
treatment	NN
of	IN
infection	NN
with	IN
human	JJ
immunodeficiency	NN
virus	NN
.	.

AB	LS
-	:
Cytokine	NN
dysregulation	NN
in	IN
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
(	(
HIV-1	NN
)	)
infection	NN
has	VBZ
been	VBN
documented	VBN
in	IN
numerous	JJ
studies	NNS
and	CC
has	VBZ
been	VBN
cited	VBN
as	IN
an	DT
important	JJ
component	NN
in	IN
the	DT
pathogenesis	NN
of	IN
this	DT
retroviral	JJ
infection	NN
.	.

Pharmacological	JJ
modification	NN
of	IN
cytokine	NN
dysregulation	NN
,	,
therefore	RB
,	,
has	VBZ
been	VBN
suggested	VBN
as	IN
a	DT
therapeutic	JJ
modality	NN
for	IN
HIV-1	NN
infection	NN
.	.

Dr.	NNP
Dezube	NNP
of	IN
Beth	NNP
Israel	NNP
Hospital	NNP
(	(
Boston	NNP
)	)
concisely	RB
reviews	VBZ
the	DT
state	NN
of	IN
our	PRP$
knowledge	NN
regarding	VBG
the	DT
effects	NNS
of	IN
pentoxifylline	NN
on	IN
expression	NN
of	IN
tumor	NN
necrosis	NN
factor-alpha	NN
,	,
a	DT
cytokine	NN
known	VBN
to	TO
influence	VB
HIV-1	NN
replication	NN
and	CC
to	TO
play	VB
a	DT
possible	JJ
role	NN
in	IN
the	DT
clinical	JJ
manifestations	NNS
of	IN
advanced	JJ
infection	NN
with	IN
this	DT
virus	NN
.	.

Pentoxifylline	NN
,	,
a	DT
trisubstituted	JJ
xanthine	NN
derivative	NN
,	,
has	VBZ
been	VBN
used	VBN
to	TO
decrease	VB
blood	NN
viscosity	NN
and	CC
is	VBZ
reasonably	RB
well	RB
tolerated	VBN
by	IN
most	JJS
recipients	NNS
of	IN
the	DT
drug	NN
.	.

Results	NNS
of	IN
preliminary	JJ
studies	NNS
,	,
many	JJ
of	IN
which	WDT
were	VBD
conducted	VBN
by	IN
Dr.	NNP
Dezube	NNP
,	,
suggest	VBP
that	IN
use	NN
of	IN
this	DT
agent	NN
in	IN
combination	NN
with	IN
antiretroviral	JJ
compounds	NNS
may	MD
prove	VB
useful	JJ
in	IN
the	DT
treatment	NN
of	IN
patients	NNS
with	IN
HIV-1	NN
infection	NN
.	.

UI	LS
-	:
94110342	CD

TI	LS
-	:
Steroid-resistant	JJ
asthma	NN
.	.

Cellular	JJ
mechanisms	NNS
contributing	VBG
to	TO
inadequate	JJ
response	NN
to	TO
glucocorticoid	NN
therapy	NN
.	.

AB	LS
-	:
The	DT
current	JJ
study	NN
examined	VBD
whether	IN
alterations	NNS
in	IN
glucocorticoid	NN
receptor	NN
(	(
GR	NN
)	)
binding	NN
contribute	VBP
to	TO
poor	JJ
response	NN
to	TO
glucocorticoid	NN
therapy	NN
in	IN
asthma	NN
.	.

29	CD
asthma	NN
patients	NNS
with	IN
forced	VBN
expiratory	JJ
volume	NN
in	IN
1	CD
s	NN
(	(
FEV1	NN
)	)
<	JJR
70	CD
%	NN
predicted	VBN
were	VBD
studied	VBN
.	.

Patients	NNS
were	VBD
classified	VBN
as	IN
steroid	NN
sensitive	JJ
(	(
SS	JJ
)	)
if	IN
their	PRP$
morning	NN
FEV1	NN
increased	VBD
>	RBR
30	CD
%	NN
after	IN
a	DT
1-wk	JJ
course	NN
of	IN
oral	JJ
prednisone	NN
20	CD
mg	NN
twice	RB
daily	RB
and	CC
steroid	NN
resistant	JJ
(	(
SR	JJ
)	)
if	IN
they	PRP
failed	VBD
to	TO
increase	VB
>	RBR
15	CD
%	NN
.	.

PBMC	NN
obtained	VBN
from	IN
these	DT
two	CD
groups	NNS
,	,
17	CD
SR	JJ
and	CC
12	CD
SS	JJ
,	,
as	RB
well	RB
as	IN
12	CD
normal	JJ
controls	NNS
were	VBD
analyzed	VBN
.	.
SR	JJ
patients	NNS
had	VBD
two	CD
distinguishable	JJ
GR	NN
binding	NN
abnormalities	NNS
:	:
15	CD
of	IN
the	DT
17	CD
SR	JJ
patients	NNS
demonstrated	VBD
a	DT
significantly	RB
reduced	VBN
GR	NN
binding	NN
affinity	NN
,	,
as	IN
compared	VBN
with	IN
SS	JJ
patients	NNS
(	(
P	NN
=	JJ
0.0001	CD
)	)
and	CC
normal	JJ
controls	NNS
(	(
P	NN
=	JJ
0.0001	CD
)	)
.	.

This	DT
defect	NN
was	VBD
localized	JJ
to	TO
T	NN
cells	NNS
and	CC
reverted	VBD
to	TO
normal	JJ
after	IN
48	CD
h	NN
in	IN
culture	NN
media	NNS
.	.

However	RB
,	,
incubation	NN
with	IN
a	DT
combination	NN
of	IN
IL-2	NN
and	CC
IL-4	NN
sustained	VBD
this	DT
abnormality	NN
.	.

The	DT
other	JJ
two	CD
SR	JJ
patients	NNS
had	VBD
an	DT
abnormally	RB
low	JJ
GR	NN
number	NN
with	IN
normal	JJ
binding	NN
affinity	NN
that	WDT
was	VBD
not	RB
limited	VBN
to	TO
T	NN
cells	NNS
.	.

Furthermore	RB
,	,
GR	NN
number	NN
failed	VBD
to	TO
normalize	VB
after	IN
incubation	NN
in	IN
media	NNS
alone	RB
or	CC
IL-2	NN
and	CC
IL-4	NN
.	.

Therefore	RB
,	,
SR	JJ
asthma	NN
may	MD
be	VB
due	JJ
to	TO
more	JJR
than	IN
one	CD
abnormality	NN
,	,
the	DT
majority	NN
related	JJ
to	TO
a	DT
reversible	JJ
cytokine-induced	JJ
reduction	NN
in	IN
GR	NN
binding	NN
affinity	NN
and	CC
the	DT
second	JJ
related	JJ
to	TO
an	DT
irreversible	JJ
reduction	NN
in	IN
GR	NN
number	NN
.	.

These	DT
findings	NNS
may	MD
have	VB
important	JJ
implications	NNS
for	IN
the	DT
design	NN
of	IN
alternative	JJ
treatment	NN
approaches	NNS
for	IN
recalcitrant	JJ
asthma	NN
.	.

UI	LS
-	:
97047764	CD

TI	LS
-	:
The	DT
catalytic	JJ
domain	NN
of	IN
pp56(lck)	NN
,	,
but	CC
not	RB
its	PRP$
regulatory	JJ
domain	NN
,	,
is	VBZ
sufficient	JJ
for	IN
inducing	VBG
IL-2	NN
production	NN
.	.

AB	LS
-	:
The	DT
lymphoid	JJ
src	NN
kinase	NN
pp56(lck)	NN
has	VBZ
been	VBN
shown	VBN
to	TO
be	VB
essential	JJ
for	IN
the	DT
induction	NN
of	IN
different	JJ
T	NN
lymphocyte	NN
responses	NNS
,	,
including	VBG
CD4-mediated	JJ
enhancement	NN
of	IN
Ag-induced	JJ
T	NN
cell	NN
activation	NN
,	,
early	JJ
T	NN
cell	NN
differentiation	NN
,	,
induction	NN
of	IN
IL-2	NN
production	NN
,	,
and	CC
cytotoxicity	NN
.	.

It	PRP
is	VBZ
assumed	VBN
that	IN
pp56(lck)	NN
acts	VBZ
on	IN
these	DT
processes	NNS
by	IN
phosphorylating	VBG
substrates	NNS
.	.

However	RB
,	,
it	PRP
has	VBZ
been	VBN
recently	RB
reported	VBN
that	IN
the	DT
NH2	NN
regulatory	JJ
domain	NN
is	VBZ
sufficient	JJ
to	TO
mediate	VB
CD4	NN
accessory	JJ
function	NN
.	.

In	IN
this	DT
report	NN
we	PRP
address	VBP
the	DT
contribution	NN
of	IN
the	DT
regulatory	JJ
and	CC
catalytic	JJ
domains	NNS
of	IN
pp56(lck)	NN
to	TO
another	DT
function	NN
of	IN
this	DT
enzyme	NN
independent	JJ
of	IN
CD4	NN
:	:
TCR-induced	JJ
IL-2	NN
production	NN
.	.

Two	CD
pp56(lck)	NN
mutants	NNS
lacking	VBG
either	CC
the	DT
entire	JJ
catalytic	JJ
domain	NN
or	CC
the	DT
entire	JJ
NH2	NN
regulatory	JJ
domain	NN
were	VBD
generated	VBN
,	,
and	CC
their	PRP$
abilities	NNS
to	TO
trigger	VB
transactivation	NN
of	IN
the	DT
TCR-regulated	JJ
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
(	(
NF-AT	NN
)	)
region	NN
of	IN
the	DT
IL-2	NN
promoter	NN
were	VBD
compared	VBN
.	.

Only	RB
the	DT
catalytic	JJ
,	,
but	CC
not	RB
the	DT
NH2	NN
regulatory	JJ
,	,
domain	NN
of	IN
pp56(lck)	NN
was	VBD
able	JJ
to	TO
induce	VB
NF-AT	NN
region	NN
transactivation	NN
on	IN
its	PRP$
own	JJ
and	CC
to	TO
cooperate	VB
with	IN
other	JJ
intracellular	JJ
signals	NNS
to	TO
trigger	VB
this	DT
response	NN
.	.

Moreover	RB
,	,
the	DT
catalytic	JJ
domain	NN
of	IN
pp56(lck)	NN
was	VBD
able	JJ
to	TO
induce	VB
IL-2	NN
cytokine	NN
production	NN
to	TO
an	DT
extent	NN
similar	JJ
to	TO
that	DT
of	IN
wild-type	JJ
pp56(lck)	NN
.	.

We	PRP
conclude	VBP
that	IN
different	JJ
domains	NNS
of	IN
the	DT
pp56(lck)	NN
molecule	NN
contribute	VBP
to	TO
regulate	VB
distinct	JJ
biologic	JJ
functions	NNS
.	.

In	IN
fact	NN
,	,
while	IN
the	DT
NH2	NN
regulatory	JJ
domain	NN
is	VBZ
sufficient	JJ
to	TO
mediate	VB
CD4	NN
accessory	JJ
function	NN
,	,
we	PRP
show	VBP
here	RB
that	IN
the	DT
catalytic	JJ
domain	NN
of	IN
pp56(lck)	NN
is	VBZ
sufficient	JJ
for	IN
induction	NN
of	IN
IL-2	NN
production	NN
,	,
mimicking	VBG
TCR	NN
ligation	NN
.	.

UI	LS
-	:
95104037	CD

TI	LS
-	:
[	(
The	DT
changes	NNS
in	IN
glucocorticoid	NN
receptors	NNS
in	IN
peripheral	JJ
leukocytes	NNS
in	IN
asthmatic	JJ
subjects	NNS
]	)

AB	LS
-	:
The	DT
number	NN
of	IN
glucocorticoid	NN
receptors	NNS
(	(
GCR	NN
)	)
in	IN
peripheral	JJ
leukocytes	NNS
was	VBD
determined	VBN
by	IN
radioligand-binding	JJ
assay	NN
in	IN
extrinsic	JJ
and	CC
intrinsic	JJ
asthmatics	NNS
.	.

Their	PRP$
corresponding	JJ
plasma	NN
cortisol	NN
levels	NNS
were	VBD
assessed	VBN
.	.

The	DT
results	NNS
showed	VBD
that	IN
the	DT
average	JJ
number	NN
of	IN
GCR	NN
in	IN
asthmatics	NNS
was	VBD
significantly	RB
lower	JJR
than	IN
that	DT
in	IN
healthy	JJ
subjects	NNS
(	(
P	NN
<	JJR
0.01	CD
)	)
,	,
and	CC
there	EX
was	VBD
a	DT
linear	JJ
correlation	NN
between	IN
the	DT
number	NN
of	IN
GCR	NN
and	CC
the	DT
course	NN
of	IN
asthma	NN
.	.

Besides	RB
,	,
there	EX
was	VBD
also	RB
a	DT
linear	JJ
correlation	NN
between	IN
the	DT
number	NN
of	IN
GCR	NN
and	CC
the	DT
age	NN
of	IN
the	DT
initial	JJ
attack	NN
of	IN
asthma	NN
.	.

No	DT
difference	NN
in	IN
plasma	NN
cortisol	NN
level	NN
was	VBD
found	VBN
between	IN
asthmatics	NNS
and	CC
healthy	JJ
subjects	NNS
.	.

These	DT
findings	NNS
suggest	VBP
that	IN
there	EX
is	VBZ
no	DT
primary	JJ
and	CC
general	JJ
impairment	NN
of	IN
glucocorticoid	NN
metabolism	NN
in	IN
the	DT
asthmatics	NNS
,	,
but	CC
the	DT
number	NN
of	IN
GCR	NN
in	IN
the	DT
asthmatics	NNS
is	VBZ
lower	JJR
than	IN
that	DT
in	IN
healthy	JJ
controls	NNS
.	.

The	DT
decrease	NN
of	IN
the	DT
number	NN
of	IN
GCR	NN
in	IN
asthmatics	NNS
,	,
we	PRP
think	VBP
,	,
is	VBZ
related	JJ
to	TO
heredity	NN
and	CC
repeated	VBN
attacks	NNS
of	IN
asthma	NN
.	.

UI	LS
-	:
94249033	CD

TI	LS
-	:
Novel	JJ
aldosterone	NN
receptors	NNS
:	:
specificity-conferring	JJ
mechanism	NN
at	IN
the	DT
level	NN
of	IN
the	DT
cell	NN
membrane	NN
.	.

AB	LS
-	:
Functional	JJ
studies	NNS
in	IN
extra-renal	JJ
,	,
nonepithelial	JJ
cells	NNS
such	JJ
as	IN
smooth	JJ
muscle	NN
cells	NNS
and	CC
more	RBR
recently	RB
circulating	VBG
human	JJ
lymphocytes	NNS
have	VBP
provided	VBN
increasing	VBG
evidence	NN
that	IN
aldosterone	NN
produces	VBZ
not	RB
only	RB
classical	JJ
genomic	JJ
effects	NNS
,	,
but	CC
also	RB
rapid	JJ
non-genomic	JJ
effects	NNS
on	IN
transmembrane	NN
electrolyte	NN
movements	NNS
.	.

These	DT
involve	VBP
activation	NN
of	IN
the	DT
sodium/proton-exchanger	NN
of	IN
the	DT
cell	NN
membrane	NN
at	IN
very	RB
low	JJ
,	,
physiological	JJ
concentrations	NNS
of	IN
aldosterone	NN
with	IN
an	DT
acute	JJ
onset	NN
within	IN
1-2	CD
minutes	NNS
.	.

A	DT
second	JJ
messenger	NN
cascade	NN
involved	VBN
is	VBZ
the	DT
inositol-1,4,5-trisphosphate/calcium	NN
pathway	NN
which	WDT
responds	VBZ
over	IN
the	DT
same	JJ
rapid	JJ
time	NN
course	NN
.	.

Such	JJ
changes	NNS
clearly	RB
can	MD
not	RB
be	VB
explained	VBN
by	IN
genomic	JJ
mechanisms	NNS
,	,
which	WDT
are	VBP
responsible	JJ
for	IN
later	JJ
effects	NNS
than	IN
the	DT
membrane-related	JJ
rapid	JJ
responses	NNS
.	.

In	IN
addition	NN
to	TO
its	PRP$
rapid	JJ
time	NN
course	NN
the	DT
unique	JJ
characteristics	NNS
of	IN
this	DT
new	JJ
pathway	NN
for	IN
steroid	NN
action	NN
include	VBP
a	DT
10000-fold	JJ
selectivity	NN
for	IN
aldosterone	NN
over	IN
cortisol	NN
and	CC
the	DT
ineffectiveness	NN
of	IN
spironolactones	NNS
,	,
classical	JJ
mineralocorticoid	NN
antagonists	NNS
,	,
as	IN
antagonists	NNS
of	IN
the	DT
response	NN
.	.

Subsequently	RB
binding	VBG
sites	NNS
have	VBP
been	VBN
demonstrated	VBN
in	IN
the	DT
plasma	NN
membrane	NN
of	IN
human	JJ
lymphocytes	NNS
which	WDT
show	VBP
pharmacological	JJ
(	(
aldosterone	NN
specificity	NN
)	)
and	CC
kinetic	JJ
(	(
high	JJ
turnover	NN
)	)
properties	NNS
identical	JJ
with	IN
those	DT
of	IN
the	DT
rapid	JJ
aldosterone	NN
effects	NNS
in	IN
the	DT
same	JJ
cells	NNS
.	.

SDS-PAGE	NN
analysis	NN
of	IN
the	DT
receptor	NN
protein	NN
has	VBZ
shown	VBN
a	DT
molecular	JJ
weight	NN
of	IN
approximately	RB
50	CD
kD	NN
.	.

The	DT
present	JJ
paper	NN
reviews	VBZ
the	DT
data	NNS
supporting	VBG
a	DT
new	JJ
,	,
two-step	JJ
model	NN
for	IN
non-genomic	JJ
and	CC
genomic	JJ
aldosterone	NN
effects	NNS
.	.

It	PRP
also	RB
suggests	VBZ
a	DT
novel	JJ
specificity-conferring	JJ
mechanism	NN
for	IN
mineralocorticoid	NN
action	NN
at	IN
the	DT
membrane	NN
level	NN
.	.

UI	LS
-	:
97047763	CD

TI	LS
-	:
Tyrosines	NNS
113	CD
,	,
128	CD
,	,
and	CC
145	CD
of	IN
SLP-76	NN
are	VBP
required	VBN
for	IN
optimal	JJ
augmentation	NN
of	IN
NFAT	NN
promoter	NN
activity	NN
.	.

AB	LS
-	:
SLP-76	NN
(	(
SH2	NN
domain	NN
leukocyte	NN
protein	NN
of	IN
76	CD
kDa	NN
)	)
is	VBZ
a	DT
recently	RB
identified	VBN
substrate	NN
of	IN
the	DT
TCR-stimulated	JJ
protein	NN
tyrosine	NN
kinases	NNS
that	WDT
functions	VBZ
in	IN
the	DT
signal	NN
transduction	NN
cascade	NN
linking	VBG
the	DT
TCR	NN
with	IN
IL-2	NN
gene	NN
expression	NN
.	.

In	IN
this	DT
report	NN
,	,
we	PRP
demonstrate	VBP
that	IN
engagement	NN
of	IN
the	DT
TCR	NN
results	VBZ
in	IN
tyrosine	NN
phosphorylation	NN
of	IN
SLP-76	NN
in	IN
its	PRP$
amino-terminal	JJ
acidic	JJ
region	NN
.	.

Two	CD
tyrosines	NNS
(	(
Y113	NN
and	CC
Y128	NN
)	)
fall	VBP
within	IN
an	DT
identical	JJ
five	CD
amino-acid	JJ
motif	NN
and	CC
are	VBP
shown	VBN
to	TO
be	VB
phosphorylated	VBN
upon	IN
TCR	NN
ligation	NN
.	.

Although	IN
mutation	NN
of	IN
either	CC
Y113	NN
and	CC
Y128	NN
has	VBZ
a	DT
minimal	JJ
effect	NN
on	IN
SLP-76	NN
function	NN
,	,
mutation	NN
of	IN
both	DT
residues	NNS
decreases	VBZ
significantly	RB
the	DT
ability	NN
of	IN
SLP-76	NN
to	TO
promote	VB
T	NN
cell	NN
activation	NN
.	.

A	DT
third	JJ
tyrosine	NN
within	IN
the	DT
amino-terminal	JJ
region	NN
(	(
Y145	NN
)	)
appears	VBZ
to	TO
be	VB
the	DT
most	RBS
important	JJ
for	IN
optimal	JJ
SLP-76	NN
function	NN
,	,
as	IN
altering	VBG
it	PRP
alone	RB
to	TO
phenylalanine	NN
has	VBZ
a	DT
potent	JJ
impact	NN
on	IN
SLP-76	NN
augmentation	NN
of	IN
NFAT	NN
promoter	NN
activity	NN
.	.

UI	LS
-	:
96437048	CD

TI	LS
-	:
Interstitial	JJ
deletion	NN
constitutes	VBZ
the	DT
major	JJ
mechanism	NN
for	IN
loss	NN
of	IN
heterozygosity	NN
on	IN
chromosome	NN
20q	NN
in	IN
polycythemia	NN
vera	NN
.	.

AB	LS
-	:
An	DT
acquired	VBN
deletion	NN
of	IN
the	DT
long	JJ
arm	NN
of	IN
chromosome	NN
20	CD
is	VBZ
a	DT
recurrent	JJ
abnormality	NN
in	IN
myeloproliferative	JJ
disorders	NNS
,	,
particularly	RB
polycythemia	NN
vera	NN
and	CC
myelodysplastic	JJ
syndromes	NNS
.	.

The	DT
association	NN
of	IN
20q	NN
deletions	NNS
with	IN
myeloid	JJ
"	``
stem	NN
cell	NN
"	''
disorders	NNS
suggests	VBZ
that	IN
the	DT
deletions	NNS
mark	VBP
the	DT
site	NN
of	IN
one	CD
or	CC
more	JJR
genes	NNS
,	,
loss	NN
or	CC
inactivation	NN
of	IN
which	WDT
plays	VBZ
a	DT
role	NN
in	IN
the	DT
regulation	NN
of	IN
normal	JJ
hematopoietic	JJ
progenitors	NNS
.	.

We	PRP
have	VBP
recently	RB
performed	VBN
a	DT
detailed	JJ
molecular	JJ
analysis	NN
of	IN
20q	JJ
deletions	NNS
in	IN
peripheral	JJ
blood	NN
(	(
PB	NN
)	)
granulocytes	NNS
and	CC
defined	VBN
a	DT
commonly	RB
deleted	VBN
region	NN
of	IN
16	CD
to	TO
21	CD
centimorgan	NN
(	(
cM	NN
)	)
.	.

To	TO
further	RBR
reduce	VB
the	DT
size	NN
of	IN
the	DT
common	JJ
deleted	VBN
region	NN
we	PRP
have	VBP
searched	VBN
for	IN
small	JJ
deletions	NNS
or	CC
mitotic	JJ
recombination	NN
events	NNS
,	,
neither	DT
of	IN
which	WDT
would	MD
be	VB
detected	VBN
by	IN
conventional	JJ
cytogenetics	NNS
.	.

We	PRP
have	VBP
studied	VBN
48	CD
patients	NNS
with	IN
polycythemia	NN
vera	NN
and	CC
four	CD
patients	NNS
with	IN
idiopathic	JJ
myelofibrosis	NN
.	.

In	IN
each	DT
case	NN
,	,
cytogenetic	JJ
analysis	NN
had	VBD
either	RB
failed	VBN
or	CC
had	VBD
shown	VBN
no	DT
abnormalities	NNS
of	IN
chromosome	NN
20	CD
.	.

Seventeen	CD
microsatellite	NN
markers	NNS
that	WDT
span	VBP
the	DT
common	JJ
deleted	VBN
region	NN
were	VBD
used	VBN
to	TO
search	VB
for	IN
loss	NN
of	IN
heterozygosity	NN
in	IN
granulocyte	NN
DNA	NN
.	.

No	DT
instance	NN
of	IN
microsatellite	NN
instability	NN
was	VBD
observed	VBN
in	IN
a	DT
total	NN
of	IN
880	CD
comparisons	NNS
of	IN
granulocyte	NN
and	CC
T-cell	NN
DNA	NN
.	.

Granulocyte	NN
DNA	NN
from	IN
four	CD
patients	NNS
exhibited	VBD
allele	NN
loss	NN
on	IN
20q	NN
.	.

In	IN
each	DT
case	NN
the	DT
allele	NN
loss	NN
was	VBD
caused	VBN
by	IN
an	DT
interstitial	JJ
deletion	NN
because	IN
heterozygosity	NN
at	IN
distal	JJ
markers	NNS
was	VBD
retained	VBN
and	CC
because	IN
quantitative	JJ
Southern	NN
blotting	NN
demonstrated	VBD
hemizygosity	NN
.	.

Loss	NN
of	IN
heterozygosity	NN
in	IN
PB	NN
granulocytes	NNS
would	MD
be	VB
masked	VBN
by	IN
the	DT
presence	NN
of	IN
significant	JJ
numbers	NNS
of	IN
normal	JJ
granulocytes	NNS
not	RB
derived	VBN
from	IN
the	DT
malignant	JJ
clone	NN
.	.

Therefore	RB
,	,
the	DT
human	JJ
androgen	NN
receptor	NN
assay	NN
(	(
HUMARA	NN
)	)
was	VBD
used	VBN
to	TO
determine	VB
granulocyte	NN
clonality	NN
.	.

In	IN
21	CD
of	IN
27	CD
informative	JJ
female	NN
patients	NNS
the	DT
majority	NN
of	IN
the	DT
granulocytes	NNS
were	VBD
clonally	RB
derived	VBN
.	.

In	IN
5	CD
patients	NNS
the	DT
granulocytes	NNS
appeared	VBD
polyclonal	JJ
and	CC
in	IN
1	CD
patient	NN
unilateral	JJ
X	NN
inactivation	NN
was	VBD
observed	VBN
in	IN
both	CC
granulocytes	NNS
and	CC
T	JJ
cells	NNS
.	.

These	DT
results	NNS
show	VBP
that	IN
,	,
in	IN
the	DT
vast	JJ
majority	NN
of	IN
patients	NNS
presented	VBN
here	RB
,	,
the	DT
failure	NN
to	TO
detect	VB
loss	NN
of	IN
heterozygosity	NN
can	MD
not	RB
be	VB
attributed	VBN
to	TO
the	DT
presence	NN
of	IN
normal	JJ
polyclonal	JJ
granulocytes	NNS
.	.

Our	PRP$
results	NNS
therefore	RB
show	VBP
that	IN
allele	NN
loss	NN
on	IN
chromosome	NN
20q	NN
in	IN
polycythemia	NN
vera	NN
does	VBZ
not	RB
commonly	RB
involve	VB
mitotic	JJ
recombination	NN
or	CC
chromosome	NN
loss	NN
and	CC
that	IN
microsatellite	NN
instability	NN
is	VBZ
a	DT
rare	JJ
event	NN
in	IN
this	DT
disorder	NN
.	.

UI	LS
-	:
96323103	CD

TI	LS
-	:
Various	JJ
modes	NNS
of	IN
basic	JJ
helix-loop-helix	JJ
protein-mediated	JJ
regulation	NN
of	IN
murine	JJ
leukemia	NN
virus	NN
transcription	NN
in	IN
lymphoid	JJ
cell	NN
lines	NNS
.	.

AB	LS
-	:
The	DT
transcriptionally	RB
regulatory	JJ
regions	NNS
of	IN
the	DT
lymphomagenic	JJ
Akv	NN
and	CC
SL3-3	NN
murine	JJ
leukemia	NN
retroviruses	NNS
(	(
MLVs	NNS
)	)
contain	VBP
two	CD
types	NNS
of	IN
E-box	NN
consensus	NN
motifs	NNS
,	,
CAGATG	NN
.	.

One	CD
type	NN
,	,
EA/S	NN
,	,
is	VBZ
located	JJ
in	IN
the	DT
upstream	JJ
promoter	NN
region	NN
,	,
and	CC
the	DT
other	JJ
,	,
E	NN
(	(
gre	NN
)	)
,	,
is	VBZ
located	JJ
in	IN
a	DT
tandem	JJ
repeat	NN
with	IN
enhancer	NN
properties	NNS
.	.

We	PRP
have	VBP
examined	VBN
the	DT
requirements	NNS
of	IN
the	DT
individual	JJ
E-boxes	NNS
in	IN
MLV	NN
transcriptional	JJ
regulation	NN
.	.

In	IN
lymphoid	JJ
cell	NN
lines	NNS
only	RB
,	,
the	DT
E	NN
(	(
gre	NN
)	)
-binding	JJ
protein	NN
complexes	NNS
included	VBD
ALF1	NN
or	CC
HEB	NN
and	CC
E2A	NN
basic	JJ
helix-loop-helix	JJ
proteins	NNS
.	.

Ectopic	JJ
ALF1	NN
and	CC
E2A	NN
proteins	NNS
required	VBD
intact	JJ
E	NN
(	(
gre	NN
)	)
motifs	NNS
for	IN
mediating	VBG
transcriptional	JJ
activation	NN
.	.

ALF1	NNP
transactivated	VBD
transcription	NN
of	IN
Akv	NN
MLV	NN
through	IN
the	DT
two	CD
E	NN
(	(
gre	NN
)	)
motifs	NNS
equally	RB
,	,
whereas	IN
E2A	NN
protein	NN
required	VBD
the	DT
promoter-proximal	JJ
E	NN
(	(
gre	NN
)	)
motif	NN
.	.

In	IN
T-	NN
and	CC
B-cell	NN
lines	NNS
,	,
the	DT
E	NN
(	(
gre	NN
)	)
motifs	NNS
were	VBD
of	IN
major	JJ
importance	NN
for	IN
Akv	NN
MLV	NN
transcriptional	JJ
activity	NN
,	,
while	IN
the	DT
EA/S	NN
motif	NN
had	VBD
some	DT
effect	NN
.	.

In	IN
contrast	NN
,	,
neither	CC
E	NN
(	(
gre	NN
)	)
nor	CC
EA/S	NN
motifs	NNS
contributed	VBD
pronouncedly	RB
to	TO
Akv	NN
MLV	NN
transcription	NN
in	IN
NIH	NN
3T3	NN
cells	NNS
lacking	VBG
DNA-binding	JJ
ALF1	NN
or	CC
HEB	NN
and	CC
E2A	NN
proteins	NNS
.	.

The	DT
Id1	NN
protein	NN
was	VBD
found	VBN
to	TO
repress	VB
ALF1	NN
activity	NN
in	FW
vitro	FW
and	CC
in	FW
vivo	FW
.	.

Moreover	RB
,	,
ectopic	JJ
Id1	NN
repressed	VBD
E	NN
(	(
gre	NN
)	)
-directed	JJ
but	CC
not	RB
EA/S-directed	JJ
MLV	NN
transcription	NN
in	IN
lymphoid	JJ
cell	NN
lines	NNS
.	.

In	IN
conclusion	NN
,	,
E	NN
(	(
gre	NN
)	)
motifs	NNS
and	CC
interacting	VBG
basic	JJ
helix-loop-helix	JJ
proteins	NNS
are	VBP
important	JJ
determinants	NNS
for	IN
MLV	NN
transcriptional	JJ
activity	NN
in	IN
lymphocytic	JJ
cell	NN
lines	NNS
.	.

UI	LS
-	:
96353908	CD

TI	LS
-	:
Peptide	NN
vaccination	NN
can	MD
lead	VB
to	TO
enhanced	VBN
tumor	NN
growth	NN
through	IN
specific	JJ
T-cell	NN
tolerance	NN
induction	NN
.	.

AB	LS
-	:
Vaccination	NN
with	IN
synthetic	JJ
peptides	NNS
representing	VBG
cytotoxic	JJ
T	NN
lymphocyte	NN
(	(
CTL	NN
)	)
epitopes	NNS
can	MD
lead	VB
to	TO
a	DT
protective	JJ
CTL-mediated	JJ
immunity	NN
against	IN
tumors	NNS
or	CC
viruses	NNS
.	.

We	PRP
now	RB
report	VBP
that	IN
vaccination	NN
with	IN
a	DT
CTL	NN
epitope	NN
derived	VBN
from	IN
the	DT
human	JJ
adenovirus	NN
type	NN
5	CD
E1A-region	NN
(	(
Ad5E1A234-243	NN
)	)
,	,
which	WDT
can	MD
serve	VB
as	IN
a	DT
target	NN
for	IN
tumor-eradicating	JJ
CTL	NN
,	,
enhances	VBZ
rather	RB
than	IN
inhibits	VBZ
the	DT
growth	NN
of	IN
Ad5E1A-expressing	JJ
tumors	NNS
.	.

This	DT
adverse	JJ
effect	NN
of	IN
peptide	NN
vaccination	NN
was	VBD
rapidly	RB
evoked	VBN
,	,
required	VBD
low	JJ
doses	NNS
of	IN
peptide	NN
(	(
10	CD
micrograms	NNS
)	)
,	,
and	CC
was	VBD
achieved	VBN
by	IN
a	DT
mode	NN
of	IN
peptide	NN
delivery	NN
that	WDT
induces	VBZ
protective	JJ
T-cell-mediated	JJ
immunity	NN
in	IN
other	JJ
models	NNS
.	.

Ad5E1A-specific	JJ
CTL	NN
activity	NN
could	MD
no	RB
longer	RB
be	VB
isolated	VBN
from	IN
mice	NNS
after	IN
injection	NN
of	IN
Ad5E1A-peptide	NN
,	,
indicating	VBG
that	IN
tolerization	NN
of	IN
Ad5E1A-specific	JJ
CTL	NN
activity	NN
causes	VBZ
the	DT
enhanced	VBN
tumor	NN
outgrowth	NN
.	.

In	IN
contrast	NN
to	TO
peptide	NN
vaccination	NN
,	,
immunization	NN
with	IN
adenovirus	NN
,	,
expressing	VBG
Ad5E1A	NN
,	,
induced	VBD
Ad5E1A-specific	JJ
immunity	NN
and	CC
prevented	VBD
the	DT
outgrowth	NN
of	IN
Ad5E1A-expressing	JJ
tumors	NNS
.	.

These	DT
results	NNS
show	VBP
that	IN
immunization	NN
with	IN
synthetic	JJ
peptides	NNS
can	MD
lead	VB
to	TO
the	DT
elimination	NN
of	IN
anti-tumor	JJ
CTL	NN
responses	NNS
.	.

These	DT
findings	NNS
are	VBP
important	JJ
for	IN
the	DT
design	NN
of	IN
safe	JJ
peptide-based	JJ
vaccines	NNS
against	IN
tumors	NNS
,	,
allogeneic	JJ
organ	NN
transplants	NNS
,	,
and	CC
T-cell-mediated	JJ
autoimmune	JJ
diseases	NNS
.	.

UI	LS
-	:
96409256	CD

TI	LS
-	:
Abnormality	NN
of	IN
Oct-1	NN
DNA	NN
binding	NN
in	IN
T	NN
cells	NNS
from	IN
Sjogren	NN
's	POS
syndrome	NN
patients	NNS
.	.

AB	LS
-	:
Primary	JJ
Sjogren	NN
's	POS
syndrome	NN
(	(
SS	NN
)	)
is	VBZ
an	DT
autoimmune	JJ
rheumatic	JJ
disease	NN
characterized	VBN
by	IN
T	NN
cell	NN
hypoactivity	NN
.	.

To	TO
understand	VB
the	DT
diminished	VBN
T	NN
cell	NN
response	NN
to	TO
activation	NN
signals	NNS
,	,
we	PRP
measured	VBD
nucleoprotein	NN
DNA-binding	JJ
activities	NNS
regulating	VBG
gene	NN
expression	NN
during	IN
T	NN
cell	NN
activation	NN
using	VBG
the	DT
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
.	.

Peripheral	JJ
blood	NN
lymphocytes	NNS
from	IN
9/19	CD
SS	NN
patients	NNS
were	VBD
found	VBN
to	TO
be	VB
defective	JJ
in	IN
their	PRP$
ability	NN
to	TO
bind	VB
an	DT
october	NN
sequence	NN
(	(
Oct-1	NN
)	)
.	.

This	DT
Oct-1-binding	JJ
phenotype	NN
remained	VBD
stable	JJ
in	IN
culture	NN
for	IN
up	IN
to	TO
3	CD
days	NNS
prior	RB
to	TO
activation	NN
.	.

This	DT
abnormality	NN
was	VBD
not	RB
seen	VBN
in	IN
resting	VBG
T	NN
cells	NNS
nor	CC
T	NN
cells	NNS
from	IN
patients	NNS
with	IN
systemic	JJ
lupus	NN
erythematosus	NN
,	,
rheumatoid	JJ
arthritis	NN
(	(
RA	NN
)	)
,	,
or	CC
SS	NN
accompanied	VBN
by	IN
RA	NN
.	.

The	DT
SS	NN
Oct-1	NN
DNA-binding	JJ
abnormality	NN
correlated	VBD
significantly	RB
with	IN
an	DT
inability	NN
of	IN
cells	NNS
to	TO
exit	VB
the	DT
Gzero/G1	NN
cell	NN
cycle	NN
phase	NN
when	WRB
stimulated	VBN
in	FW
vitro	FW
.	.

Importantly	RB
,	,
nucleoprotein	NN
extracts	NNS
showing	VBG
decreased	VBN
DNA-binding	JJ
activity	NN
had	VBD
normal	JJ
amounts	NNS
of	IN
Oct-1	NN
proteins	NNS
as	IN
determined	VBN
by	IN
immunoprecipitation	NN
,	,
implying	VBG
a	DT
functional	JJ
defect	NN
in	IN
the	DT
Oct-1	NN
protein	NN
.	.

Moreover	RB
,	,
defective	JJ
DNA	NN
binding	NN
was	VBD
corrected	VBN
by	IN
treatment	NN
with	IN
acid	NN
phosphatase	NN
.	.

UI	LS
-	:
97119289	CD

TI	LS
-	:
Lymphocytes	NNS
from	IN
CML	NN
patients	NNS
lack	VBP
a	DT
47	CD
kDa	NN
factor	NN
having	VBG
affinity	NN
for	IN
a	DT
genomic	JJ
sterol	NN
regulatory	JJ
sequence	NN
.	.

AB	LS
-	:
Deranged	VBN
cellular	JJ
cholesterol	NN
homeostasis	NN
has	VBZ
been	VBN
widely	RB
recognized	VBN
in	IN
the	DT
initiation	NN
as	RB
well	RB
as	IN
progression	NN
of	IN
various	JJ
types	NNS
of	IN
cancers	NNS
including	VBG
chronic	JJ
myeloid	JJ
leukaemia	NN
(	(
CML	NN
)	)
.	.

Since	IN
the	DT
human	JJ
genomic	JJ
sterol	NN
regulatory	JJ
element	NN
(	(
SRE	NN
)	)
has	VBZ
been	VBN
shown	VBN
to	TO
regulate	VB
various	JJ
key	JJ
genes	NNS
involved	VBN
in	IN
this	DT
phenomenon	NN
,	,
the	DT
present	JJ
study	NN
revealed	VBD
the	DT
existence	NN
of	IN
a	DT
unique	JJ
47	CD
kDa	NN
protein	NN
factor	NN
having	VBG
affinity	NN
for	IN
this	DT
SRE	JJ
sequence	NN
in	IN
lymphocytes	NNS
from	IN
normal	JJ
subjects	NNS
,	,
as	RB
well	RB
as	IN
its	PRP$
absence	NN
in	IN
lymphocytes	NNS
from	IN
untreated	JJ
CML	NN
patients	NNS
.	.

However	RB
,	,
this	DT
factor	NN
appeared	VBD
when	WRB
these	DT
CML	NN
patients	NNS
achieved	VBD
complete	JJ
haematological	JJ
remission	NN
(	(
CHR	NN
)	)
through	IN
alpha-interferon	NN
therapy	NN
.	.

Furthermore	RB
,	,
an	DT
inverse	JJ
relationship	NN
was	VBD
also	RB
observed	VBN
between	IN
the	DT
LDL	NN
receptor	NN
gene	NN
expression	NN
at	IN
the	DT
transcriptional	JJ
level	NN
and	CC
the	DT
binding	NN
affinity	NN
of	IN
this	DT
47	CD
kDa	NN
protein	NN
factor	NN
to	TO
the	DT
SRE	NN
sequence	NN
.	.

Based	VBN
upon	IN
these	DT
results	NNS
we	PRP
propose	VBP
that	IN
this	DT
factor	NN
may	MD
have	VB
a	DT
role	NN
in	IN
pathophysiology	NN
of	IN
chronic	JJ
myeloid	JJ
leukaemia	NN
.	.

UI	LS
-	:
96413292	CD

TI	LS
-	:
Cloning	NN
and	CC
characterization	NN
of	IN
the	DT
beta	NN
subunit	NN
of	IN
human	JJ
proximal	JJ
sequence	NN
element-binding	JJ
transcription	NN
factor	NN
and	CC
its	PRP$
involvement	NN
in	IN
transcription	NN
of	IN
small	JJ
nuclear	JJ
RNA	NN
genes	NNS
by	IN
RNA	NN
polymerases	NNS
II	CD
and	CC
III	CD
.	.

AB	LS
-	:
The	DT
proximal	JJ
sequence	NN
element	NN
(	(
PSE	NN
)	)
-binding	JJ
transcription	NN
factor	NN
(	(
PTF	NN
)	)
,	,
which	WDT
binds	VBZ
the	DT
PSE	NN
of	IN
both	CC
RNA	NN
polymerase	NN
II-	NN
and	CC
RNA	NN
polymerase	NN
III-transcribed	JJ
mammalian	JJ
small	JJ
nuclear	JJ
RNA	NN
(	(
snRNA	NN
)	)
genes	NNS
,	,
is	VBZ
essential	JJ
for	IN
their	PRP$
transcription	NN
.	.

We	PRP
previously	RB
reported	VBD
the	DT
purification	NN
of	IN
human	JJ
PTF	NN
,	,
a	DT
complex	NN
of	IN
four	CD
subunits	NNS
,	,
and	CC
the	DT
molecular	JJ
cloning	NN
and	CC
characterization	NN
of	IN
PTF	NN
gamma	NN
and	CC
delta	NN
subunits	NNS
.	.

Here	RB
we	PRP
describe	VBP
the	DT
isolation	NN
and	CC
expression	NN
of	IN
a	DT
cDNA	NN
encoding	VBG
PTF	NN
beta	NN
,	,
as	RB
well	RB
as	IN
functional	JJ
studies	NNS
using	VBG
anti-PTF	JJ
beta	NN
antibodies	NNS
.	.

Native	JJ
PTF	NN
beta	NN
,	,
in	IN
either	CC
protein	NN
fractions	NNS
or	CC
a	DT
PTF-Oct-1-DNA	NN
complex	NN
,	,
can	MD
be	VB
recognized	VBN
by	IN
polyclonal	JJ
antibodies	NNS
raised	VBN
against	IN
recombinant	JJ
PTF	NN
beta	NN
.	.

Immunodepletion	NN
studies	NNS
show	VBP
that	IN
PTF	NN
beta	NN
is	VBZ
required	VBN
for	IN
transcription	NN
of	IN
both	DT
classes	NNS
of	IN
snRNA	NN
genes	NNS
in	FW
vitro	FW
.	.

In	IN
addition	NN
,	,
immunoprecipitation	NN
analyses	NNS
demonstrate	VBP
that	IN
substantial	JJ
and	CC
similar	JJ
molar	JJ
amounts	NNS
of	IN
TATA-binding	JJ
protein	NN
(	(
TBP	NN
)	)
and	CC
TFIIIB90	NN
can	MD
weakly	RB
associate	VBP
with	IN
PTF	NN
at	IN
low	JJ
salt	NN
conditions	NNS
,	,
but	CC
this	DT
association	NN
is	VBZ
dramatically	RB
reduced	VBN
at	IN
high	JJ
salt	NN
concentrations	NNS
.	.

Along	IN
with	IN
our	PRP$
previous	JJ
demonstration	NN
of	IN
both	DT
physical	JJ
interactions	NNS
between	IN
PTF	NN
gamma	NN
/	:
PTF	NN
delta	NN
and	CC
TBP	NN
and	CC
the	DT
involvement	NN
of	IN
TFIIIB90	NN
in	IN
the	DT
transcription	NN
of	IN
class	NN
III	CD
snRNA	NN
genes	NNS
,	,
these	DT
results	NNS
are	VBP
consistent	JJ
with	IN
the	DT
notion	NN
that	IN
a	DT
TBP-containing	JJ
complex	NN
related	JJ
to	TO
TFIIIB	NN
is	VBZ
required	VBN
for	IN
the	DT
transcription	NN
of	IN
class	NN
III	CD
snRNA	NN
genes	NNS
,	,
and	CC
acts	VBZ
through	IN
weak	JJ
interaction	NN
with	IN
the	DT
four-subunit	JJ
PTF	NN
.	.

UI	LS
-	:
96293454	CD

TI	LS
-	:
BCL-6	NN
,	,
a	DT
POZ/zinc-finger	NN
protein	NN
,	,
is	VBZ
a	DT
sequence-specific	JJ
transcriptional	JJ
repressor	NN
.	.

AB	LS
-	:
Approximately	RB
40	CD
%	NN
of	IN
diffuse	JJ
large	JJ
cell	NN
lymphoma	NN
are	VBP
associated	VBN
with	IN
chromosomal	JJ
translocations	NNS
that	WDT
deregulate	VBP
the	DT
expression	NN
of	IN
the	DT
BCL6	NN
gene	NN
by	IN
juxtaposing	VBG
heterologous	JJ
promoters	NNS
to	TO
the	DT
BCL-6	NN
coding	NN
domain	NN
.	.

The	DT
BCL6	NN
gene	NN
encodes	VBZ
a	DT
95-kDa	JJ
protein	NN
containing	VBG
six	CD
C-terminal	JJ
zinc-finger	NN
motifs	NNS
and	CC
an	DT
N-terminal	JJ
POZ	NN
domain	NN
,	,
suggesting	VBG
that	IN
it	PRP
may	MD
function	VB
as	IN
a	DT
transcription	NN
factor	NN
.	.

By	IN
using	VBG
a	DT
DNA	NN
sequence	NN
selected	VBN
for	IN
its	PRP$
ability	NN
to	TO
bind	VB
recombinant	JJ
BCL-6	NN
in	FW
vitro	FW
,	,
we	PRP
show	VBP
here	RB
that	IN
BCL-6	NN
is	VBZ
present	JJ
in	IN
DNA-binding	JJ
complexes	NNS
in	IN
nuclear	JJ
extracts	NNS
from	IN
various	JJ
B-cell	NN
lines	NNS
.	.

In	IN
transient	JJ
transfectin	NN
experiments	NNS
,	,
BCL6	NN
can	MD
repress	VB
transcription	NN
from	IN
promoters	NNS
linked	VBN
to	TO
its	PRP$
DNA	NN
target	NN
sequence	NN
and	CC
this	DT
activity	NN
is	VBZ
dependent	JJ
upon	IN
specific	JJ
DNA-binding	NN
and	CC
the	DT
presence	NN
of	IN
an	DT
intact	JJ
N-terminal	JJ
half	NN
of	IN
the	DT
protein	NN
.	.

We	PRP
demonstrate	VBP
that	IN
this	DT
part	NN
of	IN
the	DT
BCL6	NN
molecule	NN
contains	VBZ
an	DT
autonomous	JJ
transrepressor	NN
domain	NN
and	CC
that	IN
two	CD
noncontiguous	JJ
regions	NNS
,	,
including	VBG
the	DT
POZ	NN
motif	NN
,	,
mediate	VBP
maximum	JJ
transrepressive	JJ
activity	NN
.	.

These	DT
results	NNS
indicate	VBP
that	IN
the	DT
BCL-6	NN
protein	NN
can	MD
function	VB
as	IN
a	DT
sequence-specific	JJ
transcriptional	JJ
repressor	NN
and	CC
have	VBP
implications	NNS
for	IN
the	DT
role	NN
of	IN
BCL6	NN
in	IN
normal	JJ
lymphoid	JJ
development	NN
and	CC
lymphomagenesis	NN
.	.

UI	LS
-	:
97016536	CD

TI	LS
-	:
Uneven	JJ
X	NN
inactivation	NN
in	IN
a	DT
female	JJ
monozygotic	JJ
twin	JJ
pair	NN
with	IN
Fabry	NN
disease	NN
and	CC
discordant	JJ
expression	NN
of	IN
a	DT
novel	JJ
mutation	NN
in	IN
the	DT
alpha-galactosidase	NN
A	NN
gene	NN
.	.

AB	LS
-	:
We	PRP
describe	VBP
two	CD
female	JJ
monozygotic	JJ
(	(
MZ	JJ
)	)
twins	NNS
heterozygous	JJ
for	IN
Fabry	NN
disease	NN
,	,
an	DT
X	NN
linked	VBN
disorder	NN
resulting	VBG
from	IN
the	DT
deficient	JJ
activity	NN
of	IN
alpha-galactosidase	NN
A	NN
.	.

While	IN
one	CD
of	IN
the	DT
twins	NNS
was	VBD
clinically	RB
affected	VBN
,	,
the	DT
other	JJ
was	VBD
asymptomatic	JJ
.	.

Enzymatic	JJ
assay	NN
of	IN
alpha-galactosidase	NN
in	IN
blood	NN
leucocytes	NNS
,	,
skin	NN
fibroblasts	NNS
,	,
Epstein-Barr	JJ
virus	NN
transformed	VBD
lymphoid	JJ
cell	NN
lines	NNS
,	,
and	CC
hair	NN
follicles	NNS
of	IN
the	DT
twins	NNS
and	CC
their	PRP$
parents	NNS
confirmed	VBD
the	DT
heterozygous	JJ
status	NN
of	IN
the	DT
twins	NNS
and	CC
indicated	VBD
that	IN
Fabry	NN
disease	NN
had	VBD
occurred	VBN
as	IN
a	DT
result	NN
of	IN
a	DT
de	FW
novo	FW
mutation	NN
.	.

The	DT
son	NN
of	IN
the	DT
unaffected	JJ
twin	NN
sister	NN
was	VBD
shown	VBN
to	TO
be	VB
hemizygous	JJ
.	.

Molecular	JJ
analysis	NN
of	IN
the	DT
alpha-galactosidase	NN
A	NN
gene	NN
permitted	VBD
the	DT
identification	NN
of	IN
an	DT
as	RB
yet	RB
undescribed	JJ
point	NN
mutation	NN
at	IN
position	NN
10182	CD
of	IN
exon	NN
5	CD
which	WDT
causes	VBZ
an	DT
Asp	NN
to	TO
Asn	NN
substitution	NN
at	IN
codon	NN
231	CD
.	.

Single	JJ
strand	NN
conformation	NN
polymorphism	NN
(	(
SSCP	NN
)	)
analysis	NN
again	RB
showed	VBD
the	DT
heterozygous	JJ
status	NN
of	IN
the	DT
twins	NNS
and	CC
a	DT
normal	JJ
pattern	NN
in	IN
their	PRP$
parents	NNS
.	.

The	DT
basis	NN
for	IN
the	DT
discordant	JJ
expression	NN
of	IN
this	DT
d	FW
novo	FW
mutation	NN
in	IN
the	DT
twins	NNS
was	VBD
investigated	VBN
by	IN
studying	VBG
their	PRP$
X	NN
inactivation	NN
status	NN
.	.

Analysis	NN
of	IN
the	DT
inactive	JJ
X	NN
specific	JJ
methylation	NN
at	IN
the	DT
androgen	NN
receptor	NN
gene	NN
showed	VBD
unbalanced	JJ
inactivation	NN
in	IN
the	DT
twins	NNS
'	POS
fibroblasts	NNS
and	CC
in	IN
opposite	JJ
directions	NNS
.	.

While	IN
the	DT
maternally	RB
derived	VBN
X	NN
chromosome	NN
was	VBD
preferentially	RB
active	JJ
in	IN
the	DT
asymptomatic	JJ
twin	NN
,	,
the	DT
paternal	JJ
X	NN
chromosome	NN
was	VBD
active	JJ
in	IN
the	DT
other	JJ
,	,
affected	VBN
twin	NN
and	CC
was	VBD
found	VBN
in	IN
her	PRP$
hemizygotic	JJ
nephew	NN
.	.

These	DT
data	NNS
suggest	VBP
that	IN
the	DT
paternal	JJ
X	NN
chromosome	NN
carries	VBZ
the	DT
de	FW
novo	FW
alpha-galactosidase	NN
A	NN
mutation	NN
and	CC
that	IN
uneven	JJ
X	NN
inactivation	NN
is	VBZ
the	DT
underlying	VBG
mechanism	NN
for	IN
disease	NN
expression	NN
in	IN
this	DT
novel	JJ
female	NN
MZ	JJ
twin	NN
pair	NN
.	.

This	DT
is	VBZ
the	DT
first	JJ
documented	VBN
case	NN
of	IN
female	JJ
twins	NNS
discordant	JJ
for	IN
Fabry	NN
disease	NN
.	.

UI	LS
-	:
97108276	CD

TI	LS
-	:
[	(
Cortisone-resistant	JJ
bronchial	JJ
asthma	NN
]	)

AB	LS
-	:
There	EX
is	VBZ
general	JJ
agreement	NN
on	IN
the	DT
inflammatory	JJ
pathogenesis	NN
of	IN
bronchial	JJ
asthma	NN
:	:
an	DT
accumulation	NN
of	IN
activated	VBN
eosinophils	NNS
,	,
degranulated	VBN
mast	NN
cells	NNS
,	,
T	NN
lymphocytes	NNS
and	CC
in	IN
very	RB
severe	JJ
forms	NNS
,	,
granulocytes	NNS
has	VBZ
constantly	RB
been	VBN
found	VBN
in	IN
the	DT
bronchial	JJ
mucosa	NN
.	.

In	IN
allergic	JJ
bronchial	JJ
asthma	NN
,	,
inflammation	NN
seems	VBZ
to	TO
be	VB
orchestrated	VBN
predominantly	RB
by	IN
a	DT
subset	NN
of	IN
T	NN
lymphocytes	NNS
,	,
with	IN
a	DT
phenotype	NN
similar	JJ
to	TO
the	DT
Th2	NN
subset	NN
able	JJ
to	TO
produce	VB
IL-4	NN
and	CC
IL-5	NN
.	.

Although	IN
corticosteroids	NNS
are	VBP
the	DT
most	RBS
potent	JJ
therapeutic	JJ
agents	NNS
used	VBN
for	IN
this	DT
disease	NN
,	,
their	PRP$
anti-inflammatory	JJ
effect	NN
differs	VBZ
from	IN
patient	NN
to	TO
patient	NN
.	.

Some	DT
criteria	NNS
which	WDT
can	MD
be	VB
used	VBN
to	TO
define	VB
steroid-resistant	JJ
bronchial	JJ
asthma	NN
are	VBP
listed	VBN
here	RB
.	.

This	DT
review	NN
analyzes	VBZ
various	JJ
molecular	JJ
alterations	NNS
responsible	JJ
for	IN
the	DT
deficient	JJ
response	NN
to	TO
corticosteroid	NN
treatment	NN
observed	VBN
in	IN
steroid-resistant	JJ
bronchial	JJ
asthmatic	JJ
subjects	NNS
.	.

New	JJ
knowledge	NN
on	IN
the	DT
mechanism	NN
of	IN
steroid	NN
resistance	NN
may	MD
have	VB
important	JJ
implications	NNS
for	IN
the	DT
treatment	NN
of	IN
chronic	JJ
asthma	NN
and	CC
other	JJ
diseases	NNS
.	.

UI	LS
-	:
96382503	CD

TI	LS
-	:
Cross	NN
talk	NN
between	IN
cell	NN
death	NN
and	CC
cell	NN
cycle	NN
progression	NN
:	:
BCL-2	NN
regulates	VBZ
NFAT-mediated	JJ
activation	NN
.	.

AB	LS
-	:
BCL-2-deficient	JJ
T	NN
cells	NNS
demonstrate	VBP
accelerated	VBN
cell	NN
cycle	NN
progression	NN
and	CC
increased	VBN
apoptosis	NN
following	VBG
activation	NN
.	.

Increasing	VBG
the	DT
levels	NNS
of	IN
BCL-2	NN
retarded	VBD
the	DT
G0	NN
-->	TO
S	NN
transition	NN
,	,
sustained	VBD
the	DT
levels	NNS
of	IN
cyclin-dependent	JJ
kinase	NN
inhibitor	NN
p27Kip1	NN
,	,
and	CC
repressed	VBD
postactivation	NN
death	NN
.	.

Proximal	JJ
signal	NN
transduction	NN
events	NNS
and	CC
immediate	JJ
early	JJ
gene	NN
transcription	NN
were	VBD
unaffected	JJ
.	.

However	RB
,	,
the	DT
transcription	NN
and	CC
synthesis	NN
of	IN
interleukin	NN
2	CD
and	CC
other	JJ
delayed	VBN
early	JJ
cytokines	NNS
were	VBD
markedly	RB
attenuated	VBN
by	IN
BCL-2	NN
.	.

In	IN
contrast	NN
,	,
a	DT
cysteine	NN
protease	NN
inhibitor	NN
that	WDT
also	RB
blocks	VBZ
apoptosis	NN
had	VBD
no	DT
substantial	JJ
affect	NN
upon	IN
cytokine	NN
production	NN
.	.

InterleUkin	NN
2	CD
expression	NN
requires	VBZ
several	JJ
transcription	NN
factors	NNS
of	IN
which	WDT
nuclear	JJ
translocation	NN
of	IN
NFAT	NN
(	(
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
)	)
and	CC
NFAT-mediated	JJ
transactivation	NN
were	VBD
impaired	VBN
by	IN
BCL-2	NN
.	.

Thus	RB
,	,
select	JJ
genetic	JJ
aberrations	NNS
in	IN
the	DT
apoptotic	JJ
pathway	NN
reveal	VBP
a	DT
cell	NN
autonomous	JJ
coregulation	NN
of	IN
activation	NN
.	.

UI	LS
-	:
96180219	CD

TI	LS
-	:
Differential	JJ
regulation	NN
of	IN
IL-6	NN
gene	NN
transcription	NN
and	CC
expression	NN
by	IN
IL-4	NN
and	CC
IL-10	NN
in	IN
human	JJ
monocytic	JJ
cell	NN
lines	NNS
.	.

AB	LS
-	:
IL-4	NN
and	CC
IL-10	NN
inhibit	VBP
the	DT
cytokine	NN
production	NN
and	CC
mRNA	NN
expression	NN
by	IN
monocytes/macrophages	NNS
.	.

To	TO
investigate	VB
the	DT
molecular	JJ
mechanism	NN
of	IN
the	DT
inhibitory	JJ
effect	NN
on	IN
transcriptional	JJ
or	CC
post-transcriptional	JJ
regulation	NN
of	IN
IL-6	NN
gene	NN
expression	NN
by	IN
IL-4	NN
and	CC
IL-10	NN
,	,
we	PRP
studied	VBD
IL-6	NN
production	NN
,	,
expression	NN
level	NN
of	IN
IL-6	NN
mRNA	NN
,	,
IL-6	NN
promoter	NN
activity	NN
,	,
transcriptional	JJ
activity	NN
of	IN
NF-kappaB	NN
and	CC
NF-IL-6	NN
,	,
and	CC
IL-6	NN
mRNA	NN
stability	NN
in	IN
human	JJ
monocytic	JJ
cell	NN
lines	NNS
,	,
THP-1	NN
and	CC
U937	NN
,	,
stimulated	VBN
by	IN
PMA	NN
and	CC
LPS	NN
in	IN
the	DT
absence	NN
or	CC
the	DT
presence	NN
of	IN
IL-4	NN
or	CC
IL-10	NN
.	.

Both	CC
IL-4	NN
and	CC
IL-10	NN
were	VBD
seen	VBN
to	TO
inhibit	VB
IL-6	NN
production	NN
and	CC
the	DT
expression	NN
of	IN
IL-6	NN
mRNA	NN
in	IN
both	DT
monocytic	JJ
cell	NN
lines	NNS
studied	VBN
.	.

In	IN
chloramphenicol	NN
acetyltransferase	NN
assays	NNS
,	,
utilizing	VBG
the	DT
transient	JJ
transfection	NN
of	IN
a	DT
chloramphenicol	NN
acetyltransferase	NN
reporter	NN
plasmid	NN
containing	VBG
the	DT
IL-6	NN
gene	NN
promoter	NN
,	,
IL-4	NN
,	,
but	CC
not	RB
IL-10	NN
,	,
suppressed	VBD
the	DT
transcriptional	JJ
activity	NN
of	IN
the	DT
IL-6	NN
gene	NN
promoter	NN
stimulated	VBN
by	IN
PMA	NN
and	CC
LPS	NN
.	.

Electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
showed	VBD
that	IN
IL-4	NN
,	,
but	CC
not	RB
IL-10	NN
,	,
inhibited	VBD
nuclear	JJ
NF-kappaB	NN
activity	NN
,	,
and	CC
that	IN
IL-4	NN
and	CC
IL-10	NN
did	VBD
not	RB
affect	VB
NF-IL-6	NN
activity	NN
.	.

On	IN
the	DT
other	JJ
hand	NN
,	,
IL-10	NN
enhanced	VBD
the	DT
degradation	NN
of	IN
IL-6	NN
mRNA	NN
in	IN
a	DT
mRNA	NN
stability	NN
assay	NN
.	.

These	DT
results	NNS
suggest	VBP
that	IN
IL-4	NN
may	MD
inhibit	VB
the	DT
transcription	NN
of	IN
the	DT
IL-6	NN
gene	NN
by	IN
affecting	VBG
NF-kappaB	NN
binding	NN
activity	NN
,	,
while	IN
IL-10	NN
may	MD
inhibit	VB
the	DT
IL-6	NN
mRNA	NN
levels	NNS
post-transcriptionally	RB
,	,
without	IN
suppressing	VBG
promoter	NN
activity	NN
.	.

Therefore	RB
,	,
we	PRP
conclude	VBP
that	IN
IL-4	NN
and	CC
IL-10	NN
inhibit	VBP
IL-6	NN
production	NN
by	IN
different	JJ
mechanisms	NNS
in	IN
human	JJ
monocytic	JJ
cell	NN
lines	NNS
.	.

UI	LS
-	:
96203119	CD

TI	LS
-	:
C-terminal	JJ
activating	VBG
and	CC
inhibitory	JJ
domains	NNS
determine	VBP
the	DT
transactivation	NN
potential	NN
of	IN
BSAP	NN
(	(
Pax-5	NN
)	)
,	,
Pax-2	NN
and	CC
Pax-8	NN
.	.

AB	LS
-	:
Pax-5	NN
encodes	VBZ
the	DT
transcription	NN
factor	NN
BSAP	NN
which	WDT
plays	VBZ
an	DT
essential	JJ
role	NN
in	IN
early	JJ
B	NN
cell	NN
development	NN
and	CC
midbrain	JJ
patterning	NN
.	.

In	IN
this	DT
study	NN
we	PRP
have	VBP
analysed	VBN
the	DT
structural	JJ
requirements	NNS
for	IN
transcriptional	JJ
activation	NN
by	IN
BSAP	NN
.	.

In	FW
vitro	FW
mutagenesis	NN
and	CC
transient	JJ
transfection	NN
experiments	NNS
indicate	VBP
that	IN
the	DT
C-terminal	JJ
serine/threonine/proline-rich	JJ
region	NN
of	IN
BSAP	NN
contains	VBZ
a	DT
potent	JJ
transactivation	NN
domain	NN
of	IN
55	CD
amino	NN
acids	NNS
which	WDT
is	VBZ
active	JJ
from	IN
promoter	NN
and	CC
enhancer	NN
positions	NNS
.	.

This	DT
transactivation	NN
domain	NN
was	VBD
found	VBN
to	TO
be	VB
inactivated	VBN
by	IN
a	DT
naturally	RB
occurring	VBG
frameshift	NN
mutation	NN
in	IN
one	CD
PAX-5	NN
allele	NN
of	IN
the	DT
acute	JJ
lymphoblastic	JJ
leukemia	NN
cell	NN
line	NN
REH	NN
.	.

The	DT
function	NN
of	IN
the	DT
transactivation	NN
domain	NN
is	VBZ
negatively	RB
regulated	VBN
by	IN
adjacent	JJ
sequences	NNS
from	IN
the	DT
extreme	JJ
C-terminus	NN
.	.

The	DT
activating	VBG
and	CC
inhibitory	JJ
domains	NNS
function	VBP
together	RB
as	IN
an	DT
independent	JJ
regulatory	JJ
module	NN
in	IN
different	JJ
cell	NN
types	NNS
as	IN
shown	VBN
by	IN
fusion	NN
to	TO
the	DT
GAL4	NN
DNA	NN
binding	NN
domain	NN
.	.

The	DT
same	JJ
arrangement	NN
of	IN
positively	RB
and	CC
negatively	RB
acting	VBG
sequences	NNS
has	VBZ
been	VBN
conserved	VBN
in	IN
the	DT
mammalian	JJ
Pax-2	NN
and	CC
Pax-8	NN
,	,
the	DT
zebrafish	NN
Pax-b	NN
as	RB
well	RB
as	IN
the	DT
sea	NN
urchin	NN
Pax-258	NN
proteins	NNS
.	.

These	DT
data	NNS
demonstrate	VBP
that	IN
the	DT
transcriptional	JJ
competence	NN
of	IN
a	DT
subfamily	NN
of	IN
Pax	NN
proteins	NNS
is	VBZ
determined	VBN
by	IN
a	DT
C-terminal	JJ
regulatory	JJ
module	NN
composed	VBN
of	IN
activating	VBG
and	CC
inhibitory	JJ
sequences	NNS
.	.

UI	LS
-	:
96189121	CD

TI	LS
-	:
Identification	NN
of	IN
an	DT
inducible	JJ
regulator	NN
of	IN
c-myb	NN
expression	NN
during	IN
T-cell	NN
activation	NN
.	.

AB	LS
-	:
Resting	VBG
T	NN
cells	NNS
express	VBP
very	RB
low	JJ
levels	NNS
of	IN
c-Myb	NN
protein	NN
.	.

During	IN
T-cell	NN
activation	NN
,	,
c-myb	NN
expression	NN
is	VBZ
induced	VBN
and	CC
much	JJ
of	IN
the	DT
increase	NN
in	IN
expression	NN
occurs	VBZ
at	IN
the	DT
transcriptional	JJ
level	NN
.	.

We	PRP
identified	VBD
a	DT
region	NN
of	IN
the	DT
c-myb	NN
5'	JJ
flanking	JJ
sequence	NN
that	WDT
increased	VBD
c-myb	NN
expression	NN
during	IN
T-cell	NN
activation	NN
.	.

In	FW
vivo	FW
footprinting	NN
by	IN
ligation-mediated	JJ
PCR	NN
was	VBD
performed	VBN
to	TO
correlate	VB
in	FW
vivo	FW
protein	NN
binding	NN
with	IN
functional	JJ
activity	NN
.	.

A	DT
protein	NN
footprint	NN
was	VBD
visible	JJ
over	IN
this	DT
region	NN
of	IN
the	DT
c-myb	NN
5'	JJ
flanking	JJ
sequence	NN
in	IN
activated	VBN
T	NN
cells	NNS
but	CC
not	RB
in	IN
unactivated	JJ
T	NN
cells	NNS
.	.

An	DT
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
(	(
EMSA	NN
)	)
with	IN
nuclear	JJ
extract	NN
from	IN
activated	VBN
T	NN
cells	NNS
and	CC
an	DT
oligonucleotide	NN
of	IN
this	DT
binding	VBG
site	NN
demonstrated	VBD
a	DT
new	JJ
protein-DNA	JJ
complex	NN
,	,
referred	VBN
to	TO
as	IN
CMAT	NN
for	IN
c-myb	NN
in	IN
activated	VBN
T	NN
cells	NNS
;	:
this	DT
complex	NN
was	VBD
not	RB
present	JJ
in	IN
unactivated	JJ
T	NN
cells	NNS
.	.

Because	IN
the	DT
binding	VBG
site	NN
showed	VBD
some	DT
sequence	NN
similarity	NN
with	IN
the	DT
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
(	(
NFAT	NN
)	)
binding	NN
site	NN
,	,
we	PRP
compared	VBD
the	DT
kinetics	NNS
of	IN
induction	NN
of	IN
the	DT
two	CD
binding	VBG
complexes	NNS
and	CC
the	DT
molecular	JJ
masses	NNS
of	IN
the	DT
two	CD
proteins	NNS
.	.

Studies	NNS
of	IN
the	DT
kinetics	NNS
of	IN
induction	NN
showed	VBD
that	IN
the	DT
NFAT	NN
EMSA	NN
binding	NN
complex	NN
appeared	VBD
earlier	RBR
than	IN
the	DT
CMAT	NN
complex	NN
.	.

The	DT
NFAT	NN
protein	NN
migrated	VBD
more	RBR
slowly	RB
in	IN
a	DT
sodium	NN
dodecyl	NN
sulfate-polyacrylamide	JJ
gel	NN
than	IN
the	DT
CMAT	NN
protein	NN
did	VBD
.	.

In	IN
addition	NN
,	,
an	DT
antibody	NN
against	IN
NFAT	NN
did	VBD
not	RB
cross-react	VB
with	IN
the	DT
CMAT	NN
protein	NN
.	.

The	DT
appearance	NN
of	IN
the	DT
CMAT	NN
binding	NN
complex	NN
was	VBD
inhibited	VBN
by	IN
both	CC
cyclosporin	NN
A	NN
and	CC
rapamycin	NN
.	.

The	DT
CMAT	NN
protein	NN
appears	VBZ
to	TO
be	VB
a	DT
novel	JJ
inducible	JJ
protein	NN
involved	VBN
in	IN
the	DT
regulation	NN
of	IN
c-myb	NN
expression	NN
during	IN
T-cell	NN
activation	NN
.	.

UI	LS
-	:
96210575	CD

TI	LS
-	:
CNI-1493	NN
inhibits	VBZ
monocyte/macrophage	JJ
tumor	NN
necrosis	NN
factor	NN
by	IN
suppression	NN
of	IN
translation	NN
efficiency	NN
.	.

AB	LS
-	:
Tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
mediates	VBZ
a	DT
wide	JJ
variety	NN
of	IN
disease	NN
states	NNS
including	VBG
septic	JJ
shock	NN
,	,
acute	JJ
and	CC
chronic	JJ
inflammation	NN
,	,
and	CC
cachexia	NN
.	.

Recently	RB
,	,
a	DT
multivalent	JJ
guanylhydrazone	NN
(	(
CNI-1493	NN
)	)
developed	VBN
as	IN
an	DT
inhibitor	NN
of	IN
macrophage	NN
activation	NN
was	VBD
shown	VBN
to	TO
suppress	VB
TNF	NN
production	NN
and	CC
protect	NN
against	IN
tissue	NN
inflammation	NN
and	CC
endotoxin	NN
lethality	NN
[	(
Bianchi	NNP
,	,
M.	NNP
,	,
Ulrich	NNP
,	,
P.	NNP
,	,
Bloom	NNP
,	,
O.	NNP
,	,
Meistrell	NNP
,	,
M.	NNP
,	,
Zimmerman	NNP
,	,
G.A.	NNP
,	,
Schmidtmayerova	NNP
,	,
H.	NNP
,	,
Bukrinsky	NNP
,	,
M.	NNP
,	,
Donnelley	NNP
,	,
T.	NNP
,	,
Bucala	NNP
,	,
R.	NNP
,	,
Sherry	NNP
,	,
B.	NNP
,	,
Manogue	NNP
,	,
K.R.	NNP
,	,
Tortolani	NNP
,	,
A.J.	NNP
,	,
Cerami	NNP
,	,
A.	NNP
&	CC
Tracey	NNP
,	,
K.J.	NNP
(	(
1995	CD
)	)
Mol.Med.1	NNP
,	,
254-266	CD
,	,
and	CC
Bianchi	NNP
,	,
M.	NNP
,	,
Bloom	NNP
,	,
O.	NNP
,	,
Raabe	NNP
,	,
T.	NNP
,	,
Cohen	NNP
,	,
P.	NNP
S.	NNP
,	,
Chesney	NNP
,	,
J.	NNP
,	,
Sherry	NNP
,	,
B.	NNP
,	,
Schmidtmayerova	NNP
,	,
H.	NNP
,	,
Zhang	NNP
,	,
X.	NNP
,	,
Bukrinsky	NNP
,	,
M.	NNP
,	,
Ulrich	NNP
,	,
P.	NNP
,	,
Cerami	NNP
,	,
A.	NNP
&	CC
Tracey	NNP
,	,
J.	NNP
(	(
1996	CD
)	)
J.Exp.Med.	NNP
,	,
in	IN
press	NN
]	)
.	.

We	PRP
have	VBP
now	RB
elucidated	VBN
the	DT
mechanism	NN
by	IN
which	WDT
CNI-1493	NN
inhibits	VBZ
macrophage	NN
TNF	NN
synthesis	NN
and	CC
show	VBP
here	RB
that	IN
it	PRP
acts	VBZ
through	IN
suppression	NN
of	IN
TNF	NN
translation	NN
efficiency	NN
.	.

CNI-1493	NN
blocked	VBD
neither	CC
the	DT
lipopolysaccharide	NN
(	(
LPS	NN
)	)
-induced	JJ
increases	NNS
in	IN
the	DT
expression	NN
of	IN
TNF	NN
mRNA	NN
nor	CC
the	DT
translocation	NN
of	IN
nuclear	JJ
factor	NN
NF-kappa	NN
B	NN
to	TO
the	DT
nucleus	NN
in	IN
macrophages	NNS
activated	VBN
by	IN
15	CD
min	NN
of	IN
LPS	NN
stimulation	NN
,	,
indicating	VBG
that	IN
CNI-1493	NN
does	VBZ
not	RB
interfere	VB
with	IN
early	JJ
NF-kappa	NN
B-mediated	JJ
transcriptional	JJ
regulation	NN
of	IN
TNF	NN
.	.

However	RB
,	,
synthesis	NN
of	IN
the	DT
26-kDa	JJ
membrane	NN
form	NN
of	IN
TNF	NN
was	VBD
effectively	RB
blocked	VBN
by	IN
CNI-1493	NN
.	.

Further	RB
evidence	NN
for	IN
the	DT
translational	JJ
suppression	NN
of	IN
TNF	NN
is	VBZ
given	VBN
by	IN
experiments	NNS
using	VBG
chloram-phenicol	NN
acetyltransferase	NN
(	(
CAT	NN
)	)
constructs	VBZ
containing	VBG
elements	NNS
of	IN
the	DT
TNF	NN
gene	NN
that	WDT
are	VBP
involved	VBN
in	IN
TNF	NN
translational	JJ
regulation	NN
.	.

Both	CC
the	DT
5'	JJ
and	CC
3'	JJ
untranslated	JJ
regions	NNS
of	IN
the	DT
TNF	NN
gene	NN
were	VBD
required	VBN
to	TO
elicit	VB
maximal	JJ
translational	JJ
suppression	NN
by	IN
CNI-1493	NN
.	.

Identification	NN
of	IN
the	DT
molecular	JJ
target	NN
through	IN
which	WDT
CNI-1493	NN
inhibits	VBZ
TNF	NN
translation	NN
should	MD
provide	VB
insight	NN
into	IN
the	DT
regulation	NN
of	IN
macrophage	NN
activation	NN
and	CC
mechanisms	NNS
of	IN
inflammation	NN
.	.

UI	LS
-	:
96310948	CD

TI	LS
-	:
IL-10	NN
inhibits	VBZ
nuclear	JJ
factor-kappa	NN
B/Rel	NN
nuclear	JJ
activity	NN
in	IN
CD3-stimulated	JJ
human	JJ
peripheral	JJ
T	NN
lymphocytes	NNS
.	.

AB	LS
-	:
IL-10	NN
markedly	RB
reduces	VBZ
nuclear	JJ
factor	NN
(	(
NF	NN
)	)
-kappa	NN
B/Rel	NN
nuclear	JJ
activity	NN
induced	VBN
in	IN
PBMC	NN
by	IN
stimulation	NN
with	IN
the	DT
anti-CD3	JJ
mAb	NN
OKT3	NN
.	.

The	DT
inhibition	NN
is	VBZ
exerted	VBN
specifically	RB
on	IN
the	DT
NF-kappa	NN
B/Rel	NN
activation	NN
induced	VBN
by	IN
mAb	NN
OKT3	NN
,	,
and	CC
not	RB
that	DT
produced	VBN
by	IN
PMA	NN
.	.

As	IN
judged	VBN
by	IN
supershifting	VBG
the	DT
DNA-protein	JJ
complexes	NNS
with	IN
Abs	NN
recognizing	VBG
specific	JJ
components	NNS
of	IN
the	DT
NF-kappa	NN
B/Rel	NN
protein	NN
family	NN
,	,
the	DT
p50/p65	NN
(	(
Rel	NN
A	NN
)	)
heterodimeric	JJ
form	NN
of	IN
NF-kappa	NN
B	NN
is	VBZ
primarily	RB
affected	VBN
.	.

The	DT
maximal	JJ
effect	NN
is	VBZ
observed	VBN
at	IN
the	DT
IL-10	NN
concentration	NN
of	IN
20	CD
U/ml	NN
.	.

IL-10	NN
inhibitory	JJ
activity	NN
is	VBZ
exerted	VBN
on	IN
T	NN
lymphocytes	NNS
and	CC
is	VBZ
mediated	VBN
by	IN
monocytes	NNS
.	.

Indeed	RB
,	,
monocytes	NNS
pretreated	VBN
with	IN
IL-10	NN
are	VBP
able	JJ
so	RB
inhibit	VBP
NF-kappa	NN
B	NN
nuclear	JJ
activity	NN
in	IN
purified	VBN
T	NN
lymphocytes	NNS
stimulated	VBN
with	IN
OKT3	NN
.	.

Soluble	JJ
factors	NNS
do	VBP
not	RB
appear	VB
to	TO
be	VB
involved	VBN
in	IN
the	DT
mechanism	NN
of	IN
inhibition	NN
.	.

On	IN
the	DT
other	JJ
hand	NN
,	,
the	DT
up-regulation	NN
of	IN
CD80	NN
Ag	NN
,	,
found	VBN
on	IN
monocytes	NNS
obtained	VBN
from	IN
PBMC	NN
incubated	VBN
with	IN
OKT3	NN
,	,
is	VBZ
not	RB
detected	VBN
after	IN
addition	NN
of	IN
IL-10	NN
,	,
and	CC
the	DT
anti-CD28	JJ
mAb	NN
CLB-CD28/1	NN
restores	VBZ
the	DT
NF-kappa	NN
B/Rel	NN
nuclear	JJ
activity	NN
in	IN
IL-10-inhibited	JJ
lymphocytes	NNS
.	.

Therefore	RB
,	,
the	DT
NF-kappa	NN
B/Rel	NN
inhibition	NN
might	MD
be	VB
ascribed	VBN
to	TO
a	DT
lack	NN
of	IN
cooperation	NN
between	IN
accessory	NN
cells	NNS
and	CC
T	NN
lymphocytes	NNS
,	,
resulting	VBG
from	IN
down-regulation	NN
of	IN
a	DT
costimulatory	JJ
molecule	NN
,	,
such	JJ
as	IN
CD80	NN
,	,
produced	VBN
by	IN
IL-10	NN
on	IN
activated	VBN
monocytes	NNS
.	.

Our	PRP$
results	NNS
demonstrate	VBP
that	IN
IL-10	NN
can	MD
inhibit	VB
the	DT
induction	NN
of	IN
NF-kappa	NN
B/Rel	NN
nuclear	JJ
activity	NN
in	IN
CD3-stimulated	JJ
T	NN
lymphocytes	NNS
.	.

Since	IN
inappropriate	JJ
activation	NN
of	IN
kappa	NN
B-driven	JJ
genes	NNS
has	VBZ
a	DT
physiopathologic	JJ
role	NN
in	IN
a	DT
number	NN
of	IN
diseases	NNS
,	,
such	JJ
as	IN
HIV	NN
infection	NN
,	,
our	PRP$
findings	NNS
support	VBP
the	DT
possibility	NN
of	IN
using	VBG
this	DT
cytokine	NN
to	TO
suppress	VB
an	DT
undesirable	JJ
activation	NN
of	IN
these	DT
transcription	NN
factors	NNS
.	.

UI	LS
-	:
96202514	CD

TI	LS
-	:
Expression	NN
of	IN
A-myb	NN
,	,
but	CC
not	RB
c-myb	NN
and	CC
B-myb	NN
,	,
is	VBZ
restricted	JJ
to	TO
Burkitt	NN
's	POS
lymphoma	NN
,	,
sIg+	NN
B-acute	JJ
lymphoblastic	JJ
leukemia	NN
,	,
and	CC
a	DT
subset	NN
of	IN
chronic	JJ
lymphocytic	JJ
leukemias	NNS
.	.

AB	LS
-	:
The	DT
A-myb	NN
gene	NN
encodes	VBZ
a	DT
transcription	NN
factor	NN
that	WDT
is	VBZ
related	JJ
both	CC
functionally	RB
and	CC
structurally	RB
to	TO
the	DT
v-myb	NN
oncogene	NN
.	.

Following	VBG
our	PRP$
observations	NNS
that	IN
A-myb	NN
is	VBZ
expressed	VBN
in	IN
a	DT
restricted	JJ
subset	NN
of	IN
normal	JJ
mature	JJ
human	JJ
B	NN
lymphocytes	NNS
,	,
with	IN
the	DT
phenotype	NN
CD38+	NN
,	,
CD39-	NN
,	,
slgM-	JJ
,	,
we	PRP
have	VBP
now	RB
investigated	VBN
the	DT
pattern	NN
of	IN
A-myb	NN
expression	NN
in	IN
neoplastic	JJ
B	NN
cells	NNS
representating	VBG
the	DT
whole	JJ
spectrum	NN
of	IN
B-cell	NN
differentiation	NN
and	CC
compared	VBD
it	PRP
to	TO
that	DT
of	IN
c-myb	NN
and	CC
B-myb	NN
.	.

In	IN
a	DT
panel	NN
of	IN
32	CD
B-cell	NN
lines	NNS
,	,
A-myb	NN
was	VBD
very	RB
strongly	RB
expressed	VBN
in	IN
most	JJS
Burkitt	NN
's	POS
lymphoma	NN
(	(
BL	NN
)	)
cell	NN
lines	NNS
,	,
but	CC
weak	JJ
or	CC
negative	JJ
in	IN
2	CD
pre-B	NN
acute	JJ
lymphoblastic	JJ
leukemia	NN
(	(
ALL	NN
)	)
,	,
4	CD
non-Hodgkin	JJ
's	POS
lymphoma	NN
(	(
NHL	NN
)	)
,	,
6	CD
Epstein-Barr	JJ
virus-immortalized	JJ
lymphoblastoid	JJ
cell	NN
lines	NNS
,	,
and	CC
6	CD
myeloma	NN
lines	NNS
.	.

Protein	NN
expression	NN
paralleled	VBD
that	DT
of	IN
the	DT
RNA	NN
.	.

We	PRP
have	VBP
also	RB
investigated	VBN
A-myb	NN
expression	NN
in	IN
49	CD
fresh	JJ
cases	NNS
of	IN
B	NN
leukemias	NN
.	.

Among	IN
24	CD
ALL	NN
,	,
6	CD
were	VBD
of	IN
the	DT
null	JJ
and	CC
11	CD
of	IN
the	DT
common	JJ
type	NN
and	CC
all	DT
these	DT
were	VBD
negative	JJ
for	IN
A-myb	NN
expression	NN
;	:
on	IN
the	DT
other	JJ
hand	NN
,	,
all	DT
7	CD
B-ALL	NN
cases	NNS
(	(
slg+	JJ
)	)
,	,
as	RB
well	RB
as	IN
one	CD
fresh	JJ
BL	NN
case	NN
with	IN
bone	NN
marrow	NN
infiltration	NN
,	,
expressed	VBD
A-myb	NN
.	.

A-myb	NN
was	VBD
undetectable	JJ
in	IN
4	CD
prolymphocytic	JJ
leukemias	NNS
(	(
PLL	NN
)	)
but	CC
was	VBD
strongly	RB
expressed	VBN
in	IN
5/20	CD
(	(
25	CD
%	NN
)	)
of	IN
chronic	JJ
lymphocytic	JJ
leukemia	NN
(	(
CLL	NN
)	)
samples	NNS
.	.

In	IN
the	DT
latter	JJ
A-myb	NN
did	VBD
not	RB
correlate	VB
with	IN
phenotype	NN
or	CC
clinical	JJ
stage	NN
.	.

Finally	RB
,	,
we	PRP
have	VBP
studied	VBN
the	DT
progression	NN
of	IN
one	CD
case	NN
of	IN
CLL	NN
into	IN
Richter	NN
's	POS
syndrome	NN
and	CC
have	VBP
found	VBN
that	IN
the	DT
Richter	NN
's	POS
cells	NNS
expressed	VBD
about	RB
25-fold	RB
less	JJR
A-myb	NN
RNA	NN
than	IN
the	DT
CLL	NN
cells	NNS
from	IN
the	DT
same	JJ
patient	NN
.	.
The	DT
pattern	NN
of	IN
c-myb	NN
and	CC
B-myb	NN
was	VBD
clearly	RB
distinct	JJ
from	IN
that	DT
of	IN
A-myb	NN
.	.

C-myb	NN
and	CC
B-myb	NN
were	VBD
expressed	VBN
in	IN
all	DT
neoplastic	JJ
groups	NNS
,	,
except	IN
in	IN
CLL	NN
cells	NNS
.	.

Thus	RB
,	,
A-myb	NN
expression	NN
,	,
unlike	IN
that	DT
of	IN
c-myb	NN
and	CC
B-myb	NN
,	,
is	VBZ
restricted	JJ
to	TO
a	DT
subset	NN
of	IN
B-cell	NN
neoplasias	NN
(	(
in	IN
particular	JJ
BL	NN
and	CC
slg+B-ALL	NN
)	)
representative	NN
of	IN
a	DT
specific	JJ
stage	NN
of	IN
B-cell	NN
differentiation	NN
.	.

This	DT
expression	NN
may	NN
in	IN
part	NN
reflect	VBP
expression	NN
of	IN
A-myb	NN
by	IN
the	DT
normal	JJ
germinal	JJ
center	NN
B	NN
cells	NNS
that	WDT
are	VBP
the	DT
normal	JJ
counterpart	NN
of	IN
these	DT
transformed	VBN
B	NN
cells	NNS
.	.

The	DT
data	NNS
presented	VBN
strongly	RB
support	VBP
a	DT
role	NN
for	IN
this	DT
transcription	NN
factor	NN
in	IN
B-cell	NN
differentiation	NN
and	CC
perhaps	RB
in	IN
B-cell	NN
transformation	NN
in	IN
some	DT
neoplasias	NNS
.	.

UI	LS
-	:
96146497	CD

TI	LS
-	:
Inhibition	NN
of	IN
vitamin	NN
D	NN
receptor-retinoid	JJ
X	NN
receptor-vitamin	JJ
D	NN
response	NN
element	NN
complex	JJ
formation	NN
by	IN
nuclear	JJ
extracts	NNS
of	IN
vitamin	NN
D-resistant	JJ
New	NN
World	NN
primate	JJ
cells	NNS
.	.

AB	LS
-	:
Most	JJS
New	NN
World	NN
primate	NN
(	(
NWP	NN
)	)
genera	NN
evolved	VBD
to	TO
require	VB
high	JJ
circulating	JJ
levels	NNS
of	IN
steroid	NN
hormones	NNS
and	CC
vitamin	NN
D	NN
.	.

We	PRP
hypothesized	VBD
that	IN
an	DT
intracellular	JJ
vitamin	NN
D	NN
binding	NN
protein	NN
(	(
IDBP	NN
)	)
,	,
present	JJ
in	IN
both	CC
nuclear	JJ
and	CC
cytoplasmic	JJ
fractions	NNS
of	IN
NWP	NN
cells	NNS
,	,
or	CC
another	DT
protein	NN
(	(
s	NNS
)	)
may	MD
cause	VB
or	CC
contribute	VB
to	TO
the	DT
steroid	NN
hormone-resistant	JJ
state	NN
in	IN
NWP	NN
by	IN
disruption	NN
of	IN
the	DT
receptor	NN
dimerization	NN
process	NN
and/or	CC
by	IN
interference	NN
of	IN
receptor	NN
complex	NN
binding	VBG
to	TO
the	DT
consensus	NN
response	NN
elements	NNS
present	JJ
in	IN
the	DT
enhancer	NN
regions	NNS
of	IN
steroid-responsive	JJ
genes	NNS
.	.

We	PRP
employed	VBD
electromobility	NN
shift	NN
assay	NN
(	(
EMSA	NN
)	)
to	TO
screen	VB
for	IN
the	DT
presence	NN
of	IN
proteins	NNS
capable	JJ
of	IN
binding	VBG
to	TO
the	DT
vitamin	NN
D	NN
response	NN
element	NN
(	(
VDRE	NN
)	)
.	.

Nuclear	JJ
and	CC
post-nuclear	JJ
extracts	NNS
were	VBD
prepared	VBN
from	IN
two	CD
B-lymphoblastoid	JJ
cell	NN
lines	NNS
known	VBN
to	TO
be	VB
representative	JJ
of	IN
the	DT
vitamin	NN
D-resistant	JJ
and	CC
wild	JJ
type	NN
phenotypes	NNS
,	,
respectively	RB
.	.

The	DT
extracts	NNS
were	VBD
compared	VBN
for	IN
their	PRP$
ability	NN
to	TO
retard	VB
the	DT
migration	NN
of	IN
radiolabeled	VBN
double	JJ
stranded	JJ
oligomers	NNS
representative	NN
of	IN
the	DT
VDREs	NNS
of	IN
the	DT
human	JJ
osteocalcin	NN
and	CC
the	DT
mouse	NN
osteopontin	NN
gene	NN
promoters	NNS
.	.

A	DT
specific	JJ
,	,
retarded	JJ
band	NN
containing	VBG
VDR-RXR	NN
was	VBD
identified	VBN
when	WRB
wild	JJ
type	NN
cell	NN
but	CC
not	RB
when	WRB
vitamin	NN
D-resistant	JJ
cell	NN
nuclear	JJ
extract	NN
was	VBD
used	VBN
in	IN
the	DT
binding	NN
reaction	NN
with	IN
either	DT
probe	NN
.	.

In	IN
addition	NN
,	,
vitamin	NN
D-resistant	JJ
cell	NN
nuclear	JJ
extract	NN
contained	VBD
a	DT
protein	NN
(	(
s	NNS
)	)
which	WDT
was	VBD
bound	VBN
specifically	RB
to	TO
the	DT
VDRE	NN
and	CC
was	VBD
capable	JJ
of	IN
completely	RB
inhibiting	VBG
VDR-RXR-VDRE	JJ
complex	NN
formation	NN
;	:
these	DT
effects	NNS
were	VBD
not	RB
demonstrated	VBN
with	IN
nuclear	JJ
extract	NN
from	IN
the	DT
wild	JJ
type	NN
cell	NN
line	NN
or	CC
with	IN
the	DT
post-nuclear	JJ
extract	NN
of	IN
the	DT
vitamin	NN
D-resistant	JJ
cell	NN
line	NN
.	.

We	PRP
conclude	VBP
that	IN
a	DT
VDRE-binding	JJ
protein	NN
(	(
s	NNS
)	)
,	,
distinct	JJ
from	IN
IDBP	NN
and	CC
present	JJ
in	IN
nuclear	JJ
extract	NN
of	IN
cells	NNS
from	IN
a	DT
prototypical	JJ
vitamin	NN
D-resistant	JJ
NWP	NN
,	,
is	VBZ
capable	JJ
of	IN
inhibiting	VBG
normal	JJ
VDR-RXR	NN
heterodimer	NN
binding	VBG
to	TO
the	DT
VDRE	NN
.	.

UI	LS
-	:
96163492	CD

TI	LS
-	:
Translocation	NN
breakpoints	NNS
in	IN
three	CD
patients	NNS
with	IN
campomelic	JJ
dysplasia	NN
and	CC
autosomal	JJ
sex	NN
reversal	JJ
map	NN
more	JJR
than	IN
130	CD
kb	NN
from	IN
SOX9	NN
.	.

AB	LS
-	:
Campomelic	JJ
dysplasia	NN
(	(
CMPD1	NN
)	)
and	CC
autosomal	JJ
XY	NN
sex	NN
reversal	JJ
(	(
SRA1	NN
)	)
are	VBP
caused	VBN
by	IN
mutations	NNS
in	IN
the	DT
SRY-related	JJ
gene	NN
SOX9	NN
on	IN
17q	NN
.	.

Unexpectedly	RB
,	,
the	DT
17q	NN
breakpoints	NNS
in	IN
four	CD
CMPD1	NN
translocation	NN
cases	NNS
previously	RB
analyzed	VBN
by	IN
us	PRP
and	CC
others	NNS
map	VBP
50	CD
kb	NN
or	CC
more	JJR
from	IN
SOX9	NN
.	.

Here	RB
,	,
we	PRP
present	VBP
clinical	JJ
,	,
cytogenetic	JJ
,	,
and	CC
molecular	JJ
data	NNS
from	IN
a	DT
new	JJ
CMPD1/SRA1	NN
patient	NN
with	IN
t(6;17)(q14;q24)	NN
.	.

Fluorescence	NN
in	FW
situ	FW
hybridization	NN
has	VBZ
shown	VBN
that	IN
the	DT
17q	NN
breakpoint	NN
in	IN
this	DT
case	NN
maps	VBZ
to	TO
the	DT
same	JJ
region	NN
as	IN
the	DT
breakpoints	NNS
in	IN
the	DT
other	JJ
translocation	NN
cases	NNS
,	,
at	IN
least	JJS
130	CD
kb	NN
from	IN
SOX9	NN
.	.

Likewise	RB
,	,
the	DT
breakpoints	NNS
in	IN
two	CD
of	IN
the	DT
previously	RB
described	VBN
cases	NNS
also	RB
map	VBP
more	JJR
than	IN
130	CD
kb	NN
and	CC
,	,
as	IN
shown	VBN
by	IN
pulsed	JJ
field	NN
gel	NN
electrophoresis	NN
analysis	NN
,	,
at	IN
most	JJS
400	CD
kb	NN
or	CC
690	CD
kb	NN
from	IN
SOX9	NN
.	.

By	IN
using	VBG
a	DT
SOX9	NN
coding	NN
sequence	NN
polymorphism	NN
,	,
expression	NN
of	IN
both	DT
SOX9	NN
alleles	NNS
has	VBZ
been	VBN
demonstrated	VBN
by	IN
the	DT
reverse	JJ
transcriptase	NN
polymerase	NN
chain	NN
reaction	NN
in	IN
lymphoblastoid	JJ
cells	NNS
from	IN
one	CD
of	IN
the	DT
translocation	NN
cases	NNS
.	.

UI	LS
-	:
96201015	CD

TI	LS
-	:
A	DT
new	JJ
variant	JJ
translocation	NN
in	IN
acute	JJ
promyelocytic	JJ
leukaemia	NN
:	:
molecular	JJ
characterization	NN
and	CC
clinical	JJ
correlation	NN
.	.

AB	LS
-	:
Translocation	NN
t(15;17)(q22;q21)	NN
is	VBZ
an	DT
acquired	VBN
clonal	JJ
cytogenetic	JJ
change	NN
present	JJ
in	IN
almost	RB
all	DT
cases	NNS
of	IN
acute	JJ
promelocytic	JJ
leukemia	NN
(	(
APL	NN
)	)
.	.

The	DT
molecular	JJ
genetic	JJ
basis	NN
of	IN
the	DT
translocation	NN
supports	VBZ
its	PRP$
integral	JJ
role	NN
in	IN
pathogenesis	NN
.	.

We	PRP
describe	VBP
a	DT
patient	NN
with	IN
APL	NN
in	IN
whom	WP
the	DT
leukaemic	JJ
clone	NN
was	VBD
characterized	VBN
by	IN
a	DT
true	JJ
variant	NN
of	IN
the	DT
classical	JJ
t(15;17)	NN
.	.

The	DT
patient	NN
whose	WP$
disease	NN
had	VBD
numerous	JJ
atypical	JJ
clinical	JJ
features	NNS
,	,
had	VBD
t(11;17)(q13;121)	NN
.	.

The	DT
chromosome	NN
17	CD
breakpoint	NN
was	VBD
localized	JJ
to	TO
intron	NN
2	CD
of	IN
RARA	NN
by	IN
Southern	NN
blotting	NN
,	,
and	CC
there	EX
was	VBD
no	DT
evidence	NN
at	IN
the	DT
molecular	JJ
level	NN
for	IN
rearrangement	NN
at	IN
PML	NN
locus	NN
.	.

These	DT
data	NNS
,	,
along	IN
with	IN
previous	JJ
reports	NNS
of	IN
rare	JJ
variant	JJ
translocations	NNS
in	IN
APL	NN
,	,
indicate	VBP
that	IN
while	IN
dysregulation	NN
of	IN
RARA	NN
by	IN
gene	NN
fusion	NN
may	MD
be	VB
essential	JJ
for	IN
the	DT
APL	NN
phenotype	NN
,	,
the	DT
particular	JJ
fusion	NN
partner	NN
may	MD
determine	VB
clinicopathological	JJ
aspects	NNS
,	,
including	VBG
presentation	NN
,	,
response	NN
to	TO
treatment	NN
with	IN
all-trans	JJ
retinoic	JJ
acid	NN
(	(
ATRA	NN
)	)
,	,
and	CC
prognosis	NN
.	.

This	DT
heterogeneity	NN
suggests	VBZ
that	IN
the	DT
variant	JJ
fusion	NN
partners	NNS
of	IN
RARA	NN
in	IN
APL	NN
encode	VBP
factors	NNS
with	IN
properties	NNS
both	CC
common	JJ
to	TO
and	CC
distinct	JJ
from	IN
those	DT
of	IN
PML	NN
.	.

Investigation	NN
of	IN
these	DT
factors	NNS
promises	VBZ
to	TO
shed	VB
light	NN
on	IN
the	DT
complex	JJ
development	NN
pathways	NNS
involved	VBN
in	IN
the	DT
regulation	NN
of	IN
haematopoiesis	NN
.	.

UI	LS
-	:
99353321	CD

TI	LS
-	:
MHC-peptide	NN
ligand	NN
interactions	NNS
establish	VB
a	DT
functional	JJ
threshold	NN
for	IN
antigen-specific	JJ
T	NN
cell	NN
recognition	NN
.	.

AB	LS
-	:
Antigen-specific	JJ
T	NN
cell	NN
recognition	NN
is	VBZ
dependent	JJ
on	IN
the	DT
functional	JJ
density	NN
of	IN
the	DT
TCR-ligand	NN
,	,
which	WDT
consists	VBZ
of	IN
specific	JJ
MHC	NN
molecules	NNS
and	CC
a	DT
specifically	RB
bound	VBN
peptide	NN
.	.

We	PRP
have	VBP
examined	VBN
the	DT
influence	NN
of	IN
the	DT
affinity	NN
and	CC
concentration	NN
of	IN
exogenous	JJ
peptide	NN
and	CC
the	DT
density	NN
of	IN
specific	JJ
MHC	NN
molecules	NNS
on	IN
the	DT
proliferation	NN
of	IN
a	DT
CD4+	JJ
,	,
DQA1*0501/DQB1*0201	NN
(	(
DQ2.1	NN
)	)
-restricted	JJ
,	,
HSV-2-specific	JJ
T	NN
cell	NN
clone	NN
.	.

Using	VBG
antigen	JJ
peptide	NN
analogs	NNS
with	IN
different	JJ
mutations	NNS
of	IN
known	JJ
DQ2-anchor	NN
residues	NNS
,	,
T	NN
cell	NN
response	NN
was	VBD
reduced	VBN
in	IN
an	DT
peptide-affinity	NN
and	CC
-concentration	NN
specific	JJ
manner	NN
.	.

The	DT
decrease	NN
using	VBG
weaker	JJR
binding	NN
peptides	NNS
was	VBD
gradual	JJ
as	IN
stimulation	NN
with	IN
a	DT
peptide	NN
with	IN
intermediate	JJ
affinity	NN
yielded	VBD
intermediate	JJ
T	NN
cell	NN
proliferation	NN
and	CC
the	DT
poorest	JJ
binding	NN
peptide	NN
induced	VBD
an	DT
even	RB
weaker	JJR
T	NN
cell	NN
response	NN
.	.

MHC	NN
class	NN
II	CD
density	NN
on	IN
the	DT
APC	NN
was	VBD
modified	VBN
using	VBG
DQ2	NN
homo-	JJ
and	CC
heterozygous	JJ
B-LCLs	NNS
as	IN
APCs	NNS
,	,
however	RB
this	DT
variation	NN
of	IN
MHC	NN
concentration	NN
had	VBD
no	DT
effect	NN
on	IN
T	NN
cell	NN
proliferation	NN
.	.

We	PRP
interpret	VB
this	DT
as	IN
a	DT
reflection	NN
of	IN
a	DT
low	JJ
threshold	NN
for	IN
activation	NN
of	IN
the	DT
T	NN
cell	NN
clone	NN
,	,
in	IN
which	WDT
peptide-MHC	JJ
avidity	NN
is	VBZ
the	DT
over-riding	JJ
determinant	NN
of	IN
the	DT
strength	NN
of	IN
ligand	NN
signal	NN
.	.

UI	LS
-	:
96141062	CD

TI	LS
-	:
Thrombopoietin	NN
induces	VBZ
tyrosine	NN
phosphorylation	NN
of	IN
Stat3	NN
and	CC
Stat5	NN
in	IN
human	JJ
blood	NN
platelets	NNS
.	.

AB	LS
-	:
Thrombopoietin	NN
is	VBZ
known	VBN
to	TO
be	VB
essential	JJ
for	IN
megakaryocytopoiesis	NN
and	CC
thrombopoiesis	NN
.	.

Recently	RB
,	,
we	PRP
and	CC
others	NNS
have	VBP
shown	VBN
that	IN
thrombopoietin	NN
induces	VBZ
rapid	JJ
tyrosine	NN
phosphorylation	NN
of	IN
Jak2	NN
and	CC
other	JJ
proteins	NNS
in	IN
human	JJ
platelets	NNS
and	CC
BaF3	NN
cells	NNS
,	,
genetically	RB
engineered	VBN
to	TO
express	VB
c-Mpl	NN
,	,
a	DT
receptor	NN
for	IN
thrombopoietin	NN
.	.

The	DT
Jak	NN
family	NN
of	IN
tyrosine	NN
kinases	NNS
are	VBP
known	VBN
to	TO
mediate	VB
some	DT
of	IN
the	DT
effects	NNS
of	IN
cytokines	NNS
or	CC
hematopoietic	JJ
growth	NN
factors	NNS
by	IN
recruitment	NN
and	CC
tyrosine	NN
phosphorylation	NN
of	IN
a	DT
variety	NN
of	IN
Stat	NN
(	(
signal	JJ
transducers	NNS
and	CC
activators	NNS
of	IN
transcription	NN
)	)
proteins	NNS
.	.

Hence	RB
,	,
we	PRP
have	VBP
investigated	VBN
whether	IN
Stat	NN
proteins	NNS
are	VBP
present	JJ
in	IN
platelets	NNS
and	CC
,	,
if	IN
so	RB
,	,
whether	IN
they	PRP
become	VBP
tyrosine	NN
phosphorylated	JJ
in	IN
response	NN
to	TO
thrombopoietin	NN
.	.

We	PRP
immunologically	RB
identified	VBD
Stat1	NN
,	,
Stat2	NN
,	,
Stat3	NN
,	,
and	CC
Stat5	NN
in	IN
human	JJ
platelet	NN
lysates	NNS
.	.

Thrombopoietin	IN
induced	VBD
tyrosine	NN
phosphorylation	NN
of	IN
Stat3	NN
and	CC
Stat5	NN
in	IN
these	DT
cells	NNS
.	.

Thrombopoietin	NN
also	RB
induced	VBD
tyrosine	NN
phosphorylation	NN
of	IN
Stat3	NN
and	CC
Stat5	NN
in	IN
FDCP-2	NN
cells	NNS
genetically	RB
engineered	VBN
to	TO
constitutively	RB
express	VB
human	JJ
c-Mpl	NN
.	.

Thus	RB
,	,
our	PRP$
data	NNS
indicate	VBP
that	IN
Stat3	NN
and	CC
Stat5	NN
may	MD
be	VB
involved	VBN
in	IN
signal	NN
transduction	NN
after	IN
ligand	NN
binding	NN
to	TO
c-Mpl	NN
and	CC
that	IN
this	DT
event	NN
may	MD
have	VB
a	DT
role	NN
in	IN
megakaryopoiesis/thrombopoiesis	JJ
or	CC
possibly	RB
a	DT
mature	JJ
platelet	NN
function	NN
such	JJ
as	IN
aggregation	NN
.	.

UI	LS
-	:
99369970	CD

TI	LS
-	:
Cutting	JJ
edge	NN
:	:
TCR	NN
stimulation	NN
by	IN
antibody	NN
and	CC
bacterial	JJ
superantigen	NN
induces	VBZ
Stat3	NN
activation	NN
in	IN
human	JJ
T	NN
cells	NNS
.	.

AB	LS
-	:
Recent	JJ
data	NNS
show	VBP
that	IN
TCR/CD3	JJ
stimulation	NN
induces	VBZ
activation	NN
of	IN
Stat5	NN
in	IN
murine	JJ
T	NN
cells	NNS
.	.

Here	RB
,	,
we	PRP
show	VBP
that	IN
CD3	NN
ligation	NN
by	IN
mAb	NN
and	CC
Staphylococcal	JJ
enterotoxin	NN
(	(
SE	NN
)	)
induce	VBP
a	DT
rapid	JJ
,	,
gradually	RB
accumulating	VBG
,	,
long-lasting	JJ
tyrosine	NN
,	,
and	CC
serine	NN
phosphorylation	NN
of	IN
Stat3	NN
(	(
but	CC
not	RB
Stat5	NN
)	)
in	IN
allogen-specific	JJ
human	JJ
CD4+	JJ
T	NN
cell	NN
lines	NNS
.	.

In	IN
contrast	NN
,	,
IL-2	NN
induces	VBZ
a	DT
rapid	JJ
and	CC
transient	JJ
tyrosine	NN
and	CC
serine	NN
phosphorylation	NN
of	IN
Stat3	NN
.	.

Compared	VBN
with	IN
IL-2	NN
,	,
CD3	NN
ligation	NN
induces	VBZ
a	DT
delayed	VBN
Stat3	NN
binding	VBG
to	TO
oligonucleotide	NN
probes	NNS
from	IN
the	DT
ICAM-1	NN
and	CC
IL-2R	NN
alpha	NN
promoter	NN
.	.

CD3-mediated	JJ
activation	NN
of	IN
Stat3	NN
is	VBZ
almost	RB
completely	RB
inhibited	VBN
by	IN
a	DT
Src	NN
kinase	NN
inhibitor	NN
(	(
PP1	NN
)	)
,	,
whereas	IN
IL-2-induced	JJ
Stat3	NN
activation	NN
is	VBZ
unaffected	JJ
.	.

In	IN
conclusion	NN
,	,
we	PRP
show	VBP
that	IN
CD3	NN
ligation	NN
by	IN
mAb	NN
and	CC
SE	NN
triggers	VBZ
a	DT
rapid	JJ
,	,
PP1-sensitive	JJ
tyrosine	NN
and	CC
serine	NN
phosphorylation	NN
of	IN
Stat3	NN
in	IN
human	JJ
CD4+	JJ
T	NN
cells	NNS
.	.

Moreover	RB
,	,
we	PRP
provide	VBP
evidence	NN
that	IN
TCR/CD3	JJ
and	CC
IL-2	NN
induce	VBP
Stat3	NN
activation	NN
via	IN
distinct	JJ
signaling	NN
pathways	NNS
.	.

UI	LS
-	:
99376409	CD

TI	LS
-	:
Dendritic	JJ
cells	NNS
and	CC
the	DT
pathogenesis	NN
of	IN
rheumatoid	JJ
arthritis	NN
.	.

AB	LS
-	:
Rheumatoid	JJ
arthritis	NN
(	(
RA	NN
)	)
is	VBZ
a	DT
chronic	JJ
autoimmune	JJ
inflammatory	JJ
disease	NN
in	IN
which	WDT
unknown	JJ
arthrogenic	JJ
autoantigen	NN
is	VBZ
presented	VBN
to	TO
CD4+	JJ
T	NN
cells	NNS
.	.

The	DT
strong	JJ
association	NN
of	IN
the	DT
disease	NN
with	IN
an	DT
epitope	NN
within	IN
the	DT
HLA-DR	NN
chain	NN
shared	VBN
between	IN
various	JJ
alleles	NNS
of	IN
HLA-DR4	NN
and	CC
DR1	NN
emphasizes	VBZ
the	DT
importance	NN
of	IN
antigen	JJ
presentation	NN
.	.

This	DT
immune	JJ
response	NN
predominantly	RB
occurs	VBZ
in	IN
the	DT
synovial	NN
tissue	NN
and	CC
fluid	NN
of	IN
the	DT
joints	NNS
and	CC
autoreactive	JJ
T	NN
cells	NNS
are	VBP
readily	RB
demonstrable	JJ
in	IN
both	CC
the	DT
synovial	JJ
compartment	NN
and	CC
blood	NN
.	.

Circulating	VBG
dendritic	JJ
cells	NNS
(	(
DC	NN
)	)
are	VBP
phenotypically	RB
and	CC
functionally	RB
identical	JJ
with	IN
normal	JJ
peripheral	JJ
blood	NN
(	(
PB	NN
)	)
DC	NN
.	.

In	IN
the	DT
synovial	JJ
tissue	NN
,	,
fully	RB
differentiated	VBN
perivascular	JJ
DC	NN
are	VBP
found	VBN
in	IN
close	JJ
association	NN
with	IN
T	NN
cells	NNS
and	CC
with	IN
B	NN
cell	NN
follicles	NNS
,	,
sometimes	RB
containing	VBG
follicular	JJ
DC	NN
.	.

These	DT
perivascular	JJ
DC	NN
migrate	VBP
across	IN
the	DT
activated	VBN
endothelium	NN
from	IN
blood	NN
and	CC
receive	VBP
differentiative	JJ
signals	NNS
within	IN
the	DT
joint	NN
from	IN
monocyte-derived	JJ
cytokines	NNS
and	CC
CD40-ligand+	JJ
T	NN
cells	NNS
.	.

In	IN
the	DT
SF	NN
,	,
DC	NN
manifest	VBP
an	DT
intermediate	JJ
phenotype	NN
,	,
similar	JJ
to	TO
that	DT
of	IN
monocyte-derived	JJ
DC	NN
in	FW
vitro	FW
.	.

Like	IN
a	DT
delayed-type	JJ
hypersensitivity	NN
response	NN
,	,
the	DT
rheumatoid	JJ
synovium	NN
represents	VBZ
an	DT
effector	NN
site	NN
.	.

DC	NN
at	IN
many	JJ
effector	NN
sites	NNS
have	VBP
a	DT
characteristic	JJ
pattern	NN
of	IN
infiltration	NN
and	CC
differentiation	NN
.	.

It	PRP
is	VBZ
important	JJ
to	TO
note	VB
that	IN
the	DT
effector	NN
response	NN
is	VBZ
not	RB
self-limiting	JJ
in	IN
RA	NN
autoimmune	JJ
inflammation	NN
.	.

In	IN
this	DT
article	NN
,	,
we	PRP
argue	VBP
that	IN
the	DT
presentation	NN
of	IN
self-antigen	NN
by	IN
DC	NN
and	CC
by	IN
autoantibody-producing	JJ
B	NN
cells	NNS
is	VBZ
critical	JJ
for	IN
the	DT
perpetuation	NN
of	IN
the	DT
autoimmune	JJ
response	NN
.	.

Permanently	RB
arresting	VBG
this	DT
ongoing	JJ
immune	JJ
response	NN
with	IN
either	CC
pharmaceutical	JJ
agents	NNS
or	CC
immunotherapy	NN
is	VBZ
a	DT
major	JJ
challenge	NN
for	IN
immunology	NN
.	.

UI	LS
-	:
99370197	CD

TI	LS
-	:
Thymocyte-thymic	JJ
epithelial	NN
cell	NN
interaction	NN
leads	VBZ
to	TO
high-level	JJ
replication	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
exclusively	RB
in	IN
mature	JJ
CD4(+)	JJ
CD8(-)	JJ
CD3(+)	JJ
thymocytes	NNS
:	:
a	DT
critical	JJ
role	NN
for	IN
tumor	NN
necrosis	NN
factor	NN
and	CC
interleukin-7	NN
.	.

AB	LS
-	:
This	DT
work	NN
aims	VBZ
at	IN
identifying	VBG
the	DT
thymocyte	NN
subpopulation	NN
able	JJ
to	TO
support	VB
human	JJ
immunodeficiency	NN
virus	NN
(	(
HIV	NN
)	)
replication	NN
under	IN
the	DT
biological	JJ
stimuli	NNS
of	IN
the	DT
thymic	JJ
microenvironment	NN
.	.

In	IN
this	DT
report	NN
we	PRP
demonstrate	VBP
that	IN
interaction	NN
with	IN
thymic	JJ
epithelial	JJ
cells	NNS
(	(
TEC	NN
)	)
induces	VBZ
a	DT
high-level	JJ
replication	NN
of	IN
the	DT
T-tropic	JJ
primary	JJ
isolate	JJ
HIV-1	NN
(	(
B-LAIp	NN
)	)
exclusively	RB
in	IN
the	DT
mature	JJ
CD4(+)	JJ
CD8(-)	JJ
CD3(+)	JJ
thymocytes	NNS
.	.

Tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
and	CC
interleukin-7	NN
(	(
IL-7	NN
)	)
,	,
secreted	VBN
during	IN
this	DT
interaction	NN
,	,
are	VBP
critical	JJ
cytokines	NNS
for	IN
HIV	NN
long	JJ
terminal	JJ
repeat	NN
transactivation	NN
through	IN
NF-kappaB-dependent	JJ
activation	NN
.	.

TNF	NN
is	VBZ
the	DT
major	JJ
inducer	NN
of	IN
NF-kappaB	NN
and	CC
particularly	RB
of	IN
the	DT
p50-p65	JJ
complex	NN
,	,
whereas	IN
IL-7	NN
acts	VBZ
as	IN
a	DT
cofactor	NN
by	IN
sustaining	VBG
the	DT
expression	NN
of	IN
the	DT
p75	NN
TNF	NN
receptor	NN
.	.

The	DT
requirement	NN
for	IN
TNF	NN
is	VBZ
further	RBR
confirmed	VBN
by	IN
the	DT
observation	NN
that	IN
the	DT
inability	NN
of	IN
the	DT
intermediate	JJ
CD4(+)	JJ
CD8(-)	JJ
CD3(-)	JJ
thymocytes	NNS
to	TO
replicate	VB
the	DT
virus	NN
is	VBZ
associated	VBN
with	IN
a	DT
defect	NN
in	IN
TNF	NN
production	NN
during	IN
their	PRP$
interaction	NN
with	IN
TEC	NN
and	CC
correlates	VBZ
with	IN
the	DT
absence	NN
of	IN
nuclear	JJ
NF-kappaB	NN
activity	NN
in	IN
these	DT
freshly	RB
isolated	VBN
thymocytes	NNS
.	.

Addition	NN
of	IN
exogenous	JJ
TNF	NN
to	TO
the	DT
intermediate	JJ
thymocyte	NN
cultures	NNS
induces	VBZ
NF-kappaB	NN
activity	NN
and	CC
is	VBZ
sufficient	JJ
to	TO
promote	VB
HIV	NN
replication	NN
in	IN
the	DT
cocultures	NNS
with	IN
TEC	NN
.	.

The	DT
other	JJ
major	JJ
subpopulation	NN
expressing	VBG
the	DT
CD4	NN
receptor	NN
,	,
namely	RB
,	,
the	DT
double-positive	JJ
(	(
DP	NN
)	)
CD4(+)	JJ
CD8(+)	JJ
CD3(+/-)	JJ
thymocytes	NNS
,	,
despite	IN
the	DT
entry	NN
of	IN
the	DT
virus	NN
,	,
do	VBP
not	RB
produce	VB
a	DT
significant	JJ
level	NN
of	IN
virus	NN
,	,
presumably	RB
because	IN
they	PRP
are	VBP
unresponsive	JJ
to	TO
TNF	NN
and	CC
IL-7	NN
.	.

Together	RB
,	,
these	DT
data	NNS
suggest	VBP
that	IN
in	FW
vivo	FW
,	,
despite	IN
an	DT
efficient	JJ
entry	NN
of	IN
the	DT
virus	NN
in	IN
all	PDT
the	DT
CD4(+)	JJ
subpopulations	NNS
,	,
a	DT
high	JJ
viral	JJ
load	NN
may	MD
be	VB
generated	VBN
exclusively	RB
within	IN
the	DT
mature	JJ
CD4(+)	JJ
CD8(-)	JJ
CD3(+)	JJ
subset	NN
of	IN
thymocytes	NNS
.	.

However	RB
,	,
under	IN
conditions	NNS
of	IN
inflammatory	JJ
response	NN
after	IN
infection	NN
,	,
TNF	NN
might	MD
also	RB
be	VB
present	JJ
in	IN
the	DT
intermediate	JJ
thymocyte	NN
compartment	NN
,	,
leading	VBG
to	TO
efficient	JJ
HIV	NN
replication	NN
in	IN
these	DT
cells	NNS
.	.

UI	LS
-	:
96262594	CD

TI	LS
-	:
Interleukin	NN
10	CD
induced	JJ
c-fos	NN
expression	NN
in	IN
human	JJ
B	NN
cells	NNS
by	IN
activation	NN
of	IN
divergent	JJ
protein	NN
kinases	NNS
.	.

AB	LS
-	:
IL-10	NN
is	VBZ
a	DT
potent	JJ
mediator	NN
of	IN
human	JJ
B	NN
cell	NN
growth	NN
and	CC
plasma	NN
cell	NN
formation	NN
.	.

However	RB
,	,
signal	NN
transduction	NN
of	IN
IL-10	NN
in	IN
B	NN
cells	NNS
is	VBZ
poorly	RB
understood	VBN
.	.

In	IN
this	DT
study	NN
the	DT
effect	NN
of	IN
IL-10	NN
on	IN
the	DT
expression	NN
of	IN
the	DT
protooncogene	NN
c-fos	NN
was	VBD
investigated	VBN
,	,
because	IN
Fos	NN
plays	VBZ
a	DT
potential	JJ
role	NN
in	IN
the	DT
regulation	NN
of	IN
B	NN
cell	NN
proliferation	NN
and	CC
differentiation	NN
.	.

B	NN
cells	NNS
were	VBD
purified	VBN
from	IN
buffy	JJ
coat	NN
preparations	NNS
of	IN
healthy	JJ
blood	NN
donors	NNS
by	IN
positive	JJ
selection	NN
using	VBG
an	DT
anti	JJ
CD20	NN
monoclonal	JJ
antibody	NN
and	CC
a	DT
MiniMACS	NN
separation	NN
unit	NN
.	.

B	NN
cells	NNS
were	VBD
prestimulated	VBN
with	IN
SAC	NN
for	IN
48	CD
hrs	NNS
.	.

Then	RB
,	,
cells	NNS
were	VBD
incubated	VBN
with	IN
medium	NN
or	CC
IL-10	NN
(	(
100	CD
ng/ml	NN
)	)
for	IN
10	CD
to	TO
120	CD
min	NN
.	.

RNA	NN
was	VBD
extracted	VBN
by	IN
phenol/chloroform	NN
and	CC
c-fos	NN
expression	NN
was	VBD
analyzed	VBN
by	IN
PCR	NN
assisted	JJ
mRNA	NN
assay	NN
.	.

A	DT
significant	JJ
2-4	CD
fold	JJ
increase	NN
of	IN
c-fos	NN
expression	NN
was	VBD
observed	VBN
within	IN
30	CD
min	NN
of	IN
stimulation	NN
with	IN
IL-10	NN
(	(
p	NN
<	JJR
0.01	CD
)	)
.	.

After	IN
2	CD
hrs	NNS
c-fos	NN
expression	NN
declined	VBD
to	TO
basal	JJ
levels	NNS
.	.

The	DT
effect	NN
of	IN
IL-10	NN
was	VBD
dose-dependent	JJ
with	IN
a	DT
maximum	NN
stimulation	NN
using	VBG
100	CD
ng/ml	NN
of	IN
IL-10	NN
.	.

The	DT
IL-10	NN
effect	NN
on	IN
c-fos	NN
expression	NN
was	VBD
not	RB
blocked	VBN
by	IN
polymyxin	NN
B	NN
.	.

Using	VBG
the	DT
tyrosine	NN
kinase	NN
inhibitor	NN
genistein	NN
(	(
10	CD
microM	NN
)	)
a	DT
complete	JJ
inhibition	NN
of	IN
IL-10	NN
induced	JJ
c-fos	NN
expression	NN
was	VBD
observed	VBN
.	.

In	IN
addition	NN
,	,
H-7	NN
(	(
10	CD
microM	NN
)	)
,	,
a	DT
specific	JJ
inhibitor	NN
of	IN
serine/threonine	NN
kinases	NNS
,	,
significantly	RB
blocked	VBD
IL-10	NN
mediated	JJ
c-fos	NN
expression	NN
(	(
p	NN
<	JJR
0.05	CD
)	)
.	.

In	IN
conclusion	NN
,	,
these	DT
data	NNS
show	VBP
that	IN
IL-10	NN
induces	VBZ
c-fos	NN
expression	NN
in	IN
human	JJ
B-cells	NNS
by	IN
activation	NN
of	IN
tyrosine	NN
and	CC
serine/threonine	NN
kinases	NNS
.	.

Since	IN
this	DT
is	VBZ
the	DT
first	JJ
report	NN
on	IN
IL-10	NN
induced	JJ
signal	NN
transduction	NN
,	,
these	DT
data	NNS
may	MD
help	VB
to	TO
identify	VB
the	DT
intracellular	JJ
mechanisms	NNS
by	IN
which	WDT
IL-10	NN
stimulates	VBZ
human	JJ
B-cells	NNS
.	.

UI	LS
-	:
99410809	CD

TI	LS
-	:
Peroxisome	NN
proliferator-activated	JJ
receptor	NN
activators	NNS
target	VBP
human	JJ
endothelial	JJ
cells	NNS
to	TO
inhibit	VB
leukocyte-endothelial	JJ
cell	NN
interaction	NN
.	.

AB	LS
-	:
An	DT
early	JJ
event	NN
in	IN
acute	JJ
and	CC
chronic	JJ
inflammation	NN
and	CC
associated	VBN
diseases	NNS
such	JJ
as	IN
atherosclerosis	NN
and	CC
rheumatoid	JJ
arthritis	NN
is	VBZ
the	DT
induced	VBN
expression	NN
of	IN
specific	JJ
adhesion	NN
molecules	NNS
on	IN
the	DT
surface	NN
of	IN
endothelial	JJ
cells	NNS
(	(
ECs	NNS
)	)
,	,
which	WDT
subsequently	RB
bind	VBP
leukocytes	NNS
.	.

Peroxisome	NN
proliferator-activated	JJ
receptors	NNS
(	(
PPARs	NNS
)	)
,	,
members	NNS
of	IN
the	DT
nuclear	JJ
receptor	NN
superfamily	NN
of	IN
transcription	NN
factors	NNS
,	,
are	VBP
activated	VBN
by	IN
fatty	JJ
acid	JJ
metabolites	NNS
,	,
peroxisome	NN
proliferators	NNS
,	,
and	CC
thiazolidinediones	NNS
and	CC
are	VBP
now	RB
recognized	VBN
as	RB
important	JJ
mediators	NNS
in	IN
the	DT
inflammatory	JJ
response	NN
.	.

Whether	IN
PPAR	NN
activators	NNS
influence	VBP
the	DT
inflammatory	JJ
responses	NNS
of	IN
ECs	NNS
is	VBZ
unknown	JJ
.	.

We	PRP
show	VBP
that	IN
the	DT
PPAR	NN
activators	NNS
15-deoxy-Delta	NN
(	(
12	CD
,	,
14	CD
)	)
-prostaglandin	NN
J	NN
(	(
2	CD
)	)
(	(
15d-PGJ	NN
(	(
2	CD
)	)
)	)
,	,
Wyeth	NN
14643	CD
,	,
ciglitazone	NN
,	,
and	CC
troglitazone	NN
,	,
but	CC
not	RB
BRL	NN
49653	CD
,	,
partially	RB
inhibit	VBP
the	DT
induced	VBN
expression	NN
of	IN
vascular	JJ
cell	NN
adhesion	NN
molecule-1	NN
(	(
VCAM-1	NN
)	)
,	,
as	IN
measured	VBN
by	IN
ELISA	NN
,	,
and	CC
monocyte	NN
binding	VBG
to	TO
human	JJ
aortic	JJ
endothelial	JJ
cells	NNS
(	(
HAECs	NNS
)	)
activated	VBN
by	IN
phorbol	NN
12-myristate	NN
13-acetate	NN
(	(
PMA	NN
)	)
or	CC
lipopolysaccharide	NN
.	.

The	DT
"	``
natural	JJ
"	''
PPAR	NN
activator	NN
15d-PGJ	NN
(	(
2	CD
)	)
had	VBD
the	DT
greatest	JJS
potency	NN
and	CC
was	VBD
the	DT
only	RB
tested	VBN
molecule	NN
capable	JJ
of	IN
partially	RB
inhibiting	VBG
the	DT
induced	VBN
expression	NN
of	IN
E-selectin	NN
and	CC
neutrophil-like	JJ
HL60	NN
cell	NN
binding	VBG
to	TO
PMA-activated	JJ
HAECs	NNS
.	.

Intracellular	JJ
adhesion	NN
molecule-1	NN
induction	NN
by	IN
PMA	NN
was	VBD
unaffected	JJ
by	IN
any	DT
of	IN
the	DT
molecules	NNS
tested	VBN
.	.

Both	CC
PPAR-alpha	NN
and	CC
PPAR-gamma	NN
mRNAs	NNS
were	VBD
detected	VBN
in	IN
HAECs	NNS
by	IN
using	VBG
reverse	JJ
transcription-polymerase	JJ
chain	NN
reaction	NN
and	CC
a	DT
ribonuclease	NN
protection	NN
assay	NN
;	:
however	RB
,	,
we	PRP
have	VBP
yet	RB
to	TO
determine	VB
which	WDT
,	,
if	IN
any	DT
,	,
of	IN
the	DT
PPARs	NNS
are	VBP
mediating	VBG
this	DT
process	NN
.	.

These	DT
results	NNS
suggest	VBP
that	IN
certain	JJ
PPAR	NN
activators	NNS
may	MD
help	VB
limit	VB
chronic	JJ
inflammation	NN
mediated	VBN
by	IN
VCAM-1	NN
and	CC
monocytes	NNS
without	IN
affecting	VBG
acute	JJ
inflammation	NN
mediated	VBN
by	IN
E-selectin	NN
and	CC
neutrophil	JJ
binding	NN
.	.

UI	LS
-	:
99388007	CD

TI	LS
-	:
Dephosphorylation	NN
of	IN
ZAP-70	NN
and	CC
inhibition	NN
of	IN
T	NN
cell	NN
activation	NN
by	IN
activated	VBN
SHP1	NN
.	.

AB	LS
-	:
Studies	NNS
with	IN
motheaten	NN
mice	NNS
,	,
which	WDT
lack	VBP
the	DT
SHP1	NN
protein	NN
tyrosine	NN
phosphatase	NN
,	,
indicate	VBP
that	IN
this	DT
enzyme	NN
plays	VBZ
an	DT
important	JJ
negative	JJ
role	NN
in	IN
T	NN
cell	NN
antigen	NN
receptor	NN
(	(
TCR	NN
)	)
signaling	NN
.	.

The	DT
physiological	JJ
substrates	NNS
for	IN
SHP1	NN
in	IN
T	NN
lymphocytes	NNS
,	,
however	RB
,	,
have	VBP
remained	VBN
unclear	JJ
or	CC
controversial	JJ
.	.

To	TO
define	VB
these	DT
targets	NNS
for	IN
SHP1	NN
we	PRP
have	VBP
compared	VBN
the	DT
effects	NNS
of	IN
constitutively	RB
active	JJ
and	CC
inactive	JJ
mutants	NNS
of	IN
SHP1	NN
on	IN
TCR	NN
signaling	NN
.	.

Expression	NN
of	IN
wild-type	JJ
SHP1	NN
had	VBD
a	DT
very	RB
small	JJ
effect	NN
on	IN
the	DT
TCR-induced	JJ
tyrosine	NN
phosphorylation	NN
of	IN
ZAP-70	NN
and	CC
Syk	NN
,	,
even	RB
when	WRB
SHP1	NN
was	VBD
overexpressed	VBN
20-100-fold	RB
over	IN
endogenous	JJ
SHP1	NN
.	.

Inactive	JJ
SHP1-D421A	NN
and	CC
wild-type	JJ
SHP2	NN
were	VBD
without	IN
effects	NNS
.	.

Constitutively	RB
active	JJ
SHP1-DeltaSH2	NN
had	VBD
a	DT
more	RBR
pronounced	JJ
effect	NN
on	IN
ZAP-70	NN
and	CC
Syk	NN
,	,
even	RB
when	WRB
expressed	VBN
at	IN
near	JJ
physiological	JJ
levels	NNS
.	.

SHP1-DeltaSH2	NN
also	RB
inhibited	VBD
events	NNS
downstream	JJ
of	IN
ZAP-70	NN
and	CC
Syk	NN
,	,
such	JJ
as	IN
activation	NN
of	IN
the	DT
mitogen-activated	JJ
protein	NN
kinase	NN
Erk2	NN
and	CC
the	DT
transcriptional	JJ
activation	NN
of	IN
the	DT
interleukin-2	NN
gene	NN
.	.

In	IN
contrast	NN
,	,
a	DT
constitutively	RB
active	JJ
SHP2-DeltaSH2	NN
had	VBD
no	DT
statistically	RB
significant	JJ
effect	NN
(	(
although	IN
it	PRP
caused	VBD
a	DT
slight	JJ
augmentation	NN
in	IN
some	DT
individual	JJ
experiments	NNS
)	)
.	.

None	NN
of	IN
the	DT
constructs	NNS
influenced	VBD
the	DT
anti-CD3-induced	JJ
tyrosine	NN
phosphorylation	NN
of	IN
the	DT
TCR	NN
zeta-chain	NN
or	CC
phospholipase	NN
Cgamma1	NN
,	,
indicating	VBG
that	IN
Src	NN
family	NN
kinase	NN
function	NN
was	VBD
intact	JJ
.	.

Taken	VBN
together	RB
,	,
our	PRP$
findings	NNS
support	VBP
the	DT
notion	NN
that	IN
ZAP-70	NN
and	CC
Syk	NN
can	MD
be	VB
direct	JJ
substrates	NNS
for	IN
SHP1	NN
in	IN
intact	JJ
cells	NNS
.	.

However	RB
,	,
the	DT
two	CD
SH2	NN
domains	NNS
of	IN
SHP1	NN
did	VBD
not	RB
facilitate	VB
its	PRP$
recognition	NN
of	IN
ZAP-70	NN
and	CC
Syk	NN
as	IN
substrates	NNS
in	IN
intact	JJ
cells	NNS
.	.

Therefore	RB
,	,
we	PRP
suggest	VBP
that	IN
SHP1	NN
is	VBZ
not	RB
actively	RB
recruited	VBN
to	TO
inhibit	VB
TCR	NN
signaling	NN
induced	VBN
by	IN
ligation	NN
of	IN
this	DT
receptor	NN
alone	RB
.	.

Instead	RB
,	,
we	PRP
propose	VBP
that	IN
ligation	NN
of	IN
a	DT
distinct	JJ
inhibitory	JJ
receptor	NN
leads	VBZ
to	TO
the	DT
recruitment	NN
of	IN
SHP1	NN
via	IN
its	PRP$
SH2	NN
domains	NNS
,	,
activation	NN
of	IN
SHP1	NN
and	CC
subsequently	RB
inhibition	NN
of	IN
TCR	NN
signals	NNS
if	IN
the	DT
inhibitory	JJ
receptor	NN
is	VBZ
juxtaposed	VBN
to	TO
the	DT
TCR	NN
.	.

UI	LS
-	:
97126580	CD

TI	LS
-	:
Energy	NN
substrates	NNS
,	,
hormone	NN
responses	NNS
and	CC
glucocorticoid	NN
binding	NN
in	IN
lymphocytes	NNS
during	IN
intense	JJ
physical	JJ
exercise	NN
in	IN
humans	NNS
following	VBG
phosphocreatine	JJ
administration	NN
.	.

AB	LS
-	:
Eight	CD
healthy	JJ
untrained	JJ
male	JJ
volunteers	NNS
pedalled	VBD
a	DT
cycle	NN
ergometer	NN
according	VBG
to	TO
two	CD
exercise	NN
protocols	NNS
:	:
the	DT
first	JJ
involved	VBD
step-wise	RB
increasing	VBG
physical	JJ
exercise	NN
to	TO
maximal	JJ
(	(
MPE	NN
)	)
;	:
the	DT
second	JJ
involved	VBD
prolonged	JJ
(	(
35	CD
min	NN
)	)
submaximal	JJ
physical	JJ
exercise	NN
(	(
PPE	NN
)	)
at	IN
70	CD
%	NN
of	IN
the	DT
individual	NN
's	POS
maximal	JJ
oxygen	NN
uptake	NN
.	.

Each	DT
volunteer	NN
performed	VBD
these	DT
exercise	NN
twice	RB
,	,
following	VBG
either	CC
an	DT
intravenous	JJ
injection	NN
of	IN
phosphocreatine	JJ
(	(
PCr	NN
)	)
or	CC
a	DT
placebo	NN
of	IN
an	DT
isotonic	JJ
NaCl	NN
solution	NN
.	.

Anaerobic	JJ
threshold	NN
(	(
AT	NN
)	)
was	VBD
determined	VBN
from	IN
the	DT
point	NN
of	IN
departure	NN
of	IN
the	DT
ventilatory	JJ
response	NN
from	IN
linearity	NN
and	CC
from	IN
the	DT
sudden	JJ
increase	NN
in	IN
venous	JJ
blood	NN
lactate	NN
concentrations	NNS
during	IN
MPE	NN
.	.

After	IN
exercise	NN
following	VBG
placebo	NN
administration	NN
we	PRP
observed	VBD
increases	NNS
in	IN
concentrations	NNS
of	IN
blood	NN
substrates	NNS
,	,
plasma	NN
adrenocorticotropin	NN
(	(
ACTH	NN
)	)
,	,
growth	NN
hormone	NN
and	CC
cortisol	NN
and	CC
in	IN
the	DT
number	NN
of	IN
glucocorticoid	NN
receptors	NNS
in	IN
lymphocytes	NNS
without	IN
changes	NNS
in	IN
the	DT
dissociation	NN
constant	NN
.	.

Intravenous	JJ
administration	NN
of	IN
PCr	NN
(	(
starting	VBG
1	CD
day	NN
before	IN
exercise	NN
)	)
led	VBD
to	TO
an	DT
increase	NN
in	IN
the	DT
total	JJ
workload	NN
(	(
on	IN
average	NN
by	IN
5.8	CD
%	NN
)	)
and	CC
in	IN
AT	NN
(	(
on	IN
average	NN
by	IN
6.8	CD
%	NN
)	)
during	IN
MPE	NN
and	CC
to	TO
a	DT
better	JJR
tolerance	NN
of	IN
exercise	NN
during	IN
PPE	NN
.	.

Following	VBG
PCr	NN
administration	NN
we	PRP
observed	VBD
lower	JJR
blood	NN
lactate	NN
concentrations	NNS
and	CC
different	JJ
patterns	NNS
of	IN
some	DT
enzyme	NN
activities	NNS
,	,
less	RBR
pronounced	JJ
changes	NNS
in	IN
plasma	NN
ACTH	NN
and	CC
cortisol	NN
concentrations	NNS
and	CC
in	IN
glucocorticoid	NN
binding	NN
in	IN
lymphocytes	NNS
,	,
but	CC
no	DT
changes	NNS
in	IN
plasma	NN
growth	NN
hormone	NN
concentrations	NNS
compared	VBN
to	TO
the	DT
placebo	NN
.	.

The	DT
results	NNS
showed	VBD
that	IN
intense	JJ
physical	JJ
exercise	NN
led	VBD
not	RB
only	RB
to	TO
increases	NNS
in	IN
blood	NN
hormone	NN
concentrations	NNS
but	CC
also	RB
to	TO
an	DT
increase	NN
in	IN
the	DT
density	NN
of	IN
glucocorticoid	NN
receptors	NNS
in	IN
lymphocytes	NNS
.	.

Intravenous	JJ
PCr	NN
injection	NN
led	VBD
to	TO
smaller	JJR
changes	NNS
in	IN
ACTH	NN
and	CC
cortisol	NN
concentrations	NNS
as	RB
well	RB
as	IN
to	TO
a	DT
lower	JJR
activation	NN
of	IN
glucocorticoid	NN
binding	NN
in	IN
lymphocytes	NNS
.	.

UI	LS
-	:
99367411	CD

TI	LS
-	:
Protein	NN
kinase	NN
C	NN
and	CC
calcineurin	NN
synergize	VBP
to	TO
activate	VB
IkappaB	NN
kinase	NN
and	CC
NF-kappaB	NN
in	IN
T	NN
lymphocytes	NNS
.	.

AB	LS
-	:
The	DT
nuclear	JJ
factor	NN
of	IN
kappaB	NN
(	(
NF-kappaB	NN
)	)
is	VBZ
a	DT
ubiquitous	JJ
transcription	NN
factor	NN
that	WDT
is	VBZ
key	JJ
in	IN
the	DT
regulation	NN
of	IN
the	DT
immune	JJ
response	NN
and	CC
inflammation	NN
.	.

T	NN
cell	NN
receptor	NN
(	(
TCR	NN
)	)
cross-linking	NN
is	VBZ
in	IN
part	NN
required	VBN
for	IN
activation	NN
of	IN
NF-kappaB	NN
,	,
which	WDT
is	VBZ
dependent	JJ
on	IN
the	DT
phosphorylation	NN
and	CC
degradation	NN
of	IN
IkappaBalpha	NN
.	.

By	IN
using	VBG
Jurkat	NN
and	CC
primary	JJ
human	JJ
T	NN
lymphocytes	NNS
,	,
we	PRP
demonstrate	VBP
that	IN
the	DT
simultaneous	JJ
activation	NN
of	IN
two	CD
second	JJ
messengers	NNS
of	IN
the	DT
TCR-initiated	JJ
signal	NN
transduction	NN
,	,
protein	NN
kinase	NN
C	NN
(	(
PKC	NN
)	)
and	CC
calcineurin	NN
,	,
results	VBZ
in	IN
the	DT
synergistic	JJ
activation	NN
of	IN
the	DT
IkappaBalpha	NN
kinase	NN
(	(
IKK	NN
)	)
complex	NN
but	CC
not	RB
of	IN
another	DT
putative	JJ
IkappaBalpha	NN
kinase	NN
,	,
p90	NN
(	(
rsk	NN
)	)
.	.

We	PRP
also	RB
demonstrate	VBP
that	IN
the	DT
IKK	NN
complex	NN
,	,
but	CC
not	RB
p90	NN
(	(
rsk	NN
)	)
,	,
is	VBZ
responsible	JJ
for	IN
the	DT
in	FW
vivo	FW
phosphorylation	NN
of	IN
IkappaBalpha	NN
mediated	VBN
by	IN
the	DT
co-activation	NN
of	IN
PKC	NN
and	CC
calcineurin	NN
.	.

Each	DT
second	JJ
messenger	NN
is	VBZ
necessary	JJ
,	,
as	IN
inhibition	NN
of	IN
either	DT
one	CD
reverses	VBZ
the	DT
activation	NN
of	IN
the	DT
IKK	NN
complex	NN
and	CC
IkappaBalpha	NN
phosphorylation	NN
in	FW
vivo	FW
.	.

Overexpression	NN
of	IN
dominant	JJ
negative	JJ
forms	NNS
of	IN
IKKalpha	NN
and	CC
-beta	NN
demonstrates	VBZ
that	IN
only	JJ
IKKbeta	NN
is	VBZ
the	DT
target	NN
for	IN
PKC	NN
and	CC
calcineurin	NN
.	.

These	DT
results	NNS
indicate	VBP
that	IN
within	IN
the	DT
TCR/CD3	NN
signal	NN
transduction	NN
pathway	NN
both	CC
PKC	NN
and	CC
calcineurin	NN
are	VBP
required	VBN
for	IN
the	DT
effective	JJ
activation	NN
of	IN
the	DT
IKK	NN
complex	NN
and	CC
NF-kappaB	NN
in	IN
T	NN
lymphocytes	NNS
.	.

UI	LS
-	:
99354925	CD

TI	LS
-	:
Diminished	VBN
responses	NNS
to	TO
IL-13	NN
by	IN
human	JJ
monocytes	NNS
differentiated	VBN
in	FW
vitro	FW
:	:
role	NN
of	IN
the	DT
IL-13Ralpha1	NN
chain	NN
and	CC
STAT6	NN
.	.

AB	LS
-	:
The	DT
primary	JJ
IL-13	NN
receptor	NN
complex	NN
on	IN
human	JJ
monocytes	NNS
is	VBZ
believed	VBN
to	TO
be	VB
a	DT
heterodimer	NN
comprised	VBN
of	IN
the	DT
IL-4R	NN
alpha	NN
chain	NN
and	CC
the	DT
IL-2R	NN
gamma	NN
chain	NN
(	(
gamma(c)	NN
)	)
-like	JJ
molecule	NN
,	,
IL-13R	NN
alpha1	NN
.	.

mRNA	NN
levels	NNS
for	IN
IL-13R	NN
alpha1	NN
,	,
but	CC
not	RB
IL-4R	NN
alpha	NN
,	,
were	VBD
markedly	RB
decreased	VBN
in	IN
in	FW
vitro	FW
monocyte-derived	JJ
macrophages	NNS
(	(
MDMac	NN
)	)
,	,
and	CC
with	IN
increasing	VBG
time	NN
of	IN
monocytes	NNS
in	IN
culture	NN
correlated	VBN
with	IN
the	DT
loss	NN
of	IN
IL-13	NN
regulation	NN
of	IN
lipopolysaccharide-induced	JJ
TNF-alpha	NN
production	NN
.	.

Analysis	NN
of	IN
cell	NN
lines	NNS
Daudi	NN
and	CC
THP-1	NN
that	WDT
differentially	RB
express	VBP
gamma(c)	NN
and	CC
IL-13R	NN
alpha1	NN
showed	VBD
that	IN
IL-13	NN
can	MD
activate	VB
STAT6	NN
in	IN
IL-13R	NN
alpha1-positive	JJ
THP-1	NN
cells	NNS
but	CC
not	RB
in	IN
gamma(c)-positive	JJ
,	,
IL-13R	NN
alpha1-negative	JJ
Daudi	NN
cells	NNS
.	.

IL-13	NN
activation	NN
of	IN
STAT6	NN
was	VBD
reduced	VBN
in	IN
MDMac	NN
which	WDT
was	VBD
associated	VBN
with	IN
diminished	VBN
IL-13-induced	JJ
expression	NN
of	IN
CD23	NN
and	CC
MHC	NN
class	NN
II	CD
.	.

However	RB
,	,
with	IN
reduced	VBN
IL-13R	NN
alpha1	NN
expression	NN
and	CC
low	JJ
nuclear	JJ
STAT6	NN
activity	NN
,	,
some	DT
IL-13-induced	JJ
responses	NNS
were	VBD
unaltered	JJ
in	IN
magnitude	NN
in	IN
MDMac	NN
.	.

In	IN
the	DT
absence	NN
of	IN
functional	JJ
IL-13R	NN
alpha1	NN
and	CC
gamma(c)	NN
,	,
IL-13	NN
must	MD
signal	VB
through	IN
an	DT
alternative	JJ
receptor	NN
complex	NN
on	IN
MDMac	NN
.	.

Experiments	NNS
with	IN
a	DT
blocking	VBG
antibody	NN
to	TO
IL-4R	NN
alpha	NN
showed	VBD
that	IN
this	DT
chain	NN
remains	VBZ
an	DT
essential	JJ
component	NN
of	IN
the	DT
IL-13	NN
receptor	NN
complex	NN
on	IN
MDMac	NN
.	.

UI	LS
-	:
97119542	CD

TI	LS
-	:
A	DT
novel	JJ
immunosuppressive	JJ
factor	NN
in	IN
bovine	JJ
colostrum	NN
blocks	VBZ
activation	NN
of	IN
the	DT
interleukin	NN
2	CD
gene	NN
enhancer	NN
at	IN
the	DT
NFAT	NN
site	NN
.	.

AB	LS
-	:
A	DT
factor	NN
in	IN
bovine	JJ
colostrum	NN
(	(
colostrum	NN
inhibitory	JJ
factor	NN
,	,
CIF	NN
)	)
inhibits	VBZ
interleukin	NN
2	CD
(	(
IL2	NN
)	)
production	NN
in	IN
activated	JJ
T	NN
helper	NN
cells	NNS
by	IN
blocking	VBG
the	DT
accumulation	NN
of	IN
IL2	NN
mRNA	NN
.	.

To	TO
determine	VB
whether	IN
CIF	NN
blocks	VBZ
at	IN
the	DT
level	NN
of	IN
IL2	NN
transcription	NN
,	,
we	PRP
introduced	VBD
reporter	NN
plasmids	NNS
into	IN
the	DT
human	JJ
T	NN
leukemia	NN
cell	NN
line	NN
Jurkat	NN
by	IN
transient	JJ
transfection	NN
.	.

These	DT
contained	VBD
the	DT
luciferase	NN
gene	NN
under	IN
the	DT
control	NN
of	IN
either	CC
the	DT
human	JJ
IL2	NN
upstream	JJ
enhancer	NN
region	NN
(	(
segments	NNS
-326	CD
to	TO
+45	CD
)	)
or	CC
three	CD
repeats	NNS
of	IN
the	DT
NFAT	NN
element	NN
contained	VBN
within	IN
it	PRP
(	(
segments	NNS
-255	CD
to	TO
-285	CD
)	)
.	.

Expression	NN
of	IN
luciferase	NN
in	IN
these	DT
cells	NNS
was	VBD
induced	VBN
by	IN
phorbol	NN
myristate	NN
acetate	NN
plus	CC
a	DT
calcium	NN
ionophore	NN
.	.

CIF	NN
inhibited	VBD
induction	NN
of	IN
either	DT
construct	NN
as	IN
did	VBD
cyclosporine	NN
,	,
which	WDT
is	VBZ
known	VBN
to	TO
block	VB
activation	NN
of	IN
the	DT
NFAT	NN
element	NN
.	.

CIF	NN
failed	VBD
to	TO
inhibit	VB
several	JJ
other	JJ
enhancer	NN
elements	NNS
.	.

The	DT
NFAT-controlled	JJ
luciferase	NN
gene	NN
system	NN
distinguishes	VBZ
CIF	NN
from	IN
other	JJ
T	NN
cell	NN
inhibitory	JJ
activities	NNS
present	JJ
in	IN
colostrum	NN
,	,
in	IN
particular	JJ
,	,
TGF	NN
beta	NN
1	CD
and	CC
TGF	NN
beta	NN
2	CD
and	CC
the	DT
glucocorticoids	NNS
.	.

Stably	RB
transfected	VBN
Jurkat	NN
cells	NNS
behaved	VBD
similarly	RB
to	TO
the	DT
transiently	RB
transfected	VBN
ones	NNS
with	IN
respect	NN
to	TO
inhibition	NN
by	IN
CIF	NN
and	CC
cyclosporine	NN
.	.

The	DT
NFAT-luc	JJ
assay	NN
is	VBZ
a	DT
useful	JJ
technique	NN
for	IN
the	DT
rapid	JJ
,	,
sensitive	JJ
measurement	NN
of	IN
CIF	NN
or	CC
other	JJ
immunosuppressants	NNS
with	IN
a	DT
similar	JJ
mode	NN
of	IN
action	NN
.	.

UI	LS
-	:
99415656	CD

TI	LS
-	:
Increased	VBN
IkappaB	NN
expression	NN
and	CC
diminished	VBN
nuclear	JJ
NF-kappaB	NN
in	IN
human	JJ
mononuclear	JJ
cells	NNS
following	VBG
hydrocortisone	NN
injection	NN
.	.

AB	LS
-	:
We	PRP
have	VBP
recently	RB
demonstrated	VBN
that	IN
hydrocortisone	NN
and	CC
other	JJ
glucocorticoids	NNS
inhibit	VBP
reactive	JJ
oxygen	NN
species	NNS
(	(
ROS	NN
)	)
generation	NN
by	IN
mononuclear	JJ
(	(
MNC	NN
)	)
and	CC
polymorphonuclear	JJ
leucocytes	NNS
(	(
PMNL	NN
)	)
.	.

Since	IN
NF-kappaB/IkappaB	JJ
system	NN
regulates	VBZ
the	DT
transcription	NN
of	IN
proinflammatory	JJ
genes	NNS
,	,
including	VBG
those	DT
responsible	JJ
for	IN
ROS	NN
generation	NN
,	,
we	PRP
tested	VBD
the	DT
hypothesis	NN
that	IN
hydrocortisone	NN
may	MD
stimulate	VB
IkappaB	NN
production	NN
thus	RB
inhibiting	VBG
NF-kappaB	NN
translocation	NN
from	IN
the	DT
cytosol	NN
into	IN
the	DT
nucleus	NN
in	IN
MNC	NN
,	,
in	FW
vivo	FW
.	.

One	CD
hundred	CD
milligram	NN
of	IN
hydrocortisone	NN
was	VBD
injected	VBN
intravenously	RB
into	IN
4	CD
normal	JJ
subjects	NNS
.	.

Blood	NN
samples	NNS
were	VBD
obtained	VBN
prior	JJ
to	TO
the	DT
injection	NN
and	CC
at	IN
1	CD
,	,
2	CD
,	,
4	CD
,	,
8	CD
and	CC
24	CD
hr	NN
after	IN
the	DT
injection	NN
.	.

Nuclear	JJ
extracts	NNS
and	CC
total	JJ
cell	NN
lysates	NNS
were	VBD
prepared	VBN
from	IN
MNC	NN
by	IN
standard	JJ
techniques	NNS
.	.

IkappaB	NN
levels	NNS
in	IN
MNC	NN
homogenates	NNS
increased	VBD
at	IN
1	CD
hr	NN
,	,
peaked	VBD
at	IN
2-4	CD
hr	NN
,	,
started	VBD
to	TO
decrease	VB
at	IN
8	CD
hr	NN
,	,
and	CC
returned	VBD
to	TO
baseline	NN
levels	NNS
at	IN
24	CD
hr	NN
.	.

NF-kappaB	NN
in	IN
MNC	NN
nuclear	JJ
extracts	NNS
decreased	VBD
at	IN
1	CD
hr	NN
,	,
reached	VBD
a	DT
nadir	NN
at	IN
4	CD
hr	NN
,	,
gradually	RB
increased	VBD
at	IN
8	CD
hr	NN
and	CC
returned	VBD
back	RB
to	TO
baseline	NN
levels	NNS
at	IN
24	CD
hr	NN
.	.

The	DT
total	JJ
protein	NN
content	NN
of	IN
NF-kappaB	NN
subunit	NN
(	(
P65	NN
)	)
in	IN
MNC	NN
lysates	NNS
also	RB
showed	VBD
a	DT
decrease	NN
following	VBG
hydrocortisone	NN
injection	NN
.	.

This	DT
decrease	NN
was	VBD
observed	VBN
at	IN
2	CD
hr	NN
,	,
reached	VBD
a	DT
nadir	NN
at	IN
4	CD
hr	NN
,	,
and	CC
returned	VBD
to	TO
baseline	NN
levels	NNS
at	IN
24	CD
hr	NN
.	.

ROS	NN
generation	NN
inhibition	NN
paralleled	VBD
NF-kappaB	NN
levels	NNS
in	IN
the	DT
nucleus	NN
.	.

It	PRP
was	VBD
inhibited	VBN
at	IN
1	CD
hr	NN
,	,
reached	VBD
a	DT
nadir	NN
at	IN
2-4	CD
hr	NN
,	,
started	VBD
to	TO
increase	VB
at	IN
8	CD
hr	NN
,	,
and	CC
returned	VBD
to	TO
basal	JJ
levels	NNS
at	IN
24	CD
hr	NN
.	.

Our	PRP$
data	NNS
demonstrate	VBP
that	IN
hydrocortisone	NN
induces	VBZ
IkappaB	NN
and	CC
suppresses	VBZ
NF-kappaB	NN
expression	NN
in	IN
MNC	NN
in	IN
parallel	NN
.	.

IkappaB	NN
further	RB
reduces	VBZ
the	DT
translocation	NN
of	IN
NF-kappaB	NN
into	IN
the	DT
nucleus	NN
thus	RB
preventing	VBG
the	DT
expression	NN
of	IN
proinflammatory	JJ
genes	NNS
.	.

UI	LS
-	:
99323946	CD

TI	LS
-	:
Inhibition	NN
of	IN
NF-kappa	NN
B	NN
activity	NN
in	IN
human	JJ
T	NN
lymphocytes	NNS
induces	VBZ
caspase-dependent	JJ
apoptosis	NN
without	IN
detectable	JJ
activation	NN
of	IN
caspase-1	NN
and	CC
-3	CD
.	.

AB	LS
-	:
NF-kappa	NN
B	NN
is	VBZ
involved	VBN
in	IN
the	DT
transcriptional	JJ
control	NN
of	IN
various	JJ
genes	NNS
that	WDT
act	VBP
as	IN
extrinsic	JJ
and	CC
intrinsic	JJ
survival	NN
factors	NNS
for	IN
T	NN
cells	NNS
.	.

Our	PRP$
findings	NNS
show	VBP
that	IN
suppression	NN
of	IN
NF-kappa	NN
B	NN
activity	NN
with	IN
cell-permeable	JJ
SN50	NN
peptide	NN
,	,
which	WDT
masks	VBZ
the	DT
nuclear	JJ
localization	NN
sequence	NN
of	IN
NF-kappa	NN
B1	NN
dimers	NNS
and	CC
prevents	VBZ
their	PRP$
nuclear	JJ
localization	NN
,	,
induces	VBZ
apoptosis	NN
in	IN
resting	VBG
normal	JJ
human	JJ
PBL	NN
.	.

Inhibition	NN
of	IN
NF-kappa	NN
B	NN
resulted	VBD
in	IN
the	DT
externalization	NN
of	IN
phosphatidylserine	NN
,	,
induction	NN
of	IN
DNA	NN
breaks	NNS
,	,
and	CC
morphological	JJ
changes	NNS
consistent	JJ
with	IN
apoptosis	NN
.	.

DNA	NN
fragmentation	NN
was	VBD
efficiently	RB
blocked	VBN
by	IN
the	DT
caspase	NN
inhibitor	NN
Z-VAD-fmk	NN
and	CC
partially	RB
blocked	VBN
by	IN
Ac-DEVD-fmk	NN
,	,
suggesting	VBG
that	IN
SN50-mediated	JJ
apoptosis	NN
is	VBZ
caspase-dependent	JJ
.	.

Interestingly	RB
,	,
apoptosis	NN
induced	VBN
by	IN
NF-kappa	NN
B	NN
suppression	NN
,	,
in	IN
contrast	NN
to	TO
that	DT
induced	VBN
by	IN
TPEN	NN
(	(
N,N,N',N'-tetrakis	JJ
[2-pyridylmethyl]ethylenediamine	NN
)	)
or	CC
soluble	JJ
Fas	NN
ligand	NN
(	(
CD95	NN
)	)
,	,
was	VBD
observed	VBN
in	IN
the	DT
absence	NN
of	IN
active	JJ
death	NN
effector	NN
proteases	NNS
caspase-1-like	JJ
(	(
IL-1	NN
converting	NN
enzyme	NN
)	)
,	,
caspase-3-like	JJ
(	(
CPP32/Yama/apopain	NN
)	)
,	,
and	CC
caspase-6-like	JJ
and	CC
without	IN
cleavage	NN
of	IN
caspase-3	NN
substrates	NNS
poly(ADP-ribose)	JJ
polymerase	NN
and	CC
DNA	NN
fragmentation	NN
factor-45	NN
.	.

These	DT
findings	NNS
suggest	VBP
either	CC
low	JJ
level	NN
of	IN
activation	NN
is	VBZ
required	VBN
or	CC
that	IN
different	JJ
caspases	NNS
are	VBP
involved	VBN
.	.

Preactivation	NN
of	IN
T	NN
cells	NNS
resulting	VBG
in	IN
NF-kappa	NN
B	NN
nuclear	JJ
translocation	NN
protected	VBD
cells	NNS
from	IN
SN50-induced	JJ
apoptosis	NN
.	.

Our	PRP$
findings	NNS
demonstrate	VBP
an	DT
essential	JJ
role	NN
of	IN
NF-kappa	NN
B	NN
in	IN
survival	NN
of	IN
naive	JJ
PBL	NN
.	.

UI	LS
-	:
99298193	CD

TI	LS
-	:
Aiolos	NN
transcription	NN
factor	NN
controls	VBZ
cell	NN
death	NN
in	IN
T	NN
cells	NNS
by	IN
regulating	VBG
Bcl-2	NN
expression	NN
and	CC
its	PRP$
cellular	JJ
localization	NN
.	.

AB	LS
-	:
We	PRP
searched	VBD
for	IN
proteins	NNS
that	WDT
interact	VBP
with	IN
Ras	NN
in	IN
interleukin	NN
(	(
IL	NN
)	)
-2-stimulated	JJ
or	CC
IL-2-deprived	JJ
cells	NNS
,	,
and	CC
found	VBD
that	IN
the	DT
transcription	NN
factor	NN
Aiolos	NN
interacts	VBZ
with	IN
Ras	NN
.	.

The	DT
Ras-Aiolos	NN
interaction	NN
was	VBD
confirmed	VBN
in	FW
vitro	FW
and	CC
in	FW
vivo	FW
by	IN
co-immunoprecipitation	NN
.	.

Indirect	JJ
immunofluorescence	NN
shows	VBZ
that	IN
IL-2	NN
controls	VBZ
the	DT
cellular	JJ
distribution	NN
of	IN
Aiolos	NN
and	CC
induces	VBZ
its	PRP$
tyrosine	NN
phosphorylation	NN
,	,
required	VBN
for	IN
dissociation	NN
from	IN
Ras	NN
.	.

We	PRP
also	RB
identified	VBD
functional	JJ
Aiolos-binding	JJ
sites	NNS
in	IN
the	DT
Bcl-2	NN
promoter	NN
,	,
which	WDT
are	VBP
able	JJ
to	TO
activate	VB
the	DT
luciferase	NN
reporter	NN
gene	NN
.	.

Mutation	NN
of	IN
Aiolos-binding	JJ
sites	NNS
within	IN
the	DT
Bcl-2	NN
promoter	NN
inhibits	VBZ
transactivation	NN
of	IN
the	DT
reporter	NN
gene	NN
luciferase	NN
,	,
suggesting	VBG
direct	JJ
control	NN
of	IN
Bcl-2	NN
expression	NN
by	IN
Aiolos	NN
.	.

Co-transfection	NN
experiments	NNS
confirm	VBP
that	IN
Aiolos	NN
induces	VBZ
Bcl-2	NN
expression	NN
and	CC
prevents	VBZ
apoptosis	NN
in	IN
IL-2-deprived	JJ
cells	NNS
.	.

We	PRP
propose	VBP
a	DT
model	NN
for	IN
the	DT
regulation	NN
of	IN
Bcl-2	NN
expression	NN
via	IN
Aiolos	NN
.	.

UI	LS
-	:
99335895	CD

TI	LS
-	:
Clonality	NN
analysis	NN
of	IN
granulocytes	NNS
and	CC
T	NN
lymphocytes	NNS
in	IN
healthy	JJ
females	NNS
by	IN
the	DT
PCR-based	JJ
HUMARA	NN
method	NN
.	.

AB	LS
-	:
Clonality	NN
analysis	NN
utilizing	VBG
X-chromosome	NN
inactivation	NN
has	VBZ
been	VBN
used	VBN
in	IN
the	DT
study	NN
of	IN
various	JJ
diseases	NNS
,	,
including	VBG
hematological	JJ
malignancies	NNS
.	.

The	DT
human	JJ
androgen	NN
receptor	NN
gene	NN
(	(
HUMARA	NN
)	)
assay	NN
is	VBZ
the	DT
newest	JJS
of	IN
such	JJ
methods	NNS
,	,
and	CC
the	DT
majority	NN
of	IN
the	DT
female	JJ
population	NN
can	MD
be	VB
assessed	VBN
by	IN
this	DT
relatively	RB
simple	JJ
procedure	NN
.	.

One	CD
problem	NN
in	IN
using	VBG
these	DT
clonality	NN
analysis	NN
methods	NNS
,	,
however	RB
,	,
is	VBZ
that	IN
there	EX
may	MD
be	VB
significant	JJ
variation	NN
in	IN
Lyonization	NN
in	IN
blood	NN
cells	NNS
in	IN
normal	JJ
individuals	NNS
.	.

To	TO
determine	VB
the	DT
diversity	NN
in	IN
X-chromosome	NN
methylation	NN
patterns	NNS
,	,
which	WDT
reflect	VBP
Lyonization	NN
,	,
assessed	VBN
by	IN
the	DT
HUMARA	NN
assay	NN
in	IN
the	DT
supposedly	RB
normal	JJ
population	NN
,	,
we	PRP
analyzed	VBD
granulocytes	NNS
and	CC
T	NN
cells	NNS
from	IN
97	CD
relatively	RB
young	JJ
(	(
18-	CD
to	TO
35-year-old	JJ
)	)
healthy	JJ
female	JJ
volunteers	NNS
.	.

We	PRP
found	VBD
that	IN
the	DT
methylation	NN
patterns	NNS
in	IN
the	DT
two	CD
HUMARA	NN
alleles	NNS
were	VBD
distributed	VBN
even	RB
more	RBR
widely	RB
,	,
both	CC
in	IN
granuloctyes	NNS
and	CC
in	IN
T	NN
cells	NNS
,	,
than	IN
previously	RB
reported	VBN
with	IN
other	JJ
methods	NNS
.	.

We	PRP
also	RB
found	VBD
that	IN
the	DT
deviation	NN
of	IN
methylation	NN
in	IN
granulocytes	NNS
and	CC
T	NN
cells	NNS
was	VBD
well	RB
correlated	VBN
.	.

Thus	RB
,	,
we	PRP
conclude	VBP
that	IN
appropriate	JJ
controls	NNS
from	IN
the	DT
same	JJ
individuals	NNS
,	,
such	JJ
as	IN
T	NN
cells	NNS
in	IN
the	DT
case	NN
of	IN
stem	NN
cell	NN
disorders	NNS
,	,
should	MD
always	RB
be	VB
employed	VBN
to	TO
conclusively	RB
determine	VB
whether	IN
certain	JJ
cells	NNS
of	IN
hematopoietic	JJ
origin	NN
are	VBP
clonal	JJ
.	.

UI	LS
-	:
99315748	CD

TI	LS
-	:
Functional	JJ
B-cell	NN
response	NN
in	IN
intrahepatic	JJ
lymphoid	JJ
follicles	NNS
in	IN
chronic	JJ
hepatitis	NN
C	NN
.	.

AB	LS
-	:
Intrahepatic	JJ
lymphoid	JJ
follicle	NN
(	(
ILF	NN
)	)
formation	NN
is	VBZ
one	CD
of	IN
the	DT
most	RBS
characteristic	JJ
and	CC
commonly	RB
observed	VBN
histological	JJ
features	NNS
in	IN
patients	NNS
with	IN
chronic	JJ
hepatitis	NN
C	NN
.	.

However	RB
,	,
little	JJ
is	VBZ
known	VBN
regarding	VBG
whether	IN
follicles	NNS
in	IN
the	DT
liver	NN
belong	VBP
to	TO
functional	JJ
lymphoid	JJ
tissues	NNS
,	,
where	WRB
B	NN
cells	NNS
are	VBP
activated	VBN
,	,
differentiated	VBN
,	,
and	CC
proliferated	VBN
,	,
or	CC
if	IN
the	DT
lymphocytes	NNS
are	VBP
merely	RB
infiltrated	VBN
after	IN
recruitment	NN
from	IN
the	DT
secondary	JJ
lymphoid	JJ
organs	NNS
.	.

To	TO
ascertain	VB
this	DT
possibility	NN
,	,
we	PRP
examined	VBD
the	DT
expression	NN
of	IN
markers	NNS
for	IN
B-cell	NN
activation	NN
,	,
differentiation	NN
,	,
and	CC
proliferation	NN
in	IN
ILFs	NNS
in	IN
patients	NNS
with	IN
chronic	JJ
hepatitis	NN
C	NN
using	VBG
surgically	RB
resected	JJ
specimens	NNS
,	,
and	CC
compared	VBD
them	PRP
with	IN
specimens	NNS
of	IN
perihepatic	JJ
lymph	NN
nodes	NNS
by	IN
an	DT
immunohistochemical	JJ
technique	NN
.	.

Germinal	JJ
center	NN
(	(
GC	NN
)	)
formation	NN
in	IN
the	DT
ILFs	NNS
was	VBD
frequently	RB
found	VBN
in	IN
HCV-positive	JJ
cases	NNS
.	.

The	DT
distribution	NN
of	IN
immunoglobulin	NN
M	NN
(	(
IgM	NN
)	)
-	:
,	,
IgD-	NN
,	,
and	CC
IgG-positive	JJ
cells	NNS
and	CC
the	DT
expression	NN
patterns	NNS
of	IN
Ki-67	NN
,	,
CD23	NN
,	,
or	CC
bcl-2	NN
and	CC
bcl-6	JJ
gene	NN
products	NNS
in	IN
the	DT
follicles	NNS
with	IN
GC	NN
formation	NN
in	IN
the	DT
liver	NN
of	IN
patients	NNS
with	IN
chronic	JJ
hepatitis	NN
C	NN
were	VBD
similar	JJ
to	TO
those	DT
of	IN
lymph	NN
nodes	NNS
,	,
indicating	VBG
that	IN
B	NN
cells	NNS
are	VBP
activated	VBN
,	,
proliferated	VBN
,	,
and	CC
differentiated	VBN
in	IN
the	DT
ILFs	NNS
with	IN
GC	NN
formation	NN
in	IN
patients	NNS
with	IN
chronic	JJ
hepatitis	NN
C	NN
.	.

Oligoclonal	JJ
expansion	NN
of	IN
B	NN
cells	NNS
in	IN
the	DT
livers	NNS
with	IN
ILFs	NNS
was	VBD
confirmed	VBN
by	IN
an	DT
analysis	NN
of	IN
immunoglobulin	NN
heavy	JJ
chain	NN
(	(
IgH	JJ
)	)
gene	NN
rearrangement	NN
determined	VBN
by	IN
polymerase	NN
chain	NN
reaction	NN
(	(
PCR	NN
)	)
.	.

These	DT
data	NNS
strongly	RB
suggest	VBP
that	IN
ILFs	NNS
with	IN
GC	NN
formation	NN
,	,
which	WDT
are	VBP
frequently	RB
found	VBN
in	IN
patients	NNS
with	IN
chronic	JJ
hepatitis	NN
C	NN
,	,
may	MD
functionally	RB
be	VB
the	DT
same	JJ
as	IN
those	DT
found	VBN
in	IN
lymph	NN
nodes	NNS
with	IN
respect	NN
to	TO
B-cell	NN
expansion	NN
and	CC
maturation	NN
.	.

UI	LS
-	:
99307057	CD

TI	LS
-	:
PPARalpha	NN
activators	NNS
inhibit	VBP
cytokine-induced	JJ
vascular	JJ
cell	NN
adhesion	NN
molecule-1	NN
expression	NN
in	IN
human	JJ
endothelial	JJ
cells	NNS
.	.

AB	LS
-	:
BACKGROUND	NN
:	:
Adhesion	NN
molecule	NN
expression	NN
on	IN
the	DT
endothelial	JJ
cell	NN
(	(
EC	NN
)	)
surface	NN
is	VBZ
critical	JJ
for	IN
leukocyte	NN
recruitment	NN
to	TO
atherosclerotic	JJ
lesions	NNS
.	.

Better	JJR
understanding	NN
of	IN
transcriptional	JJ
regulation	NN
of	IN
adhesion	NN
molecules	NNS
in	IN
ECs	NNS
may	MD
provide	VB
important	JJ
insight	NN
into	IN
plaque	NN
formation	NN
.	.

Peroxisome	NN
proliferator-activated	JJ
receptor-alpha	NN
(	(
PPARalpha	NN
)	)
,	,
a	DT
member	NN
of	IN
the	DT
nuclear	JJ
receptor	NN
family	NN
,	,
regulates	VBZ
gene	NN
expression	NN
in	IN
response	NN
to	TO
certain	JJ
fatty	JJ
acids	NNS
and	CC
fibric	JJ
acid	NN
derivatives	NNS
.	.

The	DT
present	JJ
study	NN
investigated	VBD
PPARalpha	NN
expression	NN
in	IN
human	JJ
ECs	NNS
and	CC
their	PRP$
regulation	NN
of	IN
vascular	JJ
cell	NN
adhesion	NN
molecule-1	NN
(	(
VCAM-1	NN
)	)
.	.

METHODS	NNS
AND	CC
RESULTS	NNS
:	:
Immunohistochemistry	NN
revealed	VBD
that	IN
human	JJ
carotid	NN
artery	NN
ECs	NNS
express	VBP
PPARalpha	NN
.	.

Pretreatment	NN
of	IN
cultured	VBN
human	JJ
ECs	NNS
with	IN
the	DT
PPARalpha	NN
activators	NNS
fenofibrate	NN
or	CC
WY14643	NN
inhibited	VBD
TNF-alpha-induced	JJ
VCAM-1	NN
in	IN
a	DT
time-	NN
and	CC
concentration-dependent	JJ
manner	NN
,	,
an	DT
effect	NN
not	RB
seen	VBN
with	IN
PPARgamma	NN
activators	NNS
.	.

Both	DT
PPARalpha	NN
activators	NNS
decreased	VBD
cytokine-induced	JJ
VCAM-1	NN
mRNA	NN
expression	NN
without	IN
altering	VBG
its	PRP$
mRNA	NN
half-life	NN
.	.

Transient	JJ
transfection	NN
of	IN
deletional	JJ
VCAM-1	NN
promoter	NN
constructs	NNS
and	CC
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
suggest	VBP
that	IN
fenofibrate	NN
inhibits	VBZ
VCAM-1	NN
transcription	NN
in	IN
part	NN
by	IN
inhibiting	VBG
NF-kappaB	NN
.	.

Finally	RB
,	,
PPARalpha	NN
activators	NNS
significantly	RB
reduced	VBD
adhesion	NN
of	IN
U937	NN
cells	NNS
to	TO
cultured	VBN
human	JJ
ECs	NNS
.	.

CONCLUSIONS	NNS
:	:
Human	JJ
ECs	NNS
express	VBP
PPARalpha	NN
,	,
a	DT
potentially	RB
important	JJ
regulator	NN
of	IN
atherogenesis	NN
through	IN
its	PRP$
transcriptional	JJ
control	NN
of	IN
VCAM-1	NN
gene	NN
expression	NN
.	.

Such	JJ
findings	NNS
also	RB
have	VBP
implications	NNS
regarding	VBG
the	DT
clinical	JJ
use	NN
of	IN
lipid-lowering	JJ
agents	NNS
,	,
like	IN
fibric	JJ
acids	NNS
,	,
which	WDT
can	MD
activate	VB
PPARalpha	NN
.	.

UI	LS
-	:
99249555	CD

TI	LS
-	:
The	DT
oestrogen	NN
receptor	NN
codon	NN
10	CD
polymorphism	NN
detected	VBN
in	IN
breast	NN
cancer	NN
is	VBZ
also	RB
present	JJ
in	IN
non-malignant	JJ
cells	NNS
.	.

AB	LS
-	:
The	DT
effect	NN
of	IN
oestrogens	NNS
on	IN
oestrogen-receptive	JJ
organs	NNS
and	CC
cells	NNS
is	VBZ
mediated	VBN
via	IN
intracellular	JJ
receptors	NNS
(	(
ERalpha	NN
and	CC
ERbeta	NN
)	)
.	.

Oestrogen	NN
receptor	NN
gene	NN
polymorphisms	NNS
in	IN
the	DT
region	NN
encoding	VBG
the	DT
N-terminal	JJ
portion	NN
of	IN
the	DT
protein	NN
are	VBP
reportedly	RB
associated	VBN
with	IN
pathological	JJ
conditions	NNS
including	VBG
breast	NN
cancer	NN
,	,
hypertension	NN
,	,
spontaneous	JJ
abortion	NN
and	CC
coronary	JJ
heart	NN
disease	NN
.	.

A	DT
silent	JJ
mutation	NN
in	IN
codon	NN
10	CD
of	IN
exon	NN
1	CD
,	,
detected	VBN
in	IN
ER-negative	JJ
and	CC
ER-positive	JJ
human	JJ
breast	NN
cancer	NN
cell	NN
lines	NNS
,	,
in	IN
breast	NN
tumors	NNS
and	CC
blood	NN
DNA	NN
from	IN
breast	NN
cancer	NN
patients	NNS
,	,
has	VBZ
been	VBN
recognized	VBN
as	IN
a	DT
polymorphic	JJ
site	NN
.	.

In	IN
this	DT
study	NN
we	PRP
examined	VBD
,	,
by	IN
denaturing	VBG
gradient-gel	JJ
electrophoresis	NN
and	CC
DNA	NN
sequence	NN
analysis	NN
,	,
the	DT
possible	JJ
presence	NN
of	IN
a	DT
codon	NN
10	CD
polymorphic	JJ
site	NN
in	IN
normal	JJ
oestrogen	NN
target	NN
organs	NNS
and	CC
cells	NNS
such	JJ
as	IN
the	DT
uterus	NN
(	(
myometrium	NN
and	CC
endometrium	NN
)	)
,	,
in	IN
the	DT
placenta	NN
and	CC
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
and	CC
in	IN
a	DT
benign	JJ
uterus	NN
tumour	NN
(	(
leiomyoma	NN
)	)
.	.

We	PRP
have	VBP
detected	VBN
ER	NN
codon	NN
10	CD
polymorphism	NN
in	IN
these	DT
samples	NNS
and	CC
have	VBP
compared	VBN
them	PRP
to	TO
those	DT
observed	VBN
in	IN
breast	NN
cancer	NN
samples	NNS
.	.

All	DT
tissues	NNS
and	CC
cells	NNS
studied	VBN
were	VBD
homozygous	JJ
for	IN
the	DT
wild-type	JJ
gene	NN
,	,
and	CC
were	VBD
heterozygous	JJ
as	RB
well	RB
as	IN
homozygous	JJ
for	IN
the	DT
codon-10-variant	JJ
type	NN
.	.

These	DT
results	NNS
indicate	VBP
that	IN
the	DT
presence	NN
of	IN
the	DT
codon-10-variant	JJ
type	NN
is	VBZ
not	RB
a	DT
characteristic	NN
of	IN
breast	NN
cancer	NN
.	.

Out	IN
current	JJ
findings	NNS
suggest	VBP
that	IN
further	JJ
investigations	NNS
are	VBP
warranted	VBN
to	TO
elucidate	VB
the	DT
possible	JJ
linkage	NN
of	IN
ER	NN
codon	NN
10	CD
polymorphism	NN
to	TO
physiological	JJ
and	CC
pathological	JJ
conditions	NNS
.	.

UI	LS
-	:
99248157	CD

TI	LS
-	:
CTLA-4-Mediated	JJ
inhibition	NN
of	IN
early	JJ
events	NNS
of	IN
T	NN
cell	NN
proliferation	NN
.	.

AB	LS
-	:
CTLA-4	NN
engagement	NN
by	IN
mAbs	NNS
inhibits	VBZ
,	,
while	IN
CD28	NN
enhances	VBZ
,	,
IL-2	NN
production	NN
and	CC
proliferation	NN
upon	IN
T	NN
cell	NN
activation	NN
.	.

Here	RB
,	,
we	PRP
have	VBP
analyzed	VBN
the	DT
mechanisms	NNS
involved	VBN
in	IN
CTLA-4-mediated	JJ
inhibition	NN
of	IN
T	NN
cell	NN
activation	NN
of	IN
naive	JJ
CD4+	JJ
T	NN
cells	NNS
using	VBG
Ab	NN
cross-linking	NN
.	.

CTLA-4	NN
ligation	NN
inhibited	VBD
CD3/CD28-induced	JJ
IL-2	NN
mRNA	NN
accumulation	NN
by	IN
inhibiting	VBG
IL-2	NN
transcription	NN
,	,
which	WDT
appears	VBZ
to	TO
be	VB
mediated	VBN
in	IN
part	NN
through	IN
decreasing	VBG
NF-AT	NN
accumulation	NN
in	IN
the	DT
nuclei	NNS
.	.

However	RB
,	,
CTLA-4	NN
ligation	NN
did	VBD
not	RB
appear	VB
to	TO
affect	VB
the	DT
CD28-mediated	JJ
stabilization	NN
of	IN
IL-2	NN
mRNA	NN
.	.

Further	RB
,	,
CTLA-4	NN
engagement	NN
inhibited	VBD
progression	NN
through	IN
the	DT
cell	NN
cycle	NN
by	IN
inhibiting	VBG
the	DT
production	NN
of	IN
cyclin	NN
D3	NN
,	,
cyclin-dependent	JJ
kinase	NN
(	(
cdk	NN
)	)
4	CD
,	,
and	CC
cdk6	NN
when	WRB
the	DT
T	NN
cells	NNS
were	VBD
stimulated	VBN
with	IN
anti-CD3/CD28	NN
and	CC
with	IN
anti-CD3	NN
alone	RB
.	.

These	DT
results	NNS
indicate	VBP
that	IN
CTLA-4	NN
signaling	NN
inhibits	VBZ
events	NNS
early	RB
in	IN
T	NN
cell	NN
activation	NN
both	CC
at	IN
IL-2	NN
transcription	NN
and	CC
at	IN
the	DT
level	NN
of	IN
IL-2-independent	JJ
events	NNS
of	IN
the	DT
cell	NN
cycle	NN
,	,
and	CC
does	VBZ
not	RB
simply	RB
oppose	VB
CD28-mediated	JJ
costimulation	NN
.	.

UI	LS
-	:
99286808	CD

TI	LS
-	:
Transcriptional	JJ
regulation	NN
of	IN
T	NN
lymphocyte	NN
development	NN
and	CC
function	NN
.	.

AB	LS
-	:
The	DT
development	NN
and	CC
function	NN
of	IN
T	NN
lymphocytes	NNS
are	VBP
regulated	VBN
tightly	RB
by	IN
signal	NN
transduction	NN
pathways	NNS
that	WDT
include	VBP
specific	JJ
cell-surface	JJ
receptors	NNS
,	,
intracellular	JJ
signaling	VBG
molecules	NNS
,	,
and	CC
nuclear	JJ
transcription	NN
factors	NNS
.	.

Since	IN
1988	CD
,	,
several	JJ
families	NNS
of	IN
functionally	RB
important	JJ
T	NN
cell	NN
transcription	NN
factors	NNS
have	VBP
been	VBN
identified	VBN
.	.

These	DT
include	VBP
the	DT
Ikaros	NN
,	,
LKLF	NN
,	,
and	CC
GATA3	NN
zinc-finger	JJ
proteins	NNS
;	:
the	DT
Ets	NN
,	,
CREB/ATF	NN
,	,
and	CC
NF-kappa	NN
B/Rel/NFAT	NN
transcription	NN
factors	NNS
;	:
the	DT
Stat	NN
proteins	NNS
;	:
and	CC
HMG	NN
box	NN
transcription	NN
factors	NNS
such	JJ
as	IN
LEF1	NN
,	,
TCF1	NN
,	,
and	CC
Sox4	NN
.	.

In	IN
this	DT
review	NN
,	,
we	PRP
summarize	VBP
our	PRP$
current	JJ
understanding	NN
of	IN
the	DT
transcriptional	JJ
regulation	NN
of	IN
T	NN
cell	NN
development	NN
and	CC
function	NN
with	IN
particular	JJ
emphasis	NN
on	IN
the	DT
results	NNS
of	IN
recent	JJ
gene	NN
targeting	NN
and	CC
transgenic	JJ
experiments	NNS
.	.

In	IN
addition	NN
to	TO
increasing	VBG
our	PRP$
understanding	NN
of	IN
the	DT
molecular	JJ
pathways	NNS
that	WDT
regulate	VBP
T	NN
cell	NN
development	NN
and	CC
function	NN
,	,
these	DT
results	NNS
have	VBP
suggested	VBN
novel	JJ
targets	NNS
for	IN
genetic	JJ
and	CC
pharmacological	JJ
manipulation	NN
of	IN
T	NN
cell	NN
immunity	NN
.	.

UI	LS
-	:
99240799	CD

TI	LS
-	:
Transcription	NN
factors	NNS
Sp1	NN
and	CC
AP-2	NN
mediate	VBP
induction	NN
of	IN
acid	NN
sphingomyelinase	NN
during	IN
monocytic	JJ
differentiation	NN
.	.

AB	LS
-	:
Cells	NNS
from	IN
the	DT
human	JJ
monocytic	JJ
leukemia	NN
cell	NN
line	NN
THP-1	NN
differentiate	VBP
towards	IN
a	DT
macrophage-like	JJ
phenotype	NN
when	WRB
stimulated	VBN
with	IN
phorbol	NN
12-myristate-13-acetate	NN
(	(
PMA	NN
)	)
,	,
1,25-dihydroxy-vitamin	NN
D3	NN
,	,
and	CC
various	JJ
other	JJ
agents	NNS
.	.

We	PRP
demonstrate	VBP
here	RB
that	IN
the	DT
expression	NN
of	IN
the	DT
lysosomal	JJ
enzyme	NN
acid	NN
sphingomyelinase	NN
(	(
ASM	NN
;	:
E.C.3.1.4.12	NN
)	)
is	VBZ
induced	VBN
during	IN
this	DT
process	NN
and	CC
is	VBZ
strongly	RB
elevated	JJ
in	IN
differentiated	VBN
THP-1	NN
cells	NNS
,	,
as	RB
well	RB
as	IN
in	IN
differentiated	VBN
human	JJ
mononuclear	JJ
phagocytes	NNS
.	.

Using	VBG
Northern	NN
blotting	NN
,	,
RNase	NN
protection	NN
assay	NN
,	,
and	CC
nuclear	JJ
run-on	JJ
analyses	NNS
,	,
we	PRP
show	VBP
that	IN
the	DT
up-regulation	NN
of	IN
ASM	NN
expression	NN
is	VBZ
regulated	VBN
mainly	RB
at	IN
the	DT
level	NN
of	IN
transcription	NN
and	CC
that	IN
new	JJ
protein	NN
synthesis	NN
is	VBZ
required	VBN
for	IN
enhanced	VBN
ASM	NN
activity	NN
.	.

This	DT
cell-type	JJ
specific	JJ
induction	NN
by	IN
PMA	NN
treatment	NN
was	VBD
further	RB
investigated	VBN
with	IN
respect	NN
to	TO
transcriptional	JJ
control	NN
.	.

A	DT
series	NN
of	IN
5'	JJ
deletion	NN
derivatives	NNS
of	IN
the	DT
upstream	JJ
regulatory	JJ
region	NN
were	VBD
used	VBN
in	IN
transient	JJ
transfection	NN
assays	NNS
to	TO
identify	VB
promoter	NN
elements	NNS
required	VBN
for	IN
basal	JJ
and	CC
inducible	JJ
gene	NN
expression	NN
.	.

A	DT
PMA	NN
responsive	JJ
element	NN
was	VBD
localized	JJ
to	TO
a	DT
region	NN
between	IN
-319	CD
and	CC
-219	CD
bp	NN
upstream	RB
of	IN
the	DT
initiation	NN
codon	NN
and	CC
co-transfections	NNS
with	IN
transcription	NN
factor	NN
expression	NN
plasmids	NNS
for	IN
AP-2	NN
and	CC
Sp1	NN
resulted	VBD
in	IN
augmented	JJ
ASM	NN
promoter	NN
activity	NN
,	,
which	WDT
was	VBD
abolished	VBN
when	WRB
the	DT
binding	VBG
sites	NNS
for	IN
these	DT
two	CD
factors	NNS
were	VBD
deleted	VBN
.	.

Using	VBG
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
and	CC
supershift	NN
assays	NNS
we	PRP
demonstrate	VBP
that	IN
this	DT
region	NN
is	VBZ
specifically	RB
bound	VBN
by	IN
Sp1	NN
and	CC
AP-2	NN
.	.

These	DT
factors	NNS
are	VBP
present	JJ
in	IN
nuclear	JJ
extracts	NNS
prepared	VBN
from	IN
both	CC
induced	VBN
and	CC
uninduced	JJ
THP-1	NN
cells	NNS
.	.

However	RB
,	,
the	DT
intensity	NN
of	IN
the	DT
complex	NN
formed	VBN
appeared	VBD
to	TO
increase	VB
when	WRB
nuclear	JJ
extracts	NNS
from	IN
PMA-treated	JJ
cells	NNS
were	VBD
used	VBN
.	.

From	IN
these	DT
studies	NNS
,	,
we	PRP
conclude	VBP
that	IN
a	DT
concerted	JJ
action	NN
of	IN
the	DT
transcription	NN
factors	NNS
AP-2	NN
and	CC
Sp1	NN
is	VBZ
essential	JJ
for	IN
the	DT
up-regulation	NN
of	IN
ASM	NN
expression	NN
during	IN
the	DT
process	NN
of	IN
macrophage	NN
differentiation	NN
.	.

UI	LS
-	:
99190512	CD

TI	LS
-	:
NF-kappaB	NN
regulates	VBZ
Fas/APO-1/CD95-	NN
and	CC
TCR-mediated	JJ
apoptosis	NN
of	IN
T	NN
lymphocytes	NNS
.	.

AB	LS
-	:
The	DT
maintenance	NN
of	IN
lymphocyte	NN
homeostasis	NN
by	IN
apoptosis	NN
is	VBZ
a	DT
critical	JJ
regulatory	JJ
mechanism	NN
in	IN
the	DT
normal	JJ
immune	JJ
system	NN
.	.

The	DT
transcription	NN
factor	NN
NF-kappaB	NN
has	VBZ
been	VBN
shown	VBN
to	TO
play	VB
a	DT
role	NN
in	IN
protecting	VBG
cells	NNS
against	IN
death	NN
mediated	VBN
by	IN
TNF	NN
We	PRP
show	VBP
here	RB
that	IN
NF-kappaB	NN
also	RB
has	VBZ
a	DT
role	NN
in	IN
regulating	VBG
Fas/APO-1/CD95-mediated	JJ
death	NN
,	,
a	DT
major	JJ
pathway	NN
of	IN
peripheral	JJ
T	NN
cell	NN
death	NN
.	.

Transfection	NN
of	IN
Jurkat	NN
cells	NNS
with	IN
the	DT
NF-kappaB	NN
subunits	NNS
p50	NN
and	CC
p65	NN
confers	VBZ
resistance	NN
against	IN
Fas-mediated	JJ
apoptosis	NN
.	.

Reciprocally	RB
,	,
inhibition	NN
of	IN
NF-kappaB	NN
activation	NN
by	IN
a	DT
soluble	JJ
peptide	NN
inhibitor	NN
or	CC
a	DT
dominant	JJ
form	NN
of	IN
the	DT
NF-kappaB	NN
inhibitor	NN
,	,
IkappaB	NN
,	,
makes	VBZ
the	DT
cells	NNS
more	RBR
susceptible	JJ
to	TO
Fas-mediated	JJ
apoptosis	NN
.	.

Furthermore	RB
,	,
inhibition	NN
of	IN
NF-kappaB	NN
activation	NN
by	IN
a	DT
soluble	JJ
peptide	NN
inhibitor	NN
rendered	VBD
a	DT
T	NN
cell	NN
hybridoma	NN
more	RBR
susceptible	JJ
to	TO
TCR-mediated	JJ
apoptosis	NN
.	.

Correspondingly	RB
,	,
transfection	NN
of	IN
p50	NN
and	CC
p65	NN
provided	VBD
considerable	JJ
protection	NN
from	IN
TCR-mediated	JJ
apoptosis	NN
.	.

These	DT
observations	NNS
were	VBD
corroborated	VBN
by	IN
studies	NNS
on	IN
Fas-mediated	JJ
death	NN
in	IN
primary	JJ
T	NN
cells	NNS
.	.

Concanavalin	NN
A-activated	JJ
cycling	NN
T	NN
cell	NN
blasts	NNS
from	IN
mice	NNS
that	WDT
are	VBP
transgenic	JJ
for	IN
the	DT
dominant	JJ
IkappaB	NN
molecule	NN
have	VBP
increased	VBN
sensitivity	NN
to	TO
Fas-mediated	JJ
apoptosis	NN
,	,
associated	VBN
with	IN
a	DT
down-regulation	NN
of	IN
NF-kappaB	NN
complexes	NNS
in	IN
the	DT
nucleus	NN
.	.

In	IN
addition	NN
,	,
blocking	VBG
TNF	NN
,	,
itself	PRP
a	DT
positive	JJ
regulator	NN
of	IN
NF-kappaB	NN
,	,
with	IN
neutralizing	VBG
antibodies	NNS
renders	VBZ
the	DT
cells	NNS
more	RBR
susceptible	JJ
to	TO
anti-Fas-mediated	JJ
apoptosis	NN
.	.

In	IN
summary	NN
,	,
our	PRP$
results	NNS
provide	VBP
compelling	JJ
evidence	NN
that	IN
NF-kappaB	NN
protects	VBZ
against	IN
Fas-mediated	JJ
death	NN
and	CC
is	VBZ
likely	JJ
to	TO
be	VB
an	DT
important	JJ
regulator	NN
of	IN
T	NN
cell	NN
homeostasis	NN
and	CC
tolerance	NN
.	.

UI	LS
-	:
99178629	CD

TI	LS
-	:
Lineage-specific	JJ
activation	NN
of	IN
STAT3	NN
by	IN
interferon-gamma	NN
in	IN
human	JJ
neutrophils	NNS
.	.

AB	LS
-	:
Binding	NN
of	IN
interferon-gamma	NN
(	(
IFN-gamma	NN
)	)
to	TO
its	PRP$
heterodimeric	JJ
receptor	NN
induces	VBZ
activation	NN
of	IN
the	DT
tyrosine	NN
kinases	NNS
JAK1	NN
and	CC
JAK2	NN
followed	VBN
by	IN
tyrosine	NN
phosphorylation	NN
of	IN
STAT1alpha	NN
.	.

Selective	JJ
activation	NN
of	IN
STAT1alpha	NN
at	IN
the	DT
IFN-gamma	NN
receptor	NN
is	VBZ
achieved	VBN
by	IN
specific	JJ
interaction	NN
between	IN
a	DT
cytosolic	JJ
tyrosine	NN
motif	NN
including	VBG
Y440	NN
in	IN
the	DT
IFN-gamma	NN
receptor	NN
alpha-chain	NN
and	CC
the	DT
SH2	NN
domain	NN
of	IN
STAT1alpha	NN
.	.

We	PRP
demonstrate	VBP
that	IN
,	,
in	IN
addition	NN
to	TO
STAT1alpha	NN
,	,
STAT3	NN
is	VBZ
also	RB
activated	VBN
by	IN
IFN-gamma	NN
in	IN
human	JJ
neutrophils	NNS
.	.

The	DT
activation	NN
of	IN
STAT3	NN
was	VBD
not	RB
found	VBN
in	IN
human	JJ
eosinophils	NNS
,	,
monocytes	NNS
,	,
and	CC
HL-60	NN
cells	NNS
,	,
although	IN
the	DT
STAT3	NN
protein	NN
was	VBD
expressed	VBN
in	IN
these	DT
cells	NNS
.	.

The	DT
cell	NN
type-specific	JJ
activation	NN
of	IN
STAT3	NN
by	IN
IFN-gamma	NN
was	VBD
also	RB
observed	VBN
in	IN
neutrophils	NNS
that	WDT
are	VBP
differentiated	VBN
in	FW
vitro	FW
from	IN
human	JJ
CD34+	JJ
hematopoietic	JJ
stem	NN
cells	NNS
.	.

These	DT
results	NNS
indicate	VBP
that	IN
a	DT
single	JJ
cytokine	NN
receptor	NN
can	MD
activate	VB
different	JJ
STAT	NN
family	NN
members	NNS
in	IN
a	DT
cell-specific	JJ
manner	NN
,	,
which	WDT
might	MD
result	VB
in	IN
cell-specific	JJ
gene	NN
transcription	NN
.	.

UI	LS
-	:
99242545	CD

TI	LS
-	:
Estrogen	NN
and	CC
progesterone	NN
induction	NN
of	IN
survival	NN
of	IN
monoblastoid	JJ
cells	NNS
undergoing	VBG
TNF-alpha-induced	JJ
apoptosis	NN
.	.

AB	LS
-	:
Induction	NN
of	IN
apoptosis	NN
of	IN
mononucleated	JJ
cells	NNS
is	VBZ
a	DT
physiological	JJ
process	NN
for	IN
regulating	VBG
the	DT
intensity	NN
of	IN
the	DT
immune	JJ
response	NN
.	.

The	DT
female	JJ
steroid	NN
hormones	NNS
estrogen	NN
(	(
E2	NN
)	)
and	CC
progesterone	NN
(	(
Prog	NN
)	)
are	VBP
known	VBN
to	TO
modulate	VB
the	DT
reactivity	NN
of	IN
the	DT
immune	JJ
system	NN
;	:
recently	RB
it	PRP
has	VBZ
been	VBN
demonstrated	VBN
that	IN
they	PRP
can	MD
regulate	VB
induction	NN
of	IN
apoptosis	NN
of	IN
endothelial	JJ
cells	NNS
and	CC
osteoblasts	NNS
.	.

TNF-alpha-mediated	JJ
induction	NN
of	IN
apoptosis	NN
has	VBZ
been	VBN
well	RB
characterized	VBN
in	IN
myeloid	JJ
cells	NNS
.	.

We	PRP
investigated	VBD
whether	IN
E2	NN
and	CC
Prog	NN
could	MD
interfere	VB
with	IN
TNF-alpha-induced	JJ
apoptosis	NN
of	IN
the	DT
monoblastoid	JJ
U937	NN
cell	NN
line	NN
.	.

Treatment	NN
with	IN
E2	NN
or	CC
Prog	NN
increased	VBD
survival	NN
and	CC
prevented	VBD
apoptosis	NN
induced	VBN
by	IN
TNF-alpha	NN
in	IN
both	CC
undifferentiated	JJ
and	CC
macrophage-like	JJ
PMA-differentiated	JJ
U937	NN
cells	NNS
,	,
as	IN
assessed	VBN
by	IN
trypan	NN
blue	JJ
exclusion	NN
cell	NN
counting	NN
,	,
thymidine	NN
incorporation	NN
,	,
AnnexinV	NN
labeling	NN
,	,
followed	VBN
by	IN
flow	NN
cytometry	NN
and	CC
DNA	NN
fragmentation	NN
studies	NNS
.	.

This	DT
effect	NN
can	MD
be	VB
associated	VBN
with	IN
the	DT
activation	NN
of	IN
specific	JJ
hormone	NN
receptors	NNS
,	,
since	IN
we	PRP
observed	VBD
the	DT
expression	NN
of	IN
the	DT
estrogen	NN
receptor	NN
alpha	NN
(	(
ER-alpha	NN
)	)
,	,
ER-beta	NN
,	,
and	CC
progesterone	NN
receptor	NN
(	(
PR	NN
)	)
mRNAs	NNS
;	:
the	DT
ER-alpha	NN
protein	NN
expression	NN
was	VBD
confirmed	VBN
by	IN
immunocytochemical	JJ
analysis	NN
.	.

In	IN
addition	NN
,	,
hormone-mediated	JJ
survival	NN
against	IN
apoptosis	NN
was	VBD
concentration	NN
dependent	JJ
,	,
reaching	VBG
the	DT
half-maximal	JJ
effect	NN
at	IN
10	CD
nM	NN
and	CC
blocked	VBN
by	IN
the	DT
ER	NN
antagonist	NN
ICI	NN
182	CD
,	,
780	CD
in	IN
undifferentiated	JJ
cells	NNS
,	,
further	RB
supporting	VBG
a	DT
receptor-mediated	JJ
mechanism	NN
of	IN
cell	NN
survival	NN
.	.

Other	JJ
steroid	NN
receptor	NN
drugs	NNS
such	JJ
as	IN
Raloxifene	NN
,	,
RU486	NN
,	,
or	CC
the	DT
ICI	NN
182	CD
,	,
780	CD
in	IN
PMA-differentiated	JJ
cells	NNS
displayed	VBD
agonist	NN
activity	NN
by	IN
preventing	VBG
TNF-alpha-induced	JJ
apoptosis	NN
as	RB
efficiently	RB
as	IN
the	DT
hormones	NNS
alone	RB
,	,
providing	VBG
further	JJ
evidence	NN
to	TO
the	DT
notion	NN
that	IN
steroid	NN
receptor	NN
drugs	NNS
may	MD
manifest	VB
agonist	NN
or	CC
antagonist	NN
activities	NNS
depending	VBG
on	IN
the	DT
cellular	JJ
context	NN
in	IN
which	WDT
they	PRP
are	VBP
studied	VBN
.	.

Treatment	NN
with	IN
E2	NN
was	VBD
also	RB
associated	VBN
with	IN
a	DT
time-dependent	JJ
decrease	NN
in	IN
the	DT
mRNA	NN
level	NN
of	IN
the	DT
proapoptotic	JJ
Nip-2	NN
protein	NN
,	,
supporting	VBG
the	DT
hypothesis	NN
that	IN
hormone	NN
responsiveness	NN
of	IN
U937	NN
cells	NNS
is	VBZ
mediated	VBN
by	IN
target	NN
gene	NN
transcription	NN
.	.

Together	RB
,	,
these	DT
results	NNS
demonstrate	VBP
that	IN
ER	NN
and	CC
PR	NN
can	MD
be	VB
activated	VBN
by	IN
endogenous	JJ
or	CC
exogenous	JJ
ligands	NNS
to	TO
induce	VB
a	DT
genetic	JJ
response	NN
that	WDT
impairs	VBZ
TNF-alpha-induced	JJ
apoptosis	NN
in	IN
U937	NN
cells	NNS
.	.

The	DT
data	NNS
presented	VBN
here	RB
suggest	VBP
that	IN
the	DT
female	JJ
steroid	NN
receptors	NNS
play	VBP
a	DT
role	NN
in	IN
regulation	NN
of	IN
the	DT
immune	JJ
response	NN
by	IN
preventing	VBG
apoptosis	NN
of	IN
monoblastoid	JJ
cells	NNS
;	:
this	DT
effect	NN
might	MD
have	VB
important	JJ
consequences	NNS
in	IN
the	DT
clinical	JJ
use	NN
of	IN
steroid	NN
receptor	NN
drugs	NNS
.	.

--	:
Vegeto	NNP
,	,
E.	NNP
,	,
Pollio	NNP
,	,
G.	NNP
,	,
Pellicciari	NNP
,	,
C.	NNP
,	,
Maggi	NNP
,	,
A	NNP
.	.

Estrogen	NN
and	CC
progesterone	NN
induction	NN
of	IN
survival	NN
of	IN
monoblastoid	JJ
cells	NNS
undergoing	VBG
TNF-alpha-inuced	JJ
apoptosis	NN
.	.

UI	LS
-	:
99221887	CD

TI	LS
-	:
Suppressive	JJ
effects	NNS
of	IN
anti-inflammatory	JJ
agents	NNS
on	IN
human	JJ
endothelial	JJ
cell	NN
activation	NN
and	CC
induction	NN
of	IN
heat	NN
shock	NN
proteins	NNS
.	.

AB	LS
-	:
BACKGROUND	NN
:	:
Studies	NNS
from	IN
our	PRP$
laboratory	NN
have	VBP
shown	VBN
that	IN
the	DT
earliest	JJS
stages	NNS
of	IN
atherosclerosis	NN
may	MD
be	VB
mediated	VBN
by	IN
an	DT
autoimmune	JJ
reaction	NN
against	IN
heat	NN
shock	NN
protein	NN
60	CD
(	(
Hsp60	NN
)	)
.	.

The	DT
interactions	NNS
of	IN
Hsp60-specific	JJ
T	NN
cells	NNS
with	IN
arterial	JJ
endothelial	JJ
cells	NNS
(	(
EC	NN
)	)
require	VBP
expression	NN
of	IN
both	CC
Hsp60	NN
and	CC
certain	JJ
adhesion	NN
molecules	NNS
shown	VBN
to	TO
be	VB
induced	VBN
simultaneously	RB
in	IN
EC	NN
by	IN
mechanical	JJ
and	CC
other	JJ
types	NNS
of	IN
stress	NN
.	.

Recently	RB
,	,
it	PRP
was	VBD
shown	VBN
that	IN
suppression	NN
of	IN
T	NN
cell-mediated	JJ
immune	JJ
responses	NNS
by	IN
cyclosporin	NN
A	NN
(	(
CyA	NN
)	)
enhanced	VBD
atherosclerotic	JJ
lesion	NN
formation	NN
in	IN
mice	NNS
.	.

In	IN
contrast	NN
,	,
aspirin	NN
was	VBD
found	VBN
to	TO
lower	VB
the	DT
risk	NN
of	IN
myocardial	JJ
infarction	NN
in	IN
men	NNS
.	.

These	DT
conflicting	VBG
observations	NNS
may	MD
be	VB
due	JJ
to	TO
different	JJ
effects	NNS
of	IN
anti-inflammatory	JJ
agents	NNS
on	IN
adhesion	NN
molecule	NN
and	CC
Hsp	NN
expression	NN
in	IN
EC	NN
,	,
respectively	RB
.	.

MATERIAL	NN
AND	CC
METHODS	NNS
:	:
In	IN
the	DT
present	JJ
study	NN
,	,
we	PRP
analyzed	VBD
the	DT
effects	NNS
of	IN
CyA	NN
,	,
aspirin	NN
,	,
and	CC
indomethacin	NN
on	IN
T	NN
cell	NN
proliferation	NN
using	VBG
a	DT
proliferation	NN
assay	NN
.	.

To	TO
explore	VB
the	DT
expression	NN
of	IN
adhesion	NN
molecules	NNS
,	,
monocyte	NN
chemoattractant	NN
protein-1	NN
(	(
MCP-1	NN
)	)
,	,
and	CC
Hsp60	NN
in	IN
human	JJ
umbilical	JJ
vein	NN
endothelial	JJ
cells	NNS
(	(
HUVECs	NNS
)	)
,	,
Northern	NN
blot	NN
analyses	NNS
were	VBD
used	VBN
.	.

To	TO
examine	VB
the	DT
activation	NN
status	NN
of	IN
the	DT
transcription	NN
factors	NNS
nuclear	JJ
factor	NN
kappaB	NN
(	(
NF-kappaB	NN
)	)
and	CC
heat	NN
shock	NN
factor-1	NN
(	(
HSF-1	NN
)	)
,	,
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
were	VBD
performed	VBN
.	.

RESULTS	NNS
:	:
With	IN
the	DT
exception	NN
of	IN
indomethacin	NN
,	,
the	DT
used	VBN
immunosuppressive	JJ
and	CC
anti-inflammatory	JJ
agents	NNS
significantly	RB
inhibited	VBD
T	NN
cell	NN
proliferation	NN
in	IN
response	NN
to	TO
influenza	NN
virus	NN
antigen	NN
in	IN
a	DT
dose-dependent	JJ
manner	NN
.	.

Interestingly	RB
,	,
CyA	NN
and	CC
indomethacin	NN
did	VBD
not	RB
suppress	VB
tumor	NN
necrosis	NN
factor-alpha	NN
(	(
TNF-alpha	NN
)	)
-induced	JJ
adhesion	NN
molecule	NN
expression	NN
on	IN
HUVECs	NNS
,	,
whereas	IN
aspirin	NN
had	VBD
an	DT
inhibitory	JJ
effect	NN
.	.

These	DT
observations	NNS
correlated	VBD
with	IN
the	DT
modulation	NN
of	IN
NF-kappaB	NN
activity	NN
in	IN
EC	NN
.	.

All	DT
agents	NNS
tested	VBN
induced	VBD
expression	NN
of	IN
Hsp60	NN
6	CD
hr	NN
after	IN
application	NN
.	.

In	IN
addition	NN
,	,
aspirin	NN
and	CC
indomethacin	NN
,	,
but	CC
not	RB
CyA	NN
,	,
induced	VBD
Hsp70	NN
expression	NN
in	IN
HUVECs	NNS
that	WDT
correlated	VBD
with	IN
induction	NN
of	IN
HSF-1	NN
activity	NN
.	.

CONCLUSION	NN
:	:
Our	PRP$
results	NNS
show	VBP
that	IN
the	DT
tested	VBN
agents	NNS
(	(
except	IN
indomethacin	NN
)	)
are	VBP
inhibitors	NNS
of	IN
the	DT
T	NN
cell-mediated	JJ
immune	JJ
response	NN
,	,
as	IN
expected	VBN
,	,
that	IN
aspirin	NN
is	VBZ
an	DT
effective	JJ
suppressor	NN
of	IN
adhesion	NN
molecule	NN
expression	NN
,	,
and	CC
that	IN
all	DT
three	CD
agents	NNS
can	MD
induce	VB
Hsp60	NN
in	IN
HUVECs	NNS
.	.

These	DT
data	NNS
provide	VBP
the	DT
molecular	JJ
basis	NN
for	IN
the	DT
notion	NN
that	IN
(	(
1	LS
)	)
part	NN
of	IN
the	DT
anti-atherogenic	JJ
effect	NN
of	IN
aspirin	NN
may	MD
be	VB
due	JJ
to	TO
the	DT
prevention	NN
of	IN
the	DT
adhesion	NN
of	IN
sensitized	VBN
T	NN
cells	NNS
to	TO
stressed	JJ
EC	NN
;	:
(	(
2	LS
)	)
that	IN
part	NN
of	IN
the	DT
atherosclerosis-promoting	JJ
effect	NN
of	IN
CyA	NN
may	MD
be	VB
due	JJ
to	TO
its	PRP$
potential	NN
as	IN
an	DT
inducer	NN
of	IN
Hsp60	NN
expression	NN
and	CC
its	PRP$
inability	NN
to	TO
down-regulate	VB
adhesion	NN
molecule	NN
expression	NN
on	IN
EC	NN
;	:
and	CC
(	(
3	LS
)	)
that	IN
down-regulation	NN
of	IN
MCP-1	NN
expression	NN
by	IN
aspirin	NN
may	MD
result	VB
in	IN
decreased	VBN
recruitment	NN
of	IN
monocytes	NNS
into	IN
the	DT
arterial	JJ
intima	NN
beneath	IN
stressed	JJ
EC	NN
.	.

UI	LS
-	:
99207658	CD

TI	LS
-	:
[	(
Corticoids	NNS
and	CC
allergy	NN
]	)

AB	LS
-	:
Inflammation	NN
is	VBZ
constantly	RB
observed	VBN
in	IN
allergic	JJ
reactions	NNS
.	.

Corticosteroids	NNS
are	VBP
most	RBS
effective	JJ
in	IN
preventing	VBG
the	DT
late	JJ
phase	NN
of	IN
allergic	JJ
reaction	NN
.	.

The	DT
action	NN
of	IN
glucocorticosteroids	NNS
is	VBZ
mediated	VBN
through	IN
glucocorticoid	NN
receptors	NNS
present	JJ
in	IN
the	DT
cellular	JJ
cytoplasm	NN
.	.

When	WRB
activated	VBN
,	,
glucocorticoid	NN
receptors	NNS
form	VBP
a	DT
dimer	NN
and	CC
bind	VBP
to	TO
DNA	NN
after	IN
migration	NN
into	IN
the	DT
nucleus	NN
.	.

Interaction	NN
to	TO
DNA	NN
induces	VBZ
changes	NNS
in	IN
the	DT
transcription	NN
rate	NN
,	,
leading	VBG
to	TO
either	CC
gene	NN
induction	NN
or	CC
gene	NN
repression	NN
.	.

Glucocorticoid	NN
receptors	NNS
are	VBP
also	RB
able	JJ
to	TO
interact	VB
with	IN
transcriptional	JJ
factors	NNS
such	JJ
as	IN
AP-1	NN
(	(
activator	NN
protein-1	NN
)	)
of	IN
NF-kappa	NN
B	NN
(	(
nuclear	JJ
factor-kappa	NN
B	NN
)	)
.	.

Through	IN
these	DT
actions	NNS
glucocorticosteroids	NNS
are	VBP
susceptible	JJ
to	TO
modify	VB
functions	NNS
of	IN
cells	NNS
involved	VBN
in	IN
the	DT
allergic	JJ
inflammatory	JJ
response	NN
.	.

They	PRP
are	VBP
in	IN
particular	JJ
able	JJ
to	TO
inhibit	VB
most	JJS
of	IN
the	DT
pro-inflammatory	JJ
functions	NNS
of	IN
the	DT
eosinophils	NNS
.	.

UI	LS
-	:
99178889	CD

TI	LS
-	:
Selective	JJ
activation	NN
and	CC
functional	JJ
significance	NN
of	IN
p38alpha	NN
mitogen-activated	JJ
protein	NN
kinase	NN
in	IN
lipopolysaccharide-stimulated	JJ
neutrophils	NNS
.	.

AB	LS
-	:
Activation	NN
of	IN
leukocytes	NNS
by	IN
proinflammatory	JJ
stimuli	NNS
selectively	RB
initiates	VBZ
intracellular	JJ
signal	NN
transduction	NN
via	IN
sequential	JJ
phosphorylation	NN
of	IN
kinases	NNS
.	.

Lipopolysaccharide	NN
(	(
LPS	NN
)	)
stimulation	NN
of	IN
human	JJ
neutrophils	NNS
is	VBZ
known	VBN
to	TO
result	VB
in	IN
activation	NN
of	IN
p38	NN
mitogen-activated	JJ
protein	NN
kinase	NN
(	(
MAPk	NN
)	)
;	:
however	RB
,	,
the	DT
upstream	JJ
activator	NN
(	(
s	NNS
)	)
of	IN
p38	NN
MAPk	NN
is	VBZ
unknown	JJ
,	,
and	CC
consequences	NNS
of	IN
p38	NN
MAPk	NN
activation	NN
remain	VBP
largely	RB
undefined	JJ
.	.

We	PRP
investigated	VBD
the	DT
MAPk	NN
kinase	NN
(	(
MKK	NN
)	)
that	WDT
activates	VBZ
p38	NN
MAPk	NN
in	IN
response	NN
to	TO
LPS	NN
,	,
the	DT
p38	NN
MAPk	NN
isoforms	NNS
that	WDT
are	VBP
activated	VBN
as	IN
part	NN
of	IN
this	DT
pathway	NN
,	,
and	CC
the	DT
functional	JJ
responses	NNS
affected	VBN
by	IN
p38	NN
MAPk	NN
activation	NN
.	.

Although	IN
MKK3	NN
,	,
MKK4	NN
,	,
and	CC
MKK6	NN
all	DT
activated	VBD
p38	NN
MAPk	NN
in	IN
experimental	JJ
models	NNS
,	,
only	RB
MKK3	DT
was	VBD
found	VBN
to	TO
activate	VB
recombinant	JJ
p38	NN
MAPk	NN
in	IN
LPS-treated	JJ
neutrophils	NNS
.	.

Of	IN
p38	NN
MAPk	NN
isoforms	NNS
studied	VBN
,	,
only	RB
p38alpha	NN
and	CC
p38delta	NN
were	VBD
detected	VBN
in	IN
neutrophils	NNS
.	.

LPS	NN
stimulation	NN
selectively	RB
activated	VBD
p38alpha	NN
.	.

Specific	JJ
inhibitors	NNS
of	IN
p38alpha	NN
MAPk	NN
blocked	VBD
LPS-induced	JJ
adhesion	NN
,	,
nuclear	JJ
factor-kappa	NN
B	NN
(	(
NF-kappaB	NN
)	)
activation	NN
,	,
and	CC
synthesis	NN
of	IN
tumor	NN
necrosis	NN
factor-alpha	NN
(	(
TNF-alpha	NN
)	)
.	.

Inhibition	NN
of	IN
p38alpha	NN
MAPk	NN
resulted	VBD
in	IN
a	DT
transient	JJ
decrease	NN
in	IN
TNF-alpha	NN
mRNA	NN
accumulation	NN
but	CC
persistent	JJ
loss	NN
of	IN
TNF-alpha	NN
synthesis	NN
.	.

These	DT
findings	NNS
support	VBP
a	DT
pathway	NN
by	IN
which	WDT
LPS	NN
stimulation	NN
of	IN
neutrophils	NNS
results	VBZ
in	IN
activation	NN
of	IN
MKK3	NN
,	,
which	WDT
in	IN
turn	NN
activates	VBZ
p38alpha	NN
MAPk	NN
,	,
ultimately	RB
regulating	VBG
adhesion	NN
,	,
NF-kappaB	NN
activation	NN
,	,
enhanced	VBN
gene	NN
expression	NN
of	IN
TNF-alpha	NN
,	,
and	CC
regulation	NN
of	IN
TNF-alpha	NN
synthesis	NN
.	.

UI	LS
-	:
99225553	CD

TI	LS
-	:
GrpL	NN
,	,
a	DT
Grb2-related	JJ
adaptor	NN
protein	NN
,	,
interacts	VBZ
with	IN
SLP-76	NN
to	TO
regulate	VB
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cell	NN
activation	NN
.	.

AB	LS
-	:
Propagation	NN
of	IN
signals	NNS
from	IN
the	DT
T	NN
cell	NN
antigen	NN
receptor	NN
(	(
TCR	NN
)	)
involves	VBZ
a	DT
number	NN
of	IN
adaptor	NN
molecules	NNS
.	.

SH2	NN
domain-containing	JJ
protein	NN
76	CD
(	(
SLP-76	NN
)	)
interacts	VBZ
with	IN
the	DT
guanine	NN
nucleotide	NN
exchange	NN
factor	NN
Vav	NN
to	TO
activate	VB
the	DT
nuclear	JJ
factor	NN
of	IN
activated	VBN
cells	NNS
(	(
NF-AT	NN
)	)
,	,
and	CC
its	PRP$
expression	NN
is	VBZ
required	VBN
for	IN
normal	JJ
T	NN
cell	NN
development	NN
.	.

We	PRP
report	VBP
the	DT
cloning	NN
and	CC
characterization	NN
of	IN
a	DT
novel	JJ
Grb2-like	JJ
adaptor	NN
molecule	NN
designated	VBN
as	IN
Grb2-related	JJ
protein	NN
of	IN
the	DT
lymphoid	JJ
system	NN
(	(
GrpL	NN
)	)
.	.

Expression	NN
of	IN
GrpL	NN
is	VBZ
restricted	VBN
to	TO
hematopoietic	JJ
tissues	NNS
,	,
and	CC
it	PRP
is	VBZ
distinguished	VBN
from	IN
Grb2	NN
by	IN
having	VBG
a	DT
proline-rich	JJ
region	NN
.	.

GrpL	NN
can	MD
be	VB
coimmunoprecipitated	VBN
with	IN
SLP-76	NN
but	CC
not	RB
with	IN
Sos1	NN
or	CC
Sos2	NN
from	IN
Jurkat	NN
cell	NN
lysates	NNS
.	.

In	IN
contrast	NN
,	,
Grb2	NN
can	MD
be	VB
coimmunoprecipitated	VBN
with	IN
Sos1	NN
and	CC
Sos2	NN
but	CC
not	RB
with	IN
SLP-76	NN
.	.

Moreover	RB
,	,
tyrosine-phosphorylated	JJ
LAT/pp36/38	NN
in	IN
detergent	JJ
lysates	NNS
prepared	VBN
from	IN
anti-CD3	NN
stimulated	VBD
T	NN
cells	NNS
associated	VBN
with	IN
Grb2	NN
but	CC
not	RB
GrpL	NN
.	.

These	DT
data	NNS
reveal	VBP
the	DT
presence	NN
of	IN
distinct	JJ
complexes	NNS
involving	VBG
GrpL	NN
and	CC
Grb2	NN
in	IN
T	NN
cells	NNS
.	.

A	DT
functional	JJ
role	NN
of	IN
the	DT
GrpL-SLP-76	NN
complex	NN
is	VBZ
suggested	VBN
by	IN
the	DT
ability	NN
of	IN
GrpL	NN
to	TO
act	VB
alone	RB
or	CC
in	IN
concert	NN
with	IN
SLP-76	NN
to	TO
augment	VB
NF-AT	NN
activation	NN
in	IN
Jurkat	NN
T	NN
cells	NNS
.	.

UI	LS
-	:
99175125	CD

TI	LS
-	:
Bacterial	JJ
lipopolysaccharide	NN
activates	VBZ
nuclear	JJ
factor-kappaB	NN
through	IN
interleukin-1	NN
signaling	NN
mediators	NNS
in	IN
cultured	VBN
human	JJ
dermal	JJ
endothelial	JJ
cells	NNS
and	CC
mononuclear	JJ
phagocytes	NNS
.	.

AB	LS
-	:
Bacterial	JJ
lipopolysaccharide	NN
(	(
LPS	NN
)	)
-mediated	JJ
immune	JJ
responses	NNS
,	,
including	VBG
activation	NN
of	IN
monocytes	NNS
,	,
macrophages	NNS
,	,
and	CC
endothelial	JJ
cells	NNS
,	,
play	VBP
an	DT
important	JJ
role	NN
in	IN
the	DT
pathogenesis	NN
of	IN
Gram-negative	JJ
bacteria-induced	JJ
sepsis	NN
syndrome	NN
.	.

Activation	NN
of	IN
NF-kappaB	NN
is	VBZ
thought	VBN
to	TO
be	VB
required	VBN
for	IN
cytokine	NN
release	NN
from	IN
LPS-responsive	JJ
cells	NNS
,	,
a	DT
critical	JJ
step	NN
for	IN
endotoxic	JJ
effects	NNS
.	.

Here	RB
we	PRP
investigated	VBD
the	DT
role	NN
and	CC
involvement	NN
of	IN
interleukin-1	NN
(	(
IL-1	NN
)	)
and	CC
tumor	NN
necrosis	NN
factor	NN
(	(
TNF-alpha	NN
)	)
signal	NN
transducer	NN
molecules	NNS
in	IN
LPS	NN
signaling	NN
in	IN
human	JJ
dermal	JJ
microvessel	NN
endothelial	JJ
cells	NNS
(	(
HDMEC	NN
)	)
and	CC
THP-1	NN
monocytic	JJ
cells	NNS
.	.

LPS	NN
stimulation	NN
of	IN
HDMEC	NN
and	CC
THP-1	NN
cells	NNS
initiated	VBD
an	DT
IL-1	NN
receptor-like	JJ
NF-kappaB	NN
signaling	NN
cascade	NN
.	.

In	IN
transient	JJ
cotransfection	NN
experiments	NNS
,	,
dominant	JJ
negative	JJ
mutants	NNS
of	IN
the	DT
IL-1	NN
signaling	NN
pathway	NN
,	,
including	VBG
MyD88	NN
,	,
IRAK	NN
,	,
IRAK2	NN
,	,
and	CC
TRAF6	NN
inhibited	VBD
both	CC
IL-1-	NN
and	CC
LPS-induced	JJ
NF-kappaB-luciferase	NN
activity	NN
.	.

LPS-induced	JJ
NF-kappaB	NN
activation	NN
was	VBD
not	RB
inhibited	VBN
by	IN
a	DT
dominant	JJ
negative	JJ
mutant	NN
of	IN
TRAF2	NN
that	WDT
is	VBZ
involved	VBN
in	IN
TNF	NN
signaling	NN
.	.

LPS-induced	JJ
activation	NN
of	IN
NF-kappaB-responsive	JJ
reporter	NN
gene	NN
was	VBD
not	RB
inhibited	VBN
by	IN
IL-1	NN
receptor	NN
antagonist	NN
.	.

TLR2	NN
and	CC
TLR4	NN
were	VBD
expressed	VBN
on	IN
the	DT
cell	NN
surface	NN
of	IN
HDMEC	NN
and	CC
THP-1	NN
cells	NNS
.	.

These	DT
findings	NNS
suggest	VBP
that	IN
a	DT
signal	NN
transduction	NN
molecule	NN
in	IN
the	DT
LPS	NN
receptor	NN
complex	NN
may	MD
belong	VB
to	TO
the	DT
IL-1	NN
receptor/toll-like	JJ
receptor	NN
(	(
TLR	NN
)	)
super	JJ
family	NN
,	,
and	CC
the	DT
LPS	NN
signaling	NN
cascade	NN
uses	VBZ
an	DT
analogous	JJ
molecular	JJ
framework	NN
for	IN
signaling	NN
as	IN
IL-1	NN
in	IN
mononuclear	JJ
phagocytes	NNS
and	CC
endothelial	JJ
cells	NNS
.	.

UI	LS
-	:
99223528	CD

TI	LS
-	:
Modulation	NN
of	IN
E2F	NN
complexes	NNS
during	IN
G0	NN
to	TO
S	NN
phase	NN
transition	NN
in	IN
human	JJ
primary	JJ
B-lymphocytes	NNS
.	.

AB	LS
-	:
The	DT
pocket	NN
protein-E2F	JJ
complexes	NNS
are	VBP
convergence	NN
points	NNS
for	IN
cell	NN
cycle	NN
signaling	NN
.	.

In	IN
the	DT
present	JJ
report	NN
,	,
we	PRP
identified	VBD
and	CC
monitored	VBD
the	DT
pocket	NN
protein-E2F	JJ
complexes	NNS
in	IN
human	JJ
primary	JJ
B-lymphocytes	NNS
after	IN
activation	NN
by	IN
phorbol	NN
12-myristate	NN
13-acetate	NN
.	.

Consistent	JJ
with	IN
previous	JJ
data	NNS
from	IN
human	JJ
and	CC
mouse	NN
fibroblasts	NNS
and	CC
T-lymphocytes	NNS
,	,
E2F4	NN
and	CC
DP1	NN
form	VBP
the	DT
predominant	JJ
E2F	NN
heterodimers	NNS
both	CC
in	IN
G0	NN
and	CC
G1	NN
phases	NNS
of	IN
the	DT
human	JJ
B-lymphocyte	NN
cell	NN
cycle	NN
,	,
whereas	IN
E2F1	NN
and	CC
-3	CD
are	VBP
first	RB
detected	VBN
in	IN
late	JJ
G1	NN
,	,
and	CC
their	PRP$
expression	NN
levels	NNS
increase	VBP
towards	IN
S	NN
phase	NN
.	.

Intriguingly	RB
,	,
the	DT
major	JJ
E2F	NN
complex	NN
that	WDT
we	PRP
detected	VBD
in	IN
quiescent	JJ
human	JJ
B-lymphocytes	NNS
is	VBZ
consisted	VBN
of	IN
pRB	NN
,	,
E2F4	NN
,	,
and	CC
DP1	NN
.	.

Though	IN
the	DT
levels	NNS
of	IN
DP1	NN
and	CC
-2	CD
increase	VBP
when	WRB
cells	NNS
progress	VBP
from	IN
G0	NN
to	TO
S	NN
,	,
the	DT
proportion	NN
of	IN
DP1	NN
to	TO
DP2	NN
remains	VBZ
relatively	RB
constant	JJ
during	IN
the	DT
cell	NN
cycle	NN
.	.

We	PRP
also	RB
observed	VBD
an	DT
increase	NN
in	IN
electrophoretic	JJ
mobility	NN
of	IN
the	DT
predominant	JJ
E2F	NN
components	NNS
,	,
DP1	NN
and	CC
E2F4	NN
,	,
as	IN
B-lymphocytes	NNS
progressed	VBD
from	IN
G0	NN
into	IN
early	JJ
G1	NN
.	.

This	DT
increase	NN
in	IN
mobility	NN
was	VBD
attributable	JJ
to	TO
dephosphorylation	NN
,	,
as	IN
lambda	NN
phosphatase	NN
treatment	NN
could	MD
convert	VB
the	DT
slower	JJR
migrating	JJ
forms	NNS
into	IN
the	DT
corresponding	JJ
faster	JJR
mobility	NN
forms	NNS
.	.

We	PRP
further	RB
demonstrated	VBD
that	IN
this	DT
change	NN
in	IN
phosphorylation	NN
status	NN
correlates	VBZ
with	IN
a	DT
decrease	NN
in	IN
DNA	NN
binding	NN
activity	NN
.	.

This	DT
modulation	NN
of	IN
DNA	NN
binding	NN
activity	NN
mediated	VBN
through	IN
the	DT
dephosphorylation	NN
of	IN
DP1	NN
and	CC
E2F4	NN
could	MD
help	VB
to	TO
explain	VB
the	DT
lack	NN
of	IN
in	FW
vivo	FW
DNA	NN
footprinting	NN
in	IN
late	JJ
G1	NN
and	CC
S	NN
phases	NNS
of	IN
gene	NN
promoters	NNS
negatively	RB
regulated	VBN
through	IN
E2F	NN
sites	NNS
and	CC
suggests	VBZ
a	DT
novel	JJ
mechanism	NN
for	IN
controlling	VBG
E2F	NN
transcriptional	JJ
activity	NN
during	IN
the	DT
transition	NN
from	IN
quiescence	NN
to	TO
proliferation	NN
.	.

UI	LS
-	:
99162595	CD

TI	LS
-	:
Crossreactive	JJ
recognition	NN
of	IN
viral	JJ
,	,
self	NN
,	,
and	CC
bacterial	JJ
peptide	NN
ligands	NNS
by	IN
human	JJ
class	NN
I-restricted	JJ
cytotoxic	JJ
T	NN
lymphocyte	NN
clonotypes	NNS
:	:
implications	NNS
for	IN
molecular	JJ
mimicry	NN
in	IN
autoimmune	JJ
disease	NN
.	.

AB	LS
-	:
The	DT
immunodominant	JJ
,	,
CD8(+)	JJ
cytotoxic	JJ
T	NN
lymphocyte	NN
(	(
CTL	NN
)	)
response	NN
to	TO
the	DT
HLA-B8-restricted	JJ
peptide	NN
,	,
RAKFKQLL	NN
,	,
located	JJ
in	IN
the	DT
Epstein-Barr	JJ
virus	NN
immediate-early	JJ
antigen	NN
,	,
BZLF1	NN
,	,
is	VBZ
characterized	VBN
by	IN
a	DT
diverse	JJ
T	NN
cell	NN
receptor	NN
(	(
TCR	NN
)	)
repertoire	NN
.	.

Here	RB
,	,
we	PRP
show	VBP
that	IN
this	DT
diversity	NN
can	MD
be	VB
partitioned	VBN
on	IN
the	DT
basis	NN
of	IN
crossreactive	JJ
cytotoxicity	NN
patterns	NNS
involving	VBG
the	DT
recognition	NN
of	IN
a	DT
self	NN
peptide	NN
-	:
RSKFRQIV	NN
-	:
located	JJ
in	IN
a	DT
serine/threonine	NN
kinase	NN
and	CC
a	DT
bacterial	JJ
peptide	NN
-	:
RRKYKQII	NN
-	:
located	JJ
in	IN
Staphylococcus	FW
aureus	FW
replication	NN
initiation	NN
protein	NN
.	.

Thus	RB
CTL	NN
clones	NNS
that	WDT
recognized	VBD
the	DT
viral	JJ
,	,
self	NN
,	,
and	CC
bacterial	JJ
peptides	NNS
expressed	VBD
a	DT
highly	RB
restricted	JJ
alphabeta	NN
TCR	NN
phenotype	NN
.	.

The	DT
CTL	NN
clones	NNS
that	WDT
recognized	VBD
viral	JJ
and	CC
self	NN
peptides	NNS
were	VBD
more	RBR
oligoclonal	JJ
,	,
whereas	IN
clones	NNS
that	WDT
strictly	RB
recognized	VBD
the	DT
viral	JJ
peptide	NN
displayed	VBD
a	DT
diverse	JJ
TCR	NN
profile	NN
.	.

Interestingly	RB
,	,
the	DT
self	NN
and	CC
bacterial	JJ
peptides	NNS
equally	RB
were	VBD
substantially	RB
less	RBR
effective	JJ
than	IN
the	DT
cognate	JJ
viral	JJ
peptide	NN
in	IN
sensitizing	VBG
target	NN
cell	NN
lysis	NN
,	,
and	CC
also	RB
resulted	VBD
only	RB
in	IN
a	DT
weak	JJ
reactivation	NN
of	IN
memory	NN
CTLs	NNS
in	IN
limiting	VBG
dilution	NN
assays	NNS
,	,
whereas	IN
the	DT
cognate	JJ
peptide	NN
was	VBD
highly	RB
immunogenic	JJ
.	.

The	DT
described	VBN
crossreactions	NNS
show	VBP
that	IN
human	JJ
antiviral	JJ
,	,
CD8(+)	JJ
CTL	NN
responses	NNS
can	MD
be	VB
shaped	VBN
by	IN
peptide	NN
ligands	NNS
derived	VBN
from	IN
autoantigens	NNS
and	CC
environmental	JJ
bacterial	JJ
antigens	NNS
,	,
thereby	RB
providing	VBG
a	DT
firm	JJ
structural	JJ
basis	NN
for	IN
molecular	JJ
mimicry	NN
involving	VBG
class	NN
I-restricted	JJ
CTLs	NNS
in	IN
the	DT
pathogenesis	NN
of	IN
autoimmune	JJ
disease	NN
.	.

UI	LS
-	:
99115659	CD

TI	LS
-	:
CD80	NN
and	CC
CD86	NN
are	VBP
not	RB
equivalent	JJ
in	IN
their	PRP$
ability	NN
to	TO
induce	VB
the	DT
tyrosine	NN
phosphorylation	NN
of	IN
CD28	NN
.	.

AB	LS
-	:
Ligation	NN
of	IN
either	CC
CD80	NN
(	(
B7-1	NN
)	)
or	CC
CD86	NN
(	(
B7-2	NN
)	)
,	,
two	CD
principal	JJ
ligands	NNS
for	IN
CD28	NN
,	,
is	VBZ
thought	VBN
to	TO
skew	VB
the	DT
immune	JJ
response	NN
toward	IN
Th1	NN
or	CC
Th2	NN
differentiation	NN
.	.

We	PRP
have	VBP
examined	VBN
early	JJ
signal	NN
transduction	NN
pathways	NNS
recruited	VBN
following	VBG
T	NN
cell	NN
stimulation	NN
with	IN
either	CC
CD80	NN
or	CC
CD86	NN
.	.

Purified	VBN
human	JJ
peripheral	JJ
T	NN
cells	NNS
or	CC
Jurkat	NN
T	NN
cells	NNS
were	VBD
stimulated	VBN
with	IN
Chinese	JJ
hamster	NN
ovary	NN
(	(
CHO	NN
)	)
cells	NNS
expressing	VBG
either	CC
human	JJ
CD80	NN
(	(
CHO-CD80	NN
)	)
or	CC
human	JJ
CD86	NN
(	(
CHO-CD86	NN
)	)
or	CC
with	IN
anti-CD28	JJ
monoclonal	JJ
antibody	NN
(	(
mAb	NN
)	)
.	.

In	IN
the	DT
presence	NN
of	IN
phorbol	NN
12-myristate	NN
13-acetate	NN
,	,
both	CC
CHO-CD80	NN
and	CC
CHO-CD86	NN
,	,
like	IN
anti-CD28	JJ
mAb	NN
,	,
were	VBD
capable	JJ
of	IN
stimulating	VBG
cytokine	NN
production	NN
from	IN
both	CC
human	JJ
peripheral	JJ
T	NN
cells	NNS
and	CC
Jurkat	NN
T	NN
cells	NNS
.	.

Both	CC
CHO-CD80	NN
and	CC
CHO-CD86	NN
,	,
in	IN
the	DT
presence	NN
of	IN
anti-CD3	JJ
mAb	NN
,	,
costimulated	VBD
NFAT-dependent	JJ
transcriptional	JJ
activation	NN
.	.

Several	JJ
intracellular	JJ
signaling	VBG
proteins	NNS
,	,
such	JJ
as	IN
CBL	NN
and	CC
VAV	NN
,	,
were	VBD
phosphorylated	VBN
on	IN
tyrosine	NN
in	IN
response	NN
to	TO
CD80	NN
,	,
CD86	NN
,	,
and	CC
anti-CD28	JJ
mAb	NN
.	.

Surprisingly	RB
,	,
although	IN
stimulation	NN
of	IN
Jurkat	NN
T	NN
cells	NNS
with	IN
either	CC
CHO-CD80	NN
or	CC
anti-CD28	JJ
mAb	NN
resulted	VBD
in	IN
robust	JJ
tyrosine	NN
phosphorylation	NN
of	IN
CD28	NN
itself	PRP
,	,
ligation	NN
with	IN
CHO-CD86	NN
was	VBD
unable	JJ
to	TO
induce	VB
detectable	JJ
CD28	NN
tyrosyl	NN
phosphorylation	NN
over	IN
a	DT
range	NN
of	IN
stimulation	NN
conditions	NNS
.	.

In	IN
addition	NN
,	,
the	DT
association	NN
of	IN
phosphoinositide	NN
3-kinase	NN
with	IN
CD28	NN
and	CC
enhanced	VBN
tyrosine	NN
phosphorylation	NN
of	IN
phospholipase	NN
Cgamma	NN
were	VBD
seen	VBN
after	IN
anti-CD28	JJ
mAb	NN
and	CC
CHO-CD80	NN
stimulation	NN
but	CC
to	TO
a	DT
much	RB
lesser	JJR
extent	NN
after	IN
CHO-CD86	NN
stimulation	NN
.	.

Thus	RB
,	,
ligation	NN
of	IN
CD28	NN
with	IN
either	CC
CD80	NN
or	CC
CD86	NN
leads	VBZ
to	TO
shared	JJ
early	JJ
signal	NN
transduction	NN
events	NNS
such	JJ
as	IN
the	DT
tyrosine	NN
phosphorylation	NN
of	IN
CBL	NN
and	CC
VAV	NN
,	,
to	TO
NFAT-mediated	JJ
transcriptional	JJ
activation	NN
,	,
and	CC
to	TO
the	DT
costimulation	NN
of	IN
interleukin-2	NN
and	CC
granulocyte-macrophage	JJ
colony-stimulating	JJ
factor	NN
production	NN
.	.

However	RB
,	,
CD80	NN
and	CC
CD86	NN
also	RB
induce	VBP
distinct	JJ
signal	NN
transduction	NN
pathways	NNS
including	VBG
the	DT
tyrosine	NN
phosphorylation	NN
of	IN
CD28	NN
and	CC
phospholipase	NN
Cgamma1	NN
and	CC
the	DT
SH2-dependent	JJ
association	NN
of	IN
phosphoinositide	NN
3-kinase	NN
with	IN
CD28	NN
.	.

These	DT
quantitative	JJ
,	,
if	IN
not	RB
qualitative	JJ
,	,
differences	NNS
between	IN
signaling	NN
initiated	VBN
by	IN
these	DT
two	CD
ligands	NNS
for	IN
CD28	NN
may	MD
contribute	VB
to	TO
functional	JJ
differences	NNS
(	(
e.g.	FW
Th1	NN
or	CC
Th2	NN
differentiation	NN
)	)
in	IN
T	NN
cell	NN
responses	NNS
.	.

UI	LS
-	:
98208264	CD

TI	LS
-	:
Role	NN
of	IN
cyclic	JJ
AMP	NN
response	NN
element-binding	JJ
protein	NN
in	IN
cyclic	JJ
AMP	NN
inhibition	NN
of	IN
NF-kappaB-mediated	JJ
transcription	NN
.	.

AB	LS
-	:
The	DT
NF-kappaB	NN
family	NN
of	IN
transcription	NN
factors	NNS
regulates	VBZ
the	DT
inducible	JJ
expression	NN
of	IN
a	DT
variety	NN
of	IN
genes	NNS
.	.

Recently	RB
,	,
we	PRP
showed	VBD
that	IN
elevation	NN
of	IN
intracellular	JJ
cyclic	JJ
AMP	NN
inhibits	VBZ
NF-kappaB-mediated	JJ
transcription	NN
in	IN
human	JJ
monocytes	NNS
and	CC
endothelial	JJ
cells	NNS
without	IN
preventing	VBG
nuclear	JJ
translocation	NN
of	IN
NF-kappaB	NN
complexes	NNS
.	.

The	DT
present	JJ
study	NN
examined	VBD
the	DT
molecular	JJ
mechanism	NN
of	IN
this	DT
inhibition	NN
.	.

We	PRP
hypothesized	VBD
that	IN
activation	NN
of	IN
the	DT
protein	NN
kinase	NN
A	NN
signaling	NN
pathway	NN
may	MD
inhibit	VB
NF-kappaB-mediated	JJ
transcription	NN
by	IN
phosphorylating	VBG
proteins	NNS
,	,
such	JJ
as	IN
cAMP	NN
response	NN
element-binding	JJ
protein	NN
(	(
CREB	NN
)	)
,	,
which	WDT
compete	VBP
for	IN
limiting	VBG
amounts	NNS
of	IN
the	DT
coactivator	NN
CBP	NN
.	.

Here	RB
,	,
we	PRP
show	VBP
that	IN
the	DT
amino-terminal	JJ
region	NN
(	(
amino	NN
acids	NNS
1-450	CD
)	)
of	IN
CBP	NN
specifically	RB
interacts	VBZ
with	IN
the	DT
carboxyl-terminal	JJ
region	NN
(	(
amino	NN
acids	NNS
286-551	CD
)	)
of	IN
NF-kappaB	NN
p65	NN
(	(
RelA	NN
)	)
both	CC
in	FW
vitro	FW
and	CC
in	FW
vivo	FW
.	.

Functional	JJ
studies	NNS
using	VBG
human	JJ
endothelial	JJ
cells	NNS
demonstrated	VBD
that	IN
overexpression	NN
of	IN
CBP	NN
rescued	VBD
cAMP	NN
inhibition	NN
of	IN
NF-kappaB-mediated	JJ
transcription	NN
and	CC
transcription	NN
mediated	VBN
by	IN
a	DT
chimeric	JJ
protein	NN
,	,
GAL4-p65	NN
(	(
286-551	CD
)	)
,	,
which	WDT
contained	VBD
the	DT
GAL4	NN
DNA	NN
binding	NN
domain	NN
fused	VBN
to	TO
the	DT
carboxyl-terminal	JJ
region	NN
of	IN
p65	NN
(	(
amino	NN
acids	NNS
286-551	CD
)	)
.	.

In	IN
contrast	NN
,	,
overexpression	NN
of	IN
CREB	NN
inhibited	VBD
GAL4-p65(286-551)-mediated	JJ
transcription	NN
.	.

These	DT
results	NNS
suggest	VBP
that	IN
activation	NN
of	IN
the	DT
protein	NN
kinase	NN
A	NN
pathway	NN
inhibits	VBZ
NF-kappaB	NN
transcription	NN
by	IN
phosphorylating	VBG
CREB	NN
,	,
which	WDT
competes	VBZ
with	IN
p65	NN
for	IN
limiting	VBG
amounts	NNS
of	IN
CBP	NN
.	.

UI	LS
-	:
98104470	CD

TI	LS
-	:
Inefficient	JJ
termination	NN
of	IN
antigen	NN
responses	NNS
in	IN
NF-ATp-deficient	JJ
mice	NNS
.	.

AB	LS
-	:
In	IN
order	NN
to	TO
elucidate	VB
the	DT
role	NN
of	IN
NF-ATp	NN
,	,
one	CD
of	IN
the	DT
most	RBS
prominent	JJ
members	NNS
of	IN
family	NN
of	IN
NF-AT	NN
transcription	NN
factors	NNS
in	IN
peripheral	JJ
T	NN
lymphocytes	NNS
,	,
in	IN
T	NN
cell	NN
activation	NN
and	CC
differentiation	NN
we	PRP
created	VBD
NF-ATp-deficient	JJ
mice	NNS
by	IN
gene	NN
targeting	VBG
.	.

Such	JJ
NF-ATp-/-	JJ
mice	NNS
are	VBP
born	JJ
and	CC
appear	VBP
to	TO
develop	VB
a	DT
normal	JJ
immune	JJ
system	NN
.	.

Apart	RB
from	IN
clear-cut	JJ
defects	NNS
in	IN
the	DT
synthesis	NN
of	IN
mRNAs	NNS
for	IN
Th2-type	JJ
lymphokines	NNS
,	,
such	JJ
as	IN
IL-4	NN
,	,
IL-5	NN
,	,
IL-10	NN
and	CC
IL-13	NN
,	,
in	IN
primary	JJ
and	CC
secondary	JJ
stimulations	NNS
of	IN
spleen	NN
cells	NNS
in	FW
vitro	FW
,	,
of	IN
a	DT
distinct	JJ
impaired	JJ
deletion	NN
of	IN
V	NN
beta	NN
11+/CD4+	JJ
T	NN
lymphocytes	NNS
from	IN
these	DT
mice	NNS
was	VBD
detected	VBN
after	IN
superantigen	NN
injection	NN
.	.

Moreover	RB
,	,
NF-ATp-/-	JJ
mice	NNS
older	JJR
than	IN
6	CD
weeks	NNS
show	VBP
an	DT
2-5	CD
fold	JJ
increase	NN
in	IN
number	NN
of	IN
lymphocytes	NNS
.	.

This	DT
is	VBZ
correlated	VBN
with	IN
an	DT
increased	VBN
expression	NN
of	IN
activation	NN
markers	NNS
CD44	NN
and	CC
CD69	NN
and	CC
decreased	VBN
expression	NN
of	IN
CD62	NN
.	.

UI	LS
-	:
99078033	CD

TI	LS
-	:
Interdomain	NN
B	NN
in	IN
ZAP-70	NN
regulates	VBZ
but	CC
is	VBZ
not	RB
required	VBN
for	IN
ZAP-70	NN
signaling	NN
function	NN
in	IN
lymphocytes	NNS
.	.

AB	LS
-	:
The	DT
protein	NN
tyrosine	NN
kinase	NN
ZAP-70	NN
plays	VBZ
an	DT
important	JJ
role	NN
in	IN
T-cell	NN
activation	NN
and	CC
development	NN
.	.

After	IN
T-cell	NN
receptor	NN
stimulation	NN
,	,
ZAP-70	NN
associates	VBZ
with	IN
the	DT
receptor	NN
and	CC
is	VBZ
phosphorylated	VBN
on	IN
many	JJ
tyrosines	NNS
,	,
including	VBG
Y292	NN
,	,
Y315	NN
,	,
and	CC
Y319	NN
within	IN
interdomain	NN
B	NN
.	.

Previously	RB
,	,
we	PRP
demonstrated	VBD
that	IN
Y292	NN
negatively	RB
regulates	VBZ
ZAP-70	NN
function	NN
and	CC
that	IN
Y315	NN
positively	RB
regulates	VBZ
ZAP-70	NN
function	NN
by	IN
interacting	VBG
with	IN
Vav	NN
.	.

Recent	JJ
studies	NNS
have	VBP
suggested	VBN
that	IN
Y319	NN
also	RB
positively	RB
regulate	VBP
ZAP-70	NN
function	NN
.	.

Paradoxically	RB
,	,
removal	NN
of	IN
interdomain	NN
B	NN
(	(
to	TO
create	VB
the	DT
construct	NN
designated	VBN
Delta	NN
)	)
,	,
containing	VBG
the	DT
Y292	NN
,	,
Y315	NN
,	,
and	CC
Y319	NN
sites	NNS
,	,
did	VBD
not	RB
eliminate	VB
the	DT
ability	NN
of	IN
ZAP-70	NN
to	TO
induce	VB
multiple	JJ
gene	NN
reporters	NNS
in	IN
Syk-deficient	JJ
DT-40	NN
B	NN
cells	NNS
and	CC
ZAP-70/Syk-deficient	JJ
Jurkat	NN
cells	NNS
.	.

Here	RB
we	PRP
show	VBP
that	IN
Delta	NN
still	RB
utilizes	VBZ
the	DT
same	JJ
pathways	NNS
as	IN
wild-type	JJ
ZAP-70	NN
to	TO
mediate	VB
NF-AT	NN
induction	NN
.	.

This	DT
is	VBZ
manifested	VBN
by	IN
the	DT
ability	NN
of	IN
Delta	NN
to	TO
restore	VB
induction	NN
of	IN
calcium	NN
fluxes	NNS
and	CC
mitogen-activated	JJ
protein	NN
kinase	NN
activation	NN
and	CC
by	IN
the	DT
ability	NN
of	IN
dominant	JJ
negative	JJ
Ras	NNS
and	CC
FK506	NN
to	TO
block	VB
the	DT
induction	NN
of	IN
NF-AT	NN
activity	NN
mediated	VBN
by	IN
Delta	NN
.	.

Biochemically	RB
we	PRP
show	VBP
that	IN
the	DT
stimulated	VBN
tyrosine	NN
phosphorylation	NN
of	IN
Vav	NN
,	,
Shc	NN
,	,
and	CC
ZAP-70	NN
itself	PRP
is	VBZ
diminished	VBN
,	,
whereas	IN
that	DT
of	IN
Slp-76	NN
is	VBZ
increased	VBN
in	IN
cells	NNS
reconstituted	VBN
with	IN
Delta	NN
.	.

Deletion	NN
of	IN
interdomain	NN
B	NN
did	VBD
not	RB
affect	VB
the	DT
ability	NN
of	IN
ZAP-70	NN
to	TO
bind	VB
to	TO
the	DT
receptor	NN
.	.

The	DT
in	FW
vitro	FW
kinase	NN
activity	NN
of	IN
ZAP-70	NN
lacking	VBG
interdomain	NN
B	NN
was	VBD
markedly	RB
reduced	VBN
,	,
but	CC
the	DT
kinase	NN
activity	NN
was	VBD
still	RB
required	VBN
for	IN
the	DT
protein	NN
's	POS
in	FW
vivo	FW
activity	NN
.	.

Based	VBN
on	IN
these	DT
data	NNS
,	,
we	PRP
concluded	VBD
that	IN
interdomain	NN
B	NN
regulates	VBZ
but	CC
is	VBZ
not	RB
required	VBN
for	IN
ZAP-70	NN
signaling	NN
function	NN
leading	VBG
to	TO
cellular	JJ
responses	NNS
.	.

UI	LS
-	:
99158164	CD

TI	LS
-	:
Binding	NN
of	IN
c-Rel	NN
to	TO
STAT5	NN
target	NN
sequences	NNS
in	IN
HTLV-I-transformed	JJ
T	NN
cells	NNS
.	.

AB	LS
-	:
The	DT
type	NN
I	CD
human	JJ
T-cell	NN
leukemia	NN
virus	NN
(	(
HTLV-I	NN
)	)
induces	VBZ
abnormal	JJ
growth	NN
and	CC
subsequent	JJ
transformation	NN
of	IN
T	NN
cells	NNS
,	,
which	WDT
is	VBZ
associated	VBN
with	IN
the	DT
development	NN
of	IN
an	DT
acute	JJ
T-cell	NN
malignancy	NN
termed	VBD
adult	JJ
T-cell	NN
leukemia	NN
.	.

A	DT
characteristic	NN
of	IN
HTLV-I-transformed	JJ
T	NN
cells	NNS
is	VBZ
the	DT
constitutive	JJ
nuclear	JJ
expression	NN
of	IN
NF-kappaB/Rel	NN
family	NN
of	IN
transcription	NN
factors	NNS
,	,
which	WDT
appears	VBZ
to	TO
be	VB
essential	JJ
for	IN
the	DT
growth	NN
of	IN
these	DT
transformed	VBN
cells	NNS
.	.

Although	IN
NF-kappaB/Rel	NN
factors	NNS
are	VBP
known	VBN
to	TO
induce	VB
the	DT
expression	NN
of	IN
T-cell	NN
growth	NN
factor	NN
interleukin	NN
(	(
IL	NN
)	)
-2	CD
,	,
it	PRP
is	VBZ
unclear	JJ
how	WRB
they	PRP
participate	VBP
in	IN
the	DT
IL-2-independent	JJ
growth	NN
of	IN
HTLV-I-transformed	JJ
cells	NNS
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
show	VBP
that	IN
certain	JJ
NF-kappaB/Rel	NN
members	NNS
,	,
predominantly	RB
c-Rel	NN
,	,
interact	VBP
with	IN
enhancer	NN
sequences	NNS
for	IN
STAT5	NN
,	,
a	DT
key	JJ
transcription	NN
factor	NN
mediating	VBG
IL-2-induced	JJ
T-cell	NN
proliferation	NN
.	.

Reporter	NN
gene	NN
assays	NNS
reveal	VBP
that	IN
the	DT
binding	NN
of	IN
c-Rel	NN
to	TO
the	DT
STAT5	NN
site	NN
present	JJ
in	IN
the	DT
Fc	NN
gammaR1	NN
gene	NN
leads	VBZ
to	TO
potent	JJ
transactivation	NN
of	IN
this	DT
enhancer	NN
.	.

Binding	NN
of	IN
c-Rel	NN
to	TO
the	DT
Fc	NN
gammaR1	NN
STAT	NN
site	NN
also	RB
occurs	VBZ
in	IN
human	JJ
peripheral	JJ
blood	NN
T	NN
cells	NNS
immortalized	VBN
with	IN
HTLV-I	NN
in	FW
vitro	FW
and	CC
is	VBZ
correlated	VBN
with	IN
enhanced	VBN
levels	NNS
of	IN
proliferation	NN
of	IN
these	DT
cells	NNS
.	.

These	DT
results	NNS
raise	VBP
the	DT
possibility	NN
that	IN
NF-kappaB/Rel	NN
may	MD
participate	VB
in	IN
the	DT
growth	NN
control	NN
of	IN
HTLV-I-transformed	JJ
T	NN
cells	NNS
by	IN
regulating	VBG
genes	NNS
driven	VBN
by	IN
both	CC
kappaB	NN
and	CC
certain	JJ
STAT	NN
enhancers	NNS
.	.

UI	LS
-	:
99125803	CD

TI	LS
-	:
Comparison	NN
of	IN
HTLV-I	NN
basal	JJ
transcription	NN
and	CC
expression	NN
of	IN
CREB/ATF-1/CREM	NN
family	NN
members	NNS
in	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
and	CC
Jurkat	NN
T	NN
cells	NNS
.	.

AB	LS
-	:
HTLV-I	NN
is	VBZ
the	DT
etiologic	JJ
agent	NN
of	IN
adult	JJ
T-cell	NN
leukemia/lymphoma	NN
and	CC
is	VBZ
associated	VBN
with	IN
tropical	JJ
spastic	JJ
paraparesis/HTLV-I-associated	JJ
myelopathy	NN
.	.

Following	VBG
integration	NN
into	IN
the	DT
host	NN
cell	NN
genome	NN
,	,
HTLV-I	NN
replication	NN
is	VBZ
regulated	VBN
by	IN
both	CC
host	NN
and	CC
viral	JJ
mechanisms	NNS
that	WDT
control	VBP
transcription	NN
.	.

Low	JJ
levels	NNS
of	IN
viral	JJ
transcription	NN
(	(
basal	JJ
transcription	NN
)	)
occur	VBP
before	IN
expression	NN
of	IN
the	DT
virally	RB
encoded	VBN
Tax	NN
protein	NN
(	(
Tax-mediated	JJ
transcription	NN
)	)
.	.

Members	NNS
of	IN
the	DT
cyclic	JJ
adenosine	NN
monophosphate	NN
(	(
cAMP	NN
)	)
response	VBP
element	NN
binding	NN
(	(
CREB	NN
)	)
/activating	VBG
transcription	NN
factor	NN
1	CD
(	(
ATF-1	NN
)	)
family	NN
of	IN
transcription	NN
factors	NNS
bind	VBP
three	CD
21-bp	JJ
repeats	NNS
(	(
Tax-responsive	JJ
element-1	NN
,	,
or	CC
TRE-1	NN
)	)
within	IN
the	DT
viral	JJ
promoter	NN
and	CC
are	VBP
important	JJ
for	IN
basal	JJ
and	CC
Tax-mediated	JJ
transcription	NN
.	.

Using	VBG
mitogen	NN
stimulated	JJ
and	CC
quiescent	JJ
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
(	(
PBMC	NN
)	)
and	CC
Jurkat	NN
cells	NNS
,	,
we	PRP
compared	VBD
differences	NNS
in	IN
basal	JJ
transcription	NN
and	CC
amounts	NNS
and	CC
binding	NN
of	IN
transcription	NN
factors	NNS
with	IN
TRE-1	NN
.	.

We	PRP
demonstrate	VBP
that	IN
amounts	NNS
of	IN
transcriptionally	RB
active	JJ
phosphorylated	VBN
CREB	NN
protein	NN
(	(
P-CREB	NN
)	)
differ	VBP
between	IN
activated	VBN
PBMC	NN
and	CC
Jurkat	NN
cells	NNS
.	.

Following	VBG
stimulation	NN
,	,
P-CREB	JJ
levels	NNS
remain	VBP
elevated	JJ
in	IN
PBMC	NN
for	IN
up	RB
to	TO
24	CD
hours	NNS
whereas	IN
CREB	NN
is	VBZ
dephosphorylated	VBN
in	IN
Jurkat	NN
cells	NNS
within	IN
4	CD
hours	NNS
following	VBG
stimulation	NN
.	.

The	DT
differences	NNS
in	IN
P-CREB	NN
levels	NNS
between	IN
PBMC	NN
and	CC
Jurkat	NN
cells	NNS
were	VBD
directly	RB
correlated	VBN
with	IN
basal	JJ
transcription	NN
of	IN
HTLV-I	NN
in	IN
the	DT
two	CD
cell	NN
types	NNS
.	.

Using	VBG
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
,	,
we	PRP
determined	VBD
that	IN
the	DT
pattern	NN
of	IN
band	NN
migration	NN
differed	VBD
between	IN
the	DT
two	CD
cell	NN
types	NNS
.	.

These	DT
data	NNS
demonstrate	VBP
that	IN
PBMC	NN
differentially	RB
regulate	VBP
basal	JJ
HTLV-I	NN
transcription	NN
compared	VBN
with	IN
Jurkat	NN
T	NN
cells	NNS
,	,
and	CC
this	DT
differential	JJ
regulation	NN
is	VBZ
due	JJ
,	,
in	IN
part	NN
to	TO
differential	JJ
phosphorylation	NN
and	CC
binding	NN
of	IN
CREB/ATF-1	NN
to	TO
TRE-1	NN
in	IN
the	DT
HTLV-I	NN
promoter	NN
.	.

We	PRP
demonstrate	VBP
the	DT
utility	NN
of	IN
using	VBG
primary	JJ
lymphocyte	NN
models	NNS
to	TO
study	VB
HTLV-I	NN
transcription	NN
in	IN
the	DT
context	NN
of	IN
cell	NN
signaling	NN
and	CC
suggest	VBP
that	IN
activated	VBN
PBMC	NN
maintain	VBP
elevated	JJ
levels	NNS
of	IN
P-CREB	NN
,	,
which	WDT
promote	VBP
basal	JJ
HTLV-I	NN
transcription	NN
and	CC
enhance	VBP
viral	JJ
persistence	NN
in	FW
vivo	FW
.	.

UI	LS
-	:
99077977	CD

TI	LS
-	:
The	DT
B29	NN
(	(
immunoglobulin	NN
beta-chain	NN
)	)
gene	NN
is	VBZ
a	DT
genetic	JJ
target	NN
for	IN
early	JJ
B-cell	NN
factor	NN
.	.

AB	LS
-	:
Early	JJ
B-cell	NN
factor	NN
(	(
EBF	NN
)	)
is	VBZ
a	DT
transcription	NN
factor	NN
suggested	VBN
as	IN
essential	JJ
for	IN
early	JJ
B-lymphocyte	NN
development	NN
by	IN
findings	NNS
in	IN
mice	NNS
where	WRB
the	DT
coding	VBG
gene	NN
has	VBZ
been	VBN
inactivated	VBN
by	IN
homologous	JJ
disruption	NN
.	.

This	DT
makes	VBZ
the	DT
identification	NN
of	IN
genetic	JJ
targets	NNS
for	IN
this	DT
transcription	NN
factor	NN
pertinent	JJ
for	IN
the	DT
understanding	NN
of	IN
early	JJ
B-cell	NN
development	NN
.	.

The	DT
lack	NN
of	IN
B29	NN
transcripts	NNS
,	,
coding	VBG
for	IN
the	DT
beta	NN
subunit	NN
of	IN
the	DT
B-cell	NN
receptor	NN
complex	NN
,	,
in	IN
pro-B	JJ
cells	NNS
from	IN
EBF-deficient	JJ
mice	NNS
suggested	VBD
that	IN
B29	NN
might	MD
be	VB
a	DT
genetic	JJ
target	NN
for	IN
EBF	NN
.	.

We	PRP
here	RB
present	VBP
data	NNS
suggesting	VBG
that	IN
EBF	NN
interacts	VBZ
with	IN
three	CD
independent	JJ
sites	NNS
within	IN
the	DT
mouse	NN
B29	NN
promoter	NN
.	.

Furthermore	RB
,	,
ectopic	JJ
expression	NN
of	IN
EBF	NN
in	IN
HeLa	NN
cells	NNS
activated	VBD
a	DT
B29	NN
promoter-controlled	JJ
reporter	NN
construct	NN
13-fold	RB
and	CC
induced	VBD
a	DT
low	JJ
level	NN
of	IN
expression	NN
from	IN
the	DT
endogenous	JJ
B29	NN
gene	NN
.	.

Finally	RB
,	,
mutations	NNS
in	IN
the	DT
EBF	NN
binding	NN
sites	NNS
diminished	VBD
B29	NN
promoter	NN
activity	NN
in	IN
pre-B	JJ
cells	NNS
while	IN
the	DT
same	JJ
mutations	NNS
did	VBD
not	RB
have	VB
as	IN
striking	JJ
an	DT
effect	NN
on	IN
the	DT
promoter	NN
function	NN
in	IN
B-cell	NN
lines	NNS
of	IN
later	JJ
differentiation	NN
stages	NNS
.	.

These	DT
data	NNS
suggest	VBP
that	IN
the	DT
B29	NN
gene	NN
is	VBZ
a	DT
genetic	JJ
target	NN
for	IN
EBF	NN
in	IN
early	JJ
B-cell	NN
development	NN
.	.

UI	LS
-	:
98208262	CD

TI	LS
-	:
Delta-opioid	JJ
receptors	NNS
expressed	VBN
by	IN
Jurkat	NN
T	NN
cells	NNS
enhance	VBP
IL-2	NN
secretion	NN
by	IN
increasing	VBG
AP-1	NN
complexes	NNS
and	CC
activity	NN
of	IN
the	DT
NF-AT/AP-1-binding	JJ
promoter	NN
element	NN
.	.

AB	LS
-	:
Recent	JJ
molecular	JJ
evidence	NN
points	VBZ
to	TO
transient	JJ
and/or	CC
stage-specific	JJ
expression	NN
of	IN
delta-	NN
and	CC
kappa-opioid	JJ
receptors	NNS
by	IN
thymic	JJ
and	CC
peripheral	JJ
T	NN
lymphocytes	NNS
.	.

Since	IN
medical	JJ
treatments	NNS
or	CC
stress	NN
commonly	RB
increase	VBP
opioid	JJ
levels	NNS
,	,
it	PRP
is	VBZ
important	JJ
to	TO
understand	VB
the	DT
mechanisms	NNS
by	IN
which	WDT
opioids	NNS
affect	VBP
T	NN
lymphocyte	NN
functions	NNS
.	.

We	PRP
therefore	RB
created	VBD
and	CC
studied	VBD
a	DT
T	NN
cell	NN
line	NN
expressing	VBG
the	DT
cloned	VBN
delta-opioid	JJ
receptor	NN
(	(
DOR1	NN
)	)
.	.

DOR1	NN
ligation	NN
by	IN
a	DT
specific	JJ
DOR1	NN
agonist	NN
,	,
deltorphin	NN
,	,
augmented	VBD
IL-2	NN
secretion	NN
by	IN
synergizing	VBG
with	IN
signals	NNS
from	IN
TCR-CD3	NN
and	CC
CD28	NN
.	.

Reporter	NN
gene	NN
constructs	NNS
were	VBD
used	VBN
to	TO
map	VB
this	DT
effect	NN
of	IN
deltorphin	NN
to	TO
the	DT
AP-1-	NN
and	CC
NF-AT/AP-1-binding	JJ
sites	NNS
of	IN
the	DT
IL-2	NN
promoter	NN
.	.

Although	IN
DOR1	NN
signaling	NN
increased	VBD
[Ca2+]i	NN
,	,
deltorphin	NN
enhanced	VBD
transcriptional	JJ
activity	NN
of	IN
the	DT
NF-AT/AP-1-binding	JJ
site	NN
via	IN
a	DT
mechanism	NN
independent	JJ
of	IN
calcineurin	NN
and	CC
distinct	JJ
from	IN
the	DT
effects	NNS
of	IN
elevated	JJ
[Ca2+]i	NN
.	.

Deltorphin	NN
also	RB
increased	VBD
accumulation	NN
of	IN
AP-1	NN
transcription	NN
factor	NN
complexes	NNS
,	,
suggesting	VBG
that	IN
DOR1	NN
augments	VBZ
IL-2	NN
secretion	NN
by	IN
increasing	VBG
the	DT
AP-1	NN
component	NN
of	IN
the	DT
NF-AT/AP-1	NN
transcription	NN
factor	NN
.	.

These	DT
results	NNS
advance	VBP
the	DT
molecular	JJ
understanding	NN
of	IN
opioid	JJ
effects	NNS
on	IN
lymphocytes	NNS
,	,
and	CC
in	IN
addition	NN
,	,
demonstrate	VBP
regulation	NN
of	IN
IL-2	NN
synthesis	NN
and	CC
secretion	NN
by	IN
the	DT
novel	JJ
mechanism	NN
of	IN
receptor-mediated	JJ
AP-1	NN
induction	NN
.	.

UI	LS
-	:
98039716	CD

TI	LS
-	:
Extinction	NN
of	IN
immunoglobulin	NN
gene	NN
expression	NN
in	IN
B	NN
cells	NNS
upon	IN
fusion	NN
with	IN
HeLa	NN
cells	NNS
is	VBZ
preceded	VBN
by	IN
rapid	JJ
nuclear	JJ
depletion	NN
of	IN
essential	JJ
transcription	NN
factors	NNS
and	CC
is	VBZ
accompanied	VBN
by	IN
widespread	JJ
inactivation	NN
of	IN
genes	NNS
expressed	VBN
in	IN
a	DT
B	NN
cell-specific	JJ
manner	NN
.	.

AB	LS
-	:
When	WRB
immunoglobulin	NN
(	(
Ig	NN
)	)
expressing	NN
B	NN
cells	NNS
are	VBP
fused	VBN
with	IN
non-B	JJ
cells	NNS
,	,
Ig	NN
expression	NN
is	VBZ
rapidly	RB
suppressed	VBN
at	IN
the	DT
level	NN
of	IN
transcription	NN
,	,
a	DT
phenomenon	NN
termed	VBN
extinction	NN
.	.

Here	RB
we	PRP
demonstrate	VBP
that	IN
fusion	NN
of	IN
HeLa	NN
cells	NNS
with	IN
either	CC
diploid	JJ
or	CC
tetraploid	JJ
B	NN
cells	NNS
(	(
Daudi	NN
)	)
results	VBZ
in	IN
widespread	JJ
extinction	NN
of	IN
several	JJ
other	JJ
B	NN
cell-encoded	JJ
genes	NNS
that	WDT
are	VBP
expressed	VBN
in	IN
a	DT
B	NN
cell-specific	JJ
manner	NN
.	.

In	IN
contrast	NN
,	,
expression	NN
of	IN
B	NN
cell-expressed	JJ
genes	NNS
that	WDT
are	VBP
not	RB
dependent	JJ
on	IN
cell-specific	JJ
controls	NNS
is	VBZ
unaffected	JJ
.	.

We	PRP
show	VBP
that	IN
the	DT
molecular	JJ
mechanism	NN
(	(
s	NNS
)	)
underlying	VBG
Ig	NN
gene	NN
extinction	NN
can	MD
be	VB
explained	VBN
,	,
at	IN
least	JJS
in	IN
part	NN
,	,
by	IN
a	DT
lack	NN
of	IN
transcription	NN
factors	NNS
that	WDT
are	VBP
essential	JJ
for	IN
Ig	NN
gene	NN
transcription	NN
.	.

These	DT
transcription	NN
factors	NNS
are	VBP
either	CC
not	RB
produced	VBN
due	JJ
to	TO
block	NN
of	IN
transcription	NN
of	IN
their	PRP$
respective	JJ
genes	NNS
(	(
Oct-2	NN
,	,
OBF-1	NN
,	,
PU.1	NN
)	)
,	,
or	CC
are	VBP
rendered	VBN
inactive	JJ
posttranslationally	RB
(	(
NF-kappa	NN
B	NN
,	,
E47	NN
)	)
.	.

By	IN
isolating	VBG
Daudi	JJ
x	NN
HeLa	NN
heterokaryons	NNS
a	DT
few	JJ
hours	NNS
after	IN
fusion	NN
,	,
we	PRP
have	VBP
studied	VBN
the	DT
initial	JJ
fate	NN
of	IN
two	CD
B	NN
cell-specific	JJ
transcription	NN
factors	NNS
involved	VBN
in	IN
Ig	NN
gene	NN
transcription	NN
,	,
Oct-2	NN
and	CC
NF-kappa	NN
B	NN
.	.

This	DT
report	NN
provides	VBZ
the	DT
first	JJ
demonstration	NN
that	IN
upon	IN
fusion	NN
with	IN
HeLa	NN
cells	NNS
,	,
the	DT
nuclear	JJ
contents	NNS
of	IN
B	NN
cell-expressed	JJ
transcription	NN
factors	NNS
are	VBP
depleted	VBN
within	IN
a	DT
few	JJ
hours	NNS
with	IN
kinetics	NNS
that	WDT
are	VBP
as	IN
fast	JJ
or	CC
faster	JJR
than	IN
that	DT
of	IN
Ig	NN
gene	NN
extinction	NN
.	.

Thus	RB
,	,
the	DT
extinguishing	NN
mechanism	NN
is	VBZ
effective	JJ
very	RB
early	RB
after	IN
fusion	NN
.	.

We	PRP
suggest	VBP
that	IN
extinction	NN
of	IN
Ig	NN
genes	NNS
is	VBZ
part	NN
of	IN
a	DT
global	JJ
mechanism	NN
that	WDT
suppresses	VBZ
the	DT
differentiation	NN
program	NN
foreign	JJ
to	TO
the	DT
HeLa	NN
phenotype	NN
.	.

UI	LS
-	:
99138988	CD

TI	LS
-	:
High-level	JJ
replication	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
in	IN
thymocytes	NNS
requires	VBZ
NF-kappaB	NN
activation	NN
through	IN
interaction	NN
with	IN
thymic	JJ
epithelial	JJ
cells	NNS
.	.

AB	LS
-	:
We	PRP
have	VBP
previously	RB
demonstrated	VBN
that	IN
interaction	NN
of	IN
infected	JJ
thymocytes	NNS
with	IN
autologous	JJ
thymic	JJ
epithelial	JJ
cells	NNS
(	(
TEC	NNS
)	)
is	VBZ
a	DT
prerequisite	NN
for	IN
a	DT
high	JJ
level	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
(	(
HIV-1	NN
)	)
replication	NN
in	IN
thymocytes	NNS
(	(
M.Rothe	NNP
,	,
L.Chene	NNP
,	,
M.Nugeyre	NNP
,	,
F.Barre-Sinoussi	NNP
,	,
and	CC
N.Israel	NNP
,	,
J.Virol.72	NNP
:	:
5852-5861	CD
,	,
1998	CD
)	)
.	.

We	PRP
report	VBP
here	RB
that	IN
this	DT
activation	NN
of	IN
HIV	NN
replication	NN
takes	VBZ
place	NN
at	IN
the	DT
transcriptional	JJ
level	NN
through	IN
activation	NN
of	IN
the	DT
Rel/NF-kappaB	NN
transcription	NN
factors	NNS
.	.

We	PRP
first	RB
demonstrate	VBP
that	IN
an	DT
HIV-1	NN
provirus	NN
(	(
SF-2	NN
strain	NN
)	)
very	RB
effectively	RB
replicates	VBZ
in	IN
thymocytes	NNS
cocultured	VBN
with	IN
TEC	NNS
whereas	IN
this	DT
provirus	NN
,	,
with	IN
kappaB	NN
sites	NNS
deleted	VBN
,	,
fails	VBZ
to	TO
replicate	VB
.	.

We	PRP
provide	VBP
evidence	NN
that	IN
several	JJ
NF-kappaB	NN
complexes	NNS
are	VBP
constitutively	RB
found	VBN
in	IN
the	DT
nuclei	NNS
of	IN
thymocytes	NNS
either	CC
freshly	RB
isolated	VBN
from	IN
the	DT
thymus	NN
or	CC
maintained	VBN
in	IN
coculture	NN
with	IN
autologous	JJ
or	CC
heterologous	JJ
TEC	NNS
.	.

The	DT
prevalent	JJ
complex	NN
is	VBZ
the	DT
heterodimer	NN
p50-p65	NN
.	.

NF-kappaB	NN
activity	NN
is	VBZ
tightly	RB
correlated	VBN
with	IN
the	DT
transcriptional	JJ
activity	NN
of	IN
a	DT
long	JJ
terminal	JJ
repeat	NN
(	(
LTR	NN
)	)
of	IN
HIV-1	NN
transfected	VBN
in	IN
thymocytes	NNS
.	.

The	DT
cotransfection	NN
of	IN
this	DT
LTR	NN
with	IN
a	DT
mutated	VBN
IkappaBalpha	NN
molecule	NN
formally	RB
demonstrates	VBZ
that	IN
LTR	NN
transactivation	NN
is	VBZ
regulated	VBN
by	IN
members	NNS
of	IN
the	DT
Rel/NF-kappaB	NN
family	NN
in	IN
thymocytes	NNS
.	.

We	PRP
also	RB
showed	VBD
that	IN
tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
and	CC
to	TO
a	DT
lesser	JJR
extent	NN
interleukin-1	NN
(	(
IL-1	NN
)	)
,	,
secreted	VBN
within	IN
the	DT
coculture	NN
,	,
induce	VBP
NF-kappaB	NN
activity	NN
and	CC
a	DT
correlative	JJ
LTR	NN
transactivation	NN
.	.

However	RB
IL-7	NN
,	,
a	DT
crucial	JJ
factor	NN
for	IN
thymopoiesis	NN
that	WDT
is	VBZ
secreted	VBN
mainly	RB
by	IN
TEC	NNS
,	,
is	VBZ
a	DT
necessary	JJ
cofactor	NN
for	IN
NF-kappaB	NN
activation	NN
elicited	VBN
by	IN
TNF	NN
or	CC
IL-1	NN
.	.

Together	RB
,	,
these	DT
data	NNS
indicate	VBP
that	IN
NF-kappaB	NN
activation	NN
,	,
required	VBN
for	IN
a	DT
high	JJ
level	NN
of	IN
HIV	NN
replication	NN
in	IN
thymocytes	NNS
,	,
is	VBZ
regulated	VBN
in	IN
a	DT
specific	JJ
manner	NN
in	IN
the	DT
thymic	JJ
microenvironment	NN
which	WDT
provides	VBZ
the	DT
necessary	JJ
cytokines	NNS
:	:
TNF	NN
,	,
IL-1	NN
,	,
and	CC
IL-7	NN
.	.

UI	LS
-	:
99106021	CD

TI	LS
-	:
Tissue	NN
factor	NN
expression	NN
of	IN
human	JJ
monocytes	NNS
is	VBZ
suppressed	VBN
by	IN
lysophosphatidylcholine	NN
.	.

AB	LS
-	:
The	DT
expression	NN
of	IN
tissue	NN
factor	NN
(	(
TF	NN
)	)
,	,
the	DT
principal	JJ
initiator	NN
of	IN
coagulation	NN
,	,
is	VBZ
increased	VBN
during	IN
inflammation	NN
and	CC
atherosclerosis	NN
.	.

Both	DT
conditions	NNS
are	VBP
promoted	VBN
by	IN
lysophosphatidylcholine	NN
(	(
lysoPC	NN
)	)
.	.

We	PRP
observed	VBD
in	IN
the	DT
present	JJ
study	NN
that	IN
lysoPC	NN
(	(
1	CD
to	TO
10	CD
micromol/L	NN
)	)
dose-dependently	RB
reduced	VBD
TF	NN
activity	NN
in	IN
human	JJ
monocytes	NNS
,	,
as	IN
elicited	VBN
by	IN
lipopolysaccharide	NN
(	(
LPS	NN
)	)
.	.

Lysophosphatidylethanolamine	NN
(	(
lysoPE	NN
)	)
and	CC
other	JJ
lysophospholipids	NNS
did	VBD
not	RB
affect	VB
LPS-induced	JJ
TF	NN
activity	NN
of	IN
human	JJ
monocytes	NNS
.	.

TF	NN
antigen	NN
expression	NN
as	IN
elicited	VBN
by	IN
LPS	NN
was	VBD
also	RB
lowered	VBN
by	IN
lysoPC	NN
.	.

Phospholipid	NN
analyses	NNS
indicated	VBD
a	DT
selective	JJ
increase	NN
in	IN
the	DT
lysoPC	NN
content	NN
of	IN
the	DT
monocytes	NNS
after	IN
preincubation	NN
with	IN
the	DT
lysophospholipid	NN
.	.

LysoPC	NN
inhibited	VBD
the	DT
TF	NN
activity	NN
of	IN
Mono	NN
Mac-6	NN
cells	NNS
to	TO
a	DT
similar	JJ
extent	NN
as	IN
in	IN
the	DT
monocytes	NNS
.	.

LPS	NN
binding	NN
to	TO
plasma	NN
membrane	NN
receptors	NNS
and	CC
internalization	NN
of	IN
LPS	NN
into	IN
monocytes	NNS
were	VBD
not	RB
affected	VBN
by	IN
lysoPC	NN
.	.

In	IN
contrast	NN
,	,
LPS-mediated	JJ
nuclear	JJ
binding	NN
of	IN
nuclear	JJ
factor-kappaB/Rel	NN
to	TO
a	DT
TF-specific	JJ
kappaB	NN
site	NN
was	VBD
inhibited	VBN
by	IN
lysoPC	NN
.	.

Induction	NN
of	IN
TF	NN
mRNA	NN
expression	NN
by	IN
LPS	NN
tended	VBD
to	TO
be	VB
partially	RB
reduced	VBN
by	IN
the	DT
lysophospholipid	NN
.	.

Preincubation	NN
with	IN
lysoPC	NN
increased	VBD
monocytic	JJ
cAMP	NN
levels	NNS
.	.

Inhibition	NN
of	IN
adenylyl	JJ
cyclase	NN
by	IN
pretreatment	NN
with	IN
2'-deoxy-3'-adenosine	JJ
monophosphate	NN
partially	RB
reversed	VBD
the	DT
inhibition	NN
of	IN
TF	NN
activity	NN
promoted	VBN
by	IN
lysoPC	NN
.	.

In	IN
conclusion	NN
,	,
lysoPC	NN
markedly	RB
decreases	VBZ
LPS-mediated	JJ
TF	NN
expression	NN
of	IN
human	JJ
monocytes	NNS
,	,
the	DT
effect	NN
probably	RB
being	VBG
mediated	VBN
by	IN
both	CC
transcriptional	JJ
and	CC
posttranscriptional	JJ
mechanisms	NNS
.	.

LysoPC	NN
may	MD
thus	RB
attenuate	VB
activation	NN
of	IN
coagulation	NN
during	IN
inflammation	NN
and	CC
atherosclerosis	NN
.	.

UI	LS
-	:
98158921	CD

TI	LS
-	:
Endothelial	JJ
production	NN
of	IN
MCP-1	NN
:	:
modulation	NN
by	IN
heparin	NN
and	CC
consequences	NNS
for	IN
mononuclear	JJ
cell	NN
activation	NN
.	.

AB	LS
-	:
Heparin	NN
is	VBZ
a	DT
polyanionic	JJ
glycosaminoglycan	NN
(	(
GAG	NN
)	)
that	WDT
can	MD
bind	VB
with	IN
high	JJ
affinity	NN
to	TO
a	DT
range	NN
of	IN
cytokines	NNS
including	VBG
interferon-gamma	NN
(	(
IFN-gamma	NN
)	)
and	CC
members	NNS
of	IN
the	DT
chemokine	NN
superfamily	NN
.	.

This	DT
GAG	NN
also	RB
possesses	VBZ
immunomodulatory	JJ
activity	NN
in	FW
vivo	FW
and	CC
can	MD
antagonize	VB
the	DT
capacity	NN
of	IN
IFN-gamma	NN
to	TO
induce	VB
class	NN
II	CD
MHC	NN
antigen	NN
expression	NN
,	,
and	CC
to	TO
up-regulate	VBP
intercellular	JJ
adhesion	NN
molecule-1	NN
,	,
by	IN
cultured	VBN
endothelial	JJ
cells	NNS
.	.

Previous	JJ
studies	NNS
have	VBP
shown	VBN
that	IN
binding	NN
to	TO
cell-surface	JJ
heparan	NN
sulphate	NN
is	VBZ
essential	JJ
for	IN
optimal	JJ
activity	NN
of	IN
IFN-gamma	NN
and	CC
that	IN
free	JJ
heparin	NN
competitively	RB
inhibits	VBZ
this	DT
sequestration	NN
process	NN
.	.

The	DT
present	JJ
study	NN
was	VBD
performed	VBN
to	TO
increase	VB
our	PRP$
understanding	NN
of	IN
the	DT
immunosuppressive	JJ
activity	NN
of	IN
heparin	NN
by	IN
investigation	NN
of	IN
potential	JJ
antagonism	NN
of	IN
the	DT
production	NN
and	CC
function	NN
of	IN
monocyte	NN
chemotactic	JJ
peptide-1	NN
(	(
MCP-1	NN
)	)
,	,
a	DT
chemokine	NN
important	JJ
for	IN
mononuclear	JJ
leucocyte	NN
recruitment	NN
across	IN
vascular	JJ
endothelium	NN
.	.

It	PRP
was	VBD
found	VBN
that	IN
mixture	NN
of	IN
heparin	NN
with	IN
IFN-gamma	NN
inhibited	VBD
up-regulation	NN
of	IN
the	DT
signal	NN
transducer	NN
and	CC
activator	NN
of	IN
transcription	NN
protein	NN
,	,
STAT-1	NN
produced	VBN
normally	RB
by	IN
treatment	NN
of	IN
endothelial	JJ
cells	NNS
with	IN
IFN-gamma	NN
.	.

An	DT
inhibition	NN
of	IN
MCP-1	NN
production	NN
was	VBD
observed	VBN
that	WDT
was	VBD
specifically	RB
caused	VBN
by	IN
mixture	NN
of	IN
IFN-gamma	NN
with	IN
heparin-like	JJ
,	,
and	CC
therefore	RB
cytokine-binding	JJ
,	,
GAGs	NNS
.	.

It	PRP
was	VBD
also	RB
shown	VBN
that	IN
mixture	NN
of	IN
heparin-like	JJ
GAGs	NNS
with	IN
MCP-1	NN
inhibited	VBD
the	DT
rapid	JJ
tyrosine	NN
phosphorylation	NN
of	IN
phosphatidylinositol	NN
3-kinase	NN
which	WDT
is	VBZ
normally	RB
produced	VBN
by	IN
treatment	NN
of	IN
mononuclear	JJ
leucocytes	NNS
with	IN
this	DT
chemokine	NN
.	.

Blockade	NN
of	IN
this	DT
intracellular	JJ
signalling	NN
event	NN
was	VBD
associated	VBN
with	IN
a	DT
reduction	NN
in	IN
the	DT
normal	JJ
transendothelial	JJ
migration	NN
response	NN
towards	IN
MCP-1	NN
.	.

Results	NNS
from	IN
this	DT
study	NN
indicate	VBP
that	IN
soluble	JJ
,	,
heparin-like	JJ
GAGs	NNS
can	MD
block	VB
IFN-gamma-dependent	JJ
up-regulation	NN
of	IN
MCP-1	NN
production	NN
by	IN
cultured	VBN
endothelial	JJ
cells	NNS
,	,
and	CC
can	MD
also	RB
antagonize	VB
the	DT
leucocyte-activating	JJ
and	CC
migration-promoting	JJ
properties	NNS
of	IN
pre-existing	JJ
MCP-1	NN
.	.

These	DT
activities	NNS
may	MD
contribute	VB
to	TO
the	DT
immunomodulatory	JJ
properties	NNS
of	IN
heparin	NN
.	.

UI	LS
-	:
99113717	CD

TI	LS
-	:
Protective	JJ
effects	NNS
of	IN
notch-1	NN
on	IN
TCR-induced	JJ
apoptosis	NN
.	.

AB	LS
-	:
The	DT
Notch	NN
receptor	NN
protein	NN
was	VBD
originally	RB
identified	VBN
in	IN
Drosophila	NN
and	CC
is	VBZ
known	VBN
to	TO
mediate	VB
cell	NN
to	TO
cell	NN
communication	NN
and	CC
influence	VB
cell	NN
fate	NN
decisions	NNS
.	.

Members	NNS
of	IN
this	DT
family	NN
have	VBP
been	VBN
isolated	VBN
from	IN
invertebrates	NNS
as	RB
well	RB
as	IN
vertebrates	NNS
.	.

We	PRP
isolated	VBD
mouse	NN
Notch-1	NN
in	IN
a	DT
yeast	NN
two-hybrid	JJ
screen	NN
with	IN
Nur77	NN
,	,
which	WDT
is	VBZ
a	DT
protein	NN
that	WDT
has	VBZ
been	VBN
shown	VBN
previously	RB
to	TO
be	VB
required	VBN
for	IN
apoptosis	NN
in	IN
T	NN
cell	NN
lines	NNS
.	.

The	DT
data	NNS
presented	VBN
below	IN
indicate	VBP
that	IN
Notch-1	NN
expression	NN
provides	VBZ
significant	JJ
protection	NN
to	TO
T	NN
cell	NN
lines	NNS
from	IN
TCR-mediated	JJ
apoptosis	NN
.	.

These	DT
data	NNS
demonstrate	VBP
a	DT
new	JJ
antiapoptotic	JJ
role	NN
for	IN
Notch-1	NN
,	,
providing	VBG
evidence	NN
that	IN
,	,
in	IN
addition	NN
to	TO
regulating	VBG
cell	NN
fate	NN
decisions	NNS
,	,
Notch-1	NN
can	MD
play	VB
a	DT
critical	JJ
role	NN
in	IN
controlling	VBG
levels	NNS
of	IN
cell	NN
death	NN
in	IN
T	NN
cells	NNS
.	.

UI	LS
-	:
97456880	CD

TI	LS
-	:
Four	CD
P-like	JJ
elements	NNS
are	VBP
required	VBN
for	IN
optimal	JJ
transcription	NN
of	IN
the	DT
mouse	NN
IL-4	NN
gene	NN
:	:
involvement	NN
of	IN
a	DT
distinct	JJ
set	NN
of	IN
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
and	CC
activator	NN
protein-1	NN
family	NN
proteins	NNS
.	.

AB	LS
-	:
We	PRP
previously	RB
identified	VBD
the	DT
P	NN
sequence	NN
as	IN
a	DT
critical	JJ
regulatory	JJ
element	NN
of	IN
the	DT
human	JJ
IL-4	NN
promoter	NN
.	.

In	IN
the	DT
mouse	NN
IL-4	NN
promoter	NN
,	,
there	EX
are	VBP
five	CD
elements	NNS
homologous	JJ
to	TO
the	DT
human	JJ
P	NN
sequence	NN
designated	VBN
conserved	JJ
lymphokine	NN
element	NN
0	CD
(	(
CLE0	NN
)	)
,	,
P	NN
,	,
P2	NN
,	,
P3	NN
and	CC
P4	NN
.	.

To	TO
characterize	VB
the	DT
role	NN
of	IN
these	DT
P-like	JJ
elements	NNS
and	CC
their	PRP$
binding	NN
factors	NNS
in	IN
the	DT
native	JJ
promoter	NN
,	,
we	PRP
did	VBD
transient	JJ
transfection	NN
and	CC
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
(	(
EMSA	NN
)	)
.	.

Transfection	NN
of	IN
EL-4	NN
cells	NNS
with	IN
the	DT
IL-4	NN
promoter-reporter	NN
constructs	NNS
carrying	VBG
mutated	VBN
P-like	JJ
elements	NNS
showed	VBD
that	IN
four	CD
P-like	JJ
elements	NNS
,	,
CLE0	NN
,	,
P	NN
,	,
P2	NN
and	CC
P4	NN
,	,
but	CC
not	RB
P3	NN
,	,
were	VBD
required	VBN
for	IN
optimal	JJ
activation	NN
of	IN
the	DT
IL-4	NN
promoter	NN
.	.

EMSA	NN
showed	VBD
that	IN
both	CC
constitutive	JJ
and	CC
inducible	JJ
complexes	NNS
bound	VBD
to	TO
CLE0	NN
,	,
P	NN
,	,
P2	NN
and	CC
P4	NN
,	,
whereas	IN
only	RB
a	DT
constitutive	JJ
complex	NN
bound	VBD
to	TO
P3	NN
.	.

In	IN
competition	NN
and	CC
antibody	NN
supershift	NN
assays	NNS
in	IN
EMSA	NN
,	,
complexes	NNS
formed	VBN
with	IN
P	NN
or	CC
P2	NN
proved	VBD
to	TO
contain	VB
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
(	(
NFAT	NN
)	)
family	NN
proteins	NNS
as	IN
major	JJ
components	NNS
.	.

Activator	NN
protein	NN
(	(
AP	NN
)	)
-1	CD
family	NN
proteins	NNS
interacted	VBD
with	IN
CLE0	NN
,	,
P	NN
,	,
P2	NN
and	CC
P4	NN
.	.

NFAT/AP-1	NN
complex	NN
formed	VBD
only	RB
with	IN
P	NN
and	CC
P2	NN
.	.

Cross-competition	NN
assays	NNS
among	IN
the	DT
P-like	JJ
elements	NNS
revealed	VBD
element-specific	JJ
and	CC
common	JJ
complexes	NNS
.	.

Six	CD
tandem	JJ
repeats	NNS
of	IN
the	DT
P	NN
element	NN
linked	VBN
to	TO
the	DT
SV40	NN
promoter	NN
responded	VBD
to	TO
phorbol	NN
12-myristate	NN
13-acetate	NN
,	,
while	IN
that	DT
of	IN
other	JJ
elements	NNS
did	VBD
not	RB
.	.
It	PRP
would	MD
thus	RB
appear	VB
that	IN
components	NNS
of	IN
each	DT
P-like	JJ
element-binding	JJ
complexes	NNS
are	VBP
not	RB
identical	JJ
and	CC
may	MD
coordinately	RB
contribute	VB
to	TO
transcriptional	JJ
activity	NN
.	.

UI	LS
-	:
98090689	CD

TI	LS
-	:
Constitutive	JJ
expression	NN
c-fos	NN
,	,
c-jun	NN
,	,
and	CC
NF	NN
kappa	NN
B	NN
mRNA	NN
is	VBZ
in	IN
nucleated	JJ
fetal	JJ
blood	NN
cells	NNS
and	CC
up-regulation	NN
of	IN
c-fos	NN
and	CC
c-jun	NN
with	IN
anti-CD3	JJ
stimulation	NN
.	.

AB	LS
-	:
Fetal	JJ
and	CC
neonatal	JJ
lymphocytes	NNS
are	VBP
relatively	RB
resistant	JJ
to	TO
activation	NN
and	CC
cytokine	NN
production	NN
when	WRB
stimulated	VBN
either	CC
via	IN
their	PRP$
T-cell	NN
antigen	NN
receptors	NNS
or	CC
lectins	NNS
.	.

The	DT
molecular	JJ
mechanism	NN
(	(
s	NNS
)	)
responsible	JJ
for	IN
this	DT
phenomenon	NN
have	VBP
not	RB
been	VBN
clearly	RB
elucidated	VBN
.	.

We	PRP
have	VBP
hypothesized	VBN
that	IN
such	JJ
defects	NNS
in	IN
fetal/neonatal	JJ
T-cell	NN
activation	NN
may	MD
be	VB
due	JJ
to	TO
lack	NN
of	IN
expression	NN
of	IN
the	DT
transcriptional	JJ
regulatory	JJ
elements	NNS
required	VBN
for	IN
T-cell	NN
activation	NN
.	.

We	PRP
used	VBD
reverse	JJ
transcriptase-polymerase	JJ
chain	NN
reaction	NN
to	TO
examine	VB
both	CC
fetal	JJ
and	CC
term	JJ
neonatal	JJ
cord	NN
bloods	NNS
for	IN
mRNA	NN
expression	NN
of	IN
three	CD
transcription	NN
factors	NNS
implicated	VBN
in	IN
T-cell	NN
activation	NN
:	:
c-jun	NN
,	,
c-fos	NN
,	,
and	CC
NF	NN
kappa	NN
B	NN
(	(
p50	NN
subunit	NN
)	)
.	.

We	PRP
demonstrate	VBP
that	IN
mRNAs	NNS
for	IN
all	DT
three	CD
of	IN
these	DT
regulatory	JJ
factors	NNS
are	VBP
expressed	VBN
in	IN
fetal	JJ
blood	NN
cells	NNS
by	IN
the	DT
27th	JJ
week	NN
of	IN
gestation	NN
and	CC
in	IN
term	NN
cord	NN
bloods	NNS
.	.

Activation	NN
of	IN
term	NN
infant	NN
cord	NN
blood	NN
mononuclear	JJ
cells	NNS
with	IN
anti-CD3	JJ
monoclonal	JJ
antibodies	NNS
resulted	VBD
in	IN
up-regulation	NN
of	IN
both	CC
c-jun	NN
and	CC
c-fos	NN
mRNAs	NNS
within	IN
15	CD
min	NN
of	IN
stimulation	NN
.	.

However	RB
,	,
secretion	NN
of	IN
IL-2	NN
by	IN
anti-CD3-stimulated	JJ
cord	NN
blood	NN
mononuclear	JJ
cells	NNS
was	VBD
still	RB
blunted	VBN
compared	VBN
with	IN
control	JJ
cells	NNS
from	IN
adults	NNS
.	.

We	PRP
conclude	VBP
that	IN
fetal	JJ
nucleated	JJ
blood	NN
cells	NNS
constitutively	RB
express	VBP
important	JJ
genes	NNS
for	IN
cytokine	NN
regulation	NN
and	CC
are	VBP
able	JJ
to	TO
increase	VB
intracellular	JJ
accumulation	NN
of	IN
the	DT
mRNAs	NNS
for	IN
these	DT
factors	NNS
in	IN
response	NN
to	TO
anti-CD3	JJ
stimulation	NN
.	.

Thus	RB
,	,
qualitative	JJ
differences	NNS
in	IN
the	DT
capacity	NN
to	TO
regulate	VB
these	DT
factors	NNS
could	MD
not	RB
be	VB
shown	VBN
in	IN
fetal	JJ
blood	NN
cells	NNS
.	.

Quantitative	JJ
experiments	NNS
comparing	VBG
binding	NN
of	IN
these	DT
transcription	NN
factors	NNS
to	TO
the	DT
IL-2	NN
promoter	NN
are	VBP
currently	RB
under	IN
investigation	NN
.	.

UI	LS
-	:
98019986	CD

TI	LS
-	:
Switching	VBG
gears	NNS
during	IN
T-cell	NN
maturation	NN
:	:
RANTES	NN
and	CC
late	JJ
transcription	NN
.	.

AB	LS
-	:
Although	IN
much	JJ
is	VBZ
understood	VBN
about	IN
the	DT
induction	NN
of	IN
genes	NNS
expressed	VBN
early	RB
(	(
within	IN
24	CD
h	NN
)	)
after	IN
T-cell	NN
activation	NN
,	,
little	JJ
is	VBZ
known	VBN
about	IN
the	DT
regulation	NN
of	IN
expression	NN
of	IN
genes	NNS
expressed	VBN
'	``
late	JJ
'	''
(	(
three	CD
or	CC
more	JJR
days	NNS
)	)
post-stimulation	NN
.	.

A	DT
better	JJR
understanding	NN
of	IN
transcriptional	JJ
regulation	NN
at	IN
this	DT
important	JJ
stage	NN
of	IN
T-cell	NN
maturation	NN
may	MD
yield	VB
new	JJ
insights	NNS
into	IN
T-cell	NN
development	NN
and	CC
new	JJ
immunotherapeutic	JJ
targets	NNS
.	.

UI	LS
-	:
97462662	CD

TI	LS
-	:
The	DT
A-myb	NN
transcription	NN
factor	NN
in	IN
neoplastic	JJ
and	CC
normal	JJ
B	NN
cells	NNS
.	.

AB	LS
-	:
The	DT
myb	NN
family	NN
of	IN
transcription	NN
factors	NNS
has	VBZ
been	VBN
strongly	RB
implicated	VBN
in	IN
the	DT
regulation	NN
of	IN
cell	NN
growth	NN
and	CC
differentiation	NN
in	IN
the	DT
haematopoietic	JJ
system	NN
.	.

The	DT
v-myb	NN
oncogene	NN
,	,
carried	VBN
by	IN
avian	JJ
defective	JJ
retroviruses	NNS
,	,
causes	VBZ
leukaemias	NNS
in	IN
the	DT
chicken	NN
and	CC
transforms	VBZ
haematopoietic	JJ
cells	NNS
in	FW
vitro	FW
.	.

Its	PRP$
normal	JJ
cellular	JJ
equivalent	JJ
c-myb	NN
,	,
has	VBZ
been	VBN
shown	VBN
to	TO
promote	VB
the	DT
proliferation	NN
and	CC
block	VB
the	DT
differentiation	NN
of	IN
haematopoietic	JJ
cells	NNS
in	IN
several	JJ
experimental	JJ
models	NNS
and	CC
is	VBZ
required	VBN
for	IN
fetal	JJ
haematopoiesis	NN
.	.

Two	CD
other	JJ
members	NNS
of	IN
the	DT
family	NN
have	VBP
been	VBN
cloned	VBN
more	RBR
recently	RB
,	,
A-myb	NN
and	CC
B-myb	NN
,	,
which	WDT
show	VBP
sequence	NN
homology	NN
with	IN
c-myb	NN
in	IN
several	JJ
domains	NNS
,	,
of	IN
which	WDT
the	DT
DNA	NN
binding	NN
domain	NN
as	RB
well	RB
as	IN
other	JJ
regulatory	JJ
domains	NNS
.	.

Both	DT
have	VBP
been	VBN
shown	VBN
to	TO
be	VB
transcription	NN
factors	NNS
.	.

B-myb	NN
is	VBZ
also	RB
involved	VBN
in	IN
the	DT
control	NN
of	IN
proliferation	NN
and	CC
differentiation	NN
,	,
but	CC
,	,
unlike	IN
c-myb	NN
,	,
it	PRP
is	VBZ
expressed	VBN
in	IN
many	JJ
cell	NN
types	NNS
.	.

The	DT
third	JJ
member	NN
of	IN
the	DT
family	NN
,	,
A-myb	NN
,	,
shows	VBZ
the	DT
most	RBS
restricted	JJ
pattern	NN
of	IN
expression	NN
,	,
suggesting	VBG
a	DT
very	RB
specific	JJ
role	NN
for	IN
this	DT
transcription	NN
factor	NN
.	.

A-myb	NN
is	VBZ
expressed	VBN
in	IN
a	DT
subpopulation	NN
of	IN
normal	JJ
B	NN
lymphocytes	NNS
activated	VBN
in	FW
vivo	FW
and	CC
localised	JJ
in	IN
the	DT
germinal	JJ
center	NN
of	IN
peripheral	JJ
lymphoid	JJ
organs	NNS
and	CC
is	VBZ
not	RB
detected	VBN
at	IN
significant	JJ
levels	NNS
in	IN
all	DT
other	JJ
mature	JJ
or	CC
immature	JJ
haematopoietic	JJ
populations	NNS
studied	VBN
,	,
including	VBG
bone	NN
marrow	JJ
cells	NNS
,	,
T	NN
lymphocytes	NNS
,	,
granulocytes	NNS
,	,
monocytes	NNS
,	,
either	CC
at	IN
rest	NN
or	CC
after	RB
in	FW
vitro	FW
activation	NN
.	.

These	DT
studies	NNS
indicate	VBP
that	IN
A-myb	NN
plays	VBZ
a	DT
role	NN
during	IN
a	DT
narrow	JJ
window	NN
of	IN
normal	JJ
B	NN
cell	NN
differentiation	NN
.	.

A-myb	NN
expression	NN
has	VBZ
also	RB
been	VBN
studied	VBN
in	IN
a	DT
wide	JJ
range	NN
of	IN
neoplastic	JJ
B	NN
cells	NNS
,	,
representing	VBG
the	DT
whole	JJ
spectrum	NN
of	IN
B	NN
cell	NN
differentiation	NN
.	.

A-myb	NN
is	VBZ
strongly	RB
expressed	VBN
in	IN
Burkitt	NN
's	POS
lymphomas	NNS
(	(
BL	NNS
)	)
and	CC
slg+	JJ
B-acute	JJ
lymphoblastic	JJ
leukaemias	NNS
(	(
B-ALL	NNS
)	)
and	CC
not	RB
in	IN
all	DT
other	JJ
leukaemias/lymphomas	NNS
tested	VBN
,	,
with	IN
the	DT
exception	NN
of	IN
a	DT
subset	NN
of	IN
CLL	NN
(	(
about	RB
25	CD
%	NN
of	IN
cases	NNS
)	)
.	.

It	PRP
is	VBZ
intriguing	JJ
that	IN
the	DT
A-myb	NN
genome	NN
has	VBZ
been	VBN
localised	JJ
relatively	RB
close	RB
to	TO
the	DT
c-myc	NN
gene	NN
on	IN
chromosome	NN
8	CD
,	,
suggesting	VBG
that	IN
the	DT
c-myc	NN
translocation	NN
in	IN
BL	NNS
and	CC
B-ALL	NNS
may	MD
affect	VB
A-myb	NN
transcription	NN
.	.

Studies	NNS
are	VBP
in	IN
progress	NN
to	TO
investigate	VB
the	DT
functional	JJ
relationship	NN
between	IN
A-myb	NN
and	CC
c-myc	NN
,	,
particularly	RB
in	IN
the	DT
context	NN
of	IN
BL	NNS
cells	NNS
and	CC
to	TO
determine	VB
whether	IN
A-myb	NN
is	VBZ
deregulated	VBN
in	IN
these	DT
cells	NNS
.	.

UI	LS
-	:
98022968	CD

TI	LS
-	:
TNFalpha	NN
cooperates	VBZ
with	IN
the	DT
protein	NN
kinase	NN
A	NN
pathway	NN
to	TO
synergistically	RB
increase	VB
HIV-1	NN
LTR	NN
transcription	NN
via	IN
downstream	JJ
TRE-like	JJ
cAMP	NN
response	NN
elements	NNS
.	.

AB	LS
-	:
Activating	VBG
protein-1	NN
(	(
AP-1	NN
)	)
binding	NN
TPA	NN
responsive	JJ
elements	NNS
(	(
TRE	NN
)	)
are	VBP
located	JJ
downstream	RB
of	IN
the	DT
transcription	NN
initiation	NN
site	NN
in	IN
the	DT
U5	NN
region	NN
of	IN
the	DT
HIV-1	NN
long	JJ
terminal	JJ
repeat	NN
(	(
LTR	NN
)	)
.	.

These	DT
downstream	JJ
sequence	NN
elements	NNS
,	,
termed	VBN
DSE	NN
,	,
can	MD
bind	VB
both	CC
AP-1	NN
and	CC
CREB/ATF	NN
transcription	NN
factors	NNS
.	.

Recently	RB
,	,
we	PRP
demonstrated	VBD
that	IN
the	DT
DSE	NN
are	VBP
also	RB
cAMP-responsive	JJ
elements	NNS
(	(
CRE	NN
)	)
,	,
since	IN
they	PRP
mediated	VBD
activation	NN
signals	NNS
elicited	VBN
by	IN
cholera	NN
toxin	NN
(	(
Ctx	NN
)	)
,	,
a	DT
potent	JJ
activator	NN
of	IN
the	DT
cAMP-dependent	JJ
protein	NN
kinase	NN
A	NN
(	(
PKA	NN
)	)
signal	NN
transduction	NN
pathway	NN
.	.

In	IN
the	DT
present	JJ
study	NN
,	,
we	PRP
demonstrate	VBP
that	IN
the	DT
HIV-1	NN
DSE	NN
can	MD
mediate	VB
the	DT
transcriptional	JJ
synergy	NN
elicited	VBN
by	IN
the	DT
combination	NN
of	IN
Ctx	NN
and	CC
TNFalpha	NN
.	.

Ctx	NN
combined	VBD
with	IN
TNFalpha	NN
or	CC
IL-1beta	NN
to	TO
produce	VB
a	DT
synergistic	JJ
increase	NN
in	IN
p24	NN
antigen	NN
production	NN
in	IN
U1	NN
promonocytic	JJ
cells	NNS
.	.

Transfection	NN
studies	NNS
of	IN
LTR	NN
reporter	NN
constructs	NNS
indicated	VBD
that	IN
mutation	NN
of	IN
the	DT
DSE	NN
sites	NNS
abrogated	VBD
the	DT
LTR-mediated	JJ
synergy	NN
induced	VBN
by	IN
Ctx	NN
and	CC
TNFalpha	NN
,	,
whereas	IN
the	DT
synergy	NN
induced	VBN
by	IN
Ctx	NN
and	CC
IL-1beta	NN
was	VBD
unaffected	JJ
,	,
suggesting	VBG
TNFalpha	NN
and	CC
IL-1beta	NN
cooperate	VBP
differently	RB
with	IN
the	DT
cAMP/PKA	NN
activation	NN
pathway	NN
to	TO
induce	VB
HIV-1	NN
expression	NN
in	IN
U1	NN
cells	NNS
.	.

Because	IN
the	DT
DSE	NN
are	VBP
also	RB
TRE	NN
sites	NNS
,	,
we	PRP
assessed	VBD
the	DT
effect	NN
of	IN
the	DT
agonist	NN
combinations	NNS
on	IN
AP-1-dependent	JJ
transcription	NN
.	.

TNFalpha	NN
as	RB
well	RB
as	IN
IL-1beta	NN
cooperated	VBD
with	IN
Ctx	NN
to	TO
produce	VB
a	DT
synergistic	JJ
activation	NN
of	IN
AP-1-mediated	JJ
transcription	NN
.	.

These	DT
data	NNS
indicate	VBP
that	IN
the	DT
TRE-like	JJ
cAMP-responsive	JJ
DSE	NN
sites	NNS
within	IN
the	DT
5'-untranslated	JJ
leader	NN
can	MD
mediate	VB
the	DT
transcriptional	JJ
cooperativity	NN
between	IN
TNFalpha	NN
and	CC
the	DT
cAMP/PKA	NN
pathway	NN
.	.

Since	IN
the	DT
DSE	NN
and	CC
TRE	NN
sites	NNS
can	MD
not	RB
bind	VB
CREB/ATF	NN
homodimers	NNS
,	,
we	PRP
propose	VBP
a	DT
mechanism	NN
in	IN
which	WDT
the	DT
HIV-1	NN
DSE	NN
bind	VBP
heterodimers	NNS
composed	VBN
of	IN
both	CC
AP-1	NN
and	CC
CREB/ATF	NN
proteins	NNS
.	.

Copyright	NN
1997	CD
Academic	NNP
Press	NNP
.	.

UI	LS
-	:
98074940	CD

TI	LS
-	:
c-Rel	NN
and	CC
p65	NN
subunits	NNS
bind	VBP
to	TO
an	DT
upstream	JJ
NF-kappaB	NN
site	NN
in	IN
human	JJ
granulocyte	NN
macrophage-colony	NN
stimulating	NN
factor	NN
promoter	NN
involved	VBN
in	IN
phorbol	NN
ester	NN
response	NN
in	IN
5637	CD
cells	NNS
.	.

AB	LS
-	:
To	TO
further	RB
clarify	VB
the	DT
complex	JJ
transcriptional	JJ
regulation	NN
of	IN
the	DT
human	JJ
GM-CSF	NN
gene	NN
,	,
which	WDT
was	VBD
extensively	RB
investigated	VBN
in	IN
activated	VBN
T	NN
cells	NNS
,	,
we	PRP
have	VBP
studied	VBN
the	DT
role	NN
of	IN
an	DT
upstream	JJ
NF-kappaB	NN
like	JJ
site	NN
in	IN
the	DT
5637	CD
non-lymphoid	JJ
cell	NN
line	NN
,	,
which	WDT
derives	VBZ
from	IN
a	DT
bladder	NN
carcinoma	NN
and	CC
constitutively	RB
produces	VBZ
GM-CSF	NN
.	.

This	DT
sequence	NN
,	,
named	VBN
the	DT
A	NN
element	NN
,	,
has	VBZ
an	DT
active	JJ
role	NN
on	IN
GM-CSF	NN
transcription	NN
and	CC
is	VBZ
responsive	JJ
to	TO
the	DT
tumor	NN
promoter	NN
PMA	NN
in	IN
transient	JJ
transfection	NN
experiments	NNS
.	.

We	PRP
describe	VBP
here	RB
a	DT
heterodimeric	JJ
binding	NN
complex	NN
of	IN
NF-kappaB	NN
subunits	NNS
(	(
c-Rel	NN
and	CC
p65	NN
)	)
which	WDT
is	VBZ
identical	JJ
to	TO
the	DT
one	CD
obtained	VBN
using	VBG
the	DT
HIV-LTR-kappaB	NN
site	NN
as	IN
recognition	NN
sequence	NN
and	CC
different	JJ
from	IN
the	DT
one	CD
(	(
c-Rel	NN
and	CC
p50	NN
)	)
observed	VBN
with	IN
nuclear	JJ
extracts	NNS
from	IN
Mo	NN
T-lymphoid	NN
HTLV-II	NN
infected	JJ
cells	NNS
.	.

UI	LS
-	:
98080700	CD

TI	LS
-	:
Agonistic	JJ
activity	NN
of	IN
a	DT
CD40-specific	JJ
single-chain	JJ
Fv	NN
constructed	VBN
from	IN
the	DT
variable	JJ
regions	NNS
of	IN
mAb	NN
G28-5	NN
.	.

AB	LS
-	:
A	DT
single-chain	JJ
Fv	NN
(	(
sFv	NN
)	)
was	VBD
expressed	VBN
from	IN
the	DT
variable	JJ
regions	NNS
of	IN
the	DT
CD40-specific	JJ
mAb	NN
G28-5	NN
.	.

The	DT
molecule	NN
bound	VBD
CD40	NN
with	IN
a	DT
high	JJ
affinity	NN
(	(
2.2	CD
nM	NN
)	)
and	CC
was	VBD
a	DT
monomer	NN
in	IN
solution	NN
.	.

Surprisingly	RB
,	,
G28-5	NN
sFv	NN
was	VBD
a	DT
potent	JJ
CD40	NN
agonist	NN
that	WDT
rapidly	RB
crosslinked	VBD
CD40	NN
on	IN
the	DT
cell	NN
surface	NN
but	CC
did	VBD
not	RB
crosslink	VB
CD40-Ig	NN
in	IN
solution	NN
.	.

G28-5	NN
sFv	NN
was	VBD
a	DT
more	RBR
potent	JJ
agonist	NN
than	IN
G28-5	NN
IgG	NN
and	CC
was	VBD
able	JJ
to	TO
stimulate	VB
CD40	NN
responses	NNS
by	IN
B	NN
cells	NNS
and	CC
monocytes	NNS
.	.

G28-5	NN
IgG	NN
partially	RB
blocked	VBD
,	,
whereas	IN
G28-5	NN
sFv	NN
augmented	VBD
CD40	NN
responses	NNS
during	IN
stimulation	NN
with	IN
natural	JJ
ligand	NN
(	(
gp39-CD8	JJ
fusion	NN
protein	NN
)	)
.	.

These	DT
results	NNS
indicate	VBP
that	IN
the	DT
functional	JJ
activity	NN
of	IN
ligands	NNS
built	VBN
from	IN
the	DT
binding	VBG
site	NN
of	IN
G28-5	NN
is	VBZ
highly	RB
dependent	JJ
upon	IN
the	DT
size	NN
and	CC
physical	JJ
properties	NNS
of	IN
the	DT
molecule	NN
both	CC
in	IN
solution	NN
and	CC
on	IN
the	DT
cell	NN
surfaces	NNS
.	.

UI	LS
-	:
97472344	CD

TI	LS
-	:
Dominant	JJ
cytotoxic	JJ
T	NN
lymphocyte	NN
response	NN
to	TO
the	DT
immediate-early	JJ
trans-activator	JJ
protein	NN
,	,
BZLF1	NN
,	,
in	IN
persistent	JJ
type	NN
A	NN
or	CC
B	NN
Epstein-Barr	JJ
virus	NN
infection	NN
.	.

AB	LS
-	:
Five	CD
healthy	JJ
human	JJ
leukocyte	NN
antigen-B8	NN
(	(
HLA-B8	NN
)	)
-positive	JJ
virus	NN
carriers	NNS
were	VBD
studied	VBN
to	TO
investigate	VB
the	DT
CD8+	JJ
cytotoxic	JJ
T	NN
lymphocyte	NN
(	(
CTL	NN
)	)
response	NN
to	TO
an	DT
HLA-B8-restricted	JJ
peptide	NN
,	,
RAKFKQLLQ	NN
,	,
located	JJ
in	IN
the	DT
Epstein-Barr	JJ
virus	NN
(	(
EBV	NN
)	)
immediate-early	JJ
trans-activator	NN
protein	NN
,	,
BZLF1	NN
.	.

Of	IN
the	DT
5	CD
virus	NN
carriers	NNS
,	,
4	CD
were	VBD
infected	VBN
with	IN
type	NN
A	NN
and	CC
1	CD
with	IN
type	NN
B	NN
EBV	NN
.	.

Using	VBG
limiting-dilution	JJ
analysis	NN
of	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
,	,
a	DT
high	JJ
RAKFKQLLQ-specific	JJ
CTL	NN
precursor	NN
frequency	NN
was	VBD
demonstrated	VBN
after	IN
specific	JJ
peptide	NN
or	CC
autologous	JJ
lymphoblastoid	JJ
cell	NN
line	NN
stimulation	NN
in	IN
both	CC
type	NN
A	NN
and	CC
type	NN
B	NN
EBV	NN
carriers	NNS
.	.

The	DT
RAKFKQLLQ-specific	JJ
CTL	NN
precursor	NN
frequencies	NNS
in	IN
all	DT
5	CD
persons	NNS
were	VBD
at	IN
least	JJS
as	RB
dominant	JJ
as	IN
those	DT
observed	VBN
with	IN
two	CD
other	JJ
EBV-associated	JJ
,	,
HLA-B8-restricted	JJ
latent	JJ
epitopes	NNS
,	,
FLRGRAYGL	NN
and	CC
QAKWRLQTL	NN
.	.

These	DT
findings	NNS
show	VBP
that	IN
healthy	JJ
virus	NN
carriers	NNS
maintain	VBP
a	DT
high	JJ
frequency	NN
of	IN
BZLF1-specific	JJ
memory	NN
T	NN
cells	NNS
,	,
potentially	RB
to	TO
control	VB
virus	NN
spread	VBN
from	IN
lytically	RB
infected	JJ
cells	NNS
.	.

UI	LS
-	:
97467112	CD

TI	LS
-	:
Analysis	NN
of	IN
myeloid-associated	JJ
genes	NNS
in	IN
human	JJ
hematopoietic	JJ
progenitor	NN
cells	NNS
.	.

AB	LS
-	:
The	DT
distribution	NN
of	IN
myeloid	JJ
lineage-associated	JJ
cytokine	NN
receptors	NNS
and	CC
lysosomal	JJ
proteins	NNS
was	VBD
analyzed	VBN
in	IN
human	JJ
CD34+	JJ
cord	NN
blood	NN
cell	NN
(	(
CB	NN
)	)
subsets	NNS
at	IN
different	JJ
stages	NNS
of	IN
myeloid	JJ
commitment	NN
by	IN
reverse-transcriptase	NN
polymerase	NN
chain	NN
reaction	NN
(	(
RT-PCR	NN
)	)
.	.

The	DT
highly	RB
specific	JJ
granulomonocyte-associated	JJ
lysosomal	JJ
proteins	NNS
myeloperoxidase	NN
(	(
MPO	NN
)	)
and	CC
lysozyme	NN
(	(
LZ	NN
)	)
,	,
as	RB
well	RB
as	IN
the	DT
transcription	NN
factor	NN
PU.1	NN
,	,
were	VBD
already	RB
detectable	JJ
in	IN
the	DT
most	RBS
immature	JJ
CD34+Thy-1+	JJ
subset	NN
.	.

Messenger	NN
RNA	NN
(	(
mRNA	NN
)	)
levels	NNS
for	IN
the	DT
granulocyte-colony	NN
stimulating	NN
factor	NN
(	(
G-CSF	NN
)	)
receptor	NN
,	,
granulocyte-macrophage	JJ
(	(
GM	NN
)	)
-CSF	NN
receptor	NN
alpha	NN
subunit	NN
and	CC
tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
receptors	NNS
I	CD
(	(
p55	NN
)	)
and	CC
II	CD
(	(
p75	NN
)	)
were	VBD
also	RB
detected	VBN
in	IN
this	DT
subset	NN
in	IN
addition	NN
to	TO
c-kit	NN
and	CC
flt-3	NN
,	,
receptors	NNS
known	VBN
to	TO
be	VB
expressed	VBN
on	IN
progenitor	NN
cells	NNS
.	.

By	IN
contrast	NN
,	,
the	DT
monocyte-macrophage	JJ
colony	NN
stimulating	NN
factor	NN
(	(
M-CSF	NN
)	)
receptor	NN
was	VBD
largely	RB
absent	JJ
at	IN
this	DT
stage	NN
and	CC
in	IN
the	DT
CD34+Thy-1-CD45RA-	JJ
subsets	NNS
.	.

The	DT
M-CSF	NN
receptor	NN
was	VBD
first	RB
detectable	JJ
in	IN
the	DT
myeloid-committed	JJ
CD34+Thy-l-CD45RA+	JJ
subset	NN
.	.

All	DT
other	JJ
molecules	NNS
studied	VBN
were	VBD
found	VBN
to	TO
be	VB
expressed	VBN
at	IN
this	DT
stage	NN
of	IN
differentiation	NN
.	.

Different	JJ
cocktails	NNS
of	IN
the	DT
identified	VBN
ligands	NNS
were	VBD
added	VBN
to	TO
sorted	VBN
CD34+Thy-1+	JJ
single	JJ
cells	NNS
.	.

Low	JJ
proliferative	JJ
capacity	NN
was	VBD
observed	VBN
after	IN
1	CD
week	NN
in	IN
culture	NN
in	IN
the	DT
presence	NN
of	IN
stem	NN
cell	NN
factor	NN
(	(
SCF	NN
)	)
+	JJ
Flt-3	NN
ligand	NN
(	(
FL	NN
)	)
+	JJ
G-CSF	NN
.	.

Addition	NN
of	IN
GM-CSF	NN
to	TO
this	DT
basic	JJ
cocktail	NN
consistently	RB
increased	VBD
the	DT
clonogenic	JJ
capacity	NN
of	IN
single	JJ
CD34+Thy-1+	JJ
cells	NNS
,	,
and	CC
this	DT
effect	NN
was	VBD
further	RB
enhanced	VBN
(	(
up	RB
to	TO
72.3	CD
+/-	CC
4.3	CD
%	NN
on	IN
day	NN
7	CD
)	)
by	IN
the	DT
inclusion	NN
of	IN
TNF-alpha	NN
.	.

In	IN
conclusion	NN
,	,
the	DT
presence	NN
of	IN
myeloid-associated	JJ
growth	NN
factor	NN
receptor	NN
transcripts	NNS
in	IN
CD34+	JJ
CB	NN
subsets	NNS
does	VBZ
not	RB
discriminate	VB
the	DT
various	JJ
stages	NNS
of	IN
differentiation	NN
,	,
with	IN
the	DT
exception	NN
of	IN
the	DT
M-CSF	NN
receptor	NN
.	.

In	IN
addition	NN
,	,
we	PRP
show	VBP
that	IN
TNF-alpha	NN
is	VBZ
a	DT
potent	JJ
costimulatory	JJ
factor	NN
of	IN
the	DT
very	RB
immature	JJ
CD34+Thy-1+	JJ
CB	NN
subset	NN
.	.

UI	LS
-	:
98018275	CD

TI	LS
-	:
Regulation	NN
of	IN
nuclear	JJ
factor-kappa	NN
B	NN
and	CC
its	PRP$
inhibitor	NN
I	NN
kappa	NN
B-alpha/MAD-3	NN
in	IN
monocytes	NNS
by	IN
Mycobacterium	NN
tuberculosis	NN
and	CC
during	IN
human	JJ
tuberculosis	NN
.	.

AB	LS
-	:
Blood	NN
monocytes	NNS
from	IN
patients	NNS
with	IN
active	JJ
tuberculosis	NN
are	VBP
activated	VBN
in	FW
vivo	FW
,	,
as	IN
evidenced	VBN
by	IN
an	DT
increase	NN
in	IN
the	DT
stimulated	VBN
release	NN
of	IN
proinflammatory	JJ
cytokines	NNS
,	,
such	JJ
as	IN
TNF-alpha	NN
,	,
and	CC
the	DT
spontaneous	JJ
expression	NN
of	IN
IL-2R	NN
.	.

Further	RB
,	,
monocytes	NNS
from	IN
patients	NNS
demonstrate	VBP
an	DT
augmented	JJ
susceptibility	NN
to	TO
a	DT
productive	JJ
infection	NN
with	IN
HIV-1	NN
in	FW
vitro	FW
.	.

Mycobacterium	NN
tuberculosis	NN
and	CC
its	PRP$
components	NNS
are	VBP
strong	JJ
signals	NNS
to	TO
activate	VB
monocytes	NNS
to	TO
production	NN
of	IN
cytokines	NNS
.	.

In	IN
this	DT
study	NN
we	PRP
examined	VBD
the	DT
basis	NN
of	IN
activation	NN
of	IN
monocytes	NNS
during	IN
active	JJ
tuberculosis	NN
and	CC
by	IN
M.	NN
tuberculosis	NN
.	.

We	PRP
found	VBD
a	DT
constitutive	JJ
degradation	NN
of	IN
I	NN
kappa	NN
B-alpha	NN
,	,
the	DT
major	JJ
cytoplasmic	JJ
inhibitor	NN
of	IN
nuclear	JJ
factor	NN
kappa	NN
B	NN
(	(
NF-kappa	NN
B	NN
)	)
,	,
in	IN
freshly	RB
isolated	VBN
PBMC	NN
and	CC
monocytes	NNS
from	IN
patients	NNS
with	IN
tuberculosis	NN
.	.

In	IN
contrast	NN
,	,
I	NN
kappa	NN
B-alpha	NN
levels	NNS
in	IN
PBMC	NN
and	CC
monocytes	NNS
from	IN
healthy	JJ
subjects	NNS
or	CC
from	IN
patients	NNS
with	IN
nontuberculous	JJ
pulmonary	JJ
conditions	NNS
were	VBD
intact	JJ
.	.

Further	RB
,	,
by	IN
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
,	,
NF-kappa	NN
B	NN
was	VBD
activated	VBN
in	IN
monocytes	NNS
from	IN
tuberculous	JJ
patients	NNS
.	.

The	DT
expression	NN
of	IN
I	NN
kappa	NN
B-alpha	NN
gene	NN
,	,
which	WDT
is	VBZ
responsive	JJ
to	TO
activation	NN
by	IN
NF-kappa	NN
B	NN
,	,
was	VBD
up-regulated	VBN
in	IN
PBMC	NN
and	CC
monocytes	NNS
from	IN
patients	NNS
,	,
but	CC
not	RB
in	IN
mononuclear	JJ
cells	NNS
from	IN
healthy	JJ
subjects	NNS
or	CC
those	DT
with	IN
nontuberculous	JJ
lung	NN
diseases	NNS
.	.

By	IN
contrast	NN
,	,
the	DT
expression	NN
of	IN
other	JJ
adherence-associated	JJ
early	JJ
genes	NNS
,	,
such	JJ
as	IN
IL-8	NN
and	CC
IL-1	NN
beta	NN
,	,
was	VBD
not	RB
up-regulated	VBN
in	IN
PBMC	NN
of	IN
tuberculous	JJ
patients	NNS
.	.

Further	RB
,	,
M.	NN
tuberculosis	NN
and	CC
its	PRP$
tuberculin	NN
,	,
purified	VBN
protein	NN
derivative	NN
,	,
induced	VBD
the	DT
degradation	NN
of	IN
I	NN
kappa	NN
B-alpha	NN
and	CC
the	DT
expression	NN
of	IN
I	NN
kappa	NN
B-alpha	NN
mRNA	NN
,	,
and	CC
purified	VBN
protein	NN
derivative	NN
induced	VBD
the	DT
activation	NN
of	IN
NF-kappa	NN
B	NN
in	IN
monocytes	NNS
.	.

UI	LS
-	:
97445684	CD

TI	LS
-	:
The	DT
role	NN
of	IN
Rel/NF-kappa	NN
B	NN
proteins	NNS
in	IN
viral	JJ
oncogenesis	NN
and	CC
the	DT
regulation	NN
of	IN
viral	JJ
transcription	NN
.	.

AB	LS
-	:
Rel/NF-kappa	NN
B	NN
is	VBZ
a	DT
ubiquitous	JJ
transcription	NN
factor	NN
that	WDT
consists	VBZ
of	IN
multiple	JJ
polypeptide	NN
subunits	NNS
,	,
and	CC
is	VBZ
subject	JJ
to	TO
complex	JJ
regulatory	JJ
mechanisms	NNS
that	WDT
involve	VBP
protein-protein	JJ
interactions	NNS
,	,
phosphorylation	NN
,	,
ubiquitination	NN
,	,
proteolytic	JJ
degradation	NN
,	,
and	CC
nucleocytoplasmic	JJ
translocation	NN
.	.

The	DT
sophisticated	JJ
control	NN
of	IN
Rel/NF-kappa	NN
B	NN
activity	NN
is	VBZ
not	RB
surprising	JJ
since	IN
this	DT
transcription	NN
factor	NN
is	VBZ
involved	VBN
in	IN
a	DT
wide	JJ
array	NN
of	IN
cellular	JJ
responses	NNS
to	TO
extracellular	JJ
cues	NNS
,	,
associated	VBN
with	IN
growth	NN
,	,
development	NN
,	,
apoptosis	NN
,	,
and	CC
pathogen	NN
invasion	NN
.	.

Thus	RB
,	,
it	PRP
is	VBZ
not	RB
unexpected	JJ
that	IN
this	DT
versatile	JJ
cellular	JJ
homeostatic	JJ
switch	NN
would	MD
be	VB
affected	VBN
by	IN
a	DT
variety	NN
of	IN
viral	JJ
pathogens	NNS
,	,
which	WDT
have	VBP
evolved	VBN
mechanisms	NNS
to	TO
utilize	VB
various	JJ
aspects	NNS
of	IN
Rel/NF-kappa	NN
B	NN
activity	NN
to	TO
facilitate	VB
their	PRP$
replication	NN
,	,
cell	NN
survival	NN
and	CC
possibly	RB
evasion	NN
of	IN
immune	JJ
responses	NNS
.	.

This	DT
review	NN
will	MD
cover	VB
the	DT
molecular	JJ
mechanisms	NNS
that	WDT
are	VBP
utilized	VBN
by	IN
mammalian	JJ
oncogenic	JJ
viruses	NNS
to	TO
affect	VB
the	DT
activity	NN
of	IN
Rel/NF-kappa	NN
B	NN
transcription	NN
factors	NNS
and	CC
the	DT
role	NN
of	IN
Rel/NF-kappa	NN
B	NN
in	IN
the	DT
regulation	NN
of	IN
viral	JJ
gene	NN
expression	NN
and	CC
replication	NN
.	.

UI	LS
-	:
98099332	CD

TI	LS
-	:
Replication	NN
of	IN
human	JJ
immunodeficiency	NN
virus-1	NN
in	IN
primary	JJ
human	JJ
T	NN
cells	NNS
is	VBZ
dependent	JJ
on	IN
the	DT
autocrine	JJ
secretion	NN
of	IN
tumor	NN
necrosis	NN
factor	NN
through	IN
the	DT
control	NN
of	IN
nuclear	JJ
factor-kappa	NN
B	NN
activation	NN
.	.

AB	LS
-	:
Tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
-alpha	NN
controls	VBZ
T-cell	NN
activation	NN
and	CC
is	VBZ
a	DT
major	JJ
inducer	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
(	(
HIV	NN
)	)
-1	CD
replication	NN
in	IN
chronically	RB
infected	JJ
cells	NNS
.	.

Therefore	RB
,	,
we	PRP
have	VBP
investigated	VBN
its	PRP$
role	NN
in	IN
primary	JJ
cultures	NNS
of	IN
HIV-infected	JJ
human	JJ
T	NN
lymphocytes	NNS
by	IN
using	VBG
neutralizing	VBG
anti-TNF-alpha	JJ
antibodies	NNS
or	CC
TNF-alpha	NN
.	.

Primary	JJ
resting	VBG
T	NN
lymphocytes	NNS
produced	VBD
TNF-alpha	NN
and	CC
supported	VBD
HIV	NN
replication	NN
after	IN
T-cell	NN
receptor	NN
activation	NN
.	.

Addition	NN
of	IN
neutralizing	VBG
anti-TNF-alpha	JJ
antibodies	NNS
drastically	RB
reduced	VBD
p24	NN
antigen	NN
release	NN
and	CC
prevented	VBD
CD4+	JJ
cell	NN
depletion	NN
associated	VBN
with	IN
infection	NN
.	.

Anti-TNF-alpha	NN
also	RB
prevented	VBD
nuclear	JJ
factor-kappa	NN
B	NN
(	(
NF-kappa	NN
B	NN
)	)
activation	NN
,	,
and	CC
a	DT
good	JJ
correlation	NN
between	IN
this	DT
inhibition	NN
and	CC
inhibition	NN
of	IN
HIV	NN
replication	NN
was	VBD
observed	VBN
.	.

Moreover	RB
,	,
supplementing	VBG
the	DT
cultures	NNS
with	IN
high	JJ
doses	NNS
of	IN
IL-2	NN
reverted	VBD
anti-TNF-alpha	JJ
inhibition	NN
of	IN
cell	NN
proliferation	NN
but	CC
did	VBD
not	RB
affect	VB
the	DT
inhibition	NN
of	IN
HIV	NN
p24	NN
antigen	NN
release	NN
or	CC
NF-kappa	NN
B	NN
activation	NN
in	IN
the	DT
same	JJ
cultures	NNS
.	.

Moreover	RB
,	,
anti-TNF-alpha	NN
inhibited	VBD
HIV-1	NN
long	JJ
terminal	JJ
repeat	NN
(	(
LTR	NN
)	)
-driven	JJ
transcription	NN
of	IN
a	DT
reporter	NN
gene	NN
in	IN
primary	JJ
T	NN
cells	NNS
in	IN
response	NN
to	TO
activation	NN
,	,
either	CC
in	IN
the	DT
presence	NN
or	CC
the	DT
absence	NN
of	IN
HIV-1	NN
Tat	NN
.	.

Our	PRP$
results	NNS
support	VBP
an	DT
important	JJ
role	NN
for	IN
autocrine	JJ
TNF-alpha	NN
secretion	NN
in	IN
controlling	VBG
HIV	NN
replication	NN
in	IN
primary	JJ
T	NN
cells	NNS
because	IN
of	IN
its	PRP$
ability	NN
to	TO
maintain	VB
NF-kappa	NN
B	NN
elevated	JJ
in	IN
the	DT
nucleus	NN
of	IN
T	NN
cells	NNS
.	.

UI	LS
-	:
98012705	CD

TI	LS
-	:
Dysregulation	NN
of	IN
monocytic	JJ
nuclear	JJ
factor-kappa	NN
B	NN
by	IN
oxidized	VBN
low-density	JJ
lipoprotein	NN
.	.

AB	LS
-	:
Nuclear	JJ
factor-kappa	NN
B	NN
(	(
NF-kappa	NN
B	NN
)	)
/Rel	NN
transcription	NN
factors	NNS
may	MD
be	VB
involved	VBN
in	IN
atherosclerosis	NN
,	,
as	IN
is	VBZ
suggested	VBN
by	IN
the	DT
presence	NN
of	IN
activated	VBN
NF-kappa	NN
B	NN
in	IN
human	JJ
atherosclerotic	JJ
lesions	NNS
.	.

The	DT
aim	NN
of	IN
the	DT
present	JJ
study	NN
was	VBD
to	TO
investigate	VB
the	DT
effects	NNS
of	IN
oxidized	VBN
LDL	NN
(	(
oxLDL	NN
)	)
on	IN
the	DT
NF-kappa	NN
B	NN
system	NN
in	IN
human	JJ
THP-1	NN
monocytic	JJ
cells	NNS
as	RB
well	RB
as	IN
adherent	JJ
monocytes	NNS
.	.

Our	PRP$
results	NNS
demonstrate	VBP
that	IN
short-term	JJ
incubation	NN
of	IN
these	DT
cells	NNS
with	IN
oxLDL	NN
activated	VBD
p50/p65	NN
containing	VBG
NF-kappa	NN
B	NN
dimers	NNS
and	CC
induced	VBD
the	DT
expression	NN
of	IN
the	DT
target	NN
gene	NN
IL-8	NN
.	.

This	DT
activation	NN
of	IN
NF-kappa	NN
B	NN
was	VBD
inhibited	VBN
by	IN
the	DT
antioxidant	JJ
and	CC
H2O2	NN
scavenger	NN
pyrrolidine	NN
dithiocarbamate	NN
and	CC
the	DT
proteasome	NN
inhibitor	NN
PSI	NN
.	.

The	DT
oxLDL-induced	JJ
NF-kappa	NN
B	NN
activation	NN
was	VBD
accompanied	VBN
by	IN
an	DT
initial	JJ
depletion	NN
of	IN
I	NN
kappa	NN
B-alpha	NN
followed	VBN
by	IN
a	DT
slight	JJ
transient	JJ
increase	NN
in	IN
the	DT
level	NN
of	IN
this	DT
inhibitor	NN
protein	NN
.	.

In	IN
contrast	NN
,	,
long-term	JJ
treatment	NN
with	IN
oxLDL	NN
prevented	VBD
the	DT
lipopolysaccharide-induced	JJ
depletion	NN
of	IN
I	NN
kappa	NN
B-alpha	NN
,	,
accompanied	VBN
by	IN
an	DT
inhibition	NN
of	IN
both	CC
NF-kappa	NN
B	NN
activation	NN
and	CC
the	DT
expression	NN
of	IN
tumor	NN
necrosis	NN
factor-alpha	NN
and	CC
interleukin-1	NN
beta	NN
genes	NNS
.	.

These	DT
observations	NNS
provide	VBP
additional	JJ
evidence	NN
that	IN
oxLDL	NN
is	VBZ
a	DT
potent	JJ
modulator	NN
of	IN
gene	NN
expression	NN
and	CC
suggest	VBP
that	IN
(	(
dys	JJ
)	)
regulation	NN
of	IN
NF-kappa	NN
B/Rel	NN
is	VBZ
likely	JJ
to	TO
play	VB
an	DT
important	JJ
role	NN
in	IN
atherogenesis	NN
.	.

UI	LS
-	:
97400349	CD

TI	LS
-	:
Differential	JJ
interaction	NN
of	IN
nuclear	JJ
factors	NNS
with	IN
the	DT
leukocyte-specific	JJ
pp52	NN
promoter	NN
in	IN
B	NN
and	CC
T	NN
cells	NNS
.	.

AB	LS
-	:
The	DT
leukocyte-specific	JJ
,	,
cytoskeleton-binding	JJ
pp52	NN
(	(
LSP-1	NN
,	,
WP-34	NN
)	)
protein	NN
is	VBZ
widely	RB
expressed	VBN
in	IN
multiple	JJ
leukocyte	NN
lineages	NNS
,	,
including	VBG
B	NN
and	CC
T	NN
lymphocytes	NNS
,	,
granulocytes	NNS
,	,
and	CC
macrophages	NNS
.	.

We	PRP
previously	RB
detected	VBD
a	DT
tissue-specific	JJ
promoter	NN
preceding	VBG
the	DT
exon	NN
encoding	VBG
the	DT
N	NN
terminus	NN
of	IN
the	DT
pp52	NN
leukocyte	NN
protein	NN
.	.

Here	RB
we	PRP
describe	VBP
the	DT
functional	JJ
characterization	NN
of	IN
this	DT
promoter	NN
and	CC
identification	NN
of	IN
the	DT
factors	NNS
in	IN
B	NN
and	CC
T	NN
cells	NNS
that	WDT
regulate	VBP
its	PRP$
activity	NN
.	.

The	DT
pp52	NN
promoter	NN
contains	VBZ
an	DT
initiator	NN
specifying	VBG
the	DT
unique	JJ
5'	JJ
terminus	NN
of	IN
pp52	NN
mRNA	NN
,	,
tandem	JJ
pairs	NNS
of	IN
Ets	NN
and	CC
SP1	NN
motifs	NNS
,	,
and	CC
a	DT
lone	JJ
C/EBP	NN
motif	NN
.	.

All	PDT
these	DT
motifs	NNS
are	VBP
essential	JJ
and	CC
collectively	RB
control	VBP
transcriptional	JJ
activity	NN
.	.

DNA	NN
binding	NN
studies	NNS
and	CC
Ab	NN
supershift	NN
assays	NNS
revealed	VBD
that	IN
different	JJ
combinations	NNS
of	IN
factors	NNS
interact	VBP
with	IN
these	DT
motifs	NNS
in	IN
B	NN
cells	NNS
vs	CC
T	NN
cells	NNS
.	.

The	DT
Ets	NN
motifs	NNS
are	VBP
preferentially	RB
bound	VBN
by	IN
PU-1	NN
in	IN
B	NN
cell	NN
extracts	NNS
from	IN
all	DT
stages	NNS
of	IN
development	NN
,	,
whereas	IN
a	DT
different	JJ
Ets	NN
family	NN
member	NN
reacts	VBZ
with	IN
these	DT
motifs	NNS
in	IN
T	NN
cell	NN
extracts	NNS
.	.

The	DT
C/EBP	NN
motif	NN
is	VBZ
bound	VBN
by	IN
Ig/EBP-1	NN
in	IN
pre-B	JJ
cell	NN
and	CC
T	NN
cell	NN
extracts	NNS
,	,
but	CC
is	VBZ
replaced	VBN
by	IN
nuclear	JJ
factor-IL-6beta	NN
or	CC
a	DT
nuclear	JJ
factor-IL-6beta-Ig/EBP-1	NN
heterodimer	NN
in	IN
plasmacytoma	NN
cell	NN
extracts	NNS
.	.

Despite	IN
its	PRP$
reported	VBN
role	NN
as	IN
a	DT
negative	JJ
regulator	NN
of	IN
transcription	NN
,	,
Ig/EBP-1	NN
appears	VBZ
to	TO
exert	VB
a	DT
stimulatory	JJ
effect	NN
on	IN
this	DT
promoter	NN
.	.

These	DT
findings	NNS
reveal	VBP
the	DT
features	NNS
controlling	VBG
the	DT
pp52	NN
promoter	NN
in	IN
B	NN
and	CC
T	NN
cells	NNS
and	CC
provide	VBP
the	DT
foundation	NN
for	IN
determining	VBG
the	DT
regulation	NN
of	IN
this	DT
promoter	NN
in	IN
other	JJ
leukocyte	NN
lineages	NNS
.	.

UI	LS
-	:
97383366	CD

TI	LS
-	:
Regulation	NN
of	IN
B-cell	NN
commitment	NN
to	TO
plasma	NN
cells	NNS
or	CC
to	TO
memory	NN
B	NN
cells	NNS
.	.

AB	LS
-	:
During	IN
humoral	JJ
immune	JJ
responses	NNS
,	,
B-lymphocyte	NN
activation	NN
is	VBZ
followed	VBN
by	IN
differentiation	NN
along	IN
either	CC
the	DT
plasma	NN
cell	NN
pathway	NN
or	CC
the	DT
memory	NN
B-cell	NN
pathway	NN
.	.

Recent	JJ
studies	NNS
suggest	VBP
that	IN
CD40-CD40	JJ
ligand	NN
,	,
OX-OX40	JJ
ligand	NN
,	,
a	DT
group	NN
of	IN
cytokines	NNS
and	CC
intracellular	JJ
transcriptional	JJ
factors	NNS
may	MD
all	DT
contribute	VB
to	TO
B-lymphocyte	NN
differentiation	NN
control	NN
.	.

UI	LS
-	:
97342767	CD

TI	LS
-	:
Anti-Ehrlichia	FW
chaffeensis	FW
antibody	NN
complexed	VBN
with	IN
E.	FW
chaffeensis	FW
induces	VBZ
potent	JJ
proinflammatory	JJ
cytokine	NN
mRNA	NN
expression	NN
in	IN
human	JJ
monocytes	NNS
through	IN
sustained	JJ
reduction	NN
of	IN
IkappaB-alpha	NN
and	CC
activation	NN
of	IN
NF-kappaB	NN
.	.

AB	LS
-	:
Ehrlichia	FW
chaffeensis	FW
is	VBZ
an	DT
obligatory	JJ
intracellular	JJ
bacterium	NN
that	WDT
infects	VBZ
monocytes	NNS
and	CC
macrophages	NNS
and	CC
is	VBZ
the	DT
etiologic	JJ
agent	NN
of	IN
human	JJ
ehrlichiosis	NN
in	IN
the	DT
United	NNP
States	NNPS
.	.

Our	PRP$
previous	JJ
studies	NNS
showed	VBD
that	IN
the	DT
exposure	NN
of	IN
human	JJ
monocytes	NNS
to	TO
E.	FW
chaffeensis	FW
induces	VBZ
the	DT
expression	NN
of	IN
interleukin-1beta	NN
(	(
IL-1beta	NN
)	)
,	,
IL-8	NN
,	,
and	CC
IL-10	NN
genes	NNS
in	FW
vitro	FW
but	CC
not	RB
the	DT
expression	NN
of	IN
tumor	NN
necrosis	NN
factor	NN
alpha	NN
(	(
TNF-alpha	NN
)	)
and	CC
IL-6	NN
mRNAs	NNS
.	.

In	IN
this	DT
study	NN
,	,
the	DT
effect	NN
of	IN
anti-E.	FW
chaffeensis	FW
antibody	NN
complexed	VBN
with	IN
E.	FW
chaffeensis	FW
on	IN
the	DT
expression	NN
of	IN
major	JJ
proinflammatory	JJ
cytokines	NNS
in	IN
human	JJ
monocytes	NNS
was	VBD
examined	VBN
.	.

Human	JJ
monocytic	JJ
cell	NN
line	NN
THP-1	NN
was	VBD
treated	VBN
with	IN
E.	FW
chaffeensis	FW
which	WDT
had	VBD
been	VBN
preincubated	JJ
with	IN
human	JJ
anti-E.	FW
chaffeensis	FW
serum	NN
for	IN
2	CD
h	NN
,	,
and	CC
the	DT
levels	NNS
of	IN
cytokine	NN
mRNAs	NNS
were	VBD
evaluated	VBN
by	IN
competitive	JJ
reverse	JJ
transcription-PCR	NN
.	.

Anti-E.	FW
chaffeensis	FW
antibody	NN
complexed	VBN
with	IN
E.	FW
chaffeensis	FW
significantly	RB
enhanced	VBD
mRNA	NN
expression	NN
of	IN
IL-1beta	NN
in	IN
THP-1	NN
cells	NNS
.	.

The	DT
expression	NN
of	IN
TNF-alpha	NN
and	CC
IL-6	NN
mRNAs	NNS
was	VBD
also	RB
induced	VBN
.	.

The	DT
levels	NNS
of	IN
secreted	VBN
IL-1beta	NN
,	,
TNF-alpha	NN
,	,
and	CC
IL-6	NN
during	IN
24	CD
h	NN
of	IN
stimulation	NN
were	VBD
comparable	JJ
to	TO
those	DT
induced	VBN
by	IN
Escherichia	FW
coli	FW
lipopolysaccharide	NN
at	IN
1	CD
microg/ml	NN
.	.

Fab	NN
fragment	NN
of	IN
anti-E.	FW
chaffeensis	FW
immunoglobulin	NN
G	NN
complexed	VBN
with	IN
E.	FW
chaffeensis	FW
did	VBD
not	RB
induce	VB
any	DT
of	IN
these	DT
three	CD
cytokines	NNS
,	,
indicating	VBG
that	IN
ehrlichial	JJ
binding	NN
is	VBZ
required	VBN
for	IN
IL-1beta	NN
mRNA	NN
expression	NN
and	CC
that	IN
binding	NN
of	IN
the	DT
immune	JJ
complex	NN
to	TO
the	DT
Fc	NN
gamma	NN
receptor	NN
is	VBZ
required	VBN
for	IN
TNF-alpha	NN
and	CC
IL-6	NN
mRNA	NN
expression	NN
and	CC
enhanced	VBD
IL-1beta	NN
mRNA	NN
expression	NN
.	.

Furthermore	RB
,	,
prolonged	JJ
degradation	NN
of	IN
IkappaB-alpha	NN
and	CC
activation	NN
of	IN
NF-kappaB	NN
were	VBD
demonstrated	VBN
in	IN
THP-1	NN
cells	NNS
exposed	VBN
to	TO
anti-E.	FW
chaffeensis	FW
serum	NN
and	CC
E.	FW
chaffeensis	FW
.	.

This	DT
result	NN
implies	VBZ
that	IN
development	NN
of	IN
anti-E.	FW
chaffeensis	FW
antibody	NN
in	IN
patients	NNS
can	MD
result	VB
in	IN
the	DT
production	NN
of	IN
major	JJ
proinflammatory	JJ
cytokines	NNS
,	,
which	WDT
may	MD
play	VB
an	DT
important	JJ
role	NN
in	IN
the	DT
pathophysiology	NN
of	IN
ehrlichiosis	NN
and	CC
immune	JJ
responses	NNS
to	TO
it	PRP
.	.

UI	LS
-	:
97420486	CD

TI	LS
-	:
Activation	NN
of	IN
transcription	NN
factor	NN
NF-kappa	NN
B	NN
by	IN
phagocytic	JJ
stimuli	NNS
in	IN
human	JJ
neutrophils	NNS
.	.

AB	LS
-	:
Phagocytosis	NN
represents	VBZ
an	DT
important	JJ
physiological	JJ
trigger	NN
for	IN
the	DT
inducible	JJ
expression	NN
of	IN
several	JJ
genes	NNS
in	IN
human	JJ
neutrophils	NNS
.	.

Here	RB
,	,
we	PRP
report	VBP
that	IN
a	DT
DNA-binding	JJ
activity	NN
primarily	RB
consisting	VBG
of	IN
the	DT
classical	JJ
NF-kappa	NN
B	NN
heterodimer	NN
,	,
p50/RelA	NN
,	,
is	VBZ
induced	VBN
in	IN
phagocytosing	VBG
neutrophils	NNS
.	.

Under	IN
these	DT
conditions	NNS
,	,
NF-kappa	NN
B	NN
activation	NN
was	VBD
found	VBN
to	TO
be	VB
a	DT
rapid	JJ
and	CC
transient	JJ
response	NN
,	,
reaching	VBG
a	DT
maximum	NN
by	IN
10-15	CD
min	NN
,	,
and	CC
returning	VBG
to	TO
near-basal	JJ
levels	NNS
by	IN
30	CD
min	NN
.	.

In	IN
neutrophils	NNS
undergoing	VBG
the	DT
phagocytosis	NN
of	IN
opsonized	JJ
yeasts	NNS
,	,
the	DT
onset	NN
of	IN
NF-kappa	NN
B	NN
activation	NN
was	VBD
paralleled	VBN
by	IN
a	DT
decline	NN
in	IN
immunoreactive	JJ
I	NN
kappa	NN
B-alpha	NN
protein	NN
levels	NNS
,	,
and	CC
the	DT
cellular	JJ
I	NN
kappa	NN
B-alpha	NN
pool	NN
was	VBD
replenished	VBN
by	IN
30	CD
min	NN
,	,
in	IN
agreement	NN
with	IN
our	PRP$
gel	NN
shift	NN
data	NNS
.	.

We	PRP
conclude	VBP
that	IN
NF-kappa	NN
B	NN
activation	NN
could	MD
constitute	VB
one	CD
of	IN
the	DT
mechanisms	NNS
whereby	IN
the	DT
expression	NN
of	IN
kappa	NN
B-responsive	JJ
genes	NNS
is	VBZ
enhanced	VBN
in	IN
phagocytosing	VBG
neutrophils	NNS
.	.

To	TO
our	PRP$
knowledge	NN
,	,
this	DT
represents	VBZ
the	DT
first	JJ
demonstration	NN
that	IN
phagocytic	JJ
stimuli	NNS
can	MD
induce	VB
NF-kappa	NN
B	NN
activation	NN
in	IN
human	JJ
neutrophils	NNS
.	.

UI	LS
-	:
97379437	CD

TI	LS
-	:
A	DT
human	JJ
homologue	NN
of	IN
the	DT
Drosophila	FW
Toll	NN
protein	NN
signals	VBZ
activation	NN
of	IN
adaptive	JJ
immunity	NN
[	(
see	VB
comments	NNS
]	)

AB	LS
-	:
Induction	NN
of	IN
the	DT
adaptive	JJ
immune	JJ
response	NN
depends	VBZ
on	IN
the	DT
expression	NN
of	IN
co-stimulatory	JJ
molecules	NNS
and	CC
cytokines	NNS
by	IN
antigen-presenting	JJ
cells	NNS
.	.

The	DT
mechanisms	NNS
that	WDT
control	VBP
the	DT
initial	JJ
induction	NN
of	IN
these	DT
signals	NNS
upon	IN
infection	NN
are	VBP
poorly	RB
understood	VBN
.	.

It	PRP
has	VBZ
been	VBN
proposed	VBN
that	IN
their	PRP$
expression	NN
is	VBZ
controlled	VBN
by	IN
the	DT
non-clonal	JJ
,	,
or	CC
innate	JJ
,	,
component	NN
of	IN
immunity	NN
that	WDT
preceded	VBD
in	IN
evolution	NN
the	DT
development	NN
of	IN
an	DT
adaptive	JJ
immune	JJ
system	NN
in	IN
vertebrates	NNS
.	.

We	PRP
report	VBP
here	RB
the	DT
cloning	NN
and	CC
characterization	NN
of	IN
a	DT
human	JJ
homologue	NN
of	IN
the	DT
Drosophila	FW
toll	NN
protein	NN
(	(
Toll	NN
)	)
which	WDT
has	VBZ
been	VBN
shown	VBN
to	TO
induce	VB
the	DT
innate	JJ
immune	JJ
response	NN
in	IN
adult	JJ
Drosophila	FW
.	.

Like	IN
Drosophila	FW
Toll	NN
,	,
human	JJ
Toll	NN
is	VBZ
a	DT
type	NN
I	CD
transmembrane	JJ
protein	NN
with	IN
an	DT
extracellular	JJ
domain	NN
consisting	VBG
of	IN
a	DT
leucine-rich	JJ
repeat	NN
(	(
LRR	NN
)	)
domain	NN
,	,
and	CC
a	DT
cytoplasmic	JJ
domain	NN
homologous	JJ
to	TO
the	DT
cytoplasmic	JJ
domain	NN
of	IN
the	DT
human	JJ
interleukin	NN
(	(
IL	NN
)	)
-1	CD
receptor	NN
.	.

Both	CC
Drosophila	FW
Toll	NN
and	CC
the	DT
IL-1	NN
receptor	NN
are	VBP
known	VBN
to	TO
signal	VB
through	IN
the	DT
NF-kappaB	NN
pathway	NN
.	.

We	PRP
show	VBP
that	IN
a	DT
constitutively	RB
active	JJ
mutant	NN
of	IN
human	JJ
Toll	NN
transfected	VBN
into	IN
human	JJ
cell	NN
lines	NNS
can	MD
induce	VB
the	DT
activation	NN
of	IN
NF-kappaB	NN
and	CC
the	DT
expression	NN
of	IN
NF-kappaB-controlled	JJ
genes	NNS
for	IN
the	DT
inflammatory	JJ
cytokines	NNS
IL-1	NN
,	,
IL-6	NN
and	CC
IL-8	NN
,	,
as	RB
well	RB
as	IN
the	DT
expression	NN
of	IN
the	DT
co-stimulatory	JJ
molecule	NN
B7.1	NN
,	,
which	WDT
is	VBZ
required	VBN
for	IN
the	DT
activation	NN
of	IN
naive	JJ
T	NN
cells	NNS
.	.

UI	LS
-	:
97333610	CD

TI	LS
-	:
Construction	NN
and	CC
biological	JJ
characterization	NN
of	IN
an	DT
interleukin-12	NN
fusion	NN
protein	NN
(	(
Flexi-12	NN
)	)
:	:
delivery	NN
to	TO
acute	JJ
myeloid	JJ
leukemic	JJ
blasts	NNS
using	VBG
adeno-associated	JJ
virus	NN
.	.

AB	LS
-	:
Interleukin-12	NN
(	(
IL-12	NN
)	)
is	VBZ
a	DT
cytokine	NN
that	WDT
exhibits	VBZ
pleiotropic	JJ
effects	NNS
on	IN
lymphocytes	NNS
and	CC
natural	JJ
killer	NN
cells	NNS
and	CC
has	VBZ
been	VBN
shown	VBN
to	TO
have	VB
promise	NN
for	IN
the	DT
immunotherapy	NN
of	IN
cancer	NN
.	.

The	DT
combination	NN
of	IN
the	DT
immune	JJ
costimulatory	JJ
molecule	NN
B7.1	NN
and	CC
IL-12	NN
has	VBZ
been	VBN
shown	VBN
to	TO
be	VB
synergistic	JJ
for	IN
T	NN
cell	NN
activation	NN
.	.

By	IN
transfecting	VBG
tumor	NN
cells	NNS
with	IN
both	CC
IL-12	NN
and	CC
B7.1	NN
cDNAs	NNS
,	,
it	PRP
may	MD
be	VB
possible	JJ
to	TO
use	VB
these	DT
modified	VBN
targets	NNS
as	IN
vaccines	NNS
.	.

A	DT
major	JJ
obstacle	NN
in	IN
designing	VBG
a	DT
vector	NN
to	TO
deliver	VB
these	DT
genes	NNS
results	VBZ
from	IN
the	DT
structure	NN
of	IN
IL-12	NN
.	.

Functional	JJ
IL-12	NN
is	VBZ
a	DT
heterodimer	NN
composed	VBN
of	IN
two	CD
distinct	JJ
subunits	NNS
that	WDT
are	VBP
encoded	VBN
by	IN
separate	JJ
genes	NNS
on	IN
different	JJ
chromosomes	NNS
.	.

Production	NN
of	IN
functional	JJ
IL-12	NN
requires	VBZ
the	DT
coordinated	VBN
expression	NN
of	IN
both	DT
genes	NNS
.	.

This	DT
presents	VBZ
several	JJ
problems	NNS
in	IN
vectors	NNS
,	,
particularly	RB
those	DT
in	IN
which	WDT
additional	JJ
genes	NNS
,	,
either	CC
a	DT
co-stimulatory	JJ
gene	NN
or	CC
a	DT
selectable	JJ
marker	NN
,	,
are	VBP
inserted	VBN
.	.

Therefore	RB
,	,
we	PRP
have	VBP
constructed	VBN
a	DT
single	JJ
cDNA	NN
that	WDT
encodes	VBZ
a	DT
single-chain	JJ
protein	NN
,	,
called	VBN
Flexi-12	NN
,	,
which	WDT
retains	VBZ
all	DT
of	IN
the	DT
biological	JJ
characteristics	NNS
of	IN
recombinant	JJ
IL-12	NN
(	(
rIL-12	NN
)	)
.	.

The	DT
monomeric	JJ
polypeptide	NN
Flexi-12	NN
is	VBZ
able	JJ
to	TO
induce	VB
the	DT
proliferation	NN
of	IN
phytohemagglutinin	NN
(	(
PHA	NN
)	)
blasts	NNS
,	,
induce	VB
PHA	NN
blasts	NNS
to	TO
secrete	VB
interferon-gamma	NN
(	(
IFN-gamma	NN
)	)
and	CC
additionally	RB
,	,
by	IN
preincubation	NN
,	,
enhance	VB
the	DT
killing	NN
of	IN
K562	NN
targets	NNS
by	IN
PBLs	NNS
.	.

These	DT
phenomena	NNS
are	VBP
in	IN
a	DT
dose-dependent	JJ
manner	NN
comparable	JJ
to	TO
that	DT
seen	VBN
with	IN
rIL-12	NN
.	.

We	PRP
have	VBP
also	RB
shown	VBN
that	IN
tyrosine	NN
phosphorylation	NN
of	IN
the	DT
STAT	NN
4	CD
transcription	NN
factor	NN
,	,
which	WDT
has	VBZ
been	VBN
shown	VBN
to	TO
be	VB
unique	JJ
to	TO
the	DT
IL-12	NN
signaling	NN
pathway	NN
,	,
occurs	VBZ
with	IN
Flexi-12	NN
at	IN
levels	NNS
similar	JJ
to	TO
those	DT
seen	VBN
with	IN
rIL-12	NN
.	.

We	PRP
have	VBP
packaged	VBN
Flexi-12	NN
into	IN
a	DT
recombinant	JJ
adeno-associated	JJ
virus	NN
(	(
AAV	NN
)	)
and	CC
used	VBN
this	DT
vector	NN
to	TO
infect	VB
acute	JJ
myeloid	JJ
leukemic	JJ
(	(
AML	NN
)	)
blasts	NNS
.	.

Infected	JJ
AML	NN
blasts	NNS
produced	VBD
between	IN
2	CD
and	CC
6	CD
ng	NN
of	IN
IL-12/10	NN
(	(
6	CD
)	)
cells	NNS
per	IN
ml	NN
per	IN
48	CD
hr	NN
.	.

These	DT
studies	NNS
also	RB
confirm	VBP
that	IN
AAV	NN
is	VBZ
an	DT
efficient	JJ
delivery	NN
vehicle	NN
for	IN
cytokines	NNS
to	TO
leukemic	JJ
cells	NNS
.	.

Direct	JJ
analysis	NN
of	IN
these	DT
modified	VBN
cells	NNS
acting	VBG
as	IN
tumor	NN
vaccines	NNS
is	VBZ
underway	JJ
.	.

UI	LS
-	:
97289567	CD

TI	LS
-	:
Regulation	NN
of	IN
CD95	NN
(	(
Fas	NN
)	)
ligand	NN
expression	NN
by	IN
TCR-mediated	JJ
signaling	NN
events	NNS
.	.

AB	LS
-	:
Stimulation	NN
of	IN
mature	JJ
peripheral	JJ
T	NN
cells	NNS
by	IN
TCR	NN
engagement	NN
results	VBZ
in	IN
activation	NN
of	IN
signals	NNS
that	WDT
drive	VBP
induction	NN
of	IN
cytokine	NN
gene	NN
expression	NN
and	CC
clonal	JJ
expansion	NN
.	.

However	RB
,	,
under	IN
some	DT
conditions	NNS
,	,
engagement	NN
of	IN
the	DT
TCR	NN
leads	VBZ
instead	RB
to	TO
apoptosis	NN
.	.

Recent	JJ
studies	NNS
demonstrate	VBP
that	IN
TCR-stimulated	JJ
apoptosis	NN
requires	VBZ
expression	NN
of	IN
CD95	NN
ligand	NN
on	IN
activated	VBN
T	NN
cells	NNS
followed	VBN
by	IN
an	DT
interaction	NN
between	IN
CD95	NN
ligand	NN
and	CC
the	DT
CD95	NN
receptor	NN
also	RB
expressed	VBN
on	IN
this	DT
population	NN
.	.

The	DT
experiments	NNS
reported	VBN
in	IN
this	DT
study	NN
were	VBD
designed	VBN
to	TO
address	VB
the	DT
signaling	NN
events	NNS
triggered	VBN
by	IN
TCR	NN
engagement	NN
that	WDT
are	VBP
important	JJ
for	IN
regulating	VBG
CD95	NN
ligand	NN
gene	NN
expression	NN
.	.

To	TO
approach	VB
this	DT
,	,
we	PRP
generated	VBD
a	DT
luciferase	NN
reporter	NN
construct	NN
containing	VBG
elements	NNS
of	IN
the	DT
CD95	NN
ligand	NN
promoter	NN
.	.

Using	VBG
a	DT
previously	RB
described	VBN
mutant	NN
of	IN
the	DT
Jurkat	NN
T	NN
cell	NN
line	NN
,	,
we	PRP
show	VBP
that	IN
proximal	JJ
signaling	NN
events	NNS
dependent	JJ
on	IN
the	DT
presence	NN
of	IN
the	DT
CD45	NN
tyrosine	NN
phosphatase	NN
are	VBP
required	VBN
for	IN
TCR-stimulated	JJ
CD95	NN
ligand	NN
expression	NN
.	.

Transient	JJ
transfection	NN
studies	NNS
demonstrate	VBP
further	RB
that	IN
TCR-stimulated	JJ
activation	NN
of	IN
the	DT
Ras	NN
signaling	NN
pathway	NN
is	VBZ
required	VBN
for	IN
optimal	JJ
activation	NN
of	IN
CD95	NN
ligand	NN
.	.

Next	RB
,	,
in	IN
an	DT
effort	NN
to	TO
determine	VB
critical	JJ
transcription	NN
factors	NNS
that	WDT
regulate	VBP
CD95	NN
ligand	NN
expression	NN
,	,
we	PRP
demonstrate	VBP
a	DT
cyclosporin	NN
A-sensitive	JJ
nuclear	JJ
factor-AT	NN
response	NN
element	NN
in	IN
the	DT
promoter	NN
region	NN
of	IN
this	DT
gene	NN
that	WDT
is	VBZ
critical	JJ
for	IN
optimal	JJ
CD95	NN
ligand	NN
reporter	NN
activity	NN
in	IN
stimulated	VBN
T	NN
cells	NNS
.	.

Together	RB
,	,
these	DT
studies	NNS
begin	VBP
a	DT
dissection	NN
of	IN
the	DT
biochemical	JJ
events	NNS
that	WDT
lead	VBP
to	TO
expression	NN
of	IN
CD95	NN
ligand	NN
,	,
a	DT
required	JJ
step	NN
for	IN
TCR-induced	JJ
apoptosis	NN
.	.

UI	LS
-	:
97355572	CD

TI	LS
-	:
Increased	VBN
expression	NN
of	IN
Gs(alpha)	NN
enhances	VBZ
activation	NN
of	IN
the	DT
adenylyl	NN
cyclase	NN
signal	NN
transduction	NN
cascade	NN
.	.

AB	LS
-	:
Expression	NN
of	IN
the	DT
stimulatory	JJ
G	NN
protein	NN
,	,
G(S)alpha	NN
,	,
can	MD
vary	VB
over	IN
a	DT
3-fold	JJ
range	NN
in	IN
human	JJ
tissues	NNS
and	CC
in	IN
rodent	JJ
central	JJ
nervous	JJ
system	NN
.	.

In	IN
fact	NN
,	,
the	DT
offspring	NN
of	IN
alcoholics	NNS
have	VBP
higher	JJR
levels	NNS
of	IN
G(S)alpha	NN
expression	NN
in	IN
certain	JJ
tissues	NNS
compared	VBN
with	IN
the	DT
offspring	NN
of	IN
nonalcoholics	NNS
.	.

The	DT
aim	NN
of	IN
this	DT
research	NN
was	VBD
to	TO
test	VB
the	DT
hypothesis	NN
that	IN
a	DT
causal	JJ
relationship	NN
exists	VBZ
between	IN
the	DT
level	NN
of	IN
expression	NN
of	IN
G(S)alpha	NN
and	CC
induction	NN
of	IN
the	DT
adenylyl	NN
cyclase	NN
(	(
AC	NN
)	)
cascade	NN
.	.

The	DT
methodology	NN
employed	VBD
transient	JJ
transfection	NN
of	IN
HEK	NN
293	CD
cells	NNS
with	IN
a	DT
cDNA	NN
for	IN
the	DT
52-kDa	JJ
form	NN
of	IN
G(S)alpha	NN
under	IN
regulation	NN
by	IN
inducible	JJ
metallothionein	NN
promoters	NNS
.	.

Transfectants	NNS
were	VBD
exposed	VBN
to	TO
varying	VBG
concentrations	NNS
(	(
0-125	CD
microM	NN
)	)
of	IN
zinc	NN
sulfate	NN
that	WDT
produced	VBD
a	DT
3-fold	JJ
range	NN
of	IN
membrane	NN
G(S)alpha	NN
expression	NN
.	.

The	DT
range	NN
of	IN
G(S)alpha	NN
expression	NN
produced	VBN
was	VBD
found	VBN
to	TO
mimic	VB
a	DT
physiologically	RB
relevant	JJ
spectrum	NN
of	IN
G(S)alpha	NN
expression	NN
in	IN
membranes	NNS
derived	VBN
from	IN
human	JJ
tissues	NNS
and	CC
rat	NN
brain	NN
.	.

It	PRP
was	VBD
observed	VBN
that	IN
induction	NN
of	IN
G(S)alpha	NN
expression	NN
increased	VBD
constitutive	JJ
as	RB
well	RB
as	IN
stimulated	VBN
cAMP	NN
accumulation	NN
.	.

Moreover	RB
,	,
induction	NN
of	IN
G(S)alpha	NN
expression	NN
increased	VBD
events	NNS
distal	JJ
to	TO
the	DT
accumulation	NN
of	IN
cAMP	NN
including	VBG
the	DT
phosphorylation	NN
of	IN
the	DT
transcription	NN
factor	NN
,	,
cAMP	NN
response	NN
element	NN
binding	NN
protein	NN
and	CC
transcriptional	JJ
activation	NN
of	IN
cAMP-dependent	JJ
reporter	NN
genes	NNS
.	.

In	IN
summary	NN
,	,
these	DT
studies	NNS
show	VBP
that	IN
the	DT
amount	NN
of	IN
G(S)alpha	NN
expression	NN
has	VBZ
a	DT
marked	JJ
impact	NN
on	IN
the	DT
level	NN
of	IN
activity	NN
of	IN
the	DT
AC	NN
cascade	NN
from	IN
the	DT
membrane	NN
through	IN
to	TO
the	DT
nucleus	NN
.	.

It	PRP
is	VBZ
hypothesized	VBN
that	IN
individuals	NNS
who	WP
differ	VBP
in	IN
G(S)alpha	NN
expression	NN
may	MD
also	RB
differ	VB
in	IN
the	DT
expression	NN
of	IN
certain	JJ
cAMP-dependent	JJ
genes	NNS
.	.

UI	LS
-	:
97334241	CD

TI	LS
-	:
The	DT
IL-4	NN
receptor	NN
alpha-chain	NN
cytoplasmic	JJ
domain	NN
is	VBZ
sufficient	JJ
for	IN
activation	NN
of	IN
JAK-1	NN
and	CC
STAT6	NN
and	CC
the	DT
induction	NN
of	IN
IL-4-specific	JJ
gene	NN
expression	NN
.	.

AB	LS
-	:
The	DT
common	JJ
gamma-chain	NN
(	(
gamma(c)	NN
)	)
is	VBZ
a	DT
functional	JJ
component	NN
of	IN
the	DT
IL-4R	NN
,	,
yet	RB
cells	NNS
lacking	VBG
gamma(c)	NN
are	VBP
able	JJ
to	TO
respond	VB
to	TO
IL-4	NN
.	.

This	DT
has	VBZ
led	VBN
to	TO
the	DT
suggestion	NN
that	IN
a	DT
surrogate	JJ
gamma'-chain	NN
,	,
which	WDT
can	MD
interact	VB
with	IN
the	DT
IL-4R	NN
alpha	NN
chain	NN
to	TO
mediate	VB
signaling	NN
,	,
is	VBZ
expressed	VBN
on	IN
cells	NNS
lacking	VBG
gamma(c)	NN
.	.

An	DT
alternative	JJ
possibility	NN
is	VBZ
that	IN
in	IN
the	DT
absence	NN
of	IN
gamma(c)	NN
,	,
the	DT
IL-4R	NN
alpha	NN
chain	NN
is	VBZ
able	JJ
to	TO
transduce	VB
signals	NNS
by	IN
homodimerization	NN
.	.

To	TO
test	VB
this	DT
latter	JJ
possibility	NN
,	,
a	DT
chimeric	JJ
receptor	NN
containing	VBG
the	DT
extracellular	JJ
domain	NN
of	IN
c-kit	NN
(	(
the	DT
stem	NN
cell	NN
factor	NN
(	(
SCF	NN
)	)
receptor	NN
)	)
and	CC
the	DT
cytoplasmic	JJ
and	CC
transmembrane	JJ
domains	NNS
of	IN
the	DT
IL-4R	NN
alpha	NN
chain	NN
was	VBD
generated	VBN
.	.

Treatment	NN
of	IN
cells	NNS
expressing	VBG
the	DT
chimeric	JJ
receptor	NN
kit/IL-4R	NN
alpha	NN
with	IN
SCF	NN
induces	VBZ
activation	NN
of	IN
the	DT
IL-4R	NN
alpha-associated	JJ
kinase	NN
JAK-1	NN
and	CC
the	DT
transcription	NN
factor	NN
STAT6	NN
.	.

However	RB
,	,
tyrosine	NN
phosphorylation	NN
of	IN
JAK-3	NN
,	,
which	WDT
associates	VBZ
with	IN
gamma(c)	NN
,	,
is	VBZ
not	RB
induced	VBN
by	IN
SCF	NN
in	IN
these	DT
cells	NNS
.	.

SCF-mediated	JJ
ligation	NN
of	IN
kit/IL-4R	NN
alpha	NN
is	VBZ
sufficient	JJ
to	TO
elicit	VB
IL-4-specific	JJ
gene	NN
expression	NN
,	,
including	VBG
up-regulation	NN
of	IN
CD23	NN
and	CC
synthesis	NN
of	IN
germ-line	NN
epsilon	NN
transcripts	NNS
.	.

In	IN
the	DT
T	NN
cell	NN
line	NN
CTLL2	NN
,	,
ligation	NN
of	IN
kit/IL-4R	NN
alpha	NN
induces	VBZ
cellular	JJ
proliferation	NN
.	.

Finally	RB
,	,
in	IN
JAK-1-deficient	JJ
HeLa	NN
cells	NNS
,	,
STAT6	NN
activation	NN
by	IN
IL-4	NN
is	VBZ
completely	RB
abolished	VBN
.	.

Together	RB
,	,
these	DT
data	NNS
demonstrate	VBP
that	IN
the	DT
IL-4R	NN
alpha	NN
cytoplasmic	JJ
domain	NN
is	VBZ
sufficient	JJ
to	TO
activate	VB
JAK-1	NN
and	CC
STAT6	NN
and	CC
to	TO
induce	VB
expression	NN
of	IN
IL-4	NN
target	NN
genes	NNS
,	,
thus	RB
identifying	VBG
a	DT
mechanism	NN
by	IN
which	WDT
IL-4	NN
signaling	NN
can	MD
proceed	VB
in	IN
the	DT
absence	NN
of	IN
JAK-3	NN
and	CC
gamma(c)	NN
.	.

UI	LS
-	:
97289433	CD

TI	LS
-	:
Quantification	NN
of	IN
vitamin	NN
D	NN
receptor	NN
mRNA	NN
by	IN
competitive	JJ
polymerase	NN
chain	NN
reaction	NN
in	IN
PBMC	NN
:	:
lack	NN
of	IN
correspondence	NN
with	IN
common	JJ
allelic	JJ
variants	NNS
.	.

AB	LS
-	:
It	PRP
has	VBZ
been	VBN
recently	RB
claimed	VBN
that	IN
polymorphism	NN
for	IN
the	DT
vitamin	NN
D	NN
receptor	NN
(	(
VDR	NN
)	)
influences	VBZ
several	JJ
aspects	NNS
of	IN
calcium	NN
and	CC
bone	NN
metabolism	NN
.	.

To	TO
evaluate	VB
the	DT
physiologic	JJ
plausibility	NN
of	IN
these	DT
claims	NNS
,	,
we	PRP
compared	VBD
the	DT
abundance	NN
of	IN
the	DT
VDR	NN
mRNA	NN
in	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
(	(
PBMCs	NNS
)	)
between	IN
different	JJ
VDR	NN
genotypes	NNS
using	VBG
a	DT
quantitative	JJ
reverse	JJ
transcribed	VBN
polymerase	NN
chain	NN
reaction-based	JJ
method	NN
.	.

The	DT
method	NN
is	VBZ
based	VBN
on	IN
the	DT
coamplification	NN
of	IN
VDR	NN
cDNA	NN
and	CC
an	DT
internal	JJ
standard	NN
consisting	VBG
of	IN
known	JJ
concentrations	NNS
of	IN
a	DT
human	JJ
VDR	NN
CDNA	NN
mutated	VBN
at	IN
a	DT
BglII	NN
restriction	NN
site	NN
;	:
the	DT
interassay	JJ
coefficient	NN
of	IN
variation	NN
is	VBZ
11	CD
%	NN
.	.

To	TO
validate	VB
the	DT
method	NN
,	,
we	PRP
made	VBD
use	NN
of	IN
earlier	JJR
receptor	NN
binding	NN
studies	NNS
indicating	VBG
that	IN
normal	JJ
human	JJ
monocytes	NNS
and	CC
activated	VBN
,	,
but	CC
not	RB
resting	VBG
,	,
lymphocytes	NNS
expressed	VBD
the	DT
VDR	NN
.	.

The	DT
concentration	NN
of	IN
the	DT
VDR	NN
mRNA	NN
was	VBD
10(-8)	CD
to	TO
10(-7)	CD
g/g	NN
of	IN
total	JJ
RNA	NN
in	IN
cell-sorted	JJ
monocytes	NNS
and	CC
in	IN
in	FW
vitro	FW
activated	VBN
lymphocytes	NNS
,	,
but	CC
only	RB
10(-12)	CD
g/g	NN
of	IN
total	JJ
mRNA	NN
in	IN
resting	VBG
lymphocytes	NNS
,	,
establishing	VBG
that	IN
the	DT
VDR	NN
mRNA	NN
determined	VBN
by	IN
our	PRP$
method	NN
in	IN
PBMCs	NNS
is	VBZ
due	JJ
to	TO
constitutive	JJ
expression	NN
in	IN
monocytes	NNS
.	.

Following	VBG
an	DT
initial	JJ
genotype	NN
screening	NN
of	IN
85	CD
normal	JJ
volunteers	NNS
by	IN
polymerase	NN
chain	NN
reaction	NN
or	CC
restriction	NN
fragment	NN
length	NN
polymorphism	NN
analysis	NN
,	,
14	CD
individuals	NNS
with	IN
the	DT
Bb	NN
genotype	NN
,	,
12	CD
with	IN
the	DT
bb	NN
genotype	NN
,	,
and	CC
12	CD
with	IN
the	DT
BB	NN
genotype	NN
were	VBD
selected	VBN
.	.

The	DT
concentration	NN
of	IN
the	DT
VDR	NN
mRNA	NN
,	,
corrected	VBN
for	IN
the	DT
number	NN
of	IN
monocytes	NNS
,	,
was	VBD
similar	JJ
among	IN
the	DT
three	CD
genotype	NN
groups	NNS
,	,
as	IN
were	VBD
the	DT
other	JJ
variables	NNS
examined	VBN
:	:
serum	NN
calcitriol	NN
,	,
serum	NN
osteocalcin	NN
,	,
and	CC
vertebral	NN
and	CC
hip	NN
bone	NN
density	NN
.	.

We	PRP
conclude	VBP
that	IN
VDR	NN
polymorphism	NN
does	VBZ
not	RB
affect	VB
the	DT
abundance	NN
of	IN
the	DT
VDR	NN
mRNA	NN
.	.

UI	LS
-	:
97276819	CD

TI	LS
-	:
Retinoic	JJ
acid-induced	JJ
modulation	NN
of	IN
IL-2	NN
mRNA	NN
production	NN
and	CC
IL-2	NN
receptor	NN
expression	NN
on	IN
T	NN
cells	NNS
.	.

AB	LS
-	:
BACKGROUND	NN
:	:
Retinoic	JJ
acid	NN
(	(
RA	NN
)	)
has	VBZ
important	JJ
immune-modulating	JJ
effects	NNS
on	IN
both	CC
T	NN
and	CC
B	NN
cell	NN
function	NN
.	.

Our	PRP$
laboratory	NN
has	VBZ
shown	VBN
that	IN
RA	NN
can	MD
enhance	VB
in	FW
vitro	FW
polyclonal	JJ
B	NN
cell	NN
immunoglobulin	NN
(	(
Ig	NN
)	)
response	NN
.	.

Investigating	VBG
cytokines	NNS
known	VBN
to	TO
affect	VB
B	NN
cell	NN
differentiation	NN
,	,
we	PRP
have	VBP
recently	RB
shown	VBN
that	IN
IL-6	NN
production	NN
is	VBZ
augmented	VBN
by	IN
RA	NN
.	.

In	IN
the	DT
present	JJ
study	NN
we	PRP
have	VBP
examined	VBN
the	DT
immune	JJ
modulating	JJ
effects	NNS
of	IN
RA	NN
on	IN
IL-2	NN
mRNA	NN
,	,
another	DT
important	JJ
cytokine	NN
for	IN
B	NN
cell	NN
immunoglobulin	NN
production	NN
,	,
the	DT
expression	NN
of	IN
IL-2	NN
receptors	NNS
on	IN
T	NN
cells	NNS
,	,
and	CC
the	DT
RA	NN
nuclear	JJ
receptors	NNS
.	.

METHODS	NNS
:	:
Purified	VBN
T	NN
cells	NNS
were	VBD
obtained	VBN
from	IN
adenoidal	JJ
tissues	NNS
,	,
and	CC
incubated	VBN
with	IN
RA	NN
(	(
10(-7)	CD
M	NN
)	)
or	CC
DMSO	NN
solvent/media	NN
control	NN
for	IN
0	CD
,	,
6-8	CD
,	,
and	CC
24	CD
h	NN
.	.

Total	JJ
mRNA	NN
was	VBD
extracted	VBN
from	IN
T	NN
cells	NNS
,	,
and	CC
using	VBG
RT-PCR	NN
,	,
changes	NNS
in	IN
the	DT
production	NN
of	IN
IL-2	NN
and	CC
RA	NN
receptors	NNS
(	(
RAR	NNS
)	)
-alpha	NN
,	,
beta	NN
,	,
gamma	NN
mRNA	NN
were	VBD
determined	VBN
.	.

The	DT
effects	NNS
of	IN
RA	NN
on	IN
IL-2-alpha	NN
receptor	NN
expression	NN
was	VBD
determined	VBN
by	IN
flow	NN
cytometry	NN
on	IN
T	NN
cells	NNS
.	.

CONCLUSION	NN
:	:
These	DT
studies	NNS
suggest	VBP
that	IN
RA	NN
can	MD
augment	VB
IL-2	NN
mRNA	NN
production	NN
by	IN
T	NN
cells	NNS
with	IN
a	DT
possible	JJ
paracrine	NN
effect	NN
on	IN
IL-2R-alpha	NN
expression	NN
.	.

These	DT
changes	NNS
appear	VBP
to	TO
be	VB
mediated	VBN
by	IN
RAR-alpha	NN
.	.

Thus	RB
,	,
IL-2	NN
may	MD
be	VB
another	DT
important	JJ
cytokine	NN
modulated	VBN
by	IN
RA	NN
in	IN
the	DT
immune	JJ
response	NN
.	.

UI	LS
-	:
97218151	CD

TI	LS
-	:
Identification	NN
of	IN
sequence	NN
alterations	NNS
in	IN
the	DT
upstream	JJ
regulatory	JJ
region	NN
of	IN
the	DT
estrogen	NN
receptor	NN
gene	NN
in	IN
an	DT
ER-negative	JJ
breast	NN
cancer	NN
cell	NN
line	NN
.	.

AB	LS
-	:
Given	IN
the	DT
important	JJ
role	NN
of	IN
the	DT
estrogen	NN
receptor	NN
(	(
ER	NN
)	)
in	IN
the	DT
development	NN
and	CC
physiology	NN
of	IN
the	DT
breast	NN
,	,
it	PRP
is	VBZ
essential	JJ
to	TO
delineate	VB
the	DT
mechanisms	NNS
responsible	JJ
for	IN
its	PRP$
failed	JJ
expression	NN
in	IN
some	DT
breast	NN
tumors	NNS
.	.

We	PRP
have	VBP
cloned	VBN
and	CC
sequenced	VBN
a	DT
portion	NN
of	IN
the	DT
ER	NN
upstream	JJ
regulatory	JJ
region	NN
from	IN
the	DT
ER-positive	JJ
MCF-7	NN
and	CC
the	DT
ER-negative	JJ
MDA-MB-231	NN
breast	NN
cancer	NN
cell	NN
lines	NNS
to	TO
determine	VB
if	IN
sequence	NN
alterations	NNS
in	IN
this	DT
region	NN
account	VBP
for	IN
the	DT
ER-negative	JJ
phenotype	NN
of	IN
some	DT
tumors	NNS
.	.

From	IN
this	DT
,	,
we	PRP
identified	VBD
a	DT
number	NN
of	IN
variations	NNS
between	IN
the	DT
sequences	NNS
,	,
two	CD
of	IN
which	WDT
were	VBD
determined	VBN
to	TO
be	VB
associated	VBN
with	IN
a	DT
50	CD
%	NN
decrease	NN
in	IN
CAT	NN
activity	NN
.	.

UI	LS
-	:
97228922	CD

TI	LS
-	:
Suppression	NN
by	IN
azelastine	NN
hydrochloride	NN
of	IN
NF-kappa	NN
B	NN
activation	NN
involved	VBN
in	IN
generation	NN
of	IN
cytokines	NNS
and	CC
nitric	JJ
oxide	NN
.	.

AB	LS
-	:
The	DT
influence	NN
of	IN
the	DT
anti-allergy	JJ
agent	NN
azelastine	NN
hydrochloride	NN
(	(
Azeptin	NN
)	)
on	IN
NF-kappa	NN
B	NN
activation	NN
associated	VBN
with	IN
the	DT
generation	NN
of	IN
cytokines	NNS
and	CC
nitric	JJ
oxide	NN
(	(
NO	NN
)	)
was	VBD
investigated	VBN
in	IN
various	JJ
kinds	NNS
of	IN
human	JJ
and	CC
mouse	NN
cells	NNS
.	.

Azeptin	NN
dose-dependently	RB
suppressed	VBD
both	CC
DNA	NN
and	CC
protein	NN
synthesis	NN
in	IN
human	JJ
gingival	JJ
fibroblasts	NNS
(	(
HF	NNS
)	)
and	CC
also	RB
suppressed	VBD
blastogenesis	NN
of	IN
human	JJ
peripheral	JJ
blood	NN
lymphocytes	NNS
(	(
PBL	NNS
)	)
.	.
Generation	NN
of	IN
tumor	NN
necrosis	NN
factor-alpha	NN
,	,
interleukin	NN
1-beta	NN
,	,
granulocyte-macrophage	JJ
colony-stimulating	JJ
factor	NN
and	CC
interleukin-6	NN
from	IN
10(-5)	CD
M	NN
Azeptin-treated	JJ
PBL	NNS
and	CC
human	JJ
monocytes	NNS
(	(
HM	NNS
)	)
was	VBD
decreased	VBN
to	TO
approximately	RB
1/3	CD
to	TO
2/3	CD
of	IN
the	DT
control	NN
levels	NNS
.	.

In	IN
parallel	NN
with	IN
the	DT
decreased	VBN
cytokine	NN
generation	NN
,	,
each	DT
cytokine	NN
mRNA	NN
was	VBD
less	RBR
expressed	VBN
in	IN
the	DT
presence	NN
of	IN
10(-5)	CD
M	NN
Azeptin	NN
.	.

In	IN
addition	NN
,	,
both	CC
inducible	JJ
nitric	JJ
oxide	NN
synthase-mRNA	NN
level	NN
and	CC
NO	NN
generation	NN
in	IN
mouse	NN
peritoneal	JJ
macrophages	NNS
were	VBD
suppressed	VBN
by	IN
10(-5)	CD
M	NN
Azeptin	NN
.	.

Being	VBG
compatible	JJ
with	IN
those	DT
results	NNS
,	,
Azeptin	NN
(	(
10(-5)	CD
M	NN
)	)
suppressed	VBD
activation	NN
of	IN
NF-kappa	NN
B	NN
in	IN
PBL	NNS
,	,
HM	NNS
and	CC
HF	NNS
.	.

These	DT
results	NNS
appear	VBP
to	TO
indicate	VB
that	IN
suppression	NN
of	IN
cytokine	NN
and	CC
NO	NN
generation	NN
by	IN
Azeptin	NN
results	VBZ
at	IN
least	JJS
partially	RB
from	IN
the	DT
inhibition	NN
of	IN
NF-kappa	NN
B	NN
activation	NN
.	.

UI	LS
-	:
97278840	CD

TI	LS
-	:
Jak3	NN
is	VBZ
associated	VBN
with	IN
CD40	NN
and	CC
is	VBZ
critical	JJ
for	IN
CD40	NN
induction	NN
of	IN
gene	NN
expression	NN
in	IN
B	NN
cells	NNS
.	.

AB	LS
-	:
CD40	NN
is	VBZ
a	DT
receptor	NN
that	WDT
is	VBZ
critical	JJ
for	IN
the	DT
survival	NN
,	,
growth	NN
,	,
differentiation	NN
,	,
and	CC
isotype	NN
switching	NN
of	IN
B	NN
lymphocytes	NNS
.	.

Although	IN
CD40	NN
lacks	VBZ
intrinsic	JJ
tyrosine	NN
kinase	NN
activity	NN
,	,
its	PRP$
ligation	NN
induces	VBZ
protein	NN
tyrosine	NN
phosphorylation	NN
,	,
which	WDT
is	VBZ
necessary	JJ
for	IN
several	JJ
CD40-mediated	JJ
events	NNS
.	.

We	PRP
show	VBP
that	IN
engagement	NN
of	IN
CD40	NN
induces	VBZ
tyrosine	NN
phosphorylation	NN
and	CC
activation	NN
of	IN
Jak3	NN
as	RB
well	RB
as	IN
of	IN
STAT3	NN
.	.

Jak3	NN
is	VBZ
constitutively	RB
associated	VBN
with	IN
CD40	NN
,	,
and	CC
this	DT
interaction	NN
requires	VBZ
a	DT
proline-rich	JJ
sequence	NN
in	IN
the	DT
membrane-proximal	JJ
region	NN
of	IN
CD40	NN
.	.

Deletion	NN
of	IN
this	DT
sequence	NN
abolishes	VBZ
the	DT
capacity	NN
of	IN
CD40	NN
to	TO
induce	VB
expression	NN
of	IN
CD23	NN
,	,
ICAM-1	NN
,	,
and	CC
lymphotoxin-alpha	NN
genes	NNS
in	IN
B	NN
cells	NNS
.	.

These	DT
results	NNS
indicate	VBP
that	IN
signaling	NN
through	IN
Jak3	NN
is	VBZ
activated	VBN
by	IN
CD40	NN
and	CC
plays	VBZ
an	DT
important	JJ
role	NN
in	IN
CD40-mediated	JJ
functions	NNS
.	.

UI	LS
-	:
98145608	CD

TI	LS
-	:
Transcription	NN
factors	NNS
required	VBN
for	IN
lymphoid	JJ
lineage	NN
commitment	NN
.	.

AB	LS
-	:
Intimate	JJ
interactions	NNS
between	IN
multipotential	JJ
hemopoietic	JJ
stem	NN
cells	NNS
and	CC
their	PRP$
microenvironment	NN
work	VBP
towards	IN
redefining	VBG
the	DT
identity	NN
and	CC
the	DT
differentiative	JJ
fate	NN
of	IN
these	DT
primitive	JJ
cells	NNS
.	.

Molecular	JJ
cues	NNS
delivered	VBN
by	IN
the	DT
microenvironment	NN
frequently	RB
act	VBP
in	IN
an	DT
instructive	JJ
fashion	NN
by	IN
initiating	VBG
intracellular	JJ
signaling	NN
pathways	NNS
that	WDT
ultimately	RB
target	VBP
a	DT
select	JJ
group	NN
of	IN
transcription	NN
factors	NNS
.	.

These	DT
transcriptional	JJ
regulators	NNS
in	IN
turn	NN
trigger	VBP
a	DT
cascade	NN
of	IN
genetic	JJ
changes	NNS
that	WDT
ultimately	RB
determine	VBP
the	DT
course	NN
of	IN
the	DT
cells	NNS
during	IN
differentiation	NN
.	.

Gene	NN
inactivation	NN
studies	NNS
on	IN
the	DT
PU.1	NN
,	,
Ikaros	NN
and	CC
GATA-3	NN
genes	NNS
have	VBP
revealed	VBN
that	IN
their	PRP$
encoded	VBN
factors	NNS
are	VBP
essential	JJ
for	IN
the	DT
earliest	JJS
commitment	NN
step	NN
into	IN
the	DT
B	NN
and	CC
T	NN
lymphoid	JJ
lineages	NNS
.	.

UI	LS
-	:
97234588	CD

TI	LS
-	:
Cell-to-cell	JJ
contact	NN
activates	VBZ
the	DT
long	JJ
terminal	JJ
repeat	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
1	CD
through	IN
its	PRP$
kappaB	NN
motif	NN
.	.

AB	LS
-	:
Cell-to-cell	JJ
contact	NN
between	IN
peripheral	JJ
blood	NN
lymphocytes	NNS
and	CC
transfected	VBN
human	JJ
colonic	JJ
carcinoma	NN
cell	NN
line	NN
HT29	NN
activates	VBZ
transcription	NN
of	IN
the	DT
long	JJ
terminal	JJ
repeats	NNS
(	(
LTR	NNS
)	)
of	IN
human	JJ
immunodeficiency	NN
virus	NN
.	.

HIV-1	NN
LTR	NNS
transcription	NN
is	VBZ
controlled	VBN
by	IN
a	DT
complex	JJ
array	NN
of	IN
virus-encoded	JJ
and	CC
cellular	JJ
proteins	NNS
.	.

Using	VBG
various	JJ
constructs	NNS
expressing	VBG
a	DT
lacZ	NN
reporter	NN
gene	NN
under	IN
the	DT
control	NN
of	IN
the	DT
intact	JJ
or	CC
three	CD
deleted	JJ
forms	NNS
of	IN
HIV-1	NN
LTR	NNS
,	,
we	PRP
obtained	VBD
evidence	NN
that	IN
the	DT
kappaB	NN
regulatory	JJ
elements	NNS
located	JJ
in	IN
the	DT
U3	NN
region	NN
are	VBP
involved	VBN
in	IN
cell-to-cell	JJ
activation	NN
of	IN
HIV-1	NN
LTR	NNS
.	.

Cell-to-cell	JJ
contact	NN
activates	VBZ
in	FW
vitro	FW
binding	NN
of	IN
the	DT
nuclear	JJ
factor	NN
kappaB	NN
(	(
NF-kappaB	NN
)	)
p50/p65	NN
heterodimer	NN
to	TO
an	DT
HIV-1	NN
kappaB	NN
oligonucleotide	NN
.	.

Cell-to-cell	JJ
contact	NN
activation	NN
of	IN
NF-kappaB	NN
was	VBD
only	RB
partially	RB
inhibited	VBN
by	IN
100	CD
microM	NN
pyrrolidine	NN
dithiocarbamate	NN
and	CC
was	VBD
not	RB
correlated	VBN
with	IN
a	DT
significant	JJ
decrease	NN
of	IN
cellular	JJ
inhibitor	NN
kappaB	NN
alpha	NN
.	.

NF-kappaB	NN
nuclear	JJ
activation	NN
was	VBD
not	RB
detectable	JJ
before	IN
1	CD
h	NN
after	IN
cell	NN
contact	NN
and	CC
was	VBD
dependent	JJ
on	IN
protein	NN
synthesis	NN
.	.

UI	LS
-	:
97184478	CD

TI	LS
-	:
Transcription	NN
mediated	VBN
by	IN
NFAT	NN
is	VBZ
highly	RB
inducible	JJ
in	IN
effector	NN
CD4+	JJ
T	NN
helper	NN
2	CD
(	(
Th2	NN
)	)
cells	NNS
but	CC
not	RB
in	IN
Th1	NN
cells	NNS
.	.

AB	LS
-	:
Transcriptional	JJ
factors	NNS
of	IN
the	DT
NFAT	NN
family	NN
play	VBP
an	DT
important	JJ
role	NN
in	IN
regulating	VBG
the	DT
expression	NN
of	IN
several	JJ
cytokine	NN
genes	NNS
during	IN
the	DT
immune	JJ
response	NN
,	,
such	JJ
as	IN
the	DT
genes	NNS
for	IN
interleukin	NN
2	CD
(	(
IL-2	NN
)	)
and	CC
IL-4	NN
,	,
among	IN
others	NNS
.	.

Upon	IN
antigen	NN
stimulation	NN
,	,
precursor	NN
CD4+	JJ
T	NN
helper	NN
(	(
pTh	NN
)	)
cells	NNS
proliferate	VBP
and	CC
differentiate	VBP
into	IN
two	CD
populations	NNS
of	IN
effector	NN
cells	NNS
(	(
eTh1	NN
and	CC
eTh2	NN
)	)
,	,
each	DT
one	NN
expressing	VBG
a	DT
specific	JJ
pattern	NN
of	IN
cytokines	NNS
that	WDT
distinguishes	VBZ
them	PRP
from	IN
their	PRP$
precursors	NNS
.	.

eTh2	NN
cells	NNS
are	VBP
the	DT
major	JJ
source	NN
of	IN
IL-4	NN
,	,
while	IN
gamma	NN
interferon	NN
is	VBZ
produced	VBN
by	IN
eTh1	NN
cells	NNS
.	.

Here	RB
we	PRP
have	VBP
used	VBN
reporter	NN
transgenic	JJ
mice	NNS
to	TO
show	VB
that	IN
DNA	NN
binding	NN
and	CC
transcriptional	JJ
activities	NNS
of	IN
NFAT	NN
are	VBP
transiently	RB
induced	VBN
during	IN
the	DT
differentiation	NN
of	IN
pTh	NN
cells	NNS
into	IN
either	CC
eTh1	NN
or	CC
eTh2	NN
cells	NNS
to	TO
mediate	VB
the	DT
expression	NN
of	IN
IL-2	NN
as	IN
a	DT
common	JJ
growth	NN
factor	NN
in	IN
both	CC
pathways	NNS
.	.

However	RB
,	,
although	IN
NFAT	NN
DNA	NN
binding	NN
is	VBZ
similarly	RB
induced	VBN
in	IN
both	CC
eTh1	NN
and	CC
eTh2	NN
cells	NNS
upon	IN
antigen	NN
stimulation	NN
,	,
only	RB
the	DT
NFAT	NN
complexes	NNS
present	JJ
in	IN
eTh2	NN
cells	NNS
are	VBP
able	JJ
to	TO
mediate	VB
high-level	JJ
transcription	NN
,	,
and	CC
relatively	RB
little	JJ
NFAT	NN
transcriptional	JJ
activity	NN
was	VBD
induced	VBN
in	IN
eTh1	NN
cells	NNS
.	.

In	IN
contrast	NN
to	TO
activated	VBN
pTh	NN
cells	NNS
,	,
neither	CC
eTh1	NN
nor	CC
eTh2	NN
cells	NNS
produced	VBD
significant	JJ
IL-2	NN
upon	IN
stimulation	NN
,	,
but	CC
the	DT
high	JJ
levels	NNS
of	IN
NFAT	NN
transcriptional	JJ
activities	NNS
directly	RB
correlate	VBP
with	IN
the	DT
IL-4	NN
production	NN
induced	VBN
in	IN
response	NN
to	TO
antigen	NN
stimulation	NN
in	IN
eTh2	NN
cells	NNS
.	.

These	DT
data	NNS
suggest	VBP
that	IN
activated	VBN
NFAT	NN
is	VBZ
involved	VBN
in	IN
the	DT
effector	NN
function	NN
of	IN
eTh2	NN
cells	NNS
and	CC
that	IN
the	DT
failure	NN
of	IN
eTh1	NN
cells	NNS
to	TO
produce	VB
IL-4	NN
in	IN
response	NN
to	TO
an	DT
antigen	NN
is	VBZ
due	JJ
,	,
at	IN
least	JJS
partially	RB
,	,
to	TO
a	DT
failure	NN
to	TO
induce	VB
high-level	JJ
transcription	NN
of	IN
the	DT
IL-4	NN
gene	NN
by	IN
NFAT	NN
.	.

Regulation	NN
of	IN
NFAT	NN
could	MD
be	VB
therefore	RB
a	DT
critical	JJ
element	NN
in	IN
the	DT
polarization	NN
to	TO
eTh1	NN
or	CC
eTh2	NN
.	.

UI	LS
-	:
97265379	CD

TI	LS
-	:
Expression	NN
of	IN
NFAT-family	NN
proteins	NNS
in	IN
normal	JJ
human	JJ
T	NN
cells	NNS
.	.

AB	LS
-	:
NFAT	NN
proteins	NNS
constitute	VBP
a	DT
family	NN
of	IN
transcription	NN
factors	NNS
involved	VBN
in	IN
mediating	VBG
signal	NN
transduction	NN
.	.

Using	VBG
a	DT
panel	NN
of	IN
specific	JJ
antisera	NNS
in	IN
immunoprecipitation	NN
assays	NNS
,	,
we	PRP
found	VBD
that	IN
NFATp	NN
(	(
135	CD
kDa	NN
)	)
is	VBZ
constitutively	RB
expressed	VBN
in	IN
normal	JJ
human	JJ
T	NN
cells	NNS
,	,
while	IN
synthesis	NN
of	IN
NFATc	NN
(	(
predominant	JJ
form	NN
of	IN
86	CD
kDa	NN
)	)
is	VBZ
induced	VBN
by	IN
ionomycin	NN
treatment	NN
.	.

NFAT4/x	NN
was	VBD
very	RB
weakly	RB
expressed	VBN
in	IN
unstimulated	JJ
cells	NNS
,	,
and	CC
its	PRP$
level	NN
did	VBD
not	RB
increase	VB
upon	IN
treatment	NN
with	IN
activating	VBG
agents	NNS
.	.

NFAT3	NN
protein	NN
was	VBD
not	RB
observed	VBN
under	IN
any	DT
conditions	NNS
.	.

Higher-molecular-weight	JJ
species	NNS
of	IN
NFATc	NN
(	(
of	IN
110	CD
and	CC
140	CD
kDa	NN
)	)
were	VBD
also	RB
detected	VBN
.	.

In	IN
addition	NN
,	,
translation	NN
of	IN
NFATc	NN
mRNA	NN
apparently	RB
initiates	VBZ
at	IN
two	CD
different	JJ
AUG	NN
codons	NNS
,	,
giving	VBG
rise	NN
to	TO
proteins	NNS
that	WDT
differ	VBP
in	IN
size	NN
by	IN
36	CD
amino	NN
acids	NNS
.	.

Additional	JJ
size	NN
heterogeneity	NN
of	IN
both	CC
NFATc	NN
and	CC
NFATp	NN
results	VBZ
from	IN
phosphorylation	NN
.	.

In	IN
contrast	NN
to	TO
ionomycin	NN
treatment	NN
,	,
exposure	NN
of	IN
cells	NNS
to	TO
phorbol	NN
myristate	NN
acetate	NN
(	(
PMA	NN
)	)
plus	CC
anti-CD28	NN
did	VBD
not	RB
induce	VB
NFATc	NN
,	,
indicating	VBG
that	IN
under	IN
these	DT
conditions	NNS
,	,
interleukin-2	NN
synthesis	NN
by	IN
these	DT
cells	NNS
is	VBZ
apparently	RB
independent	JJ
of	IN
NFATc	NN
.	.

In	IN
DNA	NN
binding	NN
assays	NNS
,	,
both	CC
PMA	NN
plus	CC
anti-CD28	NN
and	CC
PMA	NN
plus	CC
ionomycin	NN
resulted	VBD
in	IN
nuclear	JJ
NFAT	NN
.	.

Surprisingly	RB
,	,
the	DT
PMA-ionomycin-induced	JJ
synthesis	NN
of	IN
NFATc	NN
that	WDT
was	VBD
detected	VBN
by	IN
immunoprecipitation	NN
was	VBD
not	RB
mirrored	VBN
in	IN
the	DT
DNA	NN
binding	NN
assays	NNS
:	:
nearly	RB
all	DT
of	IN
the	DT
activity	NN
was	VBD
due	JJ
to	TO
NFATp	NN
.	.

This	DT
is	VBZ
the	DT
first	JJ
study	NN
of	IN
expression	NN
of	IN
all	DT
family	NN
members	NNS
at	IN
the	DT
protein	NN
level	NN
in	IN
normal	JJ
human	JJ
T	NN
cells	NNS
.	.

UI	LS
-	:
97332608	CD

TI	LS
-	:
Concomitant	JJ
downregulation	NN
of	IN
IgH	NN
3'	JJ
enhancer	NN
activity	NN
and	CC
c-myc	NN
expression	NN
in	IN
a	DT
plasmacytoma	NN
x	NN
fibroblast	NN
environment	NN
:	:
implications	NNS
for	IN
dysregulation	NN
of	IN
translocated	VBN
c-myc	NN
.	.

AB	LS
-	:
Regulation	NN
of	IN
immunoglobulin	NN
heavy	JJ
chain	NN
(	(
IgH	NN
)	)
gene	NN
expression	NN
is	VBZ
controlled	VBN
by	IN
a	DT
B	NN
cell-specific	JJ
promoter	NN
,	,
intronic	JJ
enhancer	NN
and	CC
additional	JJ
B	NN
cell-specific	JJ
enhancer	NN
elements	NNS
identified	VBN
recently	RB
in	IN
the	DT
3'	JJ
end	NN
of	IN
the	DT
IgH	NN
locus	NN
.	.

One	CD
of	IN
the	DT
latter	JJ
elements	NNS
,	,
the	DT
IgH	NN
3'	JJ
enhancer	NN
,	,
is	VBZ
of	IN
particular	JJ
interest	NN
:	:
(	(
1	LS
)	)
it	PRP
is	VBZ
B	NN
cell-specific	JJ
and	CC
active	JJ
only	RB
in	IN
late	JJ
B	NN
cell	NN
development	NN
;	:
(	(
2	LS
)	)
in	IN
rodent	JJ
plasmacytomas	NNS
and	CC
in	IN
some	DT
human	JJ
Burkitt	NN
's	POS
lymphomas	NNS
it	PRP
is	VBZ
part	NN
of	IN
a	DT
locus	NN
control	NN
region	NN
(	(
LCR	NN
)	)
that	WDT
is	VBZ
involved	VBN
in	IN
deregulation	NN
of	IN
the	DT
c-myc	NN
oncogene	NN
as	IN
a	DT
result	NN
of	IN
translocation	NN
into	IN
the	DT
IgH	NN
locus	NN
;	:
and	CC
(	(
3	LS
)	)
it	PRP
has	VBZ
been	VBN
implicated	VBN
in	IN
the	DT
mechanisms	NNS
that	WDT
control	VBP
Ig	NN
gene	NN
class	NN
switch	NN
recombination	NN
.	.

We	PRP
have	VBP
used	VBN
a	DT
somatic	JJ
cell	NN
hybridization	NN
approach	NN
to	TO
genetically	RB
analyse	VB
regulation	NN
of	IN
the	DT
activity	NN
of	IN
the	DT
IgH	NN
3'	JJ
enhancer	NN
.	.

When	WRB
mouse	NN
MPC11	NN
plasmacytoma	NN
cells	NNS
,	,
in	IN
which	WDT
the	DT
IgH	NN
3'	JJ
enhancer	NN
is	VBZ
active	JJ
,	,
are	VBP
fused	VBN
with	IN
fibroblasts	NNS
,	,
Ig	NN
expression	NN
is	VBZ
extinguished	VBN
at	IN
the	DT
level	NN
of	IN
transcription	NN
.	.

Here	RB
we	PRP
show	VBP
that	IN
in	IN
a	DT
MPC11	NN
plasmacytoma	NN
x	NN
fibroblast	NN
environment	NN
,	,
the	DT
IgH	NN
3'	JJ
enhancer	NN
is	VBZ
transcriptionally	RB
inactive	JJ
.	.

Furthermore	RB
,	,
we	PRP
demonstrate	VBP
that	IN
binding	NN
of	IN
several	JJ
B	NN
cell-specific	JJ
transcription	NN
factors	NNS
,	,
essential	JJ
for	IN
IgH	NN
3'	JJ
enhancer	NN
activity	NN
,	,
is	VBZ
lacking	VBG
,	,
which	WDT
may	MD
explain	VB
3'	JJ
enhancer	NN
inactivity	NN
,	,
although	IN
the	DT
binding	NN
of	IN
repressors	NNS
can	MD
not	RB
be	VB
excluded	VBN
.	.

Moreover	RB
,	,
the	DT
high	JJ
expression	NN
level	NN
of	IN
c-myc	NN
,	,
characteristic	JJ
of	IN
the	DT
parental	JJ
MPC11	NN
cells	NNS
carrying	VBG
the	DT
t(12;15)	NN
translocation	NN
,	,
is	VBZ
down-regulated	VBN
in	IN
the	DT
hybrids	NNS
to	TO
that	DT
in	IN
unfused	JJ
fibroblasts	NNS
.	.

Therefore	RB
,	,
inactivation	NN
of	IN
the	DT
IgH	NN
3'	JJ
enhancer	NN
is	VBZ
a	DT
multifactorial	JJ
process	NN
affecting	VBG
several	JJ
transcription	NN
factors	NNS
that	WDT
control	VBP
the	DT
cell-specific	JJ
and	CC
developmental	JJ
activity	NN
of	IN
the	DT
enhancer	NN
.	.

UI	LS
-	:
97154704	CD

TI	LS
-	:
Elf-2	NN
,	,
a	DT
rhombotin-2	NN
binding	NN
ets	NN
transcription	NN
factor	NN
:	:
discovery	NN
and	CC
potential	JJ
role	NN
in	IN
T	NN
cell	NN
leukemia	NN
.	.

AB	LS
-	:
Rhombotin-2	NN
(	(
RBTN-2	NN
)	)
is	VBZ
a	DT
proto-oncogene	NN
only	RB
in	IN
the	DT
context	NN
of	IN
T	NN
lymphocytes	NNS
.	.

We	PRP
postulated	VBD
that	IN
the	DT
oncogenic	JJ
effect	NN
of	IN
RBTN-2	NN
in	IN
T	NN
cells	NNS
is	VBZ
likely	RB
mediated	VBN
by	IN
binding	VBG
protein	NN
(	(
s	NNS
)	)
with	IN
T	NN
cell-specific	JJ
expression	NN
.	.

By	IN
screening	VBG
a	DT
T	NN
cell	NN
cDNA	NN
library	NN
,	,
we	PRP
identified	VBD
a	DT
novel	JJ
ets	NN
transcription	NN
factor	NN
that	WDT
binds	VBZ
RBTN-2	NN
.	.

This	DT
protein	NN
was	VBD
named	VBN
elf-2	NN
because	IN
its	PRP$
DNA-binding	JJ
domain	NN
is	VBZ
virtually	RB
identical	JJ
to	TO
that	DT
of	IN
ets	NN
family	NN
member	NN
elf-1	NN
.	.

Northern	NN
analyses	NNS
showed	VBD
similar	JJ
levels	NNS
of	IN
two	CD
elf-2	NN
transcripts	NNS
(	(
3.5	CD
kb	NN
and	CC
3.8	CD
kb	NN
)	)
in	IN
all	DT
tissues	NNS
except	IN
thymus	NN
.	.

Thymocytes	NNS
expressed	VBD
four-	CD
to	TO
10-fold	RB
greater	JJR
amounts	NNS
of	IN
the	DT
3.5	CD
kb	NN
transcript	NN
than	IN
other	JJ
tissues	NNS
.	.

Sequence	NN
analyses	NNS
of	IN
cDNA	NN
clones	NNS
indicated	VBD
that	IN
these	DT
transcripts	NNS
encode	VBP
proteins	NNS
differing	VBG
only	RB
at	IN
their	PRP$
amino	NN
termini	NNS
,	,
and	CC
likely	RB
represent	VBP
alternatively	RB
spliced	VBN
isoforms	NNS
.	.

These	DT
isoforms	NNS
(	(
elf-2a	NN
and	CC
elf-2b	NN
)	)
contain	VBP
identical	JJ
RBTN-2	NN
binding	NN
regions	NNS
and	CC
DNA-binding	JJ
domains	NNS
.	.

Elf-2b	NN
lacks	VBZ
a	DT
putative	JJ
transactivation	NN
domain	NN
.	.

The	DT
expression	NN
patterns	NNS
suggest	VBP
that	IN
RBTN-2	NN
normally	RB
interacts	VBZ
equally	RB
with	IN
elf-2a	NN
and	CC
elf-2b	NN
.	.

In	IN
contrast	NN
,	,
when	WRB
RBTN-2	NN
is	VBZ
inappropriately	RB
expressed	VBN
in	IN
T	NN
cells	NNS
,	,
RBTN-2	NN
would	MD
interact	VB
predominantly	RB
with	IN
elf-2b	NN
;	:
this	DT
interaction	NN
may	MD
lead	VB
to	TO
T	NN
cell	NN
proliferation	NN
.	.

UI	LS
-	:
99126331	CD

TI	LS
-	:
Transcription	NN
factor	NN
effects	NNS
on	IN
chromosome	NN
constitution	NN
of	IN
cell	NN
hybrids	NNS
.	.

AB	LS
-	:
When	WRB
immunoglobulin	NN
(	(
Ig	NN
)	)
-secreting	JJ
plasmacytomas	NNS
are	VBP
fused	VBN
to	TO
a	DT
T-cell	NN
lymphoma	NN
,	,
Ig	NN
gene	NN
expression	NN
ceases	VBZ
in	IN
greater	JJR
than	IN
95	CD
%	NN
of	IN
the	DT
resulting	VBG
hybrids	NNS
.	.

In	IN
the	DT
rare	JJ
hybrids	NNS
that	WDT
continue	VBP
to	TO
express	VB
Ig	NN
,	,
all	DT
other	JJ
tested	VBN
B	NN
lymphocyte-specific	JJ
genes	NNS
also	RB
remain	VBP
active	JJ
.	.

The	DT
low	JJ
frequency	NN
with	IN
which	WDT
these	DT
Ig-expressing	JJ
hybrids	NNS
are	VBP
recovered	VBN
,	,
along	IN
with	IN
the	DT
fact	NN
that	IN
cell	NN
fusions	NNS
can	MD
lead	VB
to	TO
chromosome	NN
loss	NN
,	,
led	VBD
us	PRP
to	TO
propose	VB
that	IN
this	DT
rare	JJ
phenotype	NN
was	VBD
due	JJ
to	TO
loss	NN
of	IN
a	DT
T-cell-derived	JJ
chromosome	NN
encoding	VBG
a	DT
factor	NN
or	CC
factors	NNS
with	IN
gene	NN
silencing	NN
activity	NN
.	.

To	TO
identify	VB
the	DT
relevant	JJ
chromosome	NN
,	,
we	PRP
have	VBP
used	VBN
a	DT
polymerase	NN
chain	NN
reaction	NN
(	(
PCR	NN
)	)
-assisted	JJ
method	NN
of	IN
chromosome	NN
mapping	NN
to	TO
analyze	VB
both	CC
Ig-silenced	JJ
(	(
common	JJ
)	)
and	CC
Ig-expressing	JJ
(	(
rare	JJ
)	)
hybrids	NNS
.	.

Although	IN
no	DT
single	JJ
chromosome	NN
was	VBD
found	VBN
to	TO
correlate	VB
with	IN
Ig	NN
gene	NN
silencing	NN
,	,
we	PRP
discovered	VBD
that	IN
the	DT
two	CD
types	NNS
of	IN
hybrids	NNS
had	VBD
undergone	VBN
distinct	JJ
patterns	NNS
of	IN
chromosome	NN
loss	NN
.	.

Moreover	RB
,	,
we	PRP
found	VBD
that	IN
ectopic	JJ
expression	NN
of	IN
a	DT
B-cell-specific	JJ
transcription	NN
factor	NN
(	(
Oct-2	NN
)	)
dramatically	RB
altered	VBD
both	CC
the	DT
phenotype	NN
and	CC
chromosome	NN
constitution	NN
of	IN
hybrids	NNS
arising	VBG
in	IN
these	DT
cell	NN
fusions	NNS
.	.

UI	LS
-	:
97261053	CD

TI	LS
-	:
c-Jun	NN
and	CC
GST-pi	NN
expression	NN
in	IN
human	JJ
plasma	NN
cells	NNS
.	.

AB	LS
-	:
Bone	NN
marrow	NN
samples	NNS
from	IN
33	CD
patients	NNS
affected	VBN
by	IN
MM	NN
and	CC
MGUS	NN
,	,
and	CC
8	CD
patients	NNS
not	RB
affected	VBN
by	IN
lymphoproliferative	JJ
diseases	NNS
were	VBD
studied	VBN
for	IN
expression	NN
of	IN
c-Jun	NN
(	(
a	DT
component	NN
of	IN
the	DT
transcription	NN
factor	NN
AP-1	NN
)	)
and	CC
glutathione-S-transferase	NN
pi	NN
(	(
GST-pi	NN
)	)
using	VBG
immunocytochemical	JJ
methods	NNS
.	.

A	DT
high	JJ
and	CC
frequent	JJ
expression	NN
of	IN
these	DT
two	CD
proteins	NNS
was	VBD
found	VBN
both	CC
in	IN
MM	NN
and	CC
MGUS	NN
patients	NNS
(	(
31/33	CD
patients	NNS
positive	JJ
for	IN
c-Jun	NN
and	CC
29/33	CD
patients	NNS
positive	JJ
for	IN
GST-pi	NN
)	)
and	CC
in	IN
controls	NNS
not	RB
affected	VBN
by	IN
monoclonal	JJ
gammopathy	NN
(	(
7/8	CD
patients	NNS
positive	JJ
for	IN
both	CC
c-Jun	NN
and	CC
GST-pi	NN
)	)
.	.

No	DT
statistically	RB
significant	JJ
correlation	NN
was	VBD
found	VBN
between	IN
c-Jun-	NN
and	CC
GST-pi-positive	JJ
plasma	NN
cells	NNS
.	.

The	DT
expression	NN
of	IN
these	DT
two	CD
proteins	NNS
was	VBD
not	RB
related	JJ
to	TO
clinical	JJ
or	CC
laboratory	NN
data	NNS
.	.

Our	PRP$
results	NNS
seem	VBP
to	TO
confirm	VB
a	DT
possible	JJ
role	NN
of	IN
the	DT
transcriptional	JJ
complex	NN
AP-1	NN
in	IN
activating	VBG
GST-pi	NN
promoter	NN
in	IN
human	JJ
plasma	NN
cells	NNS
.	.

UI	LS
-	:
99041167	CD

TI	LS
-	:
Membrane-associated	JJ
lymphotoxin	NN
on	IN
natural	JJ
killer	NN
cells	NNS
activates	VBZ
endothelial	JJ
cells	NNS
via	IN
an	DT
NF-kappaB-dependent	JJ
pathway	NN
.	.

AB	LS
-	:
BACKGROUND	NN
:	:
Inhibition	NN
of	IN
complement	NN
in	IN
small	JJ
animal	NN
models	NNS
of	IN
xenotransplantation	NN
has	VBZ
demonstrated	VBN
graft	NN
infiltration	NN
with	IN
natural	JJ
killer	NN
(	(
NK	NN
)	)
cells	NNS
and	CC
monocytes	NNS
associated	VBN
with	IN
endothelial	JJ
cell	NN
(	(
EC	NN
)	)
activation	NN
.	.

We	PRP
have	VBP
previously	RB
demonstrated	VBN
that	IN
human	JJ
NK	NN
cells	NNS
activate	VBP
porcine	NN
EC	NN
in	FW
vitro	FW
,	,
which	WDT
results	VBZ
in	IN
adhesion	NN
molecule	NN
expression	NN
and	CC
cytokine	NN
secretion	NN
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
used	VBD
the	DT
NK	NN
cell	NN
line	NN
NK92	NN
to	TO
define	VB
the	DT
molecular	JJ
and	CC
cellular	JJ
basis	NN
of	IN
NK	NN
cell-mediated	JJ
EC	NN
activation	NN
.	.

METHODS	NNS
:	:
EC	NNS
were	VBD
transfected	VBN
with	IN
either	CC
reporter	NN
constructs	NNS
containing	VBG
the	DT
luciferase	NN
gene	NN
driven	VBN
either	CC
by	IN
E-selectin	NN
or	CC
interleukin	NN
(	(
IL	NN
)	)
-8	CD
promoters	NNS
or	CC
a	DT
synthetic	JJ
NF-kappaB-dependent	JJ
promoter	NN
.	.

In	IN
addition	NN
,	,
a	DT
dominant-negative	JJ
mutant	JJ
tumor	NN
necrosis	NN
factor	NN
receptor	NN
I	CD
(	(
TNFRI	NN
)	)
expression	NN
vector	NN
was	VBD
co-transfected	VBN
in	IN
inhibition	NN
studies	NNS
.	.

Forty-eight	CD
hours	NNS
after	IN
transfection	NN
,	,
EC	NNS
were	VBD
stimulated	VBN
with	IN
NK	NN
cells	NNS
or	CC
NK	NN
cell	NN
membrane	NN
extracts	NNS
for	IN
7	CD
hr	NN
and	CC
activation	NN
was	VBD
measured	VBN
by	IN
a	DT
luciferase	NN
assay	NN
.	.

RESULTS	NNS
:	:
Co-culture	NN
of	IN
NK	NN
cells	NNS
with	IN
transfected	VBN
EC	NN
enhanced	VBD
E-selectin	NN
,	,
IL-8	NN
,	,
and	CC
NF-kappaB-dependent	JJ
promoter	NN
activity	NN
.	.

NK	NN
cell	NN
membrane	NN
extracts	NNS
retained	VBD
the	DT
capacity	NN
to	TO
activate	VB
EC	NN
and	CC
induced	VBD
nuclear	JJ
translocation	NN
of	IN
NF-kappaB	NN
(	(
p50	NN
and	CC
p65	NN
)	)
.	.

Western	NN
blotting	NN
of	IN
NK	NN
cell	NN
and	CC
membrane	NN
extracts	NNS
detected	VBD
the	DT
presence	NN
of	IN
Lymphotoxin-alpha	NN
(	(
LTalpha	NN
)	)
but	CC
not	RB
tumor	NN
necrosis	NN
factor-alpha	NN
.	.

Furthermore	RB
,	,
LTalpha	NN
was	VBD
secreted	VBN
in	IN
NK:EC	NN
co-cultures	NNS
.	.

Co-transfection	NN
with	IN
dominant-negative	JJ
mutant	JJ
TNFRI	NN
inhibited	VBD
EC	NN
activation	NN
by	IN
NK	NN
cell	NN
membrane	NN
extracts	NNS
and	CC
by	IN
NK	NN
cells	NNS
by	IN
80	CD
%	NN
and	CC
47	CD
%	NN
,	,
respectively	RB
.	.

The	DT
same	JJ
pattern	NN
of	IN
inhibition	NN
was	VBD
observed	VBN
using	VBG
anti-human	JJ
LT	NN
sera	NNS
.	.

CONCLUSIONS	NNS
:	:
Human	JJ
NK	NN
cell	NN
membrane-bound	JJ
LT	NN
signals	VBZ
across	IN
species	NNS
via	IN
TNFRI	NN
,	,
leading	VBG
to	TO
NF-kappaB	NN
nuclear	JJ
translocation	NN
and	CC
transcription	NN
of	IN
E-selectin	NN
and	CC
IL-8	NN
,	,
which	WDT
results	VBZ
in	IN
EC	NN
activation	NN
.	.

The	DT
discrepancy	NN
in	IN
the	DT
degree	NN
of	IN
inhibition	NN
by	IN
membrane	NN
extracts	NNS
and	CC
NK	NN
cells	NNS
with	IN
mutant	JJ
TNFRI	NN
suggests	VBZ
that	IN
additional	JJ
pathways	NNS
are	VBP
utilized	VBN
by	IN
NK	NN
cells	NNS
to	TO
activate	VB
EC	NN

UI	LS
-	:
99089911	CD

TI	LS
-	:
X-rays-induced	JJ
secretion	NN
of	IN
cellular	JJ
factor	NN
(	(
s	NNS
)	)
that	WDT
enhance	VBP
(	(
s	VBZ
)	)
HIV-1	NN
promoter	NN
transcription	NN
in	IN
various	JJ
non-irradiated	JJ
transfected	VBN
cell	NN
lines	NNS
.	.

AB	LS
-	:
Various	JJ
cellular	JJ
stress	NN
agents	NNS
like	IN
ionizing	VBG
radiation	NN
exposure	NN
could	MD
activate	VB
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
(	(
HIV-1	NN
)	)
replication	NN
or	CC
reporter	NN
gene	NN
expression	NN
.	.

In	IN
addition	NN
,	,
extracellular	JJ
factor	NN
(	(
s	NNS
)	)
released	VBN
by	IN
X-ray-treated	JJ
human	JJ
colonic	JJ
carcinoma	NN
cell	NN
line	NN
(	(
HT29	NN
)	)
might	MD
activate	VB
the	DT
long	JJ
terminal	JJ
repeat	NN
(	(
LTR	NN
)	)
of	IN
HIV-1	NN
in	IN
non-irradiated	JJ
HT29	NN
cells	NNS
.	.

In	IN
the	DT
present	JJ
report	NN
we	PRP
show	VBP
that	IN
in	IN
various	JJ
transiently	RB
or	CC
stably	RB
transfected	VBN
cell	NN
lines	NNS
,	,
X-ray	NN
irradiation	NN
up-regulates	VBZ
HIV-1	NN
LTR	NN
transcription	NN
through	IN
the	DT
kappaB	NN
regulatory	JJ
elements	NNS
.	.

A	DT
factor	NN
(	(
s	NNS
)	)
,	,
which	WDT
is	VBZ
processed	VBN
by	IN
and	CC
acts	VBZ
upon	IN
a	DT
variety	NN
of	IN
cell	NN
types	NNS
,	,
was	VBD
detected	VBN
by	IN
addition	NN
to	TO
non-irradiated	JJ
cells	NNS
of	IN
either	CC
X-ray-treated	JJ
cells	NNS
or	CC
a	DT
conditioned	JJ
medium	NN
taken	VBN
from	IN
irradiated	JJ
cultures	NNS
.	.

The	DT
magnitude	NN
of	IN
responsiveness	NN
is	VBZ
cell	NN
type	NN
dependent	JJ
.	.

In	IN
addition	NN
,	,
X-ray	NN
activation	NN
of	IN
HIV-1	NN
LTR	NN
in	IN
transiently	RB
or	CC
stably	RB
transfected	VBN
cell	NN
lines	NNS
is	VBZ
inhibited	VBN
by	IN
a	DT
potent	JJ
antioxidant	JJ
drug	NN
,	,
pyrrolidine	NN
dithiocarbamate	NN
and	CC
by	IN
another	DT
drug	NN
,	,
known	VBN
for	IN
its	PRP$
role	NN
in	IN
the	DT
trapping	NN
of	IN
growth	NN
factors	NNS
,	,
suramin	NN
.	.

The	DT
importance	NN
of	IN
these	DT
observations	NNS
in	IN
the	DT
pathophysiology	NN
of	IN
patients	NNS
with	IN
AIDS-related	JJ
cancers	NNS
treated	VBN
by	IN
radiotherapy	NN
remains	VBZ
to	TO
be	VB
established	VBN
.	.

UI	LS
-	:
97131727	CD

TI	LS
-	:
The	DT
state	NN
of	IN
maturation	NN
of	IN
monocytes	NNS
into	IN
macrophages	NNS
determines	VBZ
the	DT
effects	NNS
of	IN
IL-4	NN
and	CC
IL-13	NN
on	IN
HIV	NN
replication	NN
.	.

AB	LS
-	:
The	DT
molecular	JJ
mechanisms	NNS
of	IN
the	DT
effects	NNS
of	IN
IL-4	NN
and	CC
IL-13	NN
on	IN
HIV	NN
infection	NN
in	IN
human	JJ
monocytes	NNS
as	IN
they	PRP
matured	VBD
into	IN
monocyte-derived	JJ
macrophages	NNS
over	IN
7	CD
days	NNS
were	VBD
investigated	VBN
using	VBG
HIV-1	NN
(	(
BaL	NN
)	)
,	,
and	CC
low	JJ
passage	NN
clinical	JJ
strains	NNS
.	.

IL-4	NN
and	CC
IL-13	NN
up-regulated	VBD
the	DT
expression	NN
of	IN
both	CC
genomic	JJ
and	CC
spliced	VBN
HIV	NN
mRNA	NN
in	IN
monocytes	NNS
cultured	VBN
on	IN
Teflon	NN
,	,
as	IN
determined	VBN
by	IN
Northern	NN
analysis	NN
and	CC
p24	NN
Ag	NN
assay	NN
.	.

Using	VBG
a	DT
nuclear	JJ
run-on	JJ
assay	NN
,	,
IL-4	NN
stimulation	NN
was	VBD
shown	VBN
to	TO
enhance	VB
transcription	NN
by	IN
two-	CD
to	TO
threefold	RB
.	.

IL-4	NN
stimulated	VBD
nuclear	JJ
factor-kappaB	NN
nuclear	JJ
translocation	NN
and	CC
binding	NN
before	IN
enhancement	NN
of	IN
HIV	NN
RNA	NN
expression	NN
.	.

Conversely	RB
,	,
IL-4	NN
and	CC
IL-13	NN
markedly	RB
and	CC
significantly	RB
inhibited	VBD
HIV	NN
replication	NN
at	IN
the	DT
transcriptional	JJ
level	NN
in	IN
monocyte-derived	JJ
macrophages	NNS
,	,
and	CC
this	DT
occurred	VBD
whether	IN
these	DT
cytokines	NNS
were	VBD
added	VBN
before	IN
or	CC
after	IN
HIV	NN
infection	NN
.	.

The	DT
reversal	NN
from	IN
stimulation	NN
to	TO
inhibition	NN
occurred	VBD
after	IN
3	CD
to	TO
5	CD
days	NNS
of	IN
adherence	NN
to	TO
plastic	NN
.	.

IL-4	NN
had	VBD
no	DT
significant	JJ
effect	NN
on	IN
HIV	NN
reverse	JJ
transcription	NN
.	.

The	DT
effect	NN
of	IN
both	DT
cytokines	NNS
on	IN
the	DT
monocyte	NN
maturation/differentiation	NN
(	(
CD11b	NN
,	,
CD13	NN
,	,
and	CC
CD26	NN
)	)
and	CC
other	JJ
macrophage	NN
markers	NNS
(	(
CD14	NN
and	CC
CD68	NN
)	)
was	VBD
examined	VBN
.	.

IL-4	NN
enhanced	VBD
CD11b	NN
,	,
but	CC
inhibited	VBD
CD26	NN
expression	NN
and	CC
delayed	VBD
CD13	NN
loss	NN
.	.

IL-13	NN
had	VBD
similar	JJ
effects	NNS
on	IN
CD11b	NN
and	CC
CD13	NN
,	,
but	CC
no	DT
effect	NN
on	IN
CD26	NN
.	.

Hence	RB
,	,
these	DT
cytokines	NNS
do	VBP
not	RB
simply	RB
enhance	VB
monocyte	NN
differentiation	NN
,	,
but	CC
have	VBP
complex	JJ
and	CC
slightly	RB
divergent	JJ
effects	NNS
that	WDT
impact	VBP
on	IN
HIV	NN
replication	NN
probably	RB
through	IN
cell	NN
signaling	NN
pathways	NNS
and	CC
nuclear	JJ
factor-kappaB	NN
translocation	NN
.	.

UI	LS
-	:
99098435	CD

TI	LS
-	:
Induction	NN
of	IN
the	DT
pro-myelocytic	JJ
leukaemia	NN
gene	NN
by	IN
type	NN
I	CD
and	CC
type	NN
II	CD
interferons	NNS
.	.

AB	LS
-	:
The	DT
physiological	JJ
role	NN
of	IN
the	DT
pro-myelocytic	JJ
leukaemia	NN
(	(
PML	NN
)	)
gene	NN
product	NN
is	VBZ
poorly	RB
defined	VBN
.	.

Among	IN
other	JJ
functions	NNS
,	,
PML	NN
is	VBZ
involved	VBN
in	IN
haematopoietic	JJ
differentiation	NN
and	CC
in	IN
control	NN
of	IN
cell	NN
growth	NN
and	CC
tumorigenesis	NN
.	.

We	PRP
investigated	VBD
the	DT
regulation	NN
of	IN
human	JJ
PML	NN
expression	NN
by	IN
interferons	NNS
(	(
IFNs	NNS
)	)
and	CC
IL-1	NN
in	IN
various	JJ
human	JJ
haematopoietic	JJ
lines	NNS
(	(
U937	NN
,	,
THP1	NN
,	,
HL60	NN
,	,
NB4	NN
)	)
,	,
in	IN
human	JJ
diploid	JJ
fibroblasts	NNS
and	CC
in	IN
human	JJ
peripheral	JJ
blood	NN
leukocytes	NNS
.	.

Cytokine-induced	JJ
modulation	NN
of	IN
PML	NN
expression	NN
was	VBD
assessed	VBN
by	IN
Northern	NN
blot	NN
analyses	NNS
,	,
flow	NN
cytometry	NN
studies	NNS
and	CC
in	FW
situ	FW
immunolabelling	NN
.	.

Our	PRP$
data	NNS
show	VBP
that	IN
IFNs	NNS
and	CC
IL-1	NN
upregulate	VBP
PML	NN
transcript	NN
and	CC
protein	NN
expression	NN
in	IN
a	DT
time	NN
and	CC
dose-dependent	JJ
manner	NN
.	.

In	FW
situ	FW
immunolabelling	NN
revealed	VBD
that	IN
upregulation	NN
of	IN
protein	NN
expression	NN
by	IN
IFN-alpha	NN
is	VBZ
a	DT
consequence	NN
of	IN
a	DT
marked	JJ
increase	NN
in	IN
both	CC
the	DT
number	NN
and	CC
the	DT
intensity	NN
of	IN
the	DT
staining	NN
of	IN
so-called	JJ
PML	NN
nuclear	JJ
bodies	NNS
.	.

Our	PRP$
data	NNS
suggest	VBP
that	IN
stimulation	NN
of	IN
PML	NN
expression	NN
by	IN
interferons	NNS
and	CC
IL-1	NN
may	MD
account	VB
for	IN
upregulation	NN
of	IN
PML	NN
proteins	NNS
observed	VBN
in	IN
inflammatory	JJ
tissues	NNS
and	CC
in	IN
proliferative	JJ
states	NNS
.	.

UI	LS
-	:
99077519	CD

TI	LS
-	:
The	DT
role	NN
of	IN
Stat4	NN
in	IN
species-specific	JJ
regulation	NN
of	IN
Th	NN
cell	NN
development	NN
by	IN
type	NN
I	CD
IFNs	NNS
.	.

AB	LS
-	:
Type	NN
I	CD
IFNs	NNS
(	(
IFN-alpha/beta	NN
)	)
,	,
in	IN
addition	NN
to	TO
IL-12	NN
,	,
have	VBP
been	VBN
shown	VBN
to	TO
play	VB
an	DT
important	JJ
role	NN
in	IN
the	DT
differentiation	NN
of	IN
human	JJ
,	,
but	CC
not	RB
mouse	NN
,	,
Th	NN
cells	NNS
.	.

We	PRP
show	VBP
here	RB
that	IN
IFN-alpha/beta	NN
act	VBP
directly	RB
on	IN
human	JJ
T	NN
cells	NNS
to	TO
drive	VB
Th1	NN
development	NN
,	,
bypassing	VBG
the	DT
need	NN
for	IN
IL-12-induced	JJ
signaling	NN
,	,
whereas	IN
IFN-alpha	NN
can	MD
not	RB
substitute	VB
IL-12	NN
for	IN
mouse	NN
Th1	NN
development	NN
.	.

The	DT
molecular	JJ
basis	NN
for	IN
this	DT
species	NNS
specificity	NN
is	VBZ
that	IN
IFN-alpha/beta	NN
activate	VBP
Stat4	NN
in	IN
differentiating	VBG
human	JJ
,	,
but	CC
not	RB
mouse	NN
,	,
Th	NN
cells	NNS
.	.

Unlike	IN
IL-12	NN
,	,
which	WDT
acts	VBZ
only	RB
on	IN
Th1	NN
cells	NNS
,	,
IFN-alpha/beta	NN
can	MD
activate	VB
Stat4	NN
not	RB
only	RB
in	IN
human	JJ
Th1	NN
,	,
but	CC
also	RB
in	IN
Th2	NN
cells	NNS
.	.

However	RB
,	,
restimulation	NN
of	IN
human	JJ
Th2	NN
lines	NNS
and	CC
clones	NNS
in	IN
the	DT
presence	NN
of	IN
IFN-alpha	NN
does	VBZ
not	RB
induce	VB
the	DT
production	NN
of	IN
IFN-gamma	NN
.	.

These	DT
results	NNS
suggest	VBP
that	IN
activation	NN
of	IN
Stat4	NN
,	,
which	WDT
is	VBZ
necessary	JJ
for	IN
the	DT
differentiation	NN
of	IN
naive	JJ
T	NN
cells	NNS
into	IN
polarized	VBN
Th1	NN
cells	NNS
,	,
is	VBZ
not	RB
sufficient	JJ
to	TO
induce	VB
phenotype	NN
reversal	NN
of	IN
human	JJ
Th2	NN
cells	NNS
.	.

UI	LS
-	:
99047534	CD

TI	LS
-	:
Cloning	NN
of	IN
ARE-containing	JJ
genes	NNS
by	IN
AU-motif-directed	JJ
display	NN
.	.

AB	LS
-	:
A	DT
procedure	NN
suitable	JJ
for	IN
cloning	VBG
labile	JJ
mRNAs	NNS
that	WDT
contain	VBP
AU	NN
motifs	NNS
is	VBZ
presented	VBN
(	(
AU-DD	NN
)	)
.	.

These	DT
motifs	NNS
are	VBP
regulatory	JJ
sequences	NNS
within	IN
the	DT
so-called	JJ
AU-rich	JJ
elements	NNS
(	(
AREs	NNS
)	)
often	RB
found	VBN
in	IN
3'	JJ
untranslated	JJ
regions	NNS
of	IN
genes	NNS
such	JJ
as	IN
cytokines	NNS
,	,
proto-oncogenes	NNS
,	,
and	CC
transcription	NN
factors	NNS
.	.

AU-DD	NN
is	VBZ
an	DT
AU-motif-directed	JJ
differential	JJ
display	NN
that	WDT
permits	VBZ
the	DT
identification	NN
of	IN
ARE-containing	JJ
genes	NNS
differentially	RB
expressed	VBN
after	IN
cell	NN
activation	NN
.	.

It	PRP
has	VBZ
been	VBN
applied	VBN
to	TO
peripheral	JJ
blood	NN
monocytes	NNS
and	CC
a	DT
T	NN
cell	NN
clone	NN
to	TO
isolate	VB
59	CD
cDNA	NN
fragments	NNS
associated	VBN
to	TO
activation	NN
.	.

Fourteen	CD
percent	NN
of	IN
isolated	VBN
fragments	NNS
belong	VBP
to	TO
already	RB
known	JJ
genes	NNS
that	WDT
certainly	RB
are	VBP
cytokines	NNS
and	CC
transduction/transcription	NN
factors	NNS
.	.

The	DT
remaining	VBG
86	CD
%	NN
correspond	VBP
to	TO
unknown	JJ
genes	NNS
of	IN
which	WDT
92	CD
%	NN
have	VBP
been	VBN
confirmed	VBN
to	TO
be	VB
differentially	RB
expressed	VBN
.	.

These	DT
data	NNS
demonstrate	VBP
the	DT
efficiency	NN
of	IN
the	DT
system	NN
and	CC
support	VBP
the	DT
notion	NN
that	IN
numerous	JJ
genes	NNS
falling	VBG
into	IN
those	DT
categories	NNS
remain	VBP
unidentified	JJ
and	CC
that	IN
they	PRP
can	MD
be	VB
cloned	VBN
by	IN
this	DT
method	NN
.	.

Copyright	NN
1998	CD
Academic	NNP
Press	NNP
.	.

UI	LS
-	:
97358652	CD

TI	LS
-	:
Expression	NN
of	IN
transcription	NN
factors	NNS
during	IN
sodium	NN
phenylacetate	NN
induced	VBD
erythroid	JJ
differentiation	NN
in	IN
K562	NN
cells	NNS
.	.

AB	LS
-	:
During	IN
15	CD
days	NNS
of	IN
treatment	NN
of	IN
K562	NN
cells	NNS
with	IN
sodium	NN
phenylacetate	NN
,	,
we	PRP
observed	VBD
an	DT
increase	NN
in	IN
the	DT
cellular	JJ
hemoglobin	NN
concentration	NN
with	IN
a	DT
similar	JJ
increase	NN
in	IN
the	DT
expression	NN
of	IN
gamma-globin	NN
mRNA	NN
.	.

Morphological	JJ
studies	NNS
demonstrated	VBD
characteristic	JJ
features	NNS
of	IN
erythroid	JJ
differentiation	NN
and	CC
maturation	NN
.	.

At	IN
the	DT
same	JJ
time	NN
there	EX
was	VBD
no	DT
change	NN
in	IN
the	DT
level	NN
of	IN
expression	NN
of	IN
the	DT
cell	NN
surface	NN
antigenes	NNS
CD33	NN
,	,
CD34	NN
,	,
CD45	NN
,	,
CD71	NN
and	CC
glycophorin	NN
A	NN
.	.

Likewise	RB
,	,
the	DT
level	NN
of	IN
expression	NN
of	IN
the	DT
erythroid	JJ
transcription	NN
factors	NNS
GATA-1	NN
,	,
GATA-2	NN
,	,
NF-E2	NN
,	,
SCL	NN
and	CC
RBTN2	NN
,	,
all	DT
expressed	VBN
in	IN
untreated	JJ
K562	NN
cells	NNS
,	,
did	VBD
not	RB
increase	VB
during	IN
sodium	NN
phenylacetate	NN
induced	JJ
erythroid	JJ
differentiation	NN
.	.

The	DT
expression	NN
of	IN
the	DT
nuclear	JJ
factors	NNS
Evi-1	NN
and	CC
c-myb	NN
,	,
known	VBN
to	TO
inhibit	VB
erythroid	JJ
differentiation	NN
,	,
did	VBD
not	RB
decrease	VB
.	.

We	PRP
conclude	VBP
that	IN
sodium	NN
phenylacetate	NN
treatment	NN
of	IN
K562	NN
cells	NNS
increases	VBZ
gamma-globin	NN
mRNA	NN
and	CC
induces	VBZ
cell	NN
maturation	NN
as	IN
judged	VBN
by	IN
morphology	NN
without	IN
affecting	VBG
the	DT
expression	NN
of	IN
the	DT
erythroid	JJ
transcription	NN
factors	NNS
,	,
some	DT
of	IN
which	WDT
are	VBP
known	VBN
to	TO
be	VB
involved	VBN
in	IN
the	DT
regulation	NN
of	IN
beta-like	JJ
globin	NN
genes	NNS
.	.

UI	LS
-	:
99060916	CD

TI	LS
-	:
Regulation	NN
of	IN
PAK	NN
activation	NN
and	CC
the	DT
T	NN
cell	NN
cytoskeleton	NN
by	IN
the	DT
linker	NN
protein	NN
SLP-76	NN
.	.

AB	LS
-	:
Tyrosine	NN
phosphorylation	NN
of	IN
linker	NN
proteins	NNS
enables	VBZ
the	DT
T	NN
cell	NN
antigen	NN
receptor	NN
(	(
TCR	NN
)	)
-associated	JJ
protein	NN
tyrosine	NN
kinases	NNS
to	TO
phosphorylate	VB
and	CC
regulate	VB
effector	NN
molecules	NNS
that	WDT
generate	VBP
second	JJ
messengers	NNS
.	.

We	PRP
demonstrate	VBP
here	RB
that	IN
the	DT
SLP-76	NN
linker	NN
protein	NN
interacts	VBZ
with	IN
both	CC
nck	NN
,	,
an	DT
adaptor	NN
protein	NN
,	,
and	CC
Vav	NN
,	,
a	DT
guanine	JJ
nucleotide	NN
exchange	NN
factor	NN
for	IN
Rho-family	JJ
GTPases	NNS
.	.

The	DT
assembly	NN
of	IN
this	DT
tri-molecular	JJ
complex	NN
permits	VBZ
the	DT
activated	VBN
Rho-family	JJ
GTPases	NNS
to	TO
regulate	VB
target	NN
effectors	NNS
that	WDT
interact	VBP
through	IN
nck	NN
.	.

In	IN
turn	NN
,	,
assembly	NN
of	IN
this	DT
complex	NN
mediates	VBZ
the	DT
enzymatic	JJ
activation	NN
of	IN
the	DT
p21-activated	JJ
protein	NN
kinase	NN
1	CD
and	CC
facilitates	VBZ
actin	NN
polymerization	NN
.	.

Hence	RB
,	,
phosphorylation	NN
of	IN
linker	NN
proteins	NNS
not	RB
only	RB
bridges	VBZ
the	DT
TCR-associated	JJ
PTK	NN
,	,
ZAP-70	NN
,	,
with	IN
downstream	JJ
effector	NN
proteins	NNS
,	,
but	CC
also	RB
provides	VBZ
a	DT
scaffold	NN
to	TO
integrate	VB
distinct	JJ
signaling	VBG
complexes	NNS
to	TO
regulate	VB
T	NN
cell	NN
function	NN
.	.

UI	LS
-	:
99047525	CD

TI	LS
-	:
The	DT
human	JJ
gene	NN
encoding	VBG
the	DT
lectin-type	JJ
oxidized	VBN
LDL	NN
receptor	NN
(	(
OLR1	NN
)	)
is	VBZ
a	DT
novel	JJ
member	NN
of	IN
the	DT
natural	JJ
killer	NN
gene	NN
complex	NN
with	IN
a	DT
unique	JJ
expression	NN
profile	NN
.	.

AB	LS
-	:
LOX-1	NN
is	VBZ
an	DT
endothelial	JJ
receptor	NN
for	IN
oxidized	VBN
low-density	JJ
lipoprotein	NN
that	WDT
plays	VBZ
essential	JJ
roles	NNS
in	IN
atherogenesis	NN
.	.

LOX-1	NN
has	VBZ
the	DT
highest	JJS
homology	NN
with	IN
C-type	JJ
lectin	NN
receptors	NNS
expressed	VBN
on	IN
natural	JJ
killer	NN
cells	NNS
.	.

In	IN
the	DT
present	JJ
study	NN
,	,
we	PRP
cloned	VBD
and	CC
characterized	VBD
the	DT
human	JJ
LOX-1	NN
gene	NN
(	(
HGMW-approved	JJ
symbol	NN
OLR1	NN
)	)
.	.

The	DT
gene	NN
structure	NN
of	IN
LOX-1	NN
resembles	VBZ
that	DT
of	IN
the	DT
natural	JJ
killer	NN
cell	NN
receptors	NNS
.	.

Fluorescence	NN
in	FW
situ	FW
hybridization	NN
and	CC
analyses	NNS
of	IN
a	DT
yeast	NN
artificial	JJ
chromosome	NN
contig	NN
revealed	VBD
that	IN
the	DT
human	JJ
LOX-1	NN
gene	NN
is	VBZ
located	JJ
in	IN
the	DT
natural	JJ
killer	NN
gene	NN
complex	NN
on	IN
chromosome	NN
12p12-p13	NN
,	,
where	WRB
the	DT
genes	NNS
of	IN
the	DT
natural	JJ
killer	NN
cell	NN
receptors	NNS
cluster	VBP
.	.

In	IN
contrast	NN
,	,
the	DT
expression	NN
pattern	NN
of	IN
LOX-1	NN
is	VBZ
different	JJ
from	IN
that	DT
of	IN
the	DT
natural	JJ
killer	NN
cell	NN
receptors	NNS
;	:
LOX-1	NN
is	VBZ
expressed	VBN
in	IN
vascular-rich	JJ
organs	NNS
,	,
but	CC
not	RB
in	IN
lymphocytes	NNS
.	.

A	DT
1753-bp	JJ
fragment	NN
of	IN
the	DT
5'	JJ
flanking	JJ
region	NN
of	IN
the	DT
LOX-1	NN
gene	NN
had	VBD
a	DT
functional	JJ
promoter	NN
activity	NN
.	.

This	DT
region	NN
contains	VBZ
binding	VBG
sites	NNS
for	IN
several	JJ
transcription	NN
factors	NNS
,	,
including	VBG
the	DT
STAT	NN
family	NN
and	CC
NF-IL6	NN
,	,
and	CC
the	DT
expression	NN
of	IN
LOX-1	NN
was	VBD
upregulated	VBN
by	IN
several	JJ
cytokines	NNS
.	.

These	DT
results	NNS
demonstrate	VBP
that	IN
the	DT
human	JJ
LOX-1	NN
gene	NN
is	VBZ
a	DT
new	JJ
member	NN
of	IN
the	DT
natural	JJ
killer	NN
gene	NN
complex	NN
with	IN
a	DT
unique	JJ
expression	NN
profile	NN
.	.

Copyright	NN
1998	CD
Academic	NNP
Press	NNP
.	.

UI	LS
-	:
99003459	CD

TI	LS
-	:
c-fos	NN
and	CC
c-jun	NN
mRNA	NN
expression	NN
in	IN
activated	VBN
cord	NN
and	CC
adult	JJ
lymphocytes	NNS
:	:
an	DT
analysis	NN
by	IN
Northern	NN
hybridization	NN
.	.

AB	LS
-	:
BACKGROUND	NN
AND	CC
OBJECTIVES	NNS
:	:
To	TO
further	RB
analyze	VB
the	DT
neonatal	JJ
immune	JJ
response	NN
to	TO
an	DT
antigenic	JJ
challenge	NN
such	JJ
as	IN
blood	NN
transfusion	NN
,	,
c-fos	NN
and	CC
c-jun	NN
mRNA	NN
expression	NN
were	VBD
analyzed	VBN
in	IN
twelve	CD
in-vitro-stimulated	JJ
normal	JJ
cord	NN
blood	NN
and	CC
ten	CD
in-vitro-stimulated	JJ
normal	JJ
adult	JJ
peripheral	JJ
blood	NN
lymphocyte	NN
samples	NNS
.	.

MATERIALS	NNS
AND	CC
METHODS	NNS
:	:
Lymphocyte	NN
samples	NNS
were	VBD
stimulated	VBN
by	IN
either	CC
the	DT
mitogen	NN
phytohemagglutinin	NN
(	(
PHA	NN
)	)
or	CC
the	DT
monoclonal	JJ
antibody	NN
alphaCD3	NN
.	.

Proliferation	NN
rate	NN
and	CC
Northern	NN
blot	NN
hybridization	NN
were	VBD
employed	VBN
.	.

RESULTS	NNS
:	:
Cord	NN
lymphocytes	NNS
revealed	VBD
a	DT
greater	JJR
proliferation	NN
rate	NN
with	IN
PHA	NN
and	CC
alphaCD3	NN
than	IN
adult	JJ
lymphocytes	NNS
(	(
p	NN
=	JJ
0.0081	CD
and	CC
0.0023	CD
,	,
respectively	RB
)	)
.	.

In	IN
addition	NN
,	,
Northern	NN
blot	NN
analysis	NN
of	IN
cord	NN
and	CC
adult	JJ
samples	NNS
revealed	VBD
similar	JJ
maximal	JJ
increases	NNS
in	IN
c-fos	NN
(	(
99+/-15	CD
and	CC
126+/-11	CD
%	NN
,	,
p	NN
=	JJ
0.0126	CD
)	)
and	CC
c-jun	NN
(	(
123+/-9	CD
and	CC
185+/-38	CD
%	NN
,	,
p	NN
=	JJ
0.0291	CD
)	)
mRNA	NN
expression	NN
,	,
respectively	RB
,	,
as	RB
early	RB
as	IN
15	CD
min	NN
post-alphaCD3	JJ
stimulation	NN
.	.

Adult	JJ
lymphocytes	NNS
showed	VBD
an	DT
equivalent	JJ
increase	NN
in	IN
mRNA	NN
expression	NN
of	IN
c-fos	NN
and	CC
c-jun	NN
(	(
140+/-25	CD
and	CC
155+/-31	CD
%	NN
)	)
at	IN
30	CD
min	NN
post-PHA	JJ
stimulation	NN
,	,
while	IN
cord	NN
lymphocyte	NN
maximum	NN
c-fos	NN
and	CC
c-jun	NN
expression	NN
(	(
82+/-6	CD
and	CC
142+/-12	CD
%	NN
)	)
occurred	VBD
at	IN
15	CD
min	NN
post-PHA	JJ
stimulation	NN
(	(
c-fos	NN
,	,
p	NN
=	JJ
0.0354	CD
;	:
c-jun	NN
,	,
p	NN
=	JJ
0.0112	CD
)	)
.	.

CONCLUSION	NN
:	:
Although	IN
cord	JJ
lymphocyte	NN
proliferation	NN
rates	NNS
were	VBD
significantly	RB
greater	JJR
than	IN
those	DT
of	IN
adult	JJ
lymphocytes	NNS
following	VBG
stimulation	NN
,	,
lymphocyte	NN
activation	NN
,	,
as	IN
analyzed	VBN
by	IN
c-fos	NN
and	CC
c-jun	NN
mRNA	NN
expression	NN
,	,
appears	VBZ
similar	JJ
in	IN
both	CC
cord	NN
and	CC
adult	JJ
samples	NNS
.	.

We	PRP
conclude	VBP
that	IN
cord	NN
lymphocyte	NN
activation	NN
exhibits	VBZ
an	DT
adult-type	JJ
profile	NN
.	.

UI	LS
-	:
98426244	CD

TI	LS
-	:
The	DT
PEBP2betaMYH11	NN
fusion	NN
created	VBN
by	IN
Inv(16)(p13;q22)	NN
in	IN
myeloid	JJ
leukemia	NN
impairs	VBZ
neutrophil	NN
maturation	NN
and	CC
contributes	VBZ
to	TO
granulocytic	JJ
dysplasia	NN
.	.

AB	LS
-	:
Chromosomal	JJ
translocations	NNS
involving	VBG
the	DT
genes	NNS
encoding	VBG
the	DT
alpha	NN
and	CC
beta	NN
subunits	NNS
of	IN
the	DT
Pebp2/Cbf	NN
transcription	NN
factor	NN
have	VBP
been	VBN
associated	VBN
with	IN
human	JJ
acute	JJ
myeloid	JJ
leukemia	NN
and	CC
the	DT
preleukemic	JJ
condition	NN
,	,
myelodysplasia	NN
.	.

Inv(16)(p13;q22)	NN
fuses	VBZ
the	DT
gene	NN
encoding	VBG
the	DT
beta	NN
subunit	NN
of	IN
Pebp2	NN
to	TO
the	DT
MYH11	NN
gene	NN
encoding	VBG
a	DT
smooth	JJ
muscle	NN
myosin	NN
heavy	NN
chain	NN
(	(
Smmhc	NN
)	)
.	.

To	TO
examine	VB
the	DT
effect	NN
of	IN
the	DT
inv(16)(p13;q22)	NN
on	IN
myelopoiesis	NN
,	,
we	PRP
used	VBD
the	DT
hMRP8	NN
promoter	NN
element	NN
to	TO
generate	VB
transgenic	JJ
mice	NNS
expressing	VBG
the	DT
Pebp2betaSmmhc	NN
chimeric	JJ
fusion	NN
protein	NN
in	IN
myeloid	JJ
cells	NNS
.	.

Neutrophil	NN
maturation	NN
was	VBD
impaired	JJ
in	IN
PEBP2betaMYH11	NN
transgenic	JJ
mice	NNS
.	.

Although	IN
the	DT
transgenic	JJ
mice	NNS
had	VBD
normal	JJ
numbers	NNS
of	IN
circulating	VBG
neutrophils	NNS
,	,
their	PRP$
bone	NN
marrow	NN
contained	VBD
increased	VBN
numbers	NNS
of	IN
immature	JJ
neutrophilic	JJ
cells	NNS
,	,
which	WDT
exhibited	VBD
abnormal	JJ
characteristics	NNS
.	.

In	IN
addition	NN
,	,
PEBP2betaMYH11	NN
inhibited	VBD
neutrophilic	JJ
differentiation	NN
in	IN
colonies	NNS
derived	VBN
from	IN
hematopoietic	JJ
progenitors	NNS
.	.

Coexpression	NN
of	IN
both	CC
PEBP2betaMYH11	NN
and	CC
activated	VBN
NRAS	NNS
induced	VBD
a	DT
more	RBR
severe	JJ
phenotype	NN
characterized	VBN
by	IN
abnormal	JJ
nuclear	JJ
morphology	NN
indicative	JJ
of	IN
granulocytic	JJ
dysplasia	NN
.	.

These	DT
results	NNS
show	VBP
that	IN
PEBP2betaMYH11	NN
can	MD
impair	VB
neutrophil	NN
development	NN
and	CC
provide	VBP
evidence	NN
that	IN
alterations	NNS
of	IN
Pebp2	NN
can	MD
contribute	VB
to	TO
the	DT
genesis	NN
of	IN
myelodysplasia	NN
.	.

UI	LS
-	:
99008372	CD

TI	LS
-	:
Signalling	NN
into	IN
the	DT
T-cell	NN
nucleus	NN
:	:
NFAT	NN
regulation	NN
.	.

AB	LS
-	:
The	DT
nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
(	(
NFAT	NN
)	)
plays	VBZ
an	DT
important	JJ
role	NN
in	IN
T-cell	NN
biology	NN
.	.

Activation	NN
of	IN
T	NN
cells	NNS
results	VBZ
in	IN
the	DT
rapid	JJ
calcineurin-dependent	JJ
translocation	NN
of	IN
NFAT	NN
transcription	NN
factors	NNS
from	IN
the	DT
cytoplasm	NN
to	TO
the	DT
nucleus	NN
.	.

This	DT
translocation	NN
process	NN
coupled	VBN
to	TO
the	DT
subsequent	JJ
active	JJ
maintenance	NN
of	IN
NFAT	NN
in	IN
the	DT
nucleus	NN
compartment	NN
is	VBZ
critical	JJ
for	IN
the	DT
induction	NN
of	IN
expression	NN
of	IN
several	JJ
genes	NNS
encoding	VBG
cytokines	NNS
and	CC
membrane	NN
proteins	NNS
that	WDT
modulate	VBP
immune	JJ
responses	NNS
.	.

The	DT
molecular	JJ
cloning	NN
of	IN
the	DT
NFAT	NN
family	NN
of	IN
transcription	NN
factors	NNS
has	VBZ
facilitated	VBN
rapid	JJ
progress	NN
in	IN
the	DT
understanding	NN
of	IN
the	DT
signalling	NN
mechanisms	NNS
that	WDT
control	VBP
the	DT
activity	NN
of	IN
NFAT	NN
.	.

UI	LS
-	:
98455033	CD

TI	LS
-	:
Seminoma	NN
in	IN
a	DT
postmenopausal	JJ
woman	NN
with	IN
a	DT
Y;15	NN
translocation	NN
in	IN
peripheral	JJ
blood	NN
lymphocytes	NNS
and	CC
a	DT
t(Y;15)/45,X	NN
Turner	NN
mosaic	JJ
pattern	NN
in	IN
skin	NN
fibroblasts	NNS
.	.

AB	LS
-	:
We	PRP
report	VBP
an	DT
unusual	JJ
case	NN
of	IN
a	DT
55	CD
year	NN
old	JJ
Japanese	NN
woman	NN
with	IN
a	DT
seminoma	NN
but	CC
relatively	RB
normal	JJ
menses	NNS
.	.

The	DT
patient	NN
was	VBD
a	DT
phenotypic	JJ
female	NN
with	IN
late	JJ
onset	NN
menarche	NN
(	(
18	CD
years	NNS
of	IN
age	NN
)	)
,	,
who	WP
was	VBD
amenorrhoeic	JJ
for	IN
the	DT
first	JJ
year	NN
,	,
followed	VBN
by	IN
menses	NNS
of	IN
one	CD
to	TO
three	CD
days	NNS
'	POS
slight	JJ
flow	NN
with	IN
dysmenorrhoea	NN
,	,
but	CC
an	DT
otherwise	RB
normal	JJ
menstrual	JJ
history	NN
.	.

A	DT
typical	JJ
seminoma	NN
was	VBD
removed	VBN
from	IN
the	DT
left	JJ
adnexal	JJ
region	NN
and	CC
an	DT
immature	JJ
testis	NN
was	VBD
identified	VBN
separately	RB
as	IN
an	DT
associated	VBN
right	JJ
adnexal	JJ
mass	NN
.	.

Repeated	JJ
karyotypic	JJ
studies	NNS
on	IN
peripheral	JJ
blood	NN
lymphocyte	NN
cultures	NNS
showed	VBD
only	RB
46,X,-Y,t(Y;15)(q12;p13)	NN
.	.

Cytogenetic	JJ
examination	NN
of	IN
the	DT
patient	NN
's	POS
younger	JJR
brother	NN
,	,
who	WP
had	VBD
fathered	VBN
three	CD
healthy	JJ
children	NNS
,	,
showed	VBD
an	DT
identical	JJ
karyotype	NN
.	.

Mosaicism	NN
of	IN
46,X,-Y,t(Y;15)(q12;p13)/45,X	NN
cell	NN
lines	NNS
was	VBD
found	VBN
in	IN
skin	NN
samples	NNS
from	IN
the	DT
patient	NN
's	POS
elbow	NN
and	CC
genital	JJ
regions	NNS
,	,
although	IN
there	EX
were	VBD
no	DT
clinical	JJ
stigmata	NN
of	IN
Turner	NN
syndrome	NN
.	.

An	DT
androgen	NN
receptor	NN
binding	NN
assay	NN
of	IN
cultured	VBN
genital	JJ
skin	NN
fibroblasts	NNS
was	VBD
negative	JJ
.	.

Molecular	JJ
analysis	NN
using	VBG
Southern	NN
blot	NN
hybridisation	NN
,	,
PCR	NN
,	,
and	CC
direct	JJ
DNA	NN
sequencing	NN
showed	VBD
that	IN
neither	CC
the	DT
patient	NN
nor	CC
her	PRP$
brother	NN
had	VBD
a	DT
detectable	JJ
deletion	NN
or	CC
other	JJ
abnormalities	NNS
of	IN
Y	NN
chromosome	NN
sequences	NNS
,	,
including	VBG
the	DT
SRY	NN
(	(
sex	NN
determining	NN
region	NN
of	IN
the	DT
Y	NN
chromosome	NN
)	)
gene	NN
sequence	NN
.	.

These	DT
findings	NNS
suggest	VBP
that	IN
Turner	NN
mosaicism	NN
of	IN
the	DT
45,X	NN
cell	NN
line	NN
may	MD
have	VB
contributed	VBN
to	TO
this	DT
atypical	JJ
presentation	NN
in	IN
an	DT
XY	NN
female	NN
,	,
although	IN
we	PRP
can	MD
not	RB
exclude	VB
abnormalities	NNS
of	IN
other	JJ
genes	NNS
related	JJ
to	TO
sex	NN
differentiation	NN
.	.

UI	LS
-	:
98380268	CD

TI	LS
-	:
The	DT
peroxisome	NN
proliferator-activated	JJ
receptor	NN
alpha	NN
(	(
PPARalpha	NN
)	)
ligand	NN
WY	NN
14,643	CD
does	VBZ
not	RB
interfere	VB
with	IN
leukotriene	NN
B4	NN
induced	JJ
adhesion	NN
of	IN
neutrophils	NNS
to	TO
endothelial	JJ
cells	NNS
.	.

AB	LS
-	:
Peroxisome	NN
proliferator-activated	JJ
receptors	NNS
(	(
PPAR	NNS
)	)
control	VBP
discrete	JJ
genes	NNS
involved	VBN
in	IN
fatty	JJ
acid	NN
and	CC
lipid	NN
metabolism	NN
.	.

Recently	RB
,	,
it	PRP
was	VBD
suggested	VBN
that	IN
activation	NN
of	IN
the	DT
alpha	NN
isoform	NN
of	IN
PPAR	NNS
by	IN
the	DT
potent	JJ
proinflammatory	JJ
mediator	NN
leukotriene	NN
B4	NN
(	(
LTB4	NN
)	)
enhanced	VBD
degradation	NN
of	IN
this	DT
eicosanoid	NN
,	,
offersuggesting	VBG
a	DT
new	JJ
aspect	NN
of	IN
down-regulation	NN
of	IN
inflammation	NN
.	.

Here	RB
,	,
we	PRP
studied	VBD
whether	IN
PPARalpha	NN
activation	NN
(	(
by	IN
means	NNS
of	IN
the	DT
selective	JJ
agonist	NN
WY	NN
14,643	CD
)	)
of	IN
endothelial	JJ
cells	NNS
,	,
pivotal	JJ
in	IN
the	DT
regulation	NN
of	IN
inflammatory	JJ
responses	NNS
,	,
interfered	VBN
with	IN
LTB4	NN
induced	VBD
adhesion	NN
of	IN
PMN	NN
neutrophil	NN
granulocytes	NNS
in	FW
vitro	FW
.	.

When	WRB
endothelial	JJ
cells	NNS
were	VBD
treated	VBN
with	IN
WY	NN
14,643	CD
prior	RB
to	TO
activation	NN
with	IN
LTB4	NN
(	(
or	CC
fMLP	NN
,	,
IL-1beta	NN
or	CC
TNFalpha	NN
,	,
as	IN
controls	NNS
)	)
we	PRP
could	MD
not	RB
document	VB
any	DT
effect	NN
on	IN
the	DT
number	NN
of	IN
adhering	JJ
PMN	NN
or	CC
duration	NN
of	IN
the	DT
response	NN
.	.

Thus	RB
,	,
this	DT
study	NN
provides	VBZ
no	DT
evidence	NN
indicating	VBG
a	DT
regulatory	JJ
function	NN
of	IN
PPARalpha	NN
in	IN
LTB4	NN
induced	JJ
adhesive	JJ
interactions	NNS
between	IN
endothelial	JJ
cells	NNS
and	CC
neutrophils	NNS

UI	LS
-	:
99025966	CD

TI	LS
-	:
Interaction	NN
of	IN
sickle	NN
erythrocytes	NNS
with	IN
endothelial	JJ
cells	NNS
in	IN
the	DT
presence	NN
of	IN
endothelial	JJ
cell	NN
conditioned	JJ
medium	NN
induces	VBZ
oxidant	JJ
stress	NN
leading	VBG
to	TO
transendothelial	JJ
migration	NN
of	IN
monocytes	NNS
.	.

AB	LS
-	:
The	DT
abnormal	JJ
adherence	NN
of	IN
sickle	NN
red	JJ
blood	NN
cells	NNS
(	(
SS	NN
RBC	NNS
)	)
to	TO
endothelial	JJ
cells	NNS
has	VBZ
been	VBN
thought	VBN
to	TO
contribute	VB
to	TO
vascular	JJ
occlusion	NN
,	,
a	DT
major	JJ
cause	NN
of	IN
morbidity	NN
in	IN
sickle	NN
cell	NN
disease	NN
(	(
SCD	NN
)	)
.	.

We	PRP
determined	VBD
whether	IN
the	DT
interaction	NN
of	IN
SS	NN
RBC	NNS
with	IN
cultured	VBN
endothelial	JJ
cells	NNS
induced	VBD
cellular	JJ
oxidant	JJ
stress	NN
that	WDT
would	MD
culminate	VB
in	IN
expression	NN
of	IN
cell	NN
adhesion	NN
molecules	NNS
(	(
CAMs	NNS
)	)
involved	VBN
in	IN
the	DT
adhesion	NN
and	CC
diapedesis	NN
of	IN
monocytes	NNS
and	CC
the	DT
adherence	NN
of	IN
SS	NN
reticulocytes	NNS
.	.

We	PRP
showed	VBD
that	IN
the	DT
interaction	NN
of	IN
SS	NN
RBC	NNS
at	IN
2	CD
%	NN
concentration	NN
in	IN
the	DT
presence	NN
of	IN
multimers	NNS
of	IN
von	NN
Willebrand	NN
factor	NN
(	(
vWf	NN
)	)
,	,
derived	VBN
from	IN
endothelial	JJ
cell-derived	JJ
conditioned	VBN
medium	NN
(	(
E-CM	NN
)	)
with	IN
cultured	VBN
human	JJ
umbilical	JJ
vein	NN
endothelial	JJ
cells	NNS
(	(
HUVEC	NN
)	)
,	,
resulted	VBD
in	IN
a	DT
fivefold	RB
increased	VBN
formation	NN
of	IN
thiobarbituric	JJ
acid-reactive	JJ
substances	NNS
(	(
TBARS	NNS
)	)
and	CC
activation	NN
of	IN
the	DT
transcription	NN
factor	NN
NF-kB	NN
,	,
both	DT
indicators	NNS
of	IN
cellular	JJ
oxidant	JJ
stress	NN
.	.

Normal	JJ
RBC	NNS
show	VBP
none	DT
of	IN
these	DT
phenomena	NNS
.	.

The	DT
oxidant	JJ
stress-induced	JJ
signaling	NN
resulted	VBD
in	IN
an	DT
increased	VBN
surface	NN
expression	NN
of	IN
a	DT
subset	NN
of	IN
CAMs	NNS
,	,
ICAM-1	NN
,	,
E-selectin	NN
,	,
and	CC
VCAM-1	NN
in	IN
HUVEC	NN
.	.

The	DT
addition	NN
of	IN
oxygen	NN
radical	JJ
scavenger	NN
enzymes	NNS
(	(
catalase	NN
,	,
superoxide	NN
dismutase	NN
)	)
and	CC
antioxidant	NN
(	(
probucol	NN
)	)
inhibited	VBD
these	DT
events	NNS
.	.

Additionally	RB
,	,
preincubation	NN
of	IN
HUVEC	NN
with	IN
a	DT
synthetic	JJ
peptide	NN
Arg-Gly-Asp	NN
(	(
RGD	NN
)	)
that	WDT
prevents	VBZ
vWf-mediated	JJ
adhesion	NN
of	IN
SS	NN
RBC	NNS
reduced	VBD
the	DT
surface	NN
expression	NN
of	IN
VCAM-1	NN
and	CC
NF-kB	NN
activation	NN
.	.

Furthermore	RB
,	,
SS	NN
RBC-induced	JJ
oxidant	JJ
stress	NN
resulted	VBD
in	IN
a	DT
twofold	JJ
increase	NN
in	IN
the	DT
transendothelial	JJ
migration	NN
of	IN
both	CC
monocyte-like	JJ
HL-60	NN
cells	NNS
and	CC
human	JJ
peripheral	JJ
blood	NN
monocytes	NNS
,	,
and	CC
approximately	RB
a	DT
sixfold	JJ
increase	NN
in	IN
platelet-endothelial	JJ
cell	NN
adhesion	NN
molecule-1	NN
(	(
PECAM-1	NN
)	)
phosphorylation	NN
,	,
each	DT
of	IN
which	WDT
was	VBD
blocked	VBN
by	IN
protein	NN
kinase	NN
C	NN
inhibitor	NN
and	CC
antioxidants	NNS
.	.

These	DT
results	NNS
suggest	VBP
that	IN
the	DT
adherence/contact	NN
of	IN
SS	NN
RBC	NNS
to	TO
endothelial	JJ
cells	NNS
in	IN
large	JJ
vessel	NN
can	MD
generate	VB
enhanced	VBN
oxidant	JJ
stress	NN
leading	VBG
to	TO
increased	VBN
adhesion	NN
and	CC
diapedesis	NN
of	IN
monocytes	NNS
,	,
as	RB
well	RB
as	IN
heightened	VBN
adherence	NN
of	IN
SS	NN
reticulocytes	NNS
,	,
indicating	VBG
that	IN
injury/activation	NN
of	IN
endothelium	NN
can	MD
contribute	VB
to	TO
vaso-occlusion	NN
in	IN
SCD	NN
.	.

UI	LS
-	:
99006780	CD

TI	LS
-	:
Identification	NN
of	IN
transcription	NN
factors	NNS
expressed	VBN
during	IN
ATRA-induced	JJ
neutrophil	NN
differentiation	NN
of	IN
HL60	NN
cells	NNS
.	.

AB	LS
-	:
A	DT
recent	JJ
clinical	JJ
therapeutic	JJ
initiative	NN
has	VBZ
been	VBN
the	DT
use	NN
of	IN
chemical	JJ
agents	NNS
which	WDT
induce	VBP
the	DT
leukaemic	JJ
cells	NNS
to	TO
overcome	VB
their	PRP$
block	NN
in	IN
differentiation	NN
.	.

In	IN
order	NN
to	TO
understand	VB
this	DT
block	NN
the	DT
cascade	NN
of	IN
molecular	JJ
events	NNS
needs	VBZ
to	TO
be	VB
characterized	VBN
.	.

Haemopoietic	JJ
differentiation	NN
is	VBZ
ultimately	RB
controlled	VBN
at	IN
the	DT
level	NN
of	IN
gene	NN
transcription	NN
which	WDT
is	VBZ
mediated	VBN
by	IN
an	DT
array	NN
of	IN
transcription	NN
factors	NNS
.	.

Many	JJ
transcription	NN
factors	NNS
contain	VBP
similar	JJ
structural	JJ
protein	NN
sequences	NNS
,	,
and	CC
we	PRP
have	VBP
used	VBN
an	DT
RT-PCR-based	JJ
approach	NN
to	TO
isolate	VB
sequences	NNS
,	,
from	IN
transcription	NN
factor	NN
gene	NN
families	NNS
which	WDT
share	VBP
similar	JJ
domains	NNS
.	.

Degenerate	NN
primers	NNS
corresponding	VBG
to	TO
the	DT
TFIIIA	NN
zinc-finger	JJ
consensus	NN
amino	NN
acid	NN
sequences	NNS
and	CC
to	TO
the	DT
POU-homeodomain	NN
and	CC
POU-specific	JJ
domain	NN
were	VBD
used	VBN
to	TO
amplify	VB
genes	NNS
on	IN
the	DT
basis	NN
that	IN
they	PRP
contained	VBD
similarities	NNS
in	IN
structural	JJ
motifs	NNS
shared	VBN
within	IN
these	DT
families	NNS
of	IN
transcription	NN
factors	NNS
.	.

A	DT
serum-independent	JJ
HL60	NN
cell	NN
line	NN
was	VBD
induced	VBN
towards	IN
the	DT
neutrophil	NN
lineage	NN
by	IN
treatment	NN
with	IN
all-trans	JJ
retinoic	JJ
acid	NN
(	(
ATRA	NN
)	)
for	IN
24	CD
h	NN
.	.

CD38+	JJ
cells	NNS
committed	VBN
towards	IN
this	DT
lineage	NN
were	VBD
enriched	JJ
and	CC
a	DT
population	NN
of	IN
these	DT
cells	NNS
treated	VBN
with	IN
dihydroxyvitamin	NN
D3	NN
to	TO
induce	VB
neutrophil	NN
maturation	NN
.	.

RNA	NN
extracted	VBN
from	IN
uninduced	JJ
,	,
ATRA-induced	JJ
CD38+	JJ
cells	NNS
,	,
and	CC
vitamin	NN
D3	NN
treated	JJ
maturing	JJ
cell	NN
cultures	NNS
were	VBD
amplified	VBN
using	VBG
the	DT
degenerate	NN
primers	NNS
.	.

PCR	NN
fragments	NNS
were	VBD
cloned	VBN
,	,
sequenced	VBN
,	,
clustered	VBN
into	IN
homologous	JJ
groups	NNS
,	,
and	CC
the	DT
group	NN
sequences	NNS
searched	VBN
on	IN
the	DT
GenBank	NN
database	NN
.	.

The	DT
Oct	NN
1	CD
transcription	NN
factor	NN
,	,
and	CC
a	DT
very	RB
close	JJ
homologue	NN
,	,
KIAA0144	NN
,	,
was	VBD
identified	VBN
using	VBG
the	DT
POU	NN
family	NN
primers	NNS
.	.

The	DT
zinc-finger	JJ
primers	NNS
identified	VBD
three	CD
zinc-finger	JJ
genes	NNS
.	.

The	DT
pattern	NN
of	IN
gene	NN
expression	NN
was	VBD
suggested	VBN
from	IN
the	DT
number	NN
of	IN
clones	NNS
in	IN
each	DT
group	NN
at	IN
neutrophil	NN
commitment	NN
and	CC
maturation	NN
.	.

The	DT
differential	JJ
expression	NN
of	IN
the	DT
genes	NNS
in	IN
the	DT
zinc	NN
finger	NN
and	CC
POU	NN
families	NNS
will	MD
lead	VB
to	TO
a	DT
better	JJR
understanding	NN
of	IN
the	DT
cascade	NN
of	IN
gene	NN
expression	NN
which	WDT
occurs	VBZ
following	VBG
ATRA-induced	JJ
differentiation	NN
.	.

UI	LS
-	:
98451423	CD

TI	LS
-	:
Cross-priming	NN
of	IN
CTL	NN
responses	NNS
in	FW
vivo	FW
does	VBZ
not	RB
require	VB
antigenic	JJ
peptides	NNS
in	IN
the	DT
endoplasmic	JJ
reticulum	NN
of	IN
immunizing	JJ
cells	NNS
.	.

AB	LS
-	:
It	PRP
has	VBZ
been	VBN
proposed	VBN
that	IN
the	DT
cross-priming	NN
of	IN
CTL	NN
responses	NNS
in	FW
vivo	FW
involves	VBZ
the	DT
transfer	NN
to	TO
host	NN
APCs	NNS
of	IN
heat	NN
shock	NN
protein	NN
glycoprotein	NN
96-chaperoned	JJ
antigenic	JJ
peptides	NNS
released	VBN
from	IN
the	DT
endoplasmic	JJ
reticulum	NN
(	(
ER	NN
)	)
of	IN
dying	VBG
or	CC
infected	JJ
cells	NNS
.	.

We	PRP
have	VBP
tested	VBN
this	DT
possibility	NN
directly	RB
using	VBG
TAP-deficient	JJ
cell	NN
lines	NNS
lacking	VBG
antigenic	JJ
ER	NN
peptides	NNS
derived	VBN
from	IN
two	CD
model	NN
Ags	NNS
,	,
the	DT
human	JJ
adenovirus	NN
type	NN
5	CD
early	JJ
regions	NNS
E1A	NN
and	CC
E1B	NN
.	.

Although	IN
both	DT
proteins	NNS
were	VBD
well	RB
expressed	VBN
,	,
the	DT
cells	NNS
were	VBD
not	RB
recognized	VBN
by	IN
E1A-	NN
or	CC
E1B-specific	JJ
CTLs	NNS
unless	IN
the	DT
relevant	JJ
epitope	NN
was	VBD
either	CC
provided	VBN
exogenously	RB
as	IN
a	DT
synthetic	JJ
peptide	NN
or	CC
targeted	VBN
to	TO
the	DT
ER	NN
in	IN
a	DT
TAP-independent	JJ
fashion	NN
.	.

Despite	IN
the	DT
absence	NN
of	IN
these	DT
ER	NN
peptides	NNS
,	,
the	DT
TAP1-/-	JJ
cells	NNS
were	VBD
able	JJ
to	TO
efficiently	RB
cross-prime	VB
E1A-	NN
and	CC
E1B-specific	JJ
CTLs	NNS
following	VBG
immunization	NN
of	IN
syngeneic	JJ
mice	NNS
.	.

These	DT
results	NNS
indicate	VBP
that	IN
,	,
although	IN
purified	VBN
peptide/glycoprotein	NN
96	CD
complexes	NNS
are	VBP
potent	JJ
immunogens	NNS
,	,
the	DT
mechanism	NN
of	IN
CTL	NN
cross-priming	NN
in	FW
vivo	FW
does	VBZ
not	RB
depend	VB
upon	IN
antigenic	JJ
peptides	NNS
in	IN
the	DT
ER	NN
of	IN
immunizing	JJ
cells	NNS
.	.

UI	LS
-	:
98406210	CD

TI	LS
-	:
Molecular	JJ
and	CC
cellular	JJ
analysis	NN
of	IN
human	JJ
immunodeficiency	NN
virus-induced	JJ
apoptosis	NN
in	IN
lymphoblastoid	JJ
T-cell-line-expressing	JJ
wild-type	JJ
and	CC
mutated	VBN
CD4	NN
receptors	NNS
.	.

AB	LS
-	:
We	PRP
have	VBP
previously	RB
shown	VBN
that	IN
the	DT
presence	NN
of	IN
the	DT
CD4	NN
cytoplasmic	JJ
tail	NN
is	VBZ
critical	JJ
for	IN
human	JJ
immunodeficiency	NN
virus	NN
(	(
HIV	NN
)	)
-induced	JJ
apoptosis	NN
(	(
J.Corbeil	NNP
,	,
M.Tremblay	NNP
,	,
and	CC
D.D.Richman	NNP
,	,
J.Exp.Med.183	NNP
:	:
39-48	CD
,	,
1996	CD
)	)
.	.

We	PRP
have	VBP
pursued	VBN
our	PRP$
investigation	NN
of	IN
the	DT
role	NN
of	IN
the	DT
CD4	NN
transduction	NN
pathway	NN
in	IN
HIV-induced	JJ
apoptosis	NN
.	.

To	TO
do	VBP
this	DT
,	,
wild-type	JJ
and	CC
mutant	JJ
forms	NNS
of	IN
the	DT
CD4	NN
cytoplasmic	JJ
tail	NN
were	VBD
stably	RB
expressed	VBN
in	IN
the	DT
lymphoblastoid	JJ
T-cell	NN
line	NN
A2.01	NN
.	.

Apoptosis	NN
was	VBD
prevented	VBN
when	WRB
CD4	NN
truncated	VBN
at	IN
residue	NN
402	CD
was	VBD
expressed	VBN
;	:
however	RB
,	,
cells	NNS
expressing	VBG
mutated	VBN
receptors	NNS
that	WDT
do	VBP
not	RB
associate	VB
with	IN
p56(lck)	NN
(	(
mutated	VBN
at	IN
the	DT
dicysteine	NN
motif	NN
and	CC
truncated	VBN
at	IN
residue	NN
418	CD
)	)
but	CC
which	WDT
conserved	VBD
proximal	JJ
domains	NNS
of	IN
the	DT
cytoplasmic	JJ
tail	NN
underwent	VBD
apoptosis	NN
like	IN
wild-type	JJ
CD4	NN
.	.

The	DT
differences	NNS
between	IN
wild-type	JJ
and	CC
mutated	VBN
receptors	NNS
in	IN
the	DT
induction	NN
of	IN
apoptosis	NN
were	VBD
not	RB
related	JJ
to	TO
levels	NNS
of	IN
p56(lck)	NN
or	CC
NF-kappaB	NN
activation	NN
.	.

Initial	JJ
signaling	NN
through	IN
the	DT
CD4	NN
receptor	NN
played	VBD
a	DT
major	JJ
role	NN
in	IN
the	DT
sensitization	NN
of	IN
HIV-infected	JJ
T	NN
cells	NNS
to	TO
undergo	VB
apoptosis	NN
.	.

Incubation	NN
of	IN
HIV-infected	JJ
cells	NNS
with	IN
monoclonal	JJ
antibody	NN
(	(
MAb	NN
)	)
13B8-2	NN
,	,
which	WDT
binds	VBZ
to	TO
CD4	NN
in	IN
a	DT
region	NN
critical	JJ
for	IN
dimerization	NN
of	IN
the	DT
receptor	NN
,	,
prevented	VBD
apoptosis	NN
without	IN
inhibiting	VBG
HIV	NN
replication	NN
.	.

Moreover	RB
,	,
the	DT
apoptotic	JJ
process	NN
was	VBD
not	RB
related	JJ
to	TO
Fas-Fas	JJ
ligand	NN
interaction	NN
;	:
however	RB
,	,
an	DT
antagonistic	JJ
anti-Fas	JJ
MAb	NN
(	(
ZB-4	NN
)	)
enhanced	VBD
apoptosis	NN
in	IN
HIV-infected	JJ
cells	NNS
without	IN
inducing	VBG
apoptosis	NN
in	IN
uninfected	JJ
cells	NNS
.	.

These	DT
observations	NNS
demonstrate	VBP
that	IN
CD4	NN
signaling	NN
mediates	VBZ
HIV-induced	JJ
apoptosis	NN
by	IN
a	DT
mechanism	NN
independent	JJ
of	IN
Fas-Fas	JJ
ligand	NN
interaction	NN
,	,
does	VBZ
not	RB
require	VB
p56(lck)	NN
signaling	NN
,	,
and	CC
may	MD
involve	VB
a	DT
critical	JJ
region	NN
for	IN
CD4	NN
dimerization	NN
.	.

UI	LS
-	:
99023375	CD

TI	LS
-	:
Decreased	VBN
IL-12	NN
production	NN
and	CC
Th1	NN
cell	NN
development	NN
by	IN
acetyl	NN
salicylic	JJ
acid-mediated	JJ
inhibition	NN
of	IN
NF-kappaB	NN
.	.

AB	LS
-	:
IL-12	NN
is	VBZ
a	DT
75-kDa	JJ
heterodimeric	JJ
cytokine	NN
composed	VBN
of	IN
two	CD
covalently	RB
linked	VBN
p35	NN
and	CC
p40	NN
chains	NNS
.	.

This	DT
pro-inflammatory	JJ
cytokine	NN
plays	VBZ
a	DT
prominent	JJ
role	NN
in	IN
the	DT
development	NN
of	IN
Th1	NN
cell-mediated	JJ
immune	JJ
responses	NNS
.	.

Th1	NN
cell-mediated	JJ
immune	JJ
responses	NNS
have	VBP
been	VBN
implicated	VBN
in	IN
the	DT
pathogenesis	NN
of	IN
chronic	JJ
inflammatory	JJ
autoimmune	JJ
diseases	NNS
.	.

Thus	RB
,	,
IL-12	NN
appears	VBZ
to	TO
be	VB
a	DT
critical	JJ
factor	NN
in	IN
the	DT
generation	NN
and	CC
maintenance	NN
of	IN
chronic	JJ
inflammatory	JJ
conditions	NNS
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
investigated	VBD
the	DT
effects	NNS
of	IN
a	DT
commonly	RB
prescribed	VBN
anti-inflammatory	JJ
drug	NN
,	,
acetyl	NN
salicylic	JJ
acid	NN
(	(
ASA	NN
)	)
,	,
on	IN
IL-12	NN
production	NN
and	CC
Th1	NN
cell	NN
development	NN
.	.

ASA	NN
was	VBD
found	VBN
to	TO
inhibit	VB
secretion	NN
of	IN
the	DT
IL-12	NN
heterodimer	NN
as	RB
well	RB
as	IN
p40	NN
monomer	NN
by	IN
human	JJ
monocytic	JJ
cells	NNS
.	.

This	DT
was	VBD
associated	VBN
with	IN
the	DT
down-regulation	NN
of	IN
IL-12p40	NN
mRNA	NN
expression	NN
.	.

Analysis	NN
of	IN
the	DT
regulation	NN
of	IN
the	DT
p40	NN
gene	NN
promoter	NN
revealed	VBD
that	IN
ASA	NN
inhibited	VBD
NF-kappaB	NN
activation	NN
and	CC
binding	NN
to	TO
the	DT
p40-kappaB	NN
site	NN
in	IN
the	DT
p40	NN
promoter	NN
,	,
leading	VBG
to	TO
transcriptional	JJ
repression	NN
of	IN
the	DT
p40	NN
gene	NN
.	.

Addition	NN
of	IN
ASA	NN
to	TO
an	DT
in	FW
vitro	FW
T	NN
helper	NN
cell	NN
differentiation	NN
system	NN
,	,
at	IN
concentrations	NNS
compatible	JJ
with	IN
plasma	NN
levels	NNS
reached	VBN
during	IN
anti-inflammatory	JJ
therapy	NN
,	,
resulted	VBD
in	IN
reduced	VBN
development	NN
of	IN
Th1	NN
cells	NNS
.	.

These	DT
results	NNS
suggest	VBP
that	IN
the	DT
inhibition	NN
of	IN
NF-kappaB	NN
activation	NN
by	IN
ASA	NN
leads	VBZ
to	TO
down-regulation	NN
of	IN
IL-12	NN
production	NN
and	CC
inhibition	NN
of	IN
Th1	NN
cell	NN
development	NN
.	.

UI	LS
-	:
98437269	CD

TI	LS
-	:
Induction	NN
of	IN
T	NN
cell	NN
anergy	NN
by	IN
high	JJ
concentrations	NNS
of	IN
immunodominant	JJ
native	JJ
peptide	NN
is	VBZ
accompanied	VBN
by	IN
IL-10	NN
production	NN
and	CC
a	DT
block	NN
in	IN
JNK	NN
activity	NN
.	.

AB	LS
-	:
The	DT
ability	NN
to	TO
induce	VB
anergy	NN
in	IN
antigen-specific	JJ
T	NN
cells	NNS
has	VBZ
potential	JJ
therapeutic	JJ
value	NN
for	IN
altering	VBG
pathologic	JJ
immune	JJ
responses	NNS
.	.

This	DT
study	NN
was	VBD
undertaken	VBN
to	TO
further	RB
analyze	VB
changes	NNS
in	IN
cytokine	NN
production	NN
and	CC
intracellular	JJ
signaling	NN
during	IN
anergy	NN
induction	NN
using	VBG
high	JJ
concentrations	NNS
of	IN
native	JJ
peptide	NN
ligand	NN
of	IN
tetanus	NN
toxoid	NN
(	(
TT	NN
)	)
-	:
and	CC
myelin	JJ
basic	JJ
protein	NN
(	(
MBP	NN
)	)
-specific	JJ
human	JJ
T	NN
cell	NN
lines	NNS
.	.

The	DT
TT-selected	JJ
T	NN
cell	NN
line	NN
could	MD
be	VB
rendered	VBN
unresponsive	JJ
to	TO
its	PRP$
dominant	JJ
epitope	NN
in	IN
a	DT
dose-dependent	JJ
manner	NN
(	(
IC50	NN
=	JJ
0.03	CD
microg/ml	NN
)	)
.	.

The	DT
TT-selected	JJ
line	NN
,	,
as	RB
well	RB
as	IN
three	CD
T	NN
cell	NN
clones	NNS
established	VBN
from	IN
this	DT
line	NN
,	,
continued	VBD
to	TO
produce	VB
IFN-gamma	NN
and	CC
significantly	RB
increased	VBD
IL-4	NN
and	CC
IL-10	NN
production	NN
when	WRB
anergy	NN
was	VBD
induced	VBN
with	IN
high	JJ
concentrations	NNS
of	IN
the	DT
immunodominant	JJ
epitope	NN
.	.

JNK	NN
enzymatic	JJ
activity	NN
was	VBD
blocked	VBN
in	IN
anergized	VBN
T	NN
cells	NNS
.	.

The	DT
MBP-selected	JJ
line	NN
could	MD
likewise	RB
be	VB
rendered	VBN
unresponsive	JJ
by	IN
incubation	NN
with	IN
supraoptimal	JJ
concentrations	NNS
of	IN
immunodominant	JJ
peptide	NN
and	CC
anergy	NN
induction	NN
was	VBD
accompanied	VBN
by	IN
IL-10	NN
release	NN
.	.

Both	DT
T	NN
cell	NN
lines	NNS
could	MD
be	VB
anergized	VBN
by	IN
the	DT
autopresentation	NN
of	IN
native	JJ
peptide	NN
since	IN
anergy	NN
was	VBD
induced	VBN
in	IN
cultures	NNS
lacking	VBG
fresh	JJ
antigen-presenting	JJ
cells	NNS
.	.

This	DT
study	NN
shows	VBZ
that	IN
the	DT
mitogen-activated	JJ
protein	NN
kinase	NN
cascade	NN
is	VBZ
blocked	VBN
when	WRB
anergy	NN
is	VBZ
induced	VBN
to	TO
high	JJ
concentrations	NNS
of	IN
soluble	JJ
peptide	NN
.	.

Copyright	NN
1998	CD
Academic	NNP
Press	NNP
.	.

UI	LS
-	:
98389481	CD

TI	LS
-	:
Peripheral	JJ
T	NN
lymphocytes	NNS
from	IN
women	NNS
with	IN
breast	NN
cancer	NN
exhibit	VBP
abnormal	JJ
protein	NN
expression	NN
of	IN
several	JJ
signaling	VBG
molecules	NNS
.	.

AB	LS
-	:
We	PRP
examined	VBD
signaling	VBG
molecules	NNS
of	IN
peripheral	JJ
blood	NN
T	NN
lymphocytes	NNS
obtained	VBN
from	IN
women	NNS
with	IN
breast	NN
cancer	NN
.	.

In	IN
6	CD
of	IN
14	CD
patients	NNS
,	,
T	NN
lymphocytes	NNS
displayed	VBD
an	DT
impaired	JJ
ability	NN
to	TO
translocate	VB
NFeB	NN
p65	NN
(	(
Rel-A	NN
)	)
following	VBG
activation	NN
by	IN
anti-CD3	NN
and	CC
IL-2	NN
.	.

This	DT
observation	NN
was	VBD
made	VBN
despite	IN
normal	JJ
cytoplasmic	JJ
levels	NNS
of	IN
the	DT
Rel-A	NN
protein	NN
.	.

We	PRP
also	RB
detected	VBD
abnormally	RB
low	JJ
levels	NNS
of	IN
the	DT
signaling	VBG
molecules	NNS
T-cell	NN
receptor	NN
(	(
TCR	NN
)	)
-zeta	NN
,	,
ZAP-70	NN
and	CC
p56lck	NN
in	IN
4	CD
of	IN
14	CD
breast	NN
cancer	NN
patients	NNS
,	,
i.e.	FW
,	,
defects	NNS
in	IN
T-cell	NN
signaling	VBG
molecules	NNS
.	.

T	NN
lymphocytes	NNS
from	IN
6	CD
of	IN
the	DT
14	CD
patients	NNS
also	RB
exhibited	VBD
an	DT
increased	VBN
expression	NN
of	IN
the	DT
dual	JJ
specificity	NN
phosphatase	NN
,	,
map	NN
kinase	NN
phosphatase-1	NN
(	(
MKP-1	NN
)	)
.	.

MKP-1	NN
inactivates	VBZ
MAP	NN
kinase	NN
and	CC
therefore	RB
may	MD
interfere	VB
with	IN
the	DT
activation	NN
of	IN
c-jun	NN
and	CC
c-fos	NN
.	.

Abnormalities	NNS
of	IN
I	CD
or	CC
more	RBR
signaling	VBG
molecules	NNS
were	VBD
found	VBN
in	IN
9	CD
of	IN
14	CD
patients	NNS
;	:
however	RB
,	,
only	RB
3	CD
patients	NNS
had	VBD
T	NN
cells	NNS
that	WDT
exhibited	VBD
all	DT
5	CD
defects	NNS
.	.

Our	PRP$
data	NNS
have	VBP
implications	NNS
for	IN
the	DT
detection	NN
of	IN
potentially	RB
dysfunctional	JJ
T	NN
cells	NNS
in	IN
patients	NNS
with	IN
cancer	NN
.	.

For	IN
example	NN
,	,
the	DT
analysis	NN
of	IN
only	RB
1	CD
signaling	VBG
molecule	NN
may	MD
allow	VB
patients	NNS
with	IN
significant	JJ
defects	NNS
in	IN
T-cell	NN
signaling	NN
to	TO
go	VB
unnoticed	JJ
.	.

Finally	RB
,	,
despite	IN
impaired	JJ
Rel-A	NN
translocation	NN
,	,
T	NN
cells	NNS
were	VBD
capable	JJ
of	IN
transcribing	VBG
IL-2	NN
.	.

Impairments	NNS
in	IN
the	DT
translocation	NN
of	IN
Rel-B	NN
and	CC
c-Rel	NN
further	RB
suggest	VBP
that	IN
the	DT
NFKB	NN
family	NN
members	NNS
Rel-A	NN
,	,
Rel-B	NN
and	CC
c-Rel	NN
are	VBP
not	RB
required	VBN
for	IN
the	DT
transcription	NN
of	IN
IL-2	NN
in	IN
the	DT
peripheral	JJ
T	NN
lymphocytes	NNS
of	IN
patients	NNS
with	IN
breast	NN
cancer	NN
.	.

UI	LS
-	:
98378510	CD

TI	LS
-	:
The	DT
small	JJ
GTP-binding	JJ
protein	NN
Rho	NN
potentiates	VBZ
AP-1	NN
transcription	NN
in	IN
T	NN
cells	NNS
.	.

AB	LS
-	:
The	DT
Rho	NN
family	NN
of	IN
small	JJ
GTP-binding	JJ
proteins	NNS
is	VBZ
involved	VBN
in	IN
the	DT
regulation	NN
of	IN
cytoskeletal	JJ
structure	NN
,	,
gene	NN
transcription	NN
,	,
specific	JJ
cell	NN
fate	NN
development	NN
,	,
and	CC
transformation	NN
.	.

We	PRP
demonstrate	VBP
in	IN
this	DT
report	NN
that	IN
overexpression	NN
of	IN
an	DT
activated	JJ
form	NN
of	IN
Rho	NN
enhances	VBZ
AP-1	NN
activity	NN
in	IN
Jurkat	NN
T	NN
cells	NNS
in	IN
the	DT
presence	NN
of	IN
phorbol	NN
myristate	NN
acetate	NN
(	(
PMA	NN
)	)
,	,
but	CC
activated	VBN
Rho	NN
(	(
V14Rho	NN
)	)
has	VBZ
little	JJ
or	CC
no	DT
effect	NN
on	IN
NFAT	NN
,	,
Oct-1	NN
,	,
and	CC
NF-kappaB	NN
enhancer	NN
element	NN
activities	NNS
under	IN
similar	JJ
conditions	NNS
.	.

Overexpression	NN
of	IN
a	DT
V14Rho	NN
construct	NN
incapable	JJ
of	IN
membrane	NN
localization	NN
(	(
CAAX	NN
deleted	VBN
)	)
abolishes	VBZ
PMA-induced	JJ
AP-1	NN
transcriptional	JJ
activation	NN
.	.

The	DT
effect	NN
of	IN
Rho	NN
on	IN
AP-1	NN
is	VBZ
independent	JJ
of	IN
the	DT
mitogen-activated	JJ
protein	NN
kinase	NN
pathway	NN
,	,
as	IN
a	DT
dominant-negative	JJ
MEK	NN
and	CC
a	DT
MEK	NN
inhibitor	NN
(	(
PD98059	NN
)	)
did	VBD
not	RB
affect	VB
Rho-induced	JJ
AP-1	NN
activity	NN
.	.

V14Rho	NN
binds	VBZ
strongly	RB
to	TO
protein	NN
kinase	NN
Calpha	NN
(	(
PKCalpha	NN
)	)
in	FW
vivo	FW
;	:
however	RB
,	,
deletion	NN
of	IN
the	DT
CAAX	NN
site	NN
on	IN
V14Rho	NN
severely	RB
diminished	VBD
this	DT
association	NN
.	.

Evidence	NN
for	IN
a	DT
role	NN
for	IN
PKCalpha	NN
as	IN
an	DT
effector	NN
of	IN
Rho	NN
was	VBD
obtained	VBN
by	IN
the	DT
observation	NN
that	IN
coexpression	NN
of	IN
the	DT
N-terminal	JJ
domain	NN
of	IN
PKCalpha	NN
blocked	VBD
the	DT
effects	NNS
of	IN
activated	VBN
Rho	NN
plus	CC
PMA	NN
on	IN
AP-1	NN
transcriptional	JJ
activity	NN
.	.

These	DT
data	NNS
suggest	VBP
that	IN
Rho	NN
potentiates	VBZ
AP-1	NN
transcription	NN
during	IN
T-cell	NN
activation	NN

UI	LS
-	:
98365377	CD

TI	LS
-	:
Changes	NNS
in	IN
PKC	NN
isoforms	NNS
in	IN
human	JJ
alveolar	JJ
macrophages	NNS
compared	VBN
with	IN
blood	NN
monocytes	NNS
.	.

AB	LS
-	:
Alveolar	JJ
macrophages	NNS
play	VBP
an	DT
important	JJ
role	NN
in	IN
host	NN
defense	NN
and	CC
in	IN
other	JJ
types	NNS
of	IN
inflammatory	JJ
processes	NNS
in	IN
the	DT
lung	NN
.	.

These	DT
cells	NNS
exhibit	VBP
many	JJ
alterations	NNS
in	IN
function	NN
compared	VBN
with	IN
their	PRP$
precursor	NN
cells	NNS
,	,
blood	NN
monocytes	NNS
.	.

To	TO
evaluate	VB
a	DT
potential	JJ
mechanism	NN
for	IN
these	DT
differences	NNS
in	IN
function	NN
,	,
we	PRP
evaluated	VBD
expression	NN
of	IN
protein	NN
kinase	NN
C	NN
(	(
PKC	NN
)	)
isoforms	NNS
.	.

We	PRP
found	VBD
an	DT
increase	NN
in	IN
Ca2+-dependent	JJ
PKC	NN
isoforms	NNS
in	IN
monocytes	NNS
compared	VBN
with	IN
alveolar	JJ
macrophages	NNS
.	.

We	PRP
also	RB
found	VBD
differential	JJ
expression	NN
of	IN
the	DT
Ca2+-independent	JJ
isoforms	NNS
in	IN
alveolar	JJ
macrophages	NNS
compared	VBN
with	IN
monocytes	NNS
.	.

One	CD
consequence	NN
of	IN
the	DT
activation	NN
of	IN
PKC	NN
can	MD
be	VB
increased	VBN
expression	NN
of	IN
mitogen-activated	JJ
protein	NN
(	(
MAP	NN
)	)
kinase	NN
pathways	NNS
.	.

Therefore	RB
,	,
we	PRP
also	RB
evaluated	VBD
activation	NN
of	IN
the	DT
MAP	NN
kinase	NN
extracellular	JJ
signal-regulated	JJ
kinase	NN
(	(
ERK	NN
)	)
2	CD
by	IN
the	DT
phorbol	NN
ester	NN
phorbol	NN
12-myristate	NN
13-acetate	NN
(	(
PMA	NN
)	)
.	.

PMA	NN
activated	JJ
ERK2	NN
kinase	NN
in	IN
both	CC
alveolar	JJ
macrophages	NNS
and	CC
monocytes	NNS
;	:
however	RB
,	,
monocytes	NNS
consistently	RB
showed	VBD
a	DT
significantly	RB
greater	JJR
activation	NN
of	IN
ERK2	NN
kinase	NN
by	IN
PMA	NN
compared	VBN
with	IN
alveolar	JJ
macrophages	NNS
.	.

Another	DT
known	JJ
consequence	NN
of	IN
the	DT
activation	NN
of	IN
PKC	NN
and	CC
subsequent	JJ
activation	NN
of	IN
ERK	NN
kinase	NN
is	VBZ
activation	NN
of	IN
the	DT
transcription	NN
factor	NN
activator	NN
protein-1	NN
(	(
AP-1	NN
)	)
.	.

We	PRP
evaluated	VBD
the	DT
activation	NN
of	IN
AP-1	NN
by	IN
PMA	NN
in	IN
both	CC
monocytes	NNS
and	CC
macrophages	NNS
.	.

We	PRP
found	VBD
very	RB
little	JJ
detectable	JJ
activation	NN
of	IN
AP-1	NN
,	,
as	IN
assessed	VBN
in	IN
a	DT
gel	NN
shift	NN
assay	NN
,	,
in	IN
alveolar	JJ
macrophages	NNS
,	,
whereas	IN
monocytes	NNS
showed	VBD
a	DT
substantial	JJ
activation	NN
of	IN
AP-1	NN
by	IN
PMA	NN
.	.

These	DT
studies	NNS
show	VBP
that	IN
the	DT
differential	JJ
expression	NN
of	IN
PKC	NN
isoforms	NNS
in	IN
alveolar	JJ
macrophages	NNS
and	CC
blood	NN
monocytes	NNS
is	VBZ
associated	VBN
with	IN
important	JJ
functional	JJ
alterations	NNS
in	IN
the	DT
cells	NNS
.	.

UI	LS
-	:
98332778	CD

TI	LS
-	:
Uncoupling	NN
of	IN
nonreceptor	JJ
tyrosine	NN
kinases	NNS
from	IN
PLC-gamma1	NN
in	IN
an	DT
SLP-76-deficient	JJ
T	NN
cell	NN
.	.

AB	LS
-	:
Activation	NN
of	IN
nonreceptor	JJ
protein	NN
tyrosine	NN
kinases	NNS
(	(
PTKs	NN
)	)
is	VBZ
essential	JJ
for	IN
T	NN
cell	NN
receptor	NN
(	(
TCR	NN
)	)
responsiveness	NN
;	:
however	RB
,	,
the	DT
function	NN
of	IN
individual	JJ
PTK	NN
substrates	NNS
is	VBZ
often	RB
uncertain	JJ
.	.

A	DT
mutant	JJ
T	NN
cell	NN
line	NN
was	VBD
isolated	VBN
that	WDT
lacked	VBD
expression	NN
of	IN
SLP-76	NN
(	(
SH2	NN
domain-containing	JJ
leukocyte	NN
protein	NN
of	IN
76	CD
kilodaltons	NNS
)	)
,	,
a	DT
hematopoietically	RB
expressed	VBN
adaptor	NN
protein	NN
and	CC
PTK	NN
substrate	NN
.	.

SLP-76	NN
was	VBD
not	RB
required	VBN
for	IN
TCR-induced	JJ
tyrosine	NN
phosphorylation	NN
of	IN
most	JJS
proteins	NNS
,	,
but	CC
was	VBD
required	VBN
for	IN
optimal	JJ
tyrosine	NN
phosphorylation	NN
and	CC
activation	NN
of	IN
phospholipase	NN
C-gamma1	NN
(	(
PLC-gamma1	NN
)	)
,	,
as	RB
well	RB
as	IN
Ras	NN
pathway	NN
activation	NN
.	.

TCR-inducible	JJ
gene	NN
expression	NN
was	VBD
dependent	JJ
on	IN
SLP-76	NN
.	.

Thus	RB
,	,
coupling	NN
of	IN
TCR-regulated	JJ
PTKs	NN
to	TO
downstream	JJ
signaling	NN
pathways	NNS
requires	VBZ
SLP-76	NN
.	.

UI	LS
-	:
98311520	CD

TI	LS
-	:
Oxidative	JJ
stress	NN
suppresses	VBZ
transcription	NN
factor	NN
activities	NNS
in	IN
stimulated	VBN
lymphocytes	NNS
.	.

AB	LS
-	:
Effects	NNS
of	IN
oxidative	JJ
stress	NN
on	IN
stimulation-dependent	JJ
signal	NN
transduction	NN
,	,
leading	VBG
to	TO
IL-2	NN
expression	NN
,	,
were	VBD
studied	VBN
.	.

Purified	VBN
quiescent	JJ
human	JJ
blood	NN
T	NN
lymphocytes	NNS
were	VBD
subjected	VBN
to	TO
:	:
(	(
i	LS
)	)
acute	JJ
exposure	NN
to	TO
hydrogen	NN
peroxide	NN
;	:
(	(
ii	LS
)	)
chronic	JJ
exposure	NN
to	TO
hydrogen	NN
peroxide	NN
;	:
and	CC
(	(
iii	LS
)	)
acute	JJ
exposure	NN
to	TO
ionizing	VBG
radiation	NN
.	.

The	DT
cells	NNS
were	VBD
then	RB
stimulated	VBN
for	IN
6	CD
h	NN
.	.

DNA-binding	JJ
activities	NNS
(	(
determined	VBN
by	IN
the	DT
electrophoretic	JJ
mobility	NN
shift	NN
assay	NN
)	)
of	IN
three	CD
transcription	NN
factors	NNS
:	:
NFkappaB	NN
,	,
AP-1	NN
and	CC
NFAT	NN
,	,
were	VBD
abolished	VBN
in	IN
the	DT
lymphocytes	NNS
by	IN
all	DT
three	CD
modes	NNS
of	IN
oxidative	JJ
stress	NN
.	.

The	DT
lymphocytes	NNS
exhibited	VBD
lipid	NN
peroxidation	NN
only	RB
upon	IN
exposure	NN
to	TO
the	DT
lowest	JJS
level	NN
of	IN
hydrogen	NN
peroxide	NN
used	VBN
(	(
20	CD
microM	NN
)	)
.	.

All	DT
three	CD
modes	NNS
of	IN
oxidative	JJ
stress	NN
induced	VBD
catalase	NN
activity	NN
in	IN
the	DT
lymphocytes	NNS
.	.

The	DT
only	RB
exception	NN
was	VBD
hydrogen	NN
peroxide	NN
at	IN
20	CD
microM	NN
,	,
which	WDT
did	VBD
not	RB
induce	VB
catalase	NN
activity	NN
.	.

We	PRP
conclude	VBP
that	IN
:	:
(	(
i	LS
)	)
suppression	NN
of	IN
specific	JJ
transcription	NN
factor	NN
functions	NNS
can	MD
potentially	RB
serve	VB
as	IN
a	DT
marker	NN
of	IN
exposure	NN
to	TO
oxidative	JJ
stress	NN
and	CC
its	PRP$
effects	NNS
on	IN
human	JJ
lymphocytes	NNS
;	:
(	(
ii	LS
)	)
lipid	NN
peroxidation	NN
is	VBZ
only	RB
detectable	JJ
in	IN
human	JJ
lymphocytes	NNS
upon	IN
exposure	NN
to	TO
weak	JJ
oxidative	JJ
stress	NN
which	WDT
does	VBZ
not	RB
induce	VB
catalase	NN
activity	NN
;	:
(	(
iii	LS
)	)
therefore	RB
,	,
transcription	NN
factor	NN
DNA-binding	JJ
activities	NNS
are	VBP
more	RBR
sensitive	JJ
to	TO
oxidative	JJ
stress	NN
than	IN
lipid	NN
peroxidation	NN
.	.

UI	LS
-	:
93209552	CD

TI	LS
-	:
p105	NN
and	CC
p98	NN
precursor	NN
proteins	NNS
play	VBP
an	DT
active	JJ
role	NN
in	IN
NF-kappa	NN
B-mediated	JJ
signal	NN
transduction	NN
.	.

AB	LS
-	:
The	DT
Rel/NF-kappa	NN
B	NN
family	NN
of	IN
transcription	NN
factors	NNS
is	VBZ
composed	VBN
of	IN
two	CD
distinct	JJ
subgroups	NNS
,	,
proteins	NNS
that	WDT
undergo	VBP
proteolytic	JJ
processing	NN
and	CC
contain	VBP
SWI6/ankyrin	NN
repeats	NNS
in	IN
their	PRP$
carboxyl	NN
termini	NNS
(	(
p105	NN
,	,
p98	NN
)	)
,	,
and	CC
those	DT
without	IN
such	JJ
repeats	NNS
that	WDT
do	VBP
not	RB
require	VB
processing	NN
(	(
p65	NN
,	,
c-Rel	NN
,	,
RelB	NN
,	,
and	CC
Dorsal	NN
)	)
.	.

We	PRP
demonstrate	VBP
that	IN
the	DT
p105	NN
and	CC
p98	NN
precursors	NNS
share	VBP
functional	JJ
properties	NNS
with	IN
the	DT
I	NN
kappa	NN
B	NN
proteins	NNS
,	,
which	WDT
also	RB
contain	VBP
SWI6/ankyrin	NN
repeats	NNS
.	.

Both	CC
p105	NN
and	CC
p98	NN
were	VBD
found	VBN
to	TO
form	VB
stable	JJ
complexes	NNS
with	IN
other	JJ
Rel/NF-kappa	NN
B	NN
family	NN
members	NNS
,	,
including	VBG
p65	NN
and	CC
c-Rel	NN
.	.

Association	NN
with	IN
the	DT
precursors	NNS
is	VBZ
sufficient	JJ
for	IN
cytoplasmic	JJ
retention	NN
of	IN
either	CC
p65	NN
or	CC
c-Rel	NN
,	,
both	DT
of	IN
which	WDT
are	VBP
otherwise	RB
nuclear	JJ
.	.

These	DT
complexes	NNS
undergo	VBP
stimulus-responsive	JJ
processing	NN
to	TO
produce	VB
active	JJ
p50/c-Rel	NN
and	CC
p55/c-Rel	NN
complexes	NNS
.	.

These	DT
observations	NNS
suggest	VBP
a	DT
second	JJ
pathway	NN
leading	VBG
to	TO
NF-kappa	NN
B	NN
induction	NN
,	,
in	IN
which	WDT
processing	NN
of	IN
the	DT
precursors	NNS
rather	RB
than	IN
phosphorylation	NN
of	IN
I	NN
kappa	NN
B	NN
plays	VBZ
a	DT
major	JJ
role	NN
.	.

UI	LS
-	:
93180777	CD

TI	LS
-	:
The	DT
human	JJ
prointerleukin	NN
1	CD
beta	NN
gene	NN
requires	VBZ
DNA	NN
sequences	NNS
both	CC
proximal	JJ
and	CC
distal	JJ
to	TO
the	DT
transcription	NN
start	NN
site	NN
for	IN
tissue-specific	JJ
induction	NN
.	.

AB	LS
-	:
In	IN
these	DT
studies	NNS
,	,
we	PRP
have	VBP
identified	VBN
DNA	NN
sequences	NNS
and	CC
specific	JJ
protein	NN
interactions	NNS
necessary	JJ
for	IN
transcriptional	JJ
regulation	NN
of	IN
the	DT
human	JJ
prointerleukin	NN
1	CD
beta	NN
(	(
proIL-1	NN
beta	NN
)	)
gene	NN
.	.

A	DT
cell-type-independent	JJ
lipopolysaccharide	NN
(	(
LPS	NN
)	)
-responsive	JJ
enhancer	NN
element	NN
located	JJ
between	IN
-3757	CD
and	CC
-2729	CD
bp	NN
upstream	RB
from	IN
the	DT
transcription	NN
start	NN
site	NN
(	(
cap	NN
site	NN
)	)
consisted	VBD
of	IN
at	IN
least	JJS
six	CD
discrete	JJ
subregions	NNS
which	WDT
were	VBD
essential	JJ
to	TO
the	DT
maximal	JJ
induction	NN
by	IN
LPS	NN
in	IN
transfected	VBN
monocytes	NNS
.	.

The	DT
enhancer	NN
also	RB
appeared	VBD
to	TO
mediate	VB
phorbol	NN
myristate	NN
acetate	NN
induction	NN
in	IN
monocytes	NNS
and	CC
IL-1	NN
responsiveness	NN
in	IN
fibroblasts	NNS
.	.

Deletion	NN
and	CC
base	NN
substitution	NN
mutations	NNS
along	IN
with	IN
DNA	NN
binding	NN
studies	NNS
demonstrated	VBD
that	IN
the	DT
enhancer	NN
contained	VBD
a	DT
minimum	NN
of	IN
three	CD
functional	JJ
protein	NN
binding	NN
sequences	NNS
,	,
two	CD
of	IN
which	WDT
appeared	VBD
to	TO
be	VB
important	JJ
for	IN
gene	NN
induction	NN
.	.

One	CD
of	IN
the	DT
essential	JJ
proteins	NNS
which	WDT
bound	VBD
to	TO
the	DT
enhancer	NN
was	VBD
similar	JJ
or	CC
identical	JJ
to	TO
members	NNS
of	IN
the	DT
C/EBP	NN
family	NN
of	IN
transcription	NN
factors	NNS
required	VBN
for	IN
both	CC
IL-1-	NN
and	CC
LPS-specific	JJ
induction	NN
of	IN
the	DT
IL-6	NN
gene	NN
(	(
i.e.	FW
,	,
the	DT
NF-IL6	NN
proteins	NNS
)	)
.	.

When	WRB
ligated	VBN
to	TO
the	DT
proIL-1	NN
beta	NN
cap	NN
site-proximal	JJ
region	NN
(	(
located	JJ
between	IN
-131	CD
to	TO
+12	CD
)	)
,	,
both	CC
the	DT
proIL-1	NN
beta	NN
and	CC
the	DT
simian	JJ
virus	NN
40	CD
enhancer	NN
elements	NNS
functioned	VBD
more	RBR
efficiently	RB
in	IN
monocytes	NNS
than	IN
in	IN
HeLa	NN
cells	NNS
,	,
which	WDT
are	VBP
not	RB
normally	RB
competent	JJ
for	IN
IL-1	NN
beta	NN
expression	NN
.	.

When	WRB
ligated	VBN
to	TO
the	DT
murine	JJ
c-fos	NN
promoter	NN
,	,
however	RB
,	,
the	DT
proIL-1	NN
beta	NN
enhancer	NN
was	VBD
inducible	JJ
in	IN
phorbol	NN
myristate	NN
acetate-stimulated	JJ
HeLa	NN
cells	NNS
,	,
suggesting	VBG
the	DT
existence	NN
of	IN
a	DT
proIL-1	NN
beta	NN
promoter-proximal	JJ
requirement	NN
for	IN
tissue	NN
specificity	NN
.	.

UI	LS
-	:
93233083	CD

TI	LS
-	:
Lymphocytes	NNS
from	IN
the	DT
site	NN
of	IN
disease	NN
suggest	VBP
adenovirus	NN
is	VBZ
one	CD
cause	NN
of	IN
persistent	JJ
or	CC
recurrent	JJ
inflammatory	JJ
arthritis	NN
.	.

AB	LS
-	:
The	DT
assessment	NN
of	IN
synovial	JJ
lymphocyte	NN
reactivity	NN
to	TO
adenovirus	NN
antigen	NN
stimulation	NN
was	VBD
undertaken	VBN
in	IN
patients	NNS
with	IN
persistent	JJ
or	CC
recurrent	JJ
inflammatory	JJ
arthritis	NN
.	.

The	DT
3H-thymidine	JJ
uptake	NN
procedure	NN
was	VBD
employed	VBN
,	,
incorporating	VBG
multiple	JJ
microbiological	JJ
antigens	NNS
.	.

Five	CD
patients	NNS
were	VBD
found	VBN
with	IN
repeated	VBN
maximal	JJ
responses	NNS
to	TO
adenovirus	NN
antigen	NN
;	:
in	IN
one	CD
of	IN
these	DT
adenovirus	NN
nucleotide	NN
sequences	NNS
were	VBD
present	JJ
in	IN
a	DT
synovial	JJ
biopsy	NN
specimen	NN
.	.

It	PRP
is	VBZ
concluded	VBN
that	IN
adenovirus	NN
may	MD
be	VB
one	CD
cause	NN
of	IN
persistent	JJ
or	CC
recurrent	JJ
inflammatory	JJ
arthritis	NN
.	.

UI	LS
-	:
93258811	CD

TI	LS
-	:
Mice	NNS
deficient	NN
for	IN
the	DT
55	CD
kd	JJ
tumor	NN
necrosis	NN
factor	NN
receptor	NN
are	VBP
resistant	JJ
to	TO
endotoxic	JJ
shock	NN
,	,
yet	RB
succumb	VBP
to	TO
L.	FW
monocytogenes	NNS
infection	NN
.	.

AB	LS
-	:
The	DT
multiple	JJ
biological	JJ
activities	NNS
of	IN
tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
are	VBP
mediated	VBN
by	IN
two	CD
distinct	JJ
cell	NN
surface	NN
receptors	NNS
of	IN
55	CD
kd	NNS
(	(
TNFRp55	NN
)	)
and	CC
75	CD
kd	NN
(	(
TNFRp75	NN
)	)
.	.

Using	VBG
gene	NN
targeting	NN
,	,
we	PRP
generated	VBD
a	DT
TNFRp55-deficient	JJ
mouse	NN
strain	NN
.	.

Cells	NNS
from	IN
TNFRp55-/-mutant	JJ
mice	NNS
lack	VBP
expression	NN
of	IN
TNFRp55	NN
but	CC
display	VBP
normal	JJ
numbers	NNS
of	IN
high	JJ
affinity	NN
TNFRp75	NN
molecules	NNS
.	.

Thymocyte	NN
development	NN
and	CC
lymphocyte	NN
populations	NNS
are	VBP
unaltered	JJ
,	,
and	CC
clonal	JJ
deletion	NN
of	IN
potentially	RB
self-reactive	JJ
T	NN
cells	NNS
is	VBZ
not	RB
impaired	JJ
.	.

However	RB
,	,
TNF	NN
signaling	NN
is	VBZ
largely	RB
abolished	VBN
,	,
as	IN
judged	VBN
by	IN
the	DT
failure	NN
of	IN
TNF	NN
to	TO
induce	VB
NF-kappa	NN
B	NN
in	IN
T	NN
lymphocytes	NNS
from	IN
TNFRp55-deficient	JJ
mice	NNS
.	.

The	DT
loss	NN
of	IN
TNFRp55	NN
function	NN
renders	VBZ
mice	NNS
resistant	JJ
to	TO
lethal	JJ
dosages	NNS
of	IN
either	CC
lipopolysaccharides	NNS
or	CC
S.	FW
aureus	FW
enterotoxin	NN
B	NN
.	.

In	IN
contrast	NN
,	,
TNFRp55-deficient	JJ
mice	NNS
are	VBP
severely	RB
impaired	JJ
to	TO
clear	VB
L.	FW
monocytogenes	FW
and	CC
readily	RB
succumb	VBP
to	TO
infection	NN
.	.

Thus	RB
,	,
the	DT
55	CD
kd	NN
TNFR	NN
plays	VBZ
a	DT
decisive	JJ
role	NN
in	IN
the	DT
host	NN
's	POS
defense	NN
against	IN
microorganisms	NNS
and	CC
their	PRP$
pathogenic	JJ
factors	NNS
.	.

UI	LS
-	:
93363253	CD

TI	LS
-	:
Tumor	NN
necrosis	NN
factor	NN
receptor	NN
expression	NN
and	CC
signal	NN
transduction	NN
in	IN
HIV-1-infected	JJ
cells	NNS
.	.

AB	LS
-	:
OBJECTIVE	NN
:	:
To	TO
examine	VB
the	DT
inter-relationship	NN
between	IN
HIV-1	NN
infection	NN
and	CC
the	DT
cell	NN
surface	NN
receptors	NNS
for	IN
tumor	NN
necrosis	NN
factor	NN
(	(
TNF	NN
)	)
-alpha	NN
,	,
an	DT
immunoregulatory	JJ
cytokine	NN
that	WDT
can	MD
enhance	VB
HIV-1	NN
replication	NN
.	.

DESIGN	NN
:	:
Infected	JJ
promyelocytic	JJ
and	CC
promonocytic	JJ
cells	NNS
were	VBD
examined	VBN
because	IN
they	PRP
normally	RB
express	VBP
both	DT
types	NNS
of	IN
TNF	NN
receptors	NNS
.	.

METHODS	NNS
:	:
TNF	NN
receptor	NN
surface	NN
expression	NN
was	VBD
determined	VBN
by	IN
specific	JJ
monoclonal	JJ
antibody	NN
recognition	NN
and	CC
flow	NN
cytometry	NN
,	,
and	CC
signal	NN
transduction	NN
was	VBD
detected	VBN
by	IN
gel	NN
shift	NN
analysis	NN
.	.

HIV-1	NN
activation	NN
and	CC
expression	NN
was	VBD
quantitated	VBN
by	IN
reverse	JJ
transcriptase	NN
assay	NN
.	.

RESULTS	NNS
:	:
In	IN
the	DT
OM-10.1	NN
promyelocytic	JJ
model	NN
of	IN
chronic	JJ
infection	NN
,	,
TNF-alpha-induced	JJ
HIV-1	NN
expression	NN
also	RB
resulted	VBD
in	IN
a	DT
substantial	JJ
increase	NN
in	IN
75	CD
kd	NN
TNF	NN
receptor	NN
(	(
TR75	NN
)	)
expression	NN
although	IN
55	CD
kD	NN
TNF	NN
receptor	NN
(	(
TR55	NN
)	)
levels	NNS
were	VBD
not	RB
dramatically	RB
altered	VBN
.	.

A	DT
series	NN
of	IN
uninfected	JJ
parental	JJ
HL-60	NN
subclones	NNS
all	DT
reduced	VBD
TR75	NN
surface	NN
expression	NN
in	IN
response	NN
to	TO
TNF-alpha	NN
treatment	NN
.	.

Enhanced	VBN
TR75	NN
expression	NN
on	IN
OM-10.1	NN
cells	NNS
followed	VBD
the	DT
same	JJ
TNF-alpha-dose	NN
dependency	NN
as	IN
that	WDT
observed	VBN
for	IN
HIV-1	NN
production	NN
.	.

An	DT
increase	NN
in	IN
TR75	NN
expression	NN
was	VBD
also	RB
evident	JJ
during	IN
the	DT
peak	NN
of	IN
an	DT
acute	JJ
HIV-1	NN
infection	NN
of	IN
HL-60	NN
promyelocytes	NNS
.	.

Although	IN
TR55	NN
expression	NN
was	VBD
unaltered	JJ
during	IN
TNF-alpha-induced	JJ
HIV	NN
activation	NN
,	,
this	DT
receptor	NN
was	VBD
still	RB
involved	VBN
in	IN
the	DT
viral	JJ
activation	NN
process	NN
.	.

Antibody	NN
cross-linking	NN
of	IN
TR55	NN
,	,
in	IN
the	DT
absence	NN
of	IN
exogenous	JJ
TNF-alpha	NN
,	,
induced	VBN
maximal	JJ
HIV-1	NN
expression	NN
,	,
an	DT
up-modulation	NN
of	IN
surface	NN
TR75	NN
,	,
and	CC
nuclear	JJ
NF-kappa	NN
B	NN
activity	NN
in	IN
OM-10.1	NN
cultures	NNS
.	.

Surprisingly	RB
,	,
this	DT
was	VBD
the	DT
case	NN
even	RB
when	WRB
an	DT
antagonistic	JJ
anti-TR55	JJ
antibody	NN
was	VBD
used	VBN
.	.

Anti-TR55	JJ
antibody	NN
cross-linking	NN
in	IN
chronically	RB
infected	JJ
U1	NN
promonocytic	JJ
cultures	NNS
could	MD
only	RB
partially	RB
substitute	VB
for	IN
TNF-alpha-induced	JJ
HIV-1	NN
expression	NN
.	.

CONCLUSIONS	NNS
:	:
Our	PRP$
results	NNS
demonstrated	VBD
that	IN
HIV-1	NN
infection	NN
can	MD
selectively	RB
influence	VB
the	DT
surface	NN
expression	NN
of	IN
TNF	NN
receptors	NNS
,	,
potentially	RB
influencing	VBG
its	PRP$
own	JJ
expression	NN
and	CC
altering	VBG
normal	JJ
immunoregulatory	JJ
signal	NN
transduction	NN
.	.

UI	LS
-	:
93224755	CD

TI	LS
-	:
Functional	JJ
antagonism	NN
between	IN
vitamin	NN
D3	NN
and	CC
retinoic	JJ
acid	NN
in	IN
the	DT
regulation	NN
of	IN
CD14	NN
and	CC
CD23	NN
expression	NN
during	IN
monocytic	JJ
differentiation	NN
of	IN
U-937	NN
cells	NNS
.	.

AB	LS
-	:
1,25	CD
alpha-Dihydroxicholecalciferol	NN
(	(
VitD3	NN
)	)
and	CC
retinoic	JJ
acid	NN
(	(
RA	NN
)	)
are	VBP
important	JJ
regulators	NNS
of	IN
the	DT
proliferation	NN
and	CC
differentiation	NN
of	IN
several	JJ
cell	NN
types	NNS
.	.

This	DT
paper	NN
describes	VBZ
how	WRB
the	DT
expression	NN
of	IN
the	DT
monocyte-macrophage	JJ
Ag	NN
,	,
CD14	NN
,	,
and	CC
the	DT
low	JJ
affinity	NN
Fc	NN
receptor	NN
for	IN
IgE	NN
,	,
CD23	NN
,	,
were	VBD
inversely	RB
regulated	VBN
during	IN
VitD3-	NN
and	CC
RA-induced	JJ
monocytic	JJ
differentiation	NN
of	IN
human	JJ
U-937	NN
monoblasts	NNS
.	.

PMA	NN
induced	VBD
the	DT
expression	NN
of	IN
both	CC
CD14	NN
and	CC
CD23	NN
mRNA	NN
and	CC
protein	NN
.	.

Exposure	NN
to	TO
VitD3	NN
rapidly	RB
induced	VBD
the	DT
de	FW
novo	FW
expression	NN
of	IN
CD14	NN
mRNA	NN
and	CC
protein	NN
.	.

The	DT
addition	NN
of	IN
cycloheximide	NN
completely	RB
blocked	VBD
the	DT
VitD3	NN
induction	NN
of	IN
CD14	NN
mRNA	NN
expression	NN
,	,
indicating	VBG
that	IN
the	DT
induction	NN
was	VBD
dependent	JJ
on	IN
ongoing	JJ
protein	NN
synthesis	NN
.	.

While	IN
inducing	VBG
CD14	NN
expression	NN
,	,
VitD3	NN
concomitantly	RB
suppressed	VBD
the	DT
basal	JJ
,	,
PMA-	NN
,	,
and	CC
RA-inducible	JJ
CD23	NN
expression	NN
in	IN
a	DT
dose-dependent	JJ
manner	NN
.	.

In	IN
contrast	NN
,	,
U-937	NN
cells	NNS
induced	VBN
by	IN
RA	NN
strongly	RB
increased	VBD
their	PRP$
expression	NN
of	IN
CD23	NN
mRNA	NN
and	CC
protein	NN
,	,
whereas	IN
they	PRP
completely	RB
lacked	VBD
detectable	JJ
CD14	NN
cell	NN
surface	NN
or	CC
mRNA	NN
expression	NN
.	.

Furthermore	RB
,	,
the	DT
VitD3-	NN
and	CC
the	DT
PMA-induced	JJ
CD14	NN
expression	NN
was	VBD
inhibited	VBN
as	IN
a	DT
temporal	JJ
consequence	NN
of	IN
the	DT
RA-induced	JJ
differentiation	NN
.	.

The	DT
results	NNS
suggest	VBP
that	IN
there	EX
exists	VBZ
a	DT
functional	JJ
antagonism	NN
between	IN
VitD3	NN
and	CC
RA	NN
that	WDT
may	MD
have	VB
important	JJ
implications	NNS
for	IN
the	DT
regulation	NN
of	IN
certain	JJ
immune	JJ
and	CC
inflammatory	JJ
responses	NNS
through	IN
their	PRP$
inverse	JJ
effects	NNS
on	IN
CD14	NN
and	CC
CD23	NN
gene	NN
expression	NN
.	.

UI	LS
-	:
93259462	CD

TI	LS
-	:
Cloning	NN
and	CC
functional	JJ
characterization	NN
of	IN
early	JJ
B-cell	NN
factor	NN
,	,
a	DT
regulator	NN
of	IN
lymphocyte-specific	JJ
gene	NN
expression	NN
.	.

AB	LS
-	:
Early	JJ
B-cell	NN
factor	NN
(	(
EBF	NN
)	)
was	VBD
identified	VBN
previously	RB
as	IN
a	DT
tissue-specific	JJ
and	CC
differentiation	NN
stage-specific	JJ
DNA-binding	JJ
protein	NN
that	WDT
participates	VBZ
in	IN
the	DT
regulation	NN
of	IN
the	DT
pre-B	JJ
and	CC
B	NN
lymphocyte-specific	JJ
mb-1	NN
gene	NN
.	.

Partial	JJ
amino	NN
acid	NN
sequences	NNS
obtained	VBN
from	IN
purified	VBN
EBF	NN
were	VBD
used	VBN
to	TO
isolate	VB
cDNA	NN
clones	NNS
,	,
which	WDT
by	IN
multiple	JJ
criteria	NNS
encode	VB
EBF	NN
.	.

The	DT
recombinant	JJ
polypeptide	NN
formed	VBD
sequence-specific	JJ
complexes	NNS
with	IN
the	DT
EBF-binding	NN
site	NN
in	IN
the	DT
mb-1	NN
promoter	NN
.	.

The	DT
cDNA	NN
hybridized	VBD
to	TO
multiple	JJ
transcripts	NNS
in	IN
pre-B	JJ
and	CC
B-cell	NN
lines	NNS
,	,
but	CC
transcripts	NNS
were	VBD
not	RB
detected	VBN
at	IN
significant	JJ
levels	NNS
in	IN
plasmacytoma	NN
,	,
T-cell	NN
,	,
and	CC
nonlymphoid	JJ
cell	NN
lines	NNS
.	.

Expression	NN
of	IN
recombinant	JJ
EBF	NN
in	IN
transfected	VBN
nonlymphoid	JJ
cells	NNS
strongly	RB
activated	VBD
transcription	NN
from	IN
reporter	NN
plasmids	NNS
containing	VBG
functional	JJ
EBF-binding	JJ
sites	NNS
.	.

Analysis	NN
of	IN
DNA	NN
binding	NN
by	IN
deletion	NN
mutants	NNS
of	IN
EBF	NN
identified	VBD
an	DT
amino-terminal	JJ
cysteine-rich	JJ
DNA-binding	JJ
domain	NN
lacking	VBG
obvious	JJ
sequence	NN
similarity	NN
to	TO
known	JJ
transcription	NN
factors	NNS
.	.

DNA-binding	JJ
assays	NNS
with	IN
cotranslated	VBN
wild-type	JJ
and	CC
truncated	JJ
forms	NNS
of	IN
EBF	NN
indicated	VBD
that	IN
the	DT
protein	NN
interacts	VBZ
with	IN
its	PRP$
site	NN
as	IN
a	DT
homodimer	NN
.	.

Deletions	NNS
delineated	VBD
a	DT
carboxy-terminal	JJ
dimerization	NN
region	NN
containing	VBG
two	CD
repeats	NNS
of	IN
15	CD
amino	NN
acids	NNS
that	WDT
show	VBP
similarity	NN
with	IN
the	DT
dimerization	NN
domains	NNS
of	IN
basic-helix-loop-helix	JJ
proteins	NNS
.	.

Together	RB
,	,
these	DT
data	NNS
suggest	VBP
that	IN
EBF	NN
represents	VBZ
a	DT
novel	JJ
regulator	NN
of	IN
B	NN
lymphocyte-specific	JJ
gene	NN
expression	NN
.	.

UI	LS
-	:
92269839	CD

TI	LS
-	:
The	DT
promoter	NN
of	IN
the	DT
CD19	NN
gene	NN
is	VBZ
a	DT
target	NN
for	IN
the	DT
B-cell-specific	JJ
transcription	NN
factor	NN
BSAP	NN
.	.

AB	LS
-	:
The	DT
CD19	NN
protein	NN
is	VBZ
expressed	VBN
on	IN
the	DT
surface	NN
of	IN
all	DT
B-lymphoid	JJ
cells	NNS
with	IN
the	DT
exception	NN
of	IN
terminally	RB
differentiated	VBN
plasma	NN
cells	NNS
and	CC
has	VBZ
been	VBN
implicated	VBN
as	IN
a	DT
signal-transducing	JJ
receptor	NN
in	IN
the	DT
control	NN
of	IN
proliferation	NN
and	CC
differentiation	NN
.	.

Here	RB
we	PRP
demonstrate	VBP
complete	JJ
correlation	NN
between	IN
the	DT
expression	NN
pattern	NN
of	IN
the	DT
CD19	NN
gene	NN
and	CC
the	DT
B-cell-specific	JJ
transcription	NN
factor	NN
BSAP	NN
in	IN
a	DT
large	JJ
panel	NN
of	IN
B-lymphoid	JJ
cell	NN
lines	NNS
.	.

The	DT
human	JJ
CD19	NN
gene	NN
has	VBZ
been	VBN
cloned	VBN
,	,
and	CC
several	JJ
BSAP-binding	JJ
sites	NNS
have	VBP
been	VBN
mapped	VBN
by	IN
in	FW
vitro	FW
protein-DNA	JJ
binding	NN
studies	NNS
.	.

In	IN
particular	JJ
,	,
a	DT
high-affinity	JJ
BSAP-binding	JJ
site	NN
instead	RB
of	IN
a	DT
TATA	NN
sequence	NN
is	VBZ
located	JJ
in	IN
the	DT
-30	CD
promoter	NN
region	NN
upstream	JJ
of	IN
a	DT
cluster	NN
of	IN
heterogeneous	JJ
transcription	NN
start	NN
sites	NNS
.	.

Moreover	RB
,	,
this	DT
site	NN
is	VBZ
occupied	VBN
by	IN
BSAP	NN
in	FW
vivo	FW
in	IN
a	DT
CD19-expressing	JJ
B-cell	NN
line	NN
but	CC
not	RB
in	IN
plasma	NN
or	CC
HeLa	NN
cells	NNS
.	.

This	DT
high-affinity	JJ
site	NN
has	VBZ
been	VBN
conserved	VBN
in	IN
the	DT
promoters	NNS
of	IN
both	CC
human	JJ
and	CC
mouse	NN
CD19	NN
genes	NNS
and	CC
was	VBD
furthermore	RB
shown	VBN
to	TO
confer	VB
B-cell	NN
specificity	NN
to	TO
a	DT
beta-globin	NN
reporter	NN
gene	NN
in	IN
transient	JJ
transfection	NN
experiments	NNS
.	.

In	IN
addition	NN
,	,
BSAP	NN
was	VBD
found	VBN
to	TO
be	VB
the	DT
only	RB
abundant	JJ
DNA-binding	JJ
activity	NN
of	IN
B-cell	NN
nuclear	JJ
extracts	NNS
that	WDT
interacts	VBZ
with	IN
the	DT
CD19	NN
promoter	NN
.	.

Together	RB
,	,
this	DT
evidence	NN
strongly	RB
implicates	VBZ
BSAP	NN
in	IN
the	DT
regulation	NN
of	IN
the	DT
CD19	NN
gene	NN
.	.

UI	LS
-	:
92309248	CD

TI	LS
-	:
c-myc	NN
mRNA	NN
expression	NN
in	IN
minor	JJ
salivary	JJ
glands	NNS
of	IN
patients	NNS
with	IN
Sjogren	NN
's	POS
syndrome	NN
.	.

AB	LS
-	:
c-myc	NN
protooncogene	NN
is	VBZ
implicated	VBN
in	IN
the	DT
pathogenesis	NN
of	IN
B	NN
cell	NN
lymphoid	JJ
malignancies	NNS
and	CC
high	JJ
levels	NNS
of	IN
c-myc	NN
mRNA	NN
expression	NN
are	VBP
observed	VBN
in	IN
activated	VBN
blood	NN
mononuclear	JJ
cells	NNS
.	.

Sjogren	NN
's	POS
syndrome	NN
(	(
SS	NN
)	)
is	VBZ
characterized	VBN
by	IN
lymphocytic	JJ
infiltrates	NNS
of	IN
exocrine	JJ
glands	NNS
,	,
remarkable	JJ
B	NN
cell	NN
hyperreactivity	NN
and	CC
a	DT
strong	JJ
predisposition	NN
to	TO
B	NN
cell	NN
neoplasia	NN
.	.

In	IN
this	DT
study	NN
,	,
c-myc	NN
protooncogene	NN
mRNA	NN
expression	NN
in	IN
29	CD
labial	JJ
minor	JJ
salivary	JJ
gland	NN
biopsies	NNS
from	IN
patients	NNS
with	IN
primary	JJ
SS	NNS
and	CC
15	CD
controls	NNS
was	VBD
examined	VBN
using	VBG
in	FW
situ	FW
hybridization	NN
histochemistry	NN
.	.

Two	CD
40mer	JJ
oligonucleotides	NNS
from	IN
the	DT
1st	JJ
and	CC
the	DT
2nd	JJ
exon	NN
of	IN
the	DT
c-myc	NN
gene	NN
,	,
labeled	VBN
with	IN
35S	NN
,	,
were	VBD
used	VBN
as	IN
probes	NNS
.	.

To	TO
detect	VB
the	DT
origin	NN
of	IN
the	DT
cell	NN
hybridized	VBN
with	IN
a	DT
c-myc	NN
probe	NN
,	,
a	DT
combined	JJ
immunochemistry	NN
in	FW
situ	FW
hybridization	NN
histochemistry	NN
technique	NN
was	VBD
used	VBN
.	.

High	JJ
c-myc	NN
mRNA	NN
expression	NN
was	VBD
detected	VBN
on	IN
acinar	JJ
epithelial	JJ
cells	NNS
.	.

c-myc	NN
did	VBD
not	RB
correlate	VB
with	IN
c-fos	NN
and	CC
c-jun	NN
protein	NN
expression	NN
.	.

Stronger	JJR
c-myc	NN
mRNA	NN
expression	NN
was	VBD
detected	VBN
in	IN
labial	JJ
salivary	JJ
glands	NNS
of	IN
patients	NNS
with	IN
longer	JJR
disease	NN
duration	NN
(	(
p	NN
less	JJR
than	IN
or	CC
equal	JJ
to	TO
0.002	CD
)	)
and	CC
more	RBR
intense	JJ
T	NN
lymphocyte	NN
infiltrates	NNS
(	(
p	NN
less	JJR
than	IN
0.05	CD
)	)
although	IN
these	DT
patients	NNS
revealed	VBD
no	DT
hypergammaglobulinemia	NN
.	.

No	DT
correlation	NN
was	VBD
observed	VBN
between	IN
c-myc	NN
mRNA	NN
and	CC
B	NN
lymphocyte	NN
monoclonicity	NN
or	CC
lymphoma	NN
.	.

In	IN
conclusion	NN
,	,
strong	JJ
c-myc	NN
mRNA	NN
expression	NN
was	VBD
observed	VBN
on	IN
epithelial	JJ
cells	NNS
of	IN
labial	JJ
salivary	JJ
glands	NNS
from	IN
patients	NNS
with	IN
primary	JJ
SS	NN
.	.

Our	PRP$
findings	NNS
may	MD
indicate	VB
the	DT
presence	NN
of	IN
a	DT
reactivated	VBN
virus	NN
hosted	VBN
in	IN
these	DT
cells	NNS
.	.

UI	LS
-	:
92176657	CD

TI	LS
-	:
T	NN
cell-specific	JJ
negative	JJ
regulation	NN
of	IN
transcription	NN
of	IN
the	DT
human	JJ
cytokine	NN
IL-4	NN
.	.

AB	LS
-	:
IL-4	NN
secreted	VBN
by	IN
activated	VBN
T	NN
cells	NNS
is	VBZ
a	DT
pleiotropic	JJ
cytokine	NN
affecting	VBG
growth	NN
and	CC
differentiation	NN
of	IN
diverse	JJ
cell	NN
types	NNS
such	JJ
as	IN
T	NN
cells	NNS
,	,
B	NN
cells	NNS
,	,
and	CC
mast	NN
cells	NNS
.	.

We	PRP
investigated	VBD
the	DT
upstream	JJ
regulatory	JJ
elements	NNS
of	IN
the	DT
human	JJ
IL-4	NN
promoter	NN
.	.

A	DT
novel	JJ
T	NN
cell-specific	JJ
negative	JJ
regulatory	JJ
element	NN
(	(
NRE	NN
)	)
composed	VBN
of	IN
two	CD
protein-binding	JJ
sites	NNS
were	VBD
mapped	VBN
in	IN
the	DT
5'	JJ
flanking	JJ
region	NN
of	IN
the	DT
IL-4	NN
gene	NN
:	:
-311CTCCCTTCT-303	NN
(	(
NRE-I	NN
)	)
and	CC
-288CTTTTTGCTT-TGC-300	NN
(	(
NRE-II	NN
)	)
.	.

A	DT
T	NN
cell-specific	JJ
protein	NN
Neg-1	NN
and	CC
a	DT
ubiquitous	JJ
protein	NN
Neg-2	NN
binding	VBG
to	TO
NRE-I	NN
and	CC
NRE-II	NN
,	,
respectively	RB
,	,
were	VBD
identified	VBN
.	.

Furthermore	RB
,	,
a	DT
positive	JJ
regulatory	JJ
element	NN
was	VBD
found	VBN
45	CD
bp	NN
downstream	RB
of	IN
the	DT
NRE	NN
.	.

The	DT
enhancer	NN
activity	NN
of	IN
the	DT
PRE	NN
was	VBD
completely	RB
suppressed	VBN
when	WRB
the	DT
NRE	NN
was	VBD
present	JJ
.	.

These	DT
data	NNS
suggest	VBP
that	IN
IL-4	NN
promoter	NN
activity	NN
is	VBZ
normally	RB
down-regulated	VBN
by	IN
an	DT
NRE	NN
via	IN
repression	NN
of	IN
the	DT
enhancer	NN
positive	JJ
regulatory	JJ
element	NN
.	.

These	DT
data	NNS
may	MD
have	VB
implications	NNS
for	IN
the	DT
stringent	JJ
control	NN
of	IN
IL-4	NN
expression	NN
in	IN
T	NN
cells	NNS
.	.

UI	LS
-	:
92164748	CD

TI	LS
-	:
Interleukin	NN
6-induced	JJ
differentiation	NN
of	IN
a	DT
human	JJ
B	NN
cell	NN
line	NN
into	IN
IgM-secreting	JJ
plasma	NN
cells	NNS
is	VBZ
mediated	VBN
by	IN
c-fos	NN
.	.

AB	LS
-	:
The	DT
role	NN
of	IN
the	DT
protooncogene	NN
c-fos	NN
in	IN
interleukin	NN
(	(
IL	NN
)	)
6-induced	JJ
B	NN
cell	NN
differentiation	NN
was	VBD
assessed	VBN
.	.

Treatment	NN
of	IN
SKW	NN
6.4	CD
cells	NNS
with	IN
IL	NN
6	CD
induced	VBD
a	DT
transient	JJ
and	CC
early	JJ
stimulation	NN
of	IN
c-fos	NN
sense	NN
mRNA	NN
expression	NN
.	.

The	DT
effect	NN
appeared	VBD
within	IN
30	CD
min	NN
and	CC
returned	VBD
to	TO
basal	JJ
levels	NNS
after	IN
2	CD
h	NN
.	.

The	DT
addition	NN
of	IN
antisense	JJ
oligonucleotides	NNS
to	TO
c-fos	NN
significantly	RB
inhibited	VBD
IL	NN
6-induced	JJ
IgM	NN
production	NN
by	IN
SKW	NN
6.4	CD
cells	NNS
(	(
p	NN
less	JJR
than	IN
0.001	CD
)	)
,	,
whereas	IN
control	NN
oligonucleotides	NNS
had	VBD
no	DT
inhibitory	JJ
effect	NN
.	.

These	DT
results	NNS
indicate	VBP
that	IN
activation	NN
of	IN
c-fos	NN
is	VBZ
involved	VBN
in	IN
IL	NN
6-induced	JJ
differentiation	NN
of	IN
SKW	NN
6.4	CD
cells	NNS
into	IN
IgM-secreting	JJ
cells	NNS
.	.

UI	LS
-	:
92153263	CD

TI	LS
-	:
Transcriptional	JJ
regulation	NN
during	IN
T-cell	NN
development	NN
:	:
the	DT
alpha	NN
TCR	NN
gene	NN
as	IN
a	DT
molecular	JJ
model	NN
.	.

AB	LS
-	:
The	DT
regulation	NN
of	IN
gene	NN
expression	NN
during	IN
lymphocyte	NN
differentiation	NN
is	VBZ
a	DT
complex	JJ
process	NN
involving	VBG
interactions	NNS
between	IN
multiple	JJ
positive	JJ
and	CC
negative	JJ
transcriptional	JJ
regulatory	JJ
elements	NNS
.	.

In	IN
this	DT
article	NN
,	,
transcriptional	JJ
regulation	NN
of	IN
the	DT
archetypal	JJ
T-cell-specific	JJ
gene	NN
,	,
alpha	NN
TCR	NN
,	,
is	VBZ
discussed	VBN
.	.

Major	JJ
recent	JJ
developments	NNS
,	,
including	VBG
the	DT
identification	NN
of	IN
novel	JJ
families	NNS
of	IN
transcription	NN
factors	NNS
that	WDT
regulate	VBP
multiple	JJ
T-cell	NN
genes	NNS
during	IN
thymocyte	NN
ontogeny	NN
and	CC
T-cell	NN
activation	NN
,	,
are	VBP
described	VBN
.	.

UI	LS
-	:
92176633	CD

TI	LS
-	:
Gangliosides	NN
suppress	VBP
tumor	NN
necrosis	NN
factor	NN
production	NN
in	IN
human	JJ
monocytes	NNS
.	.

AB	LS
-	:
Both	CC
normal	JJ
and	CC
malignant	JJ
cells	NNS
contain	VBP
gangliosides	NNS
as	IN
important	JJ
cell	NN
membrane	NN
constituents	NNS
that	WDT
,	,
after	IN
being	VBG
shed	VBN
,	,
may	MD
influence	VB
cells	NNS
of	IN
the	DT
immune	JJ
system	NN
.	.

We	PRP
have	VBP
studied	VBN
the	DT
impact	NN
of	IN
gangliosides	NNS
on	IN
the	DT
expression	NN
of	IN
TNF	NN
in	IN
blood	NN
monocytes	NNS
and	CC
in	IN
the	DT
monocytic	JJ
cell	NN
line	NN
Mono	NN
Mac	NN
6	CD
.	.

Although	IN
under	IN
standard	JJ
culture	NN
conditions	NNS
,	,
bovine	JJ
brain	NN
gangliosides	NNS
(	(
100	CD
micrograms/ml	NNS
)	)
suppressed	VBD
LPS-stimulated	JJ
TNF	NN
production	NN
5-fold	RB
in	IN
PBMC	NN
and	CC
10-fold	RB
in	IN
Mono	NN
Mac	NN
6	CD
cells	NNS
,	,
suppression	NN
was	VBD
more	RBR
efficient	JJ
under	IN
serum-free	JJ
conditions	NNS
.	.

Looking	VBG
at	IN
highly	RB
purified	VBN
gangliosides	NNS
,	,
GD3	NN
,	,
GD1a	NN
,	,
GM3	NN
,	,
GM2	NN
,	,
and	CC
GM1	NN
were	VBD
all	DT
effective	JJ
in	IN
reducing	VBG
TNF	NN
production	NN
in	IN
PBMC	NN
,	,
and	CC
in	IN
Mono	NN
Mac	NN
6	CD
by	IN
factor	NN
10	CD
to	TO
50	CD
.	.

The	DT
suppressive	JJ
activity	NN
was	VBD
lost	VBN
in	IN
molecules	NNS
,	,
lacking	VBG
the	DT
sugar	NN
moiety	NN
or	CC
the	DT
lipid	NN
moiety	NN
.	.

Gangliosides	NNS
appear	VBP
to	TO
act	VB
at	IN
an	DT
early	JJ
step	NN
of	IN
activation	NN
in	IN
that	IN
TNF	NN
transcripts	NNS
were	VBD
reduced	VBN
and	CC
the	DT
mobilization	NN
of	IN
the	DT
nuclear	JJ
factor	NN
kappa	NN
B	NN
was	VBD
blocked	VBN
.	.

Furthermore	RB
,	,
in	IN
time	NN
kinetics	NNS
,	,
gangliosides	NNS
were	VBD
effective	JJ
for	IN
up	RB
to	TO
30	CD
min	NN
after	IN
addition	NN
of	IN
LPS	NN
,	,
but	CC
not	RB
thereafter	RB
.	.

However	RB
,	,
the	DT
expression	NN
of	IN
the	DT
CD14	NN
Ag	NN
,	,
a	DT
receptor	NN
molecule	NN
for	IN
LPS-LPS	NN
binding	NN
protein	NN
complexes	NNS
,	,
was	VBD
unaffected	JJ
by	IN
gangliosides	NNS
.	.

Finally	RB
,	,
when	WRB
using	VBG
Staphylococcus	FW
aureus	FW
or	CC
platelet	NN
activating	NN
factor	NN
as	IN
a	DT
stimulus	NN
,	,
gangliosides	NNS
were	VBD
able	JJ
to	TO
suppress	VB
TNF	NN
production	NN
in	IN
Mono	NN
Mac	NN
6	CD
cells	NNS
by	IN
factor	NN
5	CD
to	TO
10	CD
,	,
as	RB
well	RB
.	.

On	IN
the	DT
other	JJ
hand	NN
,	,
phorbol	NN
ester-induced	JJ
production	NN
of	IN
O2-	NN
was	VBD
similar	JJ
in	IN
cells	NNS
treated	VBN
with	IN
and	CC
without	IN
gangliosides	NNS
.	.

Taken	VBN
together	RB
,	,
our	PRP$
data	NNS
demonstrate	VBP
that	IN
TNF	NN
gene	NN
expression	NN
in	IN
monocytes	NNS
induced	VBN
by	IN
different	JJ
types	NNS
of	IN
stimuli	NNS
can	MD
be	VB
blocked	VBN
by	IN
gangliosides	NNS
at	IN
an	DT
early	JJ
step	NN
of	IN
signal	JJ
transduction	NN
.	.

UI	LS
-	:
93150054	CD

TI	LS
-	:
Activation	NN
of	IN
lymphokine	NN
genes	NNS
in	IN
T	NN
cells	NNS
:	:
role	NN
of	IN
cis-acting	JJ
DNA	NN
elements	NNS
that	WDT
respond	VBP
to	TO
T	NN
cell	NN
activation	NN
signals	NNS
.	.

AB	LS
-	:
Activation	NN
of	IN
T	NN
cells	NNS
is	VBZ
initiated	VBN
by	IN
the	DT
recognition	NN
of	IN
antigen	NN
on	IN
antigen	NN
presenting	NN
cells	NNS
to	TO
exert	VB
the	DT
effector	NN
functions	NNS
in	IN
immune	JJ
and	CC
inflammatory	JJ
responses	NNS
.	.

Two	CD
types	NNS
of	IN
helper	NN
T	NN
cell	NN
(	(
Th	NN
)	)
clones	NNS
(	(
Th1	NN
and	CC
Th2	NN
)	)
are	VBP
defined	VBN
on	IN
the	DT
basis	NN
of	IN
different	JJ
patterns	NNS
of	IN
cytokine	NN
(	(
lymphokine	NN
)	)
secretion	NN
.	.

They	PRP
determine	VBP
the	DT
outcome	NN
of	IN
an	DT
antigenic	JJ
response	NN
toward	IN
humoral	JJ
or	CC
cell-mediated	JJ
immunity	NN
.	.

Although	IN
lymphokine	NN
genes	NNS
are	VBP
coordinately	RB
regulated	VBN
upon	IN
antigen	NN
stimulation	NN
,	,
they	PRP
are	VBP
regulated	VBN
by	IN
the	DT
mechanisms	NNS
common	JJ
to	TO
all	DT
as	RB
well	RB
as	IN
those	DT
which	WDT
are	VBP
unique	JJ
to	TO
each	DT
gene	NN
.	.

For	IN
most	JJS
lymphokine	NN
genes	NNS
,	,
a	DT
combination	NN
of	IN
phorbol	NN
esters	NNS
(	(
phorbol	NN
12-myristate	NN
13	CD
acetate	NN
,	,
PMA	NN
)	)
and	CC
calcium	NN
ionophores	NNS
(	(
A23187	NN
)	)
is	VBZ
required	VBN
for	IN
their	PRP$
maximal	JJ
induction	NN
.	.

Yet	RB
phorbol	NN
ester	NN
alone	RB
or	CC
calcium	NN
ionophore	NN
alone	RB
produce	VBP
several	JJ
lymphokines	NNS
.	.

The	DT
production	NN
of	IN
the	DT
granulocyte-macrophage	JJ
colony	NN
stimulating	NN
factor	NN
(	(
GM-CSF	NN
)	)
is	VBZ
completely	RB
dependent	JJ
on	IN
the	DT
two	CD
signals	NNS
.	.

We	PRP
have	VBP
previously	RB
found	VBN
a	DT
cis-acting	JJ
region	NN
spanning	VBG
the	DT
GM-CSF	NN
promoter	NN
region	NN
(	(
positions	NNS
-95	CD
to	TO
+27	CD
)	)
that	WDT
confers	VBZ
inducibility	NN
to	TO
reporter	NN
genes	NNS
in	IN
transient	JJ
transfection	NN
assays	NNS
.	.

Further	JJ
analysis	NN
identified	VBD
three	CD
elements	NNS
required	VBN
for	IN
efficient	JJ
induction	NN
,	,
referred	VBN
to	TO
as	IN
GM2	NN
,	,
GC-box	NN
and	CC
conserved	VBN
lymphokine	NN
element	NN
(	(
CLE0	NN
)	)
.	.

GM2	NN
defines	VBZ
a	DT
binding	VBG
site	NN
for	IN
protein	NN
(	(
s	NNS
)	)
whose	WP$
binding	NN
is	VBZ
inducible	JJ
by	IN
PMA	NN
.	.

One	CD
protein	NN
,	,
NF-GM2	NN
is	VBZ
similar	JJ
to	TO
the	DT
transcription	NN
factor	NN
NF-kB	NN
.	.

GC-box	NN
is	VBZ
a	DT
binding	VBG
site	NN
for	IN
constitutively	RB
bound	VBN
proteins	NNS
.	.

CLEO	NN
defines	VBZ
a	DT
binding	VBG
site	NN
for	IN
protein	NN
(	(
s	NNS
)	)
whose	WP$
optimum	NN
binding	NN
is	VBZ
stimulated	VBN
by	IN
PMA	NN
and	CC
A23187	NN
.	.

Viral	JJ
trans-activators	NNS
such	JJ
as	IN
Tax	NN
(	(
human	JJ
T	NN
cell	NN
leukemia	NN
virus-1	NN
,	,
HTLV-1	NN
)	)
and	CC
E2	NN
(	(
bovine	JJ
papilloma	NN
virus	NN
,	,
BPV	NN
)	)
proteins	NNS
are	VBP
other	JJ
agents	NNS
which	WDT
activate	VBP
lymphokine	NN
gene	NN
expression	NN
by	IN
bypassing	VBG
T	NN
cell	NN
receptor	NN
(	(
TCR	NN
)	)
mediated	JJ
signaling	NN
.	.

The	DT
trans-activation	NN
domain	NN
of	IN
E2	NN
and	CC
Tax	NN
is	VBZ
interchangeable	JJ
although	IN
they	PRP
have	VBP
no	DT
obvious	JJ
sequence	NN
homology	NN
between	IN
them	PRP
.	.

The	DT
viral	JJ
trans-activators	NNS
appear	VBP
to	TO
target	VB
specific	JJ
DNA	NN
binding	NN
protein	NN
such	JJ
as	IN
NF-kB	NN
and	CC
Sp1	NN
to	TO
cis-acting	JJ
DNA	NN
site	NN
and	CC
promote	VB
lymphokine	NN
gene	NN
expression	NN
without	IN
TCR-mediated	JJ
stimulation	NN
.	.

UI	LS
-	:
93114357	CD

TI	LS
-	:
Activation	NN
of	IN
protein	NN
kinase	NN
C	NN
and	CC
elevation	NN
of	IN
cAMP	NN
interact	VBP
synergistically	RB
to	TO
raise	VB
c-Fos	NN
and	CC
AP-1	NN
activity	NN
in	IN
Jurkat	NN
cells	NNS
.	.

AB	LS
-	:
We	PRP
have	VBP
earlier	RBR
found	VBN
that	IN
in	IN
Jurkat	NN
cells	NNS
activation	NN
of	IN
protein	NN
kinase	NN
C	NN
(	(
PKC	NN
)	)
enhances	VBZ
the	DT
cyclic	JJ
adenosine	NN
monophosphate	NN
(	(
cAMP	NN
)	)
accumulation	NN
induced	VBN
by	IN
adenosine	NN
receptor	NN
stimulation	NN
or	CC
activation	NN
of	IN
Gs	NN
.	.

Here	RB
we	PRP
have	VBP
therefore	RB
examined	VBN
the	DT
effect	NN
of	IN
the	DT
phorbol	NN
ester	NN
PMA	NN
(	(
phorbol	NN
12-myristate	NN
13-acetate	NN
)	)
which	WDT
stimulates	VBZ
PKC	NN
and	CC
a	DT
combination	NN
of	IN
the	DT
adenosine	NN
receptor	NN
agonist	NN
NECA	NN
(	(
5'-(N-ethyl)-carboxamido	JJ
adenosine	NN
)	)
and	CC
forskolin	NN
to	TO
raise	VB
cAMP	NN
,	,
on	IN
the	DT
levels	NNS
of	IN
c-Fos	NN
and	CC
Jun	NN
and	CC
on	IN
the	DT
binding	VBG
and	CC
transcriptional	JJ
activity	NN
of	IN
the	DT
transcription	NN
factor	NN
,	,
activator	NN
protein-1	NN
(	(
AP-1	NN
)	)
.	.

PMA	NN
treatment	NN
caused	VBD
a	DT
concentration-	NN
and	CC
time-dependent	JJ
increase	NN
in	IN
both	CC
c-Fos	NN
and	CC
Jun	NN
immunoreactivity	NN
in	IN
contrast	NN
to	TO
cAMP	NN
elevation	NN
that	WDT
had	VBD
only	RB
a	DT
slight	JJ
effect	NN
.	.

Both	CC
PMA	NN
and	CC
the	DT
combination	NN
of	IN
NECA	NN
and	CC
forskolin	NN
acted	VBD
together	RB
either	CC
to	TO
increase	VB
(	(
c-Fos	NN
)	)
or	CC
decrease	VB
(	(
Jun	NN
)	)
protein	NN
levels	NNS
as	RB
well	RB
as	IN
increasing	VBG
AP-1	NN
binding	NN
,	,
as	IN
judged	VBN
by	IN
gel-shift	NN
assay	NN
,	,
and	CC
AP-1	NN
transcriptional	JJ
activity	NN
.	.

Furthermore	RB
there	EX
was	VBD
a	DT
clear-cut	JJ
synergy	NN
between	IN
the	DT
PKC	NN
stimulator	NN
and	CC
the	DT
cAMP	NN
elevating	NN
agents	NNS
.	.

The	DT
results	NNS
demonstrate	VBP
that	IN
the	DT
simultaneous	JJ
activation	NN
of	IN
PKC	NN
and	CC
elevation	NN
of	IN
cAMP	NN
leads	VBZ
to	TO
an	DT
enhanced	VBN
AP-1	NN
transcriptional	JJ
activity	NN
in	IN
a	DT
T-leukemia	NN
cell	NN
line	NN
,	,
suggesting	VBG
that	IN
the	DT
previously	RB
observed	VBN
interaction	NN
between	IN
the	DT
parallel	JJ
signal	NN
transduction	NN
pathways	NNS
may	MD
have	VB
functional	JJ
consequences	NNS
at	IN
the	DT
level	NN
of	IN
gene	NN
transcription	NN
.	.

UI	LS
-	:
93101981	CD

TI	LS
-	:
Ablation	NN
of	IN
transplanted	VBN
HTLV-I	NN
Tax-transformed	JJ
tumors	NNS
in	IN
mice	NNS
by	IN
antisense	JJ
inhibition	NN
of	IN
NF-kappa	NN
B	NN
[	(
published	VBN
erratum	NN
appears	VBZ
in	IN
Science	NNP
1993	CD
Mar	NNP
12	CD
;	:
259	CD
(	(
5101	CD
)	)
:	:
1523	CD
]	)

AB	LS
-	:
Mice	NNS
transgenic	JJ
for	IN
the	DT
human	JJ
T	NN
cell	NN
leukemia	NN
virus	NN
(	(
HTLV-I	NN
)	)
Tax	NN
gene	NN
develop	VBP
fibroblastic	JJ
tumors	NNS
that	WDT
express	VBP
NF-kappa	NN
B-inducible	JJ
early	JJ
genes	NNS
.	.

In	FW
vitro	FW
inhibition	NN
of	IN
NF-kappa	NN
B	NN
expression	NN
by	IN
antisense	JJ
oligodeoxynucleotides	NNS
(	(
ODNs	NNS
)	)
inhibited	VBD
growth	NN
of	IN
these	DT
culture-adapted	JJ
Tax-transformed	JJ
fibroblasts	NNS
as	RB
well	RB
as	IN
an	DT
HTLV-I-transformed	JJ
human	JJ
lymphocyte	NN
line	NN
.	.

In	IN
contrast	NN
,	,
antisense	JJ
inhibition	NN
of	IN
Tax	NN
itself	PRP
had	VBD
no	DT
apparent	JJ
effect	NN
on	IN
cell	NN
growth	NN
.	.

Mice	NNS
treated	VBN
with	IN
antisense	NN
to	TO
NF-kappa	NN
B	NN
ODNs	NNS
showed	VBD
rapid	JJ
regression	NN
of	IN
transplanted	VBN
fibrosarcomas	NNS
.	.

This	DT
suggests	VBZ
that	IN
NF-kappa	NN
B	NN
expression	NN
may	MD
be	VB
necessary	JJ
for	IN
the	DT
maintenance	NN
of	IN
the	DT
malignant	JJ
phenotype	NN
and	CC
provides	VBZ
a	DT
therapeutic	JJ
approach	NN
for	IN
HTLV-I-associated	JJ
disease	NN
.	.

UI	LS
-	:
93072349	CD

TI	LS
-	:
Membrane	NN
receptors	NNS
for	IN
aldosterone	NN
:	:
a	DT
novel	JJ
pathway	NN
for	IN
mineralocorticoid	NN
action	NN
.	.

AB	LS
-	:
Rapid	JJ
nongenomic	JJ
in	FW
vitro	FW
effects	NNS
of	IN
aldosterone	NN
on	IN
intracellular	JJ
electrolytes	NNS
,	,
cell	NN
volume	NN
,	,
and	CC
Na(+)-H+	JJ
antiport	NN
have	VBP
been	VBN
found	VBN
in	IN
human	JJ
mononuclear	JJ
leukocytes	NNS
(	(
HML	NN
)	)
.	.

Binding	NN
of	IN
125I-labeled	JJ
aldosterone	NN
to	TO
plasma	NN
membranes	NNS
of	IN
HML	NN
shares	VBZ
important	JJ
features	NNS
with	IN
these	DT
functional	JJ
data	NNS
.	.

This	DT
includes	VBZ
a	DT
very	RB
low	JJ
apparent	JJ
dissociation	NN
constant	NN
(	(
Kd	NN
)	)
of	IN
0.1	CD
nM	NN
for	IN
both	CC
aldosterone	NN
and	CC
the	DT
effect	NN
on	IN
the	DT
Na(+)-H(+)-antiport	NN
,	,
a	DT
high	JJ
turnover	NN
rate	NN
,	,
and	CC
the	DT
almost	RB
exclusive	JJ
binding	NN
selectivity	NN
for	IN
aldosterone	NN
.	.

Dexamethasone	NN
,	,
RU	NN
26988	CD
,	,
corticosterone	NN
,	,
ouabain	NN
,	,
amiloride	NN
,	,
and	CC
18-hydroxyprogesterone	NN
were	VBD
inactive	JJ
as	IN
ligands	NNS
.	.

Deoxycorticosterone	NN
acetate	NN
had	VBD
an	DT
intermediate	JJ
activity	NN
with	IN
an	DT
apparent	JJ
Kd	NN
of	IN
100	CD
nM	NN
.	.

These	DT
findings	NNS
are	VBP
the	DT
first	JJ
to	TO
demonstrate	VB
membrane	NN
binding	NN
of	IN
aldosterone	NN
being	VBG
compatible	JJ
with	IN
major	JJ
aspects	NNS
of	IN
its	PRP$
nongenomic	JJ
effects	NNS
.	.

UI	LS
-	:
92362919	CD

TI	LS
-	:
[	(
Age-related	JJ
changes	NNS
in	IN
glucocorticoid	NN
and	CC
mineralocorticoid	NN
receptors	NNS
in	IN
lymphocytes	NNS
of	IN
healthy	JJ
persons	NNS
and	CC
patients	NNS
with	IN
hypertension	NN
]	)

AB	LS
-	:
It	PRP
has	VBZ
been	VBN
found	VBN
that	IN
the	DT
number	NN
of	IN
glucocorticoid	NN
receptors	NNS
in	IN
lymphocytes	NNS
of	IN
the	DT
peripheral	JJ
blood	NN
of	IN
healthy	JJ
elderly	JJ
subjects	NNS
increases	VBZ
,	,
while	IN
the	DT
number	NN
of	IN
mineralocorticoid	NN
receptors	NNS
decreases	VBZ
.	.

The	DT
mechanisms	NNS
of	IN
hormone-receptor	NN
interactions	NNS
in	IN
hypertension	NN
are	VBP
activated	VBN
:	:
the	DT
number	NN
of	IN
glucocorticoid	NN
and	CC
mineralocorticoid	NN
binding	NN
sites	NNS
grows	VBZ
in	IN
hypertensive	JJ
patients	NNS
.	.

Still	RB
a	DT
more	RBR
essential	JJ
rise	NN
in	IN
the	DT
number	NN
of	IN
receptors	NNS
is	VBZ
observed	VBN
in	IN
mid-age	JJ
hypertensive	NN
patients	NNS
than	IN
in	IN
elderly	JJ
ones	NNS
.	.

UI	LS
-	:
92367617	CD

TI	LS
-	:
The	DT
development	NN
of	IN
functionally	RB
responsive	JJ
T	NN
cells	NNS
.	.

AB	LS
-	:
The	DT
work	NN
reviewed	VBN
in	IN
this	DT
article	NN
separates	VBZ
T	NN
cell	NN
development	NN
into	IN
four	CD
phases	NNS
.	.

First	JJ
is	VBZ
an	DT
expansion	NN
phase	NN
prior	RB
to	TO
TCR	NN
rearrangement	NN
,	,
which	WDT
appears	VBZ
to	TO
be	VB
correlated	VBN
with	IN
programming	NN
of	IN
at	IN
least	JJS
some	DT
response	NN
genes	NNS
for	IN
inducibility	NN
.	.

This	DT
phase	NN
can	MD
occur	VB
to	TO
some	DT
extent	NN
outside	IN
of	IN
the	DT
thymus	NN
.	.

However	RB
,	,
the	DT
profound	JJ
T	NN
cell	NN
deficit	NN
of	IN
nude	JJ
mice	NNS
indicates	VBZ
that	IN
the	DT
thymus	NN
is	VBZ
by	IN
far	RB
the	DT
most	RBS
potent	JJ
site	NN
for	IN
inducing	VBG
the	DT
expansion	NN
per	FW
se	FW
,	,
even	RB
if	IN
other	JJ
sites	NNS
can	MD
induce	VB
some	DT
response	NN
acquisition	NN
.	.

Second	JJ
is	VBZ
a	DT
controlled	JJ
phase	NN
of	IN
TCR	NN
gene	NN
rearrangement	NN
.	.

The	DT
details	NNS
of	IN
the	DT
regulatory	JJ
mechanism	NN
that	WDT
selects	VBZ
particular	JJ
loci	NNS
for	IN
rearrangement	NN
are	VBP
still	RB
not	RB
known	VBN
.	.

It	PRP
seems	VBZ
that	IN
the	DT
rearrangement	NN
of	IN
the	DT
TCR	NN
gamma	NN
loci	NNS
in	IN
the	DT
gamma	NN
delta	NN
lineage	NN
may	MD
not	RB
always	RB
take	VB
place	NN
at	IN
a	DT
developmental	JJ
stage	NN
strictly	RB
equivalent	JJ
to	TO
the	DT
rearrangement	NN
of	IN
TCR	NN
beta	NN
in	IN
the	DT
alpha	NN
beta	NN
lineage	NN
,	,
and	CC
it	PRP
is	VBZ
not	RB
clear	JJ
just	RB
how	WRB
early	RB
the	DT
two	CD
lineages	NNS
diverge	VBP
.	.

In	IN
the	DT
TCR	NN
alpha	NN
beta	NN
lineage	NN
,	,
however	RB
,	,
the	DT
final	JJ
gene	NN
rearrangement	NN
events	NNS
are	VBP
accompanied	VBN
by	IN
rapid	JJ
proliferation	NN
and	CC
an	DT
interruption	NN
in	IN
cellular	JJ
response	NN
gene	NN
inducibility	NN
.	.

The	DT
loss	NN
of	IN
conventional	JJ
responsiveness	NN
is	VBZ
probably	RB
caused	VBN
by	IN
alterations	NNS
at	IN
the	DT
level	NN
of	IN
signaling	NN
,	,
and	CC
may	MD
be	VB
a	DT
manifestation	NN
of	IN
the	DT
physiological	JJ
state	NN
that	WDT
is	VBZ
a	DT
precondition	NN
for	IN
selection	NN
.	.

Third	JJ
is	VBZ
the	DT
complex	JJ
process	NN
of	IN
selection	NN
.	.

Whereas	IN
peripheral	JJ
T	NN
cells	NNS
can	MD
undergo	VB
forms	NNS
of	IN
positive	JJ
selection	NN
(	(
by	IN
antigen-driven	JJ
clonal	JJ
expansion	NN
)	)
and	CC
negative	JJ
selection	NN
(	(
by	IN
abortive	JJ
stimulation	NN
leading	VBG
to	TO
anergy	NN
or	CC
death	NN
)	)
,	,
neither	DT
is	VBZ
exactly	RB
the	DT
same	JJ
phenomenon	NN
that	WDT
occurs	VBZ
in	IN
the	DT
thymic	JJ
cortex	NN
.	.

Negative	JJ
selection	NN
in	IN
the	DT
cortex	NN
appears	VBZ
to	TO
be	VB
a	DT
suicidal	JJ
inversion	NN
of	IN
antigen	NN
responsiveness	NN
:	:
instead	RB
of	IN
turning	VBG
on	IN
IL-2	NN
expression	NN
,	,
the	DT
activated	VBN
cell	NN
destroys	VBZ
its	PRP$
own	JJ
chromatin	NN
.	.

The	DT
genes	NNS
that	WDT
need	VBP
to	TO
be	VB
induced	VBN
for	IN
this	DT
response	NN
are	VBP
not	RB
yet	RB
identified	VBN
,	,
but	CC
it	PRP
is	VBZ
unquestionably	RB
a	DT
form	NN
of	IN
activation	NN
.	.

It	PRP
is	VBZ
interesting	JJ
that	IN
in	IN
humans	NNS
and	CC
rats	NNS
,	,
cortical	JJ
thymocytes	NNS
undergoing	VBG
negative	JJ
selection	NN
can	MD
still	RB
induce	VB
IL-2R	NN
alpha	NN
expression	NN
and	CC
even	RB
be	VB
rescued	VBN
in	FW
vitro	FW
,	,
if	IN
exogenous	JJ
IL-2	NN
is	VBZ
provided	VBN
.	.

Perhaps	RB
murine	JJ
thymocytes	NNS
are	VBP
denied	VBN
this	DT
form	NN
of	IN
rescue	NN
because	IN
they	PRP
shut	VBD
off	RP
IL-2R	NN
beta	NN
chain	NN
expression	NN
at	IN
an	DT
earlier	JJR
stage	NN
or	CC
because	IN
they	PRP
may	MD
be	VB
uncommonly	RB
Bcl-2	NN
deficient	JJ
(	(
cf.	VBP
Sentman	NNP
et	FW
al.	FW
,	,
1991	CD
;	:
Strasser	NNP
et	FW
al.	FW
,	,
1991	CD
)	)
.	.

Even	RB
so	RB
,	,
medullary	JJ
thymocytes	NNS
remain	VBP
at	IN
least	JJS
partially	RB
susceptible	JJ
to	TO
negative	JJ
selection	NN
even	RB
as	IN
they	PRP
continue	VBP
to	TO
mature	VB
.	.

UI	LS
-	:
93024882	CD

TI	LS
-	:
The	DT
candidate	NN
oncoprotein	NN
Bcl-3	NN
is	VBZ
an	DT
antagonist	NN
of	IN
p50/NF-kappa	NN
B-mediated	JJ
inhibition	NN
.	.

AB	LS
-	:
The	DT
candidate	NN
oncogene	NN
bcl-3	NN
was	VBD
discovered	VBN
as	IN
a	DT
translocation	NN
into	IN
the	DT
immunoglobulin	NN
alpha-locus	NN
in	IN
some	DT
cases	NNS
of	IN
B-cell	NN
chronic	JJ
lymphocytic	JJ
leukaemias	NNS
.	.

The	DT
protein	NN
Bcl-3	NN
contains	VBZ
seven	CD
so-called	JJ
ankyrin	NN
repeats	NNS
.	.

Similar	JJ
repeat	NN
motifs	NNS
are	VBP
found	VBN
in	IN
a	DT
number	NN
of	IN
diverse	JJ
regulatory	JJ
proteins	NNS
but	CC
the	DT
motifs	NNS
of	IN
Bcl-3	NN
are	VBP
most	RBS
closely	RB
related	JJ
to	TO
those	DT
found	VBN
in	IN
I	NN
kappa	NN
B	NN
proteins	NNS
in	IN
which	WDT
the	DT
ankyrin	NN
repeat	NN
domain	NN
is	VBZ
thought	VBN
to	TO
be	VB
directly	RB
involved	VBN
in	IN
inhibition	NN
of	IN
NF-kappa	NN
B	NN
activity	NN
.	.

No	DT
biological	JJ
function	NN
has	VBZ
yet	RB
been	VBN
described	VBN
for	IN
Bcl-3	NN
,	,
but	CC
it	PRP
was	VBD
noted	VBN
recently	RB
that	IN
Bcl-3	NN
interferes	VBZ
with	IN
DNA-binding	NN
of	IN
the	DT
p50	NN
subunit	NN
of	IN
NF-kappa	NN
B	NN
in	FW
vitro	FW
.	.

Here	RB
we	PRP
demonstrate	VBP
that	IN
Bcl-3	NN
can	MD
aid	VB
kappa	NN
B	NN
site-dependent	JJ
transcription	NN
in	FW
vivo	FW
by	IN
counteracting	VBG
the	DT
inhibitory	JJ
effects	NNS
of	IN
p50/NF-kappa	NN
B	NN
homodimers	NNS
.	.

Bcl-3	NN
may	MD
therefore	RB
aid	VB
activation	NN
of	IN
select	JJ
NF-kappa	NN
B-regulated	JJ
genes	NNS
,	,
including	VBG
those	DT
of	IN
the	DT
human	JJ
immunodeficiency	NN
virus	NN
.	.

UI	LS
-	:
92244343	CD

TI	LS
-	:
Nuclear	JJ
factor	NN
of	IN
activated	VBN
T	NN
cells	NNS
contains	VBZ
Fos	NN
and	CC
Jun	NN
.	.

AB	LS
-	:
The	DT
nuclear	JJ
factor	NN
NF-AT	NN
(	(
ref.	NN
1	CD
)	)
is	VBZ
induced	VBN
in	IN
T	NN
cells	NNS
stimulated	VBN
through	IN
the	DT
T-cell	NN
receptor/CD3	NN
complex	NN
,	,
and	CC
is	VBZ
required	VBN
for	IN
interleukin-2	NN
(	(
IL-2	NN
)	)
gene	NN
induction	NN
.	.

Although	IN
NF-AT	NN
has	VBZ
not	RB
been	VBN
cloned	VBN
or	CC
purified	VBN
,	,
there	EX
is	VBZ
evidence	NN
that	IN
it	PRP
is	VBZ
a	DT
major	JJ
target	NN
for	IN
immunosuppression	NN
by	IN
cyclosporin	NN
A	NN
(	(
CsA	NN
)	)
and	CC
FK506	NN
(	(
refs	NNS
2-7	CD
)	)
.	.

NF-AT	NN
induction	NN
may	MD
require	VB
two	CD
activation-dependent	JJ
events	NNS
:	:
the	DT
CsA-sensitive	JJ
translocation	NN
of	IN
a	DT
pre-existing	JJ
component	NN
and	CC
the	DT
CsA-resistant	JJ
synthesis	NN
of	IN
a	DT
nuclear	JJ
component	NN
.	.

Here	RB
we	PRP
report	VBP
that	IN
the	DT
newly	RB
synthesized	VBN
nuclear	JJ
component	NN
of	IN
NF-AT	NN
is	VBZ
the	DT
transcription	NN
factor	NN
AP-1	NN
.	.

We	PRP
show	VBP
that	IN
the	DT
inducible	JJ
nuclear	JJ
form	NN
of	IN
NF-AT	NN
contains	VBZ
Fos	NN
and	CC
Jun	NN
proteins	NNS
.	.

Furthermore	RB
,	,
we	PRP
identify	VBP
a	DT
pre-existing	JJ
NF-AT-binding	JJ
factor	NN
that	WDT
is	VBZ
present	JJ
in	IN
hypotonic	JJ
extracts	NNS
of	IN
unstimulated	JJ
T	NN
cells	NNS
.	.

On	IN
the	DT
basis	NN
of	IN
binding	NN
,	,
reconstitution	NN
and	CC
cotransfection	NN
experiments	NNS
,	,
we	PRP
propose	VBP
that	IN
activation	NN
of	IN
NF-AT	NN
occurs	VBZ
in	IN
at	IN
least	JJS
two	CD
stages	NNS
:	:
a	DT
CsA-sensitive	JJ
stage	NN
involving	VBG
modification	NN
and/or	CC
translocation	NN
of	IN
the	DT
pre-existing	JJ
NF-AT	NN
complex	NN
,	,
and	CC
a	DT
CsA-insensitive	JJ
stage	NN
involving	VBG
the	DT
addition	NN
of	IN
newly	RB
synthesized	VBN
Fos	NN
or	CC
Fos/Jun	NN
proteins	NNS
to	TO
the	DT
pre-existing	JJ
complex	NN
.	.

UI	LS
-	:
92335296	CD

TI	LS
-	:
Cell	NN
cycle-dependent	JJ
initiation	NN
and	CC
lineage-dependent	JJ
abrogation	NN
of	IN
GATA-1	NN
expression	NN
in	IN
pure	JJ
differentiating	VBG
hematopoietic	JJ
progenitors	NNS
.	.

AB	LS
-	:
The	DT
programmed	VBN
activation/repression	NN
of	IN
transcription	NN
factors	NNS
in	IN
early	JJ
hematopoietic	JJ
differentiation	NN
has	VBZ
not	RB
yet	RB
been	VBN
explored	VBN
.	.

The	DT
DNA-binding	JJ
protein	NN
GATA-1	NN
is	VBZ
required	VBN
for	IN
normal	JJ
erythroid	JJ
development	NN
and	CC
regulates	VBZ
erythroid-expressed	JJ
genes	NNS
in	IN
maturing	VBG
erythroblasts	NNS
.	.

We	PRP
analyzed	VBD
GATA-1	NN
expression	NN
in	IN
early	JJ
human	JJ
adult	JJ
hematopoiesis	NN
by	IN
using	VBG
an	DT
in	FW
vitro	FW
system	NN
in	IN
which	WDT
"	``
pure	JJ
"	''
early	JJ
hematopoietic	JJ
progenitors	NNS
are	VBP
induced	VBN
to	TO
gradual	JJ
and	CC
synchronized	VBD
differentiation	NN
selectively	RB
along	IN
the	DT
erythroid	JJ
or	CC
granulocyte-macrophage	JJ
pathway	NN
by	IN
differential	JJ
treatment	NN
with	IN
hematopoietic	JJ
growth	NN
factors	NNS
.	.

The	DT
GATA-1	NN
gene	NN
,	,
though	IN
virtually	RB
silent	JJ
in	IN
quiescent	JJ
progenitors	NNS
,	,
is	VBZ
activated	VBN
after	IN
entrance	NN
into	IN
the	DT
cell	NN
cycle	NN
upon	IN
stimulation	NN
with	IN
hematopoietic	JJ
growth	NN
factors	NNS
.	.

Subsequently	RB
,	,
increasing	VBG
expression	NN
along	IN
the	DT
erythroid	JJ
pathway	NN
contrasts	VBZ
with	IN
an	DT
abrupt	JJ
downregulation	NN
in	IN
the	DT
granulocyte-macrophage	JJ
lineage	NN
.	.

These	DT
results	NNS
suggest	VBP
a	DT
microenvironment-directed	JJ
,	,
two-step	JJ
model	NN
for	IN
GATA-1	NN
expression	NN
in	IN
differentiating	VBG
hematopoietic	JJ
progenitors	NNS
that	WDT
involves	VBZ
(	(
i	LS
)	)
cycle-dependent	JJ
initiation	NN
and	CC
(	(
ii	LS
)	)
lineage-dependent	JJ
maintenance	NN
or	CC
suppression	NN
.	.

Hypothetically	RB
,	,
on/off	JJ
switches	NNS
of	IN
lineage-restricted	JJ
transactivators	NNS
may	MD
underlie	VB
the	DT
binary	JJ
fate	NN
decisions	NNS
of	IN
hematopoietic	JJ
progenitors	NNS
.	.

UI	LS
-	:
92260679	CD

TI	LS
-	:
Activation	NN
of	IN
the	DT
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
enhancer	NN
is	VBZ
not	RB
dependent	JJ
on	IN
NFAT-1	NN
.	.

AB	LS
-	:
The	DT
function	NN
of	IN
a	DT
putative	JJ
NFAT-1	NN
site	NN
in	IN
the	DT
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
enhancer	NN
has	VBZ
been	VBN
analyzed	VBN
.	.

Activation	NN
by	IN
the	DT
T-cell	NN
antigen	NN
receptor	NN
is	VBZ
minimal	JJ
in	IN
Jurkat	NN
cells	NNS
and	CC
is	VBZ
mediated	VBN
by	IN
the	DT
kappa	NN
B	NN
sites	NNS
.	.

The	DT
putative	JJ
NFAT-1	NN
region	NN
is	VBZ
not	RB
required	VBN
for	IN
the	DT
response	NN
to	TO
anti-CD3	NN
or	CC
to	TO
mitogens	NNS
in	IN
T-cell	NN
,	,
B-cell	NN
,	,
or	CC
monocyte/macrophage	NN
leukemia	NN
lines	NNS
,	,
nor	CC
is	VBZ
it	PRP
a	DT
cis-acting	JJ
negative	JJ
regulatory	JJ
element	NN
.	.

UI	LS
-	:
92013087	CD

TI	LS
-	:
Nuclear	JJ
transcription	NN
factors	NNS
that	WDT
bind	VBP
to	TO
elements	NNS
of	IN
the	DT
IL-2	NN
promoter	NN
.	.

Induction	NN
requirements	NNS
in	IN
primary	JJ
human	JJ
T	NN
cells	NNS
.	.

AB	LS
-	:
Prior	JJ
studies	NNS
have	VBP
identified	VBN
several	JJ
elements	NNS
that	WDT
contribute	VBP
to	TO
the	DT
activity	NN
of	IN
the	DT
IL-2	NN
promoter	NN
in	IN
the	DT
stimulated	VBN
T	NN
cell	NN
line	NN
,	,
Jurkat	NN
.	.

The	DT
sites	NNS
and	CC
their	PRP$
corresponding	JJ
nuclear	JJ
binding	VBG
factors	NNS
include	VBP
:	:
NF-kappa	NN
B	NN
,	,
AP-1	NN
,	,
AP-3	NN
,	,
OCT-1	NN
,	,
and	CC
NF-AT	NN
.	.

The	DT
latter	JJ
"	``
nuclear	JJ
factor	NN
for	IN
activated	VBN
T	NN
cells	NNS
"	''
likely	RB
contributes	VBZ
to	TO
the	DT
tissue	NN
specificity	NN
of	IN
IL-2	NN
gene	NN
expression	NN
.	.

Using	VBG
electrophoretic	JJ
mobility	NN
shift	NN
assays	NNS
,	,
we	PRP
have	VBP
studied	VBN
these	DT
transcription	NN
factors	NNS
in	IN
primary	JJ
T	NN
cells	NNS
from	IN
human	JJ
blood	NN
to	TO
verify	VB
their	PRP$
presence	NN
in	IN
a	DT
physiologic	JJ
setting	NN
and	CC
to	TO
identify	VB
the	DT
signals	NNS
that	WDT
stimulate	VBP
factor	NN
activity	NN
.	.

All	DT
factors	NNS
are	VBP
induced	VBN
in	IN
the	DT
nuclei	NNS
of	IN
T	NN
cells	NNS
upon	IN
activation	NN
with	IN
mitogens	NNS
but	CC
not	RB
with	IN
exogenous	JJ
IL-2	NN
growth	NN
factor	NN
.	.

However	RB
,	,
the	DT
signaling	NN
requirements	NNS
and	CC
sensitivity	NN
to	TO
protein	NN
synthesis	NN
inhibitors	NNS
differ	VBP
considerably	RB
.	.

Only	RB
the	DT
activities	NNS
for	IN
NF-AT	NN
and	CC
AP-1	NN
sites	NNS
require	VBP
two	CD
signals	NNS
for	IN
optimal	JJ
induction	NN
,	,
i.e.	FW
,	,
PMA	NN
plus	CC
either	CC
lectin	NN
or	CC
antibody	NN
to	TO
the	DT
CD3	NN
or	CC
CD28	NN
surface	NN
molecules	NNS
.	.

Other	JJ
factors	NNS
are	VBP
induced	VBN
by	IN
lectin	NN
,	,
antibody	NN
,	,
and/or	CC
PMA	NN
alone	RB
.	.

After	IN
appropriate	JJ
stimulation	NN
,	,
both	CC
NF-AT	NN
and	CC
AP-1	NN
are	VBP
peculiarly	RB
sensitive	JJ
to	TO
the	DT
protein	NN
synthesis	NN
inhibitor	NN
anisomycin	NN
.	.

Our	PRP$
data	NNS
correlate	VBP
the	DT
activity	NN
of	IN
NF-AT	NN
and	CC
AP-1	NN
in	IN
gel	NN
shift	NN
assays	NNS
with	IN
the	DT
two	CD
signals	NNS
requirements	NNS
for	IN
IL-2	NN
gene	NN
expression	NN
.	.

UI	LS
-	:
91292530	CD

TI	LS
-	:
Characterization	NN
of	IN
an	DT
immediate-early	JJ
gene	NN
induced	VBN
in	IN
adherent	JJ
monocytes	NNS
that	WDT
encodes	VBZ
I	NN
kappa	NN
B-like	JJ
activity	NN
.	.

AB	LS
-	:
We	PRP
have	VBP
cloned	VBN
a	DT
group	NN
of	IN
cDNAs	NNS
representing	VBG
mRNAs	NNS
that	WDT
are	VBP
rapidly	RB
induced	VBN
following	VBG
adherence	NN
of	IN
human	JJ
monocytes	NNS
.	.

One	CD
of	IN
the	DT
induced	VBN
transcripts	NNS
(	(
MAD-3	NN
)	)
encodes	VBZ
a	DT
protein	NN
of	IN
317	CD
amino	NN
acids	NNS
with	IN
one	CD
domain	NN
containing	VBG
five	CD
tandem	JJ
repeats	NNS
of	IN
the	DT
cdc10/ankyrin	JJ
motif	NN
,	,
which	WDT
is	VBZ
60	CD
%	NN
similar	JJ
(	(
46	CD
%	NN
identical	JJ
)	)
to	TO
the	DT
ankyrin	NN
repeat	NN
region	NN
of	IN
the	DT
precursor	NN
of	IN
NF-kappa	NN
B/KBF1	NN
p50	NN
.	.

The	DT
C-terminus	NN
has	VBZ
a	DT
putative	JJ
protein	NN
kinase	NN
C	NN
phosphorylation	NN
site	NN
.	.

In	FW
vitro	FW
translated	VBN
MAD-3	NN
protein	NN
was	VBD
found	VBN
to	TO
specifically	RB
inhibit	VB
the	DT
DNA-binding	JJ
activity	NN
of	IN
the	DT
p50/p65	NN
NF-kappa	NN
B	NN
complex	NN
but	CC
not	RB
that	DT
of	IN
the	DT
p50/p50	NN
KBF1	NN
factor	NN
or	CC
of	IN
other	JJ
DNA-binding	JJ
proteins	NNS
.	.

The	DT
MAD-3	NN
cDNA	NN
encodes	VBZ
an	DT
I	NN
kappa	NN
B-like	JJ
protein	NN
that	WDT
is	VBZ
likely	JJ
to	TO
be	VB
involved	VBN
in	IN
regulation	NN
of	IN
transcriptional	JJ
responses	NNS
to	TO
NF-kappa	NN
B	NN
,	,
including	VBG
adhesion-dependent	JJ
pathways	NNS
of	IN
monocyte	NN
activation	NN
.	.

UI	LS
-	:
91246215	CD

TI	LS
-	:
The	DT
human	JJ
myelomonocytic	JJ
cell	NN
line	NN
U-937	NN
as	IN
a	DT
model	NN
for	IN
studying	VBG
alterations	NNS
in	IN
steroid-induced	JJ
monokine	NN
gene	NN
expression	NN
:	:
marked	JJ
enhancement	NN
of	IN
lipopolysaccharide-stimulated	JJ
interleukin-1	NN
beta	NN
messenger	NN
RNA	NN
levels	NNS
by	IN
1,25-dihydroxyvitamin	NN
D3	NN
.	.

AB	LS
-	:
The	DT
active	JJ
metabolite	NN
of	IN
vitamin	NN
D	NN
,	,
1,25-dihydroxyvitamin	NN
D3	NN
[	(
1,25-(OH)2D3	NN
]	)
,	,
is	VBZ
a	DT
potent	JJ
regulator	NN
of	IN
human	JJ
monocyte/macrophage	JJ
function	NN
in	FW
vitro	FW
.	.

To	TO
establish	VB
a	DT
model	NN
for	IN
1,25-(OH)2D3	NN
regulation	NN
of	IN
human	JJ
monocyte	NN
monokine	NN
synthesis	NN
,	,
three	CD
human	JJ
cell	NN
lines	NNS
(	(
U-937	NN
,	,
THP-1	NN
,	,
and	CC
HL-60	NN
)	)
were	VBD
examined	VBN
for	IN
:	:
1	LS
)	)
the	DT
presence	NN
of	IN
functional	JJ
1,25-(OH)2D3	NN
receptors	NNS
;	:
2	LS
)	)
the	DT
accumulation	NN
of	IN
interleukin-1	NN
beta	NN
(	(
IL-1	NN
beta	NN
)	)
mRNA	NN
and	CC
IL-1	NN
beta	NN
protein	NN
in	IN
response	NN
to	TO
lipopolysaccharide	NN
(	(
LPS	NN
)	)
;	:
and	CC
3	LS
)	)
the	DT
regulation	NN
of	IN
this	DT
response	NN
by	IN
1,25-(OH)2D3	NN
.	.

All	DT
three	CD
cell	NN
lines	NNS
expressed	VBD
vitamin	NN
D	NN
receptor	NN
and	CC
had	VBD
increased	VBN
levels	NNS
of	IN
IL-1	NN
beta	NN
mRNA	NN
in	IN
response	NN
to	TO
LPS	NN
.	.

Preincubation	NN
of	IN
cells	NNS
with	IN
1,25-(OH)2D3	NN
augmented	VBD
IL-1	NN
beta	NN
mRNA	NN
levels	NNS
only	RB
in	IN
U-937	NN
and	CC
HL-60	NN
cells	NNS
.	.

From	IN
these	DT
data	NNS
,	,
and	CC
taking	VBG
into	IN
consideration	NN
their	PRP$
state	NN
of	IN
differentiation	NN
and	CC
relative	JJ
ease	NN
of	IN
culture	NN
,	,
U-937	NN
was	VBD
chosen	VBN
over	IN
HL-60	NN
and	CC
THP-1	NN
as	IN
the	DT
cell	NN
line	NN
we	PRP
further	RB
characterized	VBD
.	.

In	IN
U-937	NN
cells	NNS
,	,
optimum	JJ
time	NN
and	CC
dose	NN
of	IN
pretreatment	NN
with	IN
1,25-(OH)2D3	NN
were	VBD
determined	VBN
to	TO
be	VB
12-24	CD
h	NN
at	IN
a	DT
receptor	NN
saturating	JJ
concentration	NN
of	IN
1,25-(OH)2D3	NN
(	(
10	CD
nM	NN
)	)
.	.

Preincubation	NN
of	IN
cells	NNS
with	IN
1,25-(OH)2D3	NN
had	VBD
no	DT
effect	NN
on	IN
the	DT
time	NN
course	NN
of	IN
IL-1	NN
beta	NN
mRNA	NN
appearance	NN
in	IN
response	NN
to	TO
LPS	NN
.	.

However	RB
,	,
exposure	NN
of	IN
U-937	NN
cells	NNS
to	TO
1,25-(OH)2D3	NN
increased	VBD
by	IN
200	CD
%	NN
the	DT
level	NN
of	IN
IL-1	NN
beta	NN
mRNA	NN
detected	VBD
and	CC
decreased	VBD
by	IN
three	CD
orders	NNS
of	IN
magnitude	NN
the	DT
concentration	NN
of	IN
LPS	NN
required	VBN
to	TO
achieve	VB
steady	JJ
state	NN
mRNA	NN
levels	NNS
equivalent	JJ
to	TO
those	DT
observed	VBN
in	IN
U-937	NN
cells	NNS
not	RB
preincubated	VBN
with	IN
the	DT
hormone.2+o	NN

UI	LS
-	:
92038993	CD

TI	LS
-	:
v-erbA	NN
overexpression	NN
is	VBZ
required	VBN
to	TO
extinguish	VB
c-erbA	NN
function	NN
in	IN
erythroid	JJ
cell	NN
differentiation	NN
and	CC
regulation	NN
of	IN
the	DT
erbA	NN
target	NN
gene	NN
CAII	NN
.	.

AB	LS
-	:
The	DT
v-erbA	NN
oncoprotein	NN
represents	VBZ
a	DT
retrovirus-transduced	JJ
oncogenic	JJ
version	NN
of	IN
the	DT
thyroid	NN
hormone	NN
(	(
T3/T4	NN
)	)
receptor	NN
c-erbA	NN
(	(
type	NN
alpha	NN
)	)
.	.

It	PRP
contributes	VBZ
to	TO
virus-induced	JJ
erythroleukemia	NN
by	IN
efficiently	RB
arresting	VBG
differentiation	NN
of	IN
red	JJ
cell	NN
progenitors	NNS
and	CC
by	IN
suppressing	VBG
transcription	NN
of	IN
erythrocyte-specific	JJ
genes	NNS
.	.

Here	RB
,	,
we	PRP
show	VBP
that	IN
v-erbA	NN
and	CC
c-erbA	NN
bind	VBP
directly	RB
to	TO
sequences	NNS
within	IN
the	DT
promoter	NN
of	IN
the	DT
erythrocyte-specific	JJ
carbonic	JJ
anhydrase	NN
II	CD
(	(
CAII	NN
)	)
,	,
a	DT
gene	NN
whose	WP$
transcription	NN
is	VBZ
efficiently	RB
suppressed	VBN
by	IN
v-erbA	NN
.	.

This	DT
erbA-binding	JJ
site	NN
confers	VBZ
thyroid	NN
hormone	NN
responsiveness	NN
to	TO
a	DT
heterologous	JJ
promoter	NN
in	IN
transient	JJ
expression	NN
experiments	NNS
and	CC
is	VBZ
a	DT
target	NN
for	IN
efficient	JJ
down-regulation	NN
of	IN
CAII	NN
transcription	NN
by	IN
the	DT
v-erbA	NN
oncoprotein	NN
.	.

In	IN
stably	RB
transformed	VBN
erythroblasts	NNS
coexpressing	VBG
the	DT
v-erbA	NN
oncoprotein	NN
and	CC
the	DT
c-erbA/T3	NN
receptor	NN
at	IN
an	DT
approximately	RB
equimolar	JJ
ratio	NN
,	,
c-erbA	NN
activity	NN
is	VBZ
dominant	JJ
over	IN
v-erbA	NN
.	.

T3	NN
efficiently	RB
induced	VBD
erythroid	JJ
differentiation	NN
in	IN
these	DT
cells	NNS
,	,
thus	RB
overcoming	VBG
the	DT
v-erbA-mediated	JJ
differentiation	NN
arrest	NN
.	.

Likewise	RB
,	,
T3	NN
activated	VBD
CAII	NN
transcription	NN
as	RB
well	RB
as	IN
transient	JJ
expression	NN
of	IN
a	DT
T3-responsive	JJ
reporter	NN
gene	NN
containing	VBG
the	DT
CAII-specific	JJ
erbA-binding	JJ
site	NN
.	.

The	DT
c-erbA-dependent	JJ
activation	NN
of	IN
this	DT
CAII	NN
reporter	NN
construct	NN
could	MD
only	RB
be	VB
suppressed	VBN
by	IN
very	RB
high	JJ
amounts	NNS
of	IN
v-erbA	NN
.	.

Our	PRP$
results	NNS
suggest	VBP
that	IN
overexpression	NN
of	IN
v-erbA	NN
is	VBZ
required	VBN
for	IN
its	PRP$
function	NN
as	IN
an	DT
oncoprotein	NN
.	.

UI	LS
-	:
92013023	CD

TI	LS
-	:
Anti-CD2	JJ
receptor	NN
antibodies	NNS
activate	VBP
the	DT
HIV	NN
long	JJ
terminal	JJ
repeat	NN
in	IN
T	NN
lymphocytes	NNS
.	.

AB	LS
-	:
The	DT
CD2	NN
T	NN
lymphocyte	NN
glycoprotein	NN
surface	NN
molecule	NN
mediates	VBZ
both	CC
cell	NN
to	TO
cell	NN
adhesion	NN
and	CC
T	NN
cell	NN
activation	NN
,	,
two	CD
processes	NNS
that	WDT
are	VBP
involved	VBN
in	IN
the	DT
spread	NN
of	IN
HIV	NN
infection	NN
.	.

Treatment	NN
of	IN
chronically	RB
HIV-infected	JJ
PBMC	NN
with	IN
anti-CD2	JJ
mAb	NN
has	VBZ
been	VBN
shown	VBN
to	TO
induce	VB
the	DT
expression	NN
of	IN
infectious	JJ
virus	NN
from	IN
these	DT
cultures	NNS
.	.

In	IN
this	DT
study	NN
we	PRP
investigated	VBD
the	DT
mechanisms	NNS
whereby	WRB
anti-CD2	JJ
antibodies	NNS
stimulate	VBP
viral	JJ
production	NN
.	.

We	PRP
demonstrate	VBP
that	IN
treatment	NN
of	IN
transiently	RB
transfected	VBN
T	NN
lymphocytes	NNS
with	IN
anti-CD2	JJ
antibodies	NNS
results	VBZ
in	IN
activation	NN
of	IN
the	DT
HIV	NN
long	JJ
terminal	JJ
repeat	NN
.	.

Furthermore	RB
,	,
CAT	NN
assays	NNS
using	VBG
mutated	VBN
HIV	NN
long	JJ
terminal	JJ
repeat-CAT	NN
constructs	NNS
and	CC
gel	NN
shift	NN
assays	NNS
demonstrate	VBP
that	IN
this	DT
activation	NN
is	VBZ
dependent	JJ
on	IN
the	DT
NF-kappa	NN
B	NN
enhancer	NN
.	.

These	DT
studies	NNS
suggest	VBP
that	IN
interaction	NN
of	IN
CD2	NN
with	IN
its	PRP$
natural	JJ
ligand	NN
,	,
LFA-3	NN
,	,
may	MD
play	VB
a	DT
role	NN
in	IN
regulation	NN
of	IN
HIV	NN
expression	NN
.	.

UI	LS
-	:
92020850	CD

TI	LS
-	:
Demonstration	NN
of	IN
a	DT
1,25-dihydroxyvitamin	NN
D3-responsive	JJ
protein	NN
in	IN
human	JJ
lymphocytes	NNS
:	:
immunologic	JJ
crossreactivity	NN
and	CC
inverse	JJ
regulation	NN
with	IN
the	DT
vitamin	NN
D	NN
receptor	NN
.	.

AB	LS
-	:
Using	VBG
Western	NN
blot	NN
analysis	NN
with	IN
a	DT
monoclonal	JJ
antibody	NN
recognizing	VBG
a	DT
17-amino	NN
acid	NN
epitope	NN
of	IN
the	DT
1,25-dihydroxyvitamin	NN
D3	NN
[	(
1,25(OH)2D3	NN
]	)
receptor	NN
,	,
we	PRP
have	VBP
detected	VBN
two	CD
crossreacting	VBG
proteins	NNS
in	IN
activated	VBN
normal	JJ
human	JJ
lymphocytes	NNS
.	.

The	DT
smaller	JJR
of	IN
the	DT
two	CD
proteins	NNS
(	(
50	CD
kDa	NN
)	)
was	VBD
indistinguishable	JJ
from	IN
the	DT
classical	JJ
1,25(OH)2D3	NN
receptor	NN
and	CC
,	,
similar	JJ
to	TO
the	DT
classical	JJ
1,25(OH)2D3	NN
receptor	NN
,	,
was	VBD
upregulated	VBN
in	IN
a	DT
dose-dependent	JJ
fashion	NN
by	IN
1,25(OH)2D3	NN
.	.

The	DT
larger	JJR
crossreacting	VBG
protein	NN
exhibited	VBD
an	DT
electrophoretic	JJ
mobility	NN
of	IN
80	CD
kDa	NN
,	,
was	VBD
localized	JJ
in	IN
the	DT
cell	NN
cytosol	NN
,	,
and	CC
appeared	VBD
to	TO
be	VB
specific	JJ
for	IN
activated	VBN
lymphocytes	NNS
since	IN
it	PRP
was	VBD
not	RB
detected	VBN
in	IN
several	JJ
other	JJ
human	JJ
cells	NNS
including	VBG
monocytes	NNS
.	.

More	RBR
strikingly	RB
,	,
the	DT
80-kDa	JJ
protein	NN
was	VBD
downregulated	VBN
in	IN
a	DT
dose-dependent	JJ
fashion	NN
by	IN
1,25(OH)2D3	NN
;	:
this	DT
effect	NN
was	VBD
independent	JJ
of	IN
the	DT
mode	NN
of	IN
lymphocyte	NN
activation	NN
and	CC
specific	JJ
for	IN
the	DT
1,25(OH)2D3	NN
metabolite	NN
of	IN
vitamin	NN
D3	NN
.	.

However	RB
,	,
two	CD
potent	JJ
immunosuppressive	JJ
agents	NNS
,	,
glucocorticoids	NNS
and	CC
cyclosporin	NN
A	DT
,	,
also	RB
inhibited	VBD
the	DT
80-kDa	JJ
protein	NN
.	.

UI	LS
-	:
91237114	CD

TI	LS
-	:
Transforming	VBG
growth	NN
factor-beta	NN
suppresses	VBZ
human	JJ
B	NN
lymphocyte	NN
Ig	NN
production	NN
by	IN
inhibiting	VBG
synthesis	NN
and	CC
the	DT
switch	NN
from	IN
the	DT
membrane	NN
form	NN
to	TO
the	DT
secreted	JJ
form	NN
of	IN
Ig	NN
mRNA	NN
.	.

AB	LS
-	:
Transforming	VBG
growth	NN
factor-beta	NN
(	(
TGF-beta	NN
)	)
inhibits	VBZ
B	NN
cell	NN
Ig	NN
secretion	NN
and	CC
reduces	VBZ
B	NN
cell	NN
membrane	NN
Ig	NN
expression	NN
.	.

The	DT
addition	NN
of	IN
TGF-beta	NN
to	TO
human	JJ
B	NN
lymphocyte	NN
cultures	NNS
stimulated	VBN
with	IN
Staphylococcus	FW
aureus	FW
Cowan	NN
strain	NN
I	NN
and	CC
IL-2	NN
completely	RB
inhibited	VBD
B	NN
cell	NN
Ig	NN
secretion	NN
(	(
greater	JJR
than	IN
90	CD
%	NN
)	)
and	CC
decreased	VBD
B	NN
cell	NN
surface	NN
IgM	NN
,	,
IgD	NN
,	,
kappa	NN
L	NN
chain	NN
,	,
and	CC
lambda	NN
L	NN
chain	NN
expression	NN
.	.

In	IN
contrast	NN
,	,
TGF-beta	NN
had	VBD
only	RB
minimal	JJ
effects	NNS
on	IN
two	CD
other	JJ
B	NN
cell	NN
membrane	NN
proteins	NNS
,	,
HLA-DR	NN
and	CC
CD20	NN
.	.

Internal	JJ
labeling	NN
with	IN
[35S]methionine	NN
and	CC
immunoprecipitation	NN
with	IN
anti-IgM	JJ
,	,
anti-kappa	JJ
,	,
and	CC
anti-lambda	JJ
antibodies	NNS
revealed	VBD
a	DT
striking	JJ
reduction	NN
in	IN
kappa	NN
L	NN
chain	NN
in	IN
the	DT
presence	NN
of	IN
TGF-beta	NN
.	.

A	DT
less	RBR
pronounced	JJ
reduction	NN
in	IN
lambda	NN
L	NN
chain	NN
and	CC
microH	NN
chain	NN
was	VBD
also	RB
noted	VBN
.	.

Northern	NN
blot	NN
analysis	NN
of	IN
RNA	NN
purified	VBN
from	IN
B	NN
cells	NNS
treated	VBN
with	IN
TGF-beta	NN
for	IN
varying	VBG
time	NN
intervals	NNS
revealed	VBD
a	DT
significant	JJ
decrease	NN
in	IN
steady	JJ
state	NN
kappa	NN
and	CC
lambda	NN
L	NN
chain	NN
mRNA	NN
levels	NNS
.	.

Furthermore	RB
,	,
a	DT
significant	JJ
decrease	NN
in	IN
the	DT
switch	NN
from	IN
the	DT
membrane	NN
forms	NNS
of	IN
mu	NN
and	CC
gamma	NN
to	TO
their	PRP$
respective	JJ
secreted	JJ
forms	NNS
was	VBD
noted	VBN
in	IN
the	DT
presence	NN
of	IN
TGF-beta	NN
.	.

Nuclear	JJ
run-on	JJ
experiments	NNS
demonstrated	VBD
decreased	VBN
transcription	NN
of	IN
kappa	NN
L	NN
chain	NN
.	.

The	DT
effects	NNS
of	IN
TGF-beta	NN
on	IN
two	CD
transcriptional	JJ
regulatory	JJ
factors	NNS
,	,
Oct-2	NN
and	CC
nuclear	JJ
factor	NN
(	(
NF	NN
)	)
kappa	NN
B	NN
,	,
known	VBN
to	TO
be	VB
important	JJ
in	IN
Ig	NN
gene	NN
transcription	NN
were	VBD
examined	VBN
.	.

Oct-2	NN
mRNA	NN
levels	NNS
and	CC
both	DT
Oct-2	NN
and	CC
NF-kappa	NN
B	NN
proteins	NNS
in	IN
nuclear	JJ
extracts	NNS
were	VBD
not	RB
altered	VBN
by	IN
treatment	NN
with	IN
TGF-beta	NN
.	.

In	IN
contrast	NN
,	,
levels	NNS
of	IN
the	DT
transcriptional	JJ
factor	NN
AP-1	NN
,	,
which	WDT
is	VBZ
not	RB
known	VBN
to	TO
be	VB
important	JJ
in	IN
B	NN
cell	NN
Ig	NN
production	NN
,	,
were	VBD
reduced	VBN
by	IN
TGF-beta	NN
.	.

These	DT
findings	NNS
demonstrate	VBP
that	IN
TGF-beta	NN
decreases	VBZ
B	NN
lymphocyte	NN
Ig	NN
secretion	NN
by	IN
inhibiting	VBG
the	DT
synthesis	NN
of	IN
Ig	NN
mRNA	NN
and	CC
inhibiting	VBG
the	DT
switch	NN
from	IN
the	DT
membrane	NN
form	NN
to	TO
the	DT
secreted	JJ
forms	NNS
of	IN
mu	NN
and	CC
gamma	NN
mRNA	NN
.	.

The	DT
mechanism	NN
by	IN
which	WDT
TGF-beta	NN
inhibits	VBZ
Ig	NN
chain	NN
synthesis	NN
is	VBZ
unclear	JJ
although	IN
it	PRP
does	VBZ
not	RB
involve	VB
inhibition	NN
of	IN
the	DT
binding	NN
of	IN
NF-kappa	NN
B	NN
or	CC
Oct-2	NN
to	TO
their	PRP$
respective	JJ
target	NN
sequences	NNS
.	.

UI	LS
-	:
91367666	CD

TI	LS
-	:
USF-related	JJ
transcription	NN
factor	NN
,	,
HIV-TF1	NN
,	,
stimulates	VBZ
transcription	NN
of	IN
human	JJ
immunodeficiency	NN
virus-1	NN
.	.

AB	LS
-	:
The	DT
transcription	NN
factor	NN
HIV-TF1	NN
,	,
which	WDT
binds	VBZ
to	TO
a	DT
region	NN
about	IN
60	CD
bp	NN
upstream	JJ
from	IN
the	DT
enhancer	NN
of	IN
the	DT
human	JJ
immunodeficiency	NN
virus-1	NN
(	(
HIV-1	NN
)	)
,	,
was	VBD
purified	VBN
from	IN
human	JJ
B	NN
cells	NNS
.	.

HIV-TF1	NN
had	VBD
a	DT
molecular	JJ
weight	NN
of	IN
39,000	CD
.	.

Binding	NN
of	IN
HIV-TF1	NN
to	TO
the	DT
HIV	NN
long	JJ
terminal	JJ
repeat	NN
(	(
LTR	NN
)	)
activated	VBD
transcription	NN
from	IN
the	DT
HIV	NN
promoter	NN
in	FW
vitro	FW
.	.

The	DT
HIV-TF1-binding	JJ
site	NN
in	IN
HIV	NN
LTR	NN
was	VBD
similar	JJ
to	TO
the	DT
site	NN
recognized	VBN
by	IN
upstream	JJ
stimulatory	JJ
factor	NN
(	(
USF	NN
)	)
in	IN
the	DT
adenovirus	NN
major	JJ
late	JJ
promoter	NN
.	.

DNA-binding	JJ
properties	NNS
of	IN
HIV-TF1	NN
suggested	VBD
that	IN
HIV-TF1	NN
might	MD
be	VB
identical	JJ
or	CC
related	JJ
to	TO
USF	NN
.	.

Interestingly	RB
,	,
treatment	NN
of	IN
purified	VBN
HIV-TF1	NN
by	IN
phosphatase	NN
greatly	RB
reduced	VBD
its	PRP$
DNA-binding	JJ
activity	NN
,	,
suggesting	VBG
that	IN
phosphorylation	NN
of	IN
HIV-TF1	NN
was	VBD
essential	JJ
for	IN
DNA	NN
binding	NN
.	.

The	DT
disruption	NN
of	IN
HIV-TF1-binding	JJ
site	NN
induced	VBD
a	DT
60	CD
%	NN
decrease	NN
in	IN
the	DT
level	NN
of	IN
transcription	NN
from	IN
the	DT
HIV	NN
promoter	NN
in	FW
vivo	FW
.	.

These	DT
results	NNS
suggest	VBP
that	IN
HIV-TF1	NN
is	VBZ
involved	VBN
in	IN
transcriptional	JJ
regulation	NN
of	IN
HIV-1	NN
.	.

UI	LS
-	:
91292396	CD

TI	LS
-	:
Severe	JJ
5-fluorouracil	NN
toxicity	NN
secondary	JJ
to	TO
dihydropyrimidine	NN
dehydrogenase	NN
deficiency	NN
.	.

A	DT
potentially	RB
more	RBR
common	JJ
pharmacogenetic	JJ
syndrome	NN
.	.

AB	LS
-	:
This	DT
study	NN
describes	VBZ
the	DT
inheritance	NN
of	IN
a	DT
defect	NN
in	IN
pyrimidine	NN
catabolism	NN
and	CC
its	PRP$
association	NN
with	IN
drug-induced	JJ
toxicity	NN
in	IN
a	DT
patient	NN
receiving	VBG
5-fluorouracil	NN
(	(
FUra	NN
)	)
as	IN
adjuvant	JJ
chemotherapy	NN
for	IN
breast	NN
carcinoma	NN
.	.

The	DT
study	NN
population	NN
included	VBD
the	DT
affected	VBN
patient	NN
(	(
proband	NN
)	)
,	,
nine	CD
of	IN
her	PRP$
blood	NN
relatives	NNS
,	,
and	CC
seven	CD
healthy	JJ
volunteers	NNS
.	.

The	DT
activity	NN
of	IN
dihydropyrimidine	NN
dehydrogenase	NN
(	(
DPD	NN
)	)
,	,
the	DT
initial	JJ
enzyme	NN
of	IN
pyrimidine	NN
(	(
and	CC
FUra	NN
)	)
catabolism	NN
,	,
in	IN
peripheral	JJ
blood	NN
mononuclear	JJ
cells	NNS
was	VBD
measured	VBN
in	IN
each	DT
subject	NN
by	IN
a	DT
specific	JJ
radiometric	JJ
assay	NN
using	VBG
FUra	NN
as	IN
the	DT
substrate	NN
.	.

The	DT
proband	NN
had	VBD
no	DT
detectable	JJ
DPD	NN
activity	NN
.	.

When	WRB
enzyme	NN
levels	NNS
in	IN
the	DT
proband	NN
and	CC
relatives	NNS
were	VBD
compared	VBN
with	IN
that	DT
in	NN
controls	NNS
,	,
an	DT
autosomal	JJ
recessive	JJ
pattern	NN
of	IN
inheritance	NN
was	VBD
demonstrated	VBN
.	.

This	DT
is	VBZ
the	DT
third	JJ
patient	NN
with	IN
severe	JJ
FUra	NN
toxicity	NN
secondary	JJ
to	TO
an	DT
alteration	NN
in	IN
pyrimidine	NN
catabolism	NN
and	CC
the	DT
second	NN
from	IN
our	PRP$
clinic	NN
population	NN
suggesting	VBG
that	IN
the	DT
frequency	NN
of	IN
this	DT
genetic	JJ
defect	NN
may	MD
be	VB
greater	JJR
than	IN
previously	RB
thought	VBN
.	.

Monitoring	VBG
DPD	NN
activity	NN
may	MD
be	VB
important	JJ
in	IN
the	DT
management	NN
of	IN
patients	NNS
experiencing	VBG
severe	JJ
toxicity	NN
secondary	JJ
to	TO
FUra	NN
chemotherapy	NN
.	.

UI	LS
-	:
91184620	CD

TI	LS
-	:
A	DT
thymus-specific	JJ
member	NN
of	IN
the	DT
HMG	NN
protein	NN
family	NN
regulates	VBZ
the	DT
human	JJ
T	NN
cell	NN
receptor	NN
C	NN
alpha	NN
enhancer	NN
.	.

AB	LS
-	:
The	DT
human	JJ
T	NN
cell-specific	JJ
transcription	NN
factor	NN
TCF-1	NN
alpha	NN
plays	VBZ
a	DT
key	JJ
role	NN
in	IN
the	DT
tissue-specific	JJ
activation	NN
of	IN
the	DT
T	NN
cell	NN
receptor	NN
(	(
TCR	NN
)	)
C	NN
alpha	NN
enhancer	NN
and	CC
binds	VBZ
to	TO
pyrimidine-rich	JJ
elements	NNS
(	(
5'-PyCTTTG-3'	NN
)	)
present	JJ
in	IN
a	DT
variety	NN
of	IN
other	JJ
T	NN
cell-specific	JJ
control	NN
regions	NNS
.	.

Using	VBG
amino	NN
acid	NN
sequence	NN
information	NN
derived	VBN
from	IN
the	DT
DNA	NN
affinity-purified	JJ
protein	NN
,	,
we	PRP
have	VBP
now	RB
isolated	VBN
cDNA	NN
clones	NNS
encoding	VBG
TCF-1	NN
alpha	NN
.	.

The	DT
TCF-1	NN
alpha	NN
cDNA	NN
contains	VBZ
a	DT
single	JJ
68-amino-acid	JJ
domain	NN
that	WDT
is	VBZ
homologous	JJ
to	TO
a	DT
region	NN
conserved	VBN
among	IN
high-mobility	JJ
group	NN
(	(
HMG	NN
)	)
and	CC
nonhistone	JJ
chromosomal	JJ
proteins	NNS
.	.

Expression	NN
of	IN
full-length	JJ
and	CC
mutant	JJ
cDNA	NN
clones	NNS
in	IN
bacteria	NNS
reveal	VBP
that	IN
the	DT
single	JJ
HMG	NN
motif	NN
,	,
which	WDT
is	VBZ
predicted	VBN
to	TO
contain	VB
two	CD
extended	VBN
alpha-helical	JJ
segments	NNS
,	,
is	VBZ
sufficient	JJ
to	TO
direct	VB
the	DT
sequence-specific	JJ
binding	NN
of	IN
TCF-1	NN
alpha	NN
to	TO
DNA	NN
.	.

Northern	NN
blot	NN
experiments	NNS
demonstrate	VBP
further	RBR
that	IN
TCF-1	NN
alpha	NN
mRNA	NN
is	VBZ
highly	RB
tissue	NN
specific	JJ
,	,
found	VBN
primarily	RB
in	IN
the	DT
thymus	NN
or	CC
T	NN
cell	NN
lines	NNS
.	.

The	DT
immature	JJ
CEM	NN
T	NN
cell	NN
line	NN
expresses	VBZ
relatively	RB
low	JJ
levels	NNS
of	IN
TCF-1	NN
alpha	NN
mRNA	NN
,	,
which	WDT
are	VBP
increased	VBN
upon	IN
activation	NN
of	IN
these	DT
cells	NNS
by	IN
phorbol	NN
esters	NNS
.	.

Interestingly	RB
,	,
the	DT
cloned	VBN
TCF-1	NN
alpha	NN
protein	NN
is	VBZ
a	DT
potent	JJ
transcriptional	JJ
activator	NN
of	IN
the	DT
human	JJ
TCR	NN
alpha	NN
enhancer	NN
in	IN
nonlymphoid	JJ
cell	NN
lines	NNS
,	,
whereas	IN
the	DT
activity	NN
of	IN
the	DT
endogenous	JJ
protein	NN
in	IN
T	NN
cell	NN
lines	NNS
is	VBZ
strongly	RB
dependent	JJ
on	IN
an	DT
additional	JJ
T	NN
cell-specific	JJ
protein	NN
that	WDT
interacts	VBZ
with	IN
the	DT
core	NN
enhancer	NN
.	.

TCF-1	NN
alpha	NN
is	VBZ
currently	RB
unique	JJ
among	IN
the	DT
newly	RB
emerging	VBG
family	NN
of	IN
DNA-binding	JJ
regulatory	JJ
proteins	NNS
that	WDT
share	VBP
the	DT
HMG	NN
motif	NN
in	IN
that	IN
it	PRP
is	VBZ
a	DT
highly	RB
tissue-specific	JJ
RNA	NN
polymerase	NN
II	CD
transcription	NN
factor	NN
.	.

UI	LS
-	:
92052106	CD

TI	LS
-	:
Negative	JJ
regulation	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
expression	NN
in	IN
monocytes	NNS
:	:
role	NN
of	IN
the	DT
65-kDa	JJ
plus	CC
50-kDa	JJ
NF-kappa	NN
B	NN
dimer	NN
.	.

AB	LS
-	:
Although	IN
monocytic	JJ
cells	NNS
can	MD
provide	VB
a	DT
reservoir	NN
for	IN
viral	JJ
production	NN
in	FW
vivo	FW
,	,
their	PRP$
regulation	NN
of	IN
human	JJ
immunodeficiency	NN
virus	NN
type	NN
1	CD
(	(
HIV-1	NN
)	)
transcription	NN
can	MD
be	VB
either	CC
latent	JJ
,	,
restricted	JJ
,	,
or	CC
productive	JJ
.	.

These	DT
differences	NNS
in	IN
gene	NN
expression	NN
have	VBP
not	RB
been	VBN
molecularly	RB
defined	VBN
.	.

In	IN
THP-1	NN
cells	NNS
with	IN
restricted	JJ
HIV	NN
expression	NN
,	,
there	EX
is	VBZ
an	DT
absence	NN
of	IN
DNA-protein	JJ
binding	NN
complex	NN
formation	NN
with	IN
the	DT
HIV-1	NN
promoter-enhancer	NN
associated	VBN
with	IN
markedly	RB
less	JJR
viral	JJ
RNA	NN
production	NN
.	.

This	DT
absence	NN
of	IN
binding	NN
was	VBD
localized	JJ
to	TO
the	DT
NF-kappa	NN
B	NN
region	NN
of	IN
the	DT
HIV-1	NN
enhancer	NN
;	:
the	DT
65-kDa	JJ
plus	CC
50-kDa	JJ
NF-kappa	NN
B	NN
heterodimer	NN
was	VBD
preferentially	RB
lost	VBN
.	.

Adding	VBG
purified	VBN
NF-kappa	NN
B	NN
protein	NN
to	TO
nuclear	JJ
extracts	NNS
from	IN
cells	NNS
with	IN
restricted	JJ
expression	NN
overcomes	VBZ
this	DT
lack	NN
of	IN
binding	NN
.	.

In	IN
addition	NN
,	,
treatment	NN
of	IN
these	DT
nuclear	JJ
extracts	NNS
with	IN
sodium	NN
deoxycholate	NN
restored	VBD
their	PRP$
ability	NN
to	TO
form	VB
the	DT
heterodimer	NN
,	,
suggesting	VBG
the	DT
presence	NN
of	IN
an	DT
inhibitor	NN
of	IN
NF-kappa	NN
B	NN
activity	NN
.	.

Furthermore	RB
,	,
treatment	NN
of	IN
nuclear	JJ
extracts	NNS
from	IN
these	DT
cells	NNS
that	WDT
had	VBD
restricted	JJ
expression	NN
with	IN
lipopolysaccharide	NN
increased	VBD
viral	JJ
production	NN
and	CC
NF-kappa	NN
B	NN
activity	NN
.	.

Antiserum	NN
specific	JJ
for	IN
NF-kappa	NN
B	NN
binding	NN
proteins	NNS
,	,
but	CC
not	RB
c-rel-specific	JJ
antiserum	NN
,	,
disrupted	VBD
heterodimer	NN
complex	NN
formation	NN
.	.

Thus	RB
,	,
both	DT
NF-kappa	NN
B-binding	JJ
complexes	NNS
are	VBP
needed	VBN
for	IN
optimal	JJ
viral	JJ
transcription	NN
.	.

Binding	NN
of	IN
the	DT
65-kDa	JJ
plus	CC
50-kDa	JJ
heterodimer	NN
to	TO
the	DT
HIV-1	NN
enhancer	NN
can	MD
be	VB
negatively	RB
regulated	VBN
in	IN
monocytes	NNS
,	,
providing	VBG
one	CD
mechanism	NN
restricting	VBG
HIV-1	NN
gene	NN
expression	NN
.	.

UI	LS
-	:
92103005	CD

TI	LS
-	:
TCF-1	NN
,	,
a	DT
T	NN
cell-specific	JJ
transcription	NN
factor	NN
of	IN
the	DT
HMG	NN
box	NN
family	NN
,	,
interacts	VBZ
with	IN
sequence	NN
motifs	NNS
in	IN
the	DT
TCR	NN
beta	NN
and	CC
TCR	NN
delta	NN
enhancers	NNS
.	.

AB	LS
-	:
We	PRP
have	VBP
recently	RB
identified	VBN
and	CC
cloned	VBN
TCF-1	NN
,	,
a	DT
T	NN
cell-specific	JJ
transcription	NN
factor	NN
with	IN
specificity	NN
for	IN
the	DT
AACAAAG	NN
motif	NN
in	IN
the	DT
CD3	NN
epsilon	NN
enhancer	NN
and	CC
for	IN
the	DT
TTCAAAG	NN
motif	NN
in	IN
the	DT
TCR	NN
alpha	NN
enhancer	NN
.	.

TCF-1	NN
belongs	VBZ
to	TO
the	DT
family	NN
of	IN
transcription-regulating	JJ
proteins	NNS
which	WDT
share	VBP
a	DT
region	NN
of	IN
homology	NN
termed	VBN
the	DT
HMG-box	NN
.	.

Here	RB
,	,
we	PRP
show	VBP
by	IN
gel	NN
retardation	NN
analysis	NN
that	IN
TCF-1	NN
specifically	RB
recognizes	VBZ
the	DT
T	NN
beta	NN
5	CD
element	NN
of	IN
the	DT
TCR	NN
beta	NN
enhancer	NN
and	CC
the	DT
T	NN
delta	NN
7	CD
element	NN
of	IN
the	DT
TCR	NN
delta	NN
enhancer	NN
.	.

Comparison	NN
of	IN
the	DT
sequences	NNS
of	IN
all	DT
elements	NNS
recognized	VBN
by	IN
TCF-1	NN
defines	VBZ
a	DT
consensus	NN
motif	NN
A/T	NN
A/T	NN
C	NN
A	NN
A/G	NN
A	NN
G	NN
.	.

These	DT
observations	NNS
imply	VBP
that	IN
TCF-1	NN
is	VBZ
involved	VBN
in	IN
the	DT
control	NN
of	IN
several	JJ
T	NN
cell-specific	JJ
genes	NNS
and	CC
might	MD
thus	RB
play	VB
an	DT
important	JJ
role	NN
in	IN
the	DT
establishment	NN
and	CC
maintenance	NN
of	IN
the	DT
mature	JJ
T	NN
cell	NN
phenotype	NN
.	.

UI	LS
-	:
92127655	CD

TI	LS
-	:
[	(
Changes	NNS
in	IN
leucocytic	JJ
estrogen	NN
receptor	NN
levels	NNS
in	IN
patients	NNS
with	IN
climacteric	JJ
syndrome	NN
and	CC
therapeutic	JJ
effect	NN
of	IN
liuwei	FW
dihuang	FW
pills	NNS
]	)

AB	LS
-	:
The	DT
numbers	NNS
of	IN
estrogen	NN
receptor	NN
(	(
ER	NN
)	)
in	IN
human	JJ
peripheral	JJ
leucocytes	NNS
in	IN
22	CD
women	NNS
with	IN
climacteric	JJ
syndrome	NN
were	VBD
measured	VBN
by	IN
radioligand	NN
method	NN
.	.

The	DT
results	NNS
were	VBD
compared	VBN
with	IN
those	DT
of	IN
12	CD
normal	JJ
child-bearing-age	JJ
women	NNS
.	.

It	PRP
wat	VBD
found	VBN
that	IN
the	DT
contents	NNS
of	IN
leucocytic	JJ
ER	NN
in	IN
climacteric	JJ
syndrome	NN
patients	NNS
were	VBD
significantly	RB
lower	JJR
than	IN
normal	JJ
child-bearing-age	JJ
women	NNS
.	.

The	DT
authors	NNS
used	VBD
a	DT
Chinese	JJ
prescription	NN
--	:
Liuwei	FW
Dihuang	FW
Pills	NNS
(	(
LDP	NN
)	)
to	TO
treat	VB
the	DT
patients	NNS
for	IN
2	CD
months	NNS
.	.

The	DT
numbers	NNS
of	IN
leucocytic	JJ
ER	NN
were	VBD
significantly	RB
increased	VBN
after	IN
treatment	NN
.	.

The	DT
data	NNS
indicate	VBP
that	IN
decrease	NN
of	IN
ER	NN
levels	NNS
in	IN
cell	NN
may	MD
involve	VB
in	IN
the	DT
pathogenesis	NN
of	IN
climacteric	JJ
syndrome	NN
.	.

LDP	NN
not	RB
only	RB
increases	VBZ
plasma	NN
estradiol	NN
levels	NNS
,	,
but	CC
also	RB
increases	VBZ
the	DT
leucocytic	JJ
ER	NN
levels	NNS
.	.

This	DT
may	MD
be	VB
the	DT
basis	NN
of	IN
the	DT
therapeutic	JJ
effect	NN
on	IN
the	DT
disease	NN
.	.

UI	LS
-	:
91339573	CD

TI	LS
-	:
[	(
Changes	NNS
in	IN
leucocytic	JJ
estrogen	NN
receptor	NN
levels	NNS
in	IN
patients	NNS
with	IN
gynecomastia	NN
]	)

AB	LS
-	:
The	DT
number	NN
of	IN
estrogen	NN
receptor	NN
(	(
ER	NN
)	)
in	IN
human	JJ
peripheral	JJ
leucocytes	NNS
in	IN
13	CD
men	NNS
with	IN
gynecomastia	NNS
were	VBD
measured	VBN
by	IN
radioligand	NN
binding	NN
method	NN
.	.
The	DT
results	NNS
were	VBD
compared	VBN
with	IN
those	DT
of	IN
13	CD
sex-	NN
and	CC
age-matched	JJ
healthy	JJ
subjects	NNS
.	.

It	PRP
was	VBD
found	VBN
that	IN
the	DT
number	NN
of	IN
ER	NN
in	IN
leucocytes	NNS
was	VBD
significantly	RB
increased	VBN
in	IN
gynecomastia	NN
(	(
Rs	NN
of	IN
leucocytes	NNS
were	VBD
1054	CD
+/-	CC
254	CD
sites/cell	NN
)	)
.	.

It	PRP
suggested	VBD
that	IN
increase	NN
of	IN
ER	NN
levels	NNS
play	VBP
an	DT
important	JJ
role	NN
in	IN
the	DT
pathogenesis	NN
of	IN
gynecomastia	NN
.	.

UI	LS
-	:
91101115	CD

TI	LS
-	:
The	DT
NF	NN
kappa	NN
B	NN
independent	JJ
cis-acting	JJ
sequences	NNS
in	IN
HIV-1	NN
LTR	NN
responsive	NN
to	TO
T-cell	NN
activation	NN
.	.

AB	LS
-	:
The	DT
rate	NN
of	IN
transcription	NN
initiation	NN
directed	VBN
by	IN
the	DT
long	JJ
terminal	JJ
repeat	NN
(	(
LTR	NN
)	)
of	IN
HIV-1	NN
increases	VBZ
in	IN
response	NN
to	TO
mitogenic	JJ
stimuli	NNS
of	IN
T	NN
cells	NNS
.	.

Here	RB
we	PRP
show	VBP
that	IN
the	DT
response	NN
of	IN
the	DT
HIV-1	NN
LTR	NN
may	MD
be	VB
governed	VBN
by	IN
two	CD
independent	JJ
sequences	NNS
located	JJ
5'	JJ
to	TO
the	DT
site	NN
of	IN
transcription	NN
initiation	NN
sequences	NNS
that	WDT
bind	VBP
either	CC
NFAT-1	NN
or	CC
NF	NN
kappa	NN
B	NN
.	.

The	DT
rate	NN
of	IN
LTR-directed	JJ
gene	NN
expression	NN
increased	VBD
in	IN
response	NN
to	TO
treatment	NN
with	IN
either	CC
a	DT
phorbol	NN
ester	NN
or	CC
tumor	NN
necrosis	NN
factor	NN
alpha	NN
if	IN
either	CC
the	DT
NFAT-1	NN
or	CC
NF	NN
kappa	NN
B	NN
binding	NN
sites	NNS
were	VBD
deleted	VBN
,	,
but	CC
failed	VBD
to	TO
respond	VB
to	TO
these	DT
mitogenic	JJ
stimuli	NNS
if	IN
both	DT
sequences	NNS
were	VBD
absent	JJ
.	.

The	DT
HIV-1	NN
mutant	JJ
virus	NN
containing	VBG
both	CC
NF	NN
kappa	NN
B	NN
and	CC
NFAT-1	NN
deletion	NN
was	VBD
able	JJ
to	TO
replicate	VB
although	IN
at	IN
a	DT
much	JJ
decreased	VBN
growth	NN
rate	NN
,	,
while	IN
the	DT
deletion	NN
of	IN
NFAT-1	NN
alone	RB
increased	VBD
the	DT
viral	JJ
growth	NN
rate	NN
in	IN
Jurkat	NN
cells	NNS
.	.

Neither	CC
deletion	NN
of	IN
NF	NN
kappa	NN
B	NN
nor	CC
deletion	NN
of	IN
NFAT-1	NN
decreased	VBD
activation	NN
of	IN
viral	JJ
replication	NN
by	IN
phorbol	NN
ester	NN
.	.

UI	LS
-	:
91236696	CD

TI	LS
-	:
Inhibition	NN
of	IN
protein	NN
phosphatases	NNS
by	IN
okadaic	JJ
acid	NN
induces	VBZ
AP1	NN
in	IN
human	JJ
T	NN
cells	NNS
.	.

AB	LS
-	:
To	TO
examine	VB
the	DT
role	NN
of	IN
protein	NN
phosphatases	NNS
in	IN
T	NN
cell	NN
activation	NN
,	,
Jurkat	NN
cells	NNS
were	VBD
treated	VBN
with	IN
okadaic	JJ
acid	NN
,	,
an	DT
inhibitor	NN
of	IN
type	NN
1	CD
and	CC
2A	NN
phosphatases	NNS
,	,
and	CC
nuclear	JJ
extracts	NNS
were	VBD
examined	VBN
for	IN
the	DT
presence	NN
of	IN
AP1	NN
as	IN
a	DT
measure	NN
of	IN
early	JJ
T	NN
cell	NN
activation	NN
.	.

Okadaic	JJ
acid	NN
was	VBD
found	VBN
to	TO
be	VB
a	DT
potent	JJ
inducer	NN
of	IN
AP1	NN
.	.

In	IN
contrast	NN
to	TO
phorbol	NN
esters	NNS
such	JJ
as	IN
phorbol	NN
myristate	NN
acetate	NN
(	(
PMA	NN
)	)
,	,
the	DT
induction	NN
of	IN
AP1	NN
by	IN
okadaic	JJ
acid	NN
occurs	VBZ
predominantly	RB
by	IN
transcriptional	JJ
activation	NN
of	IN
the	DT
jun	NN
and	CC
fos	NN
family	NN
of	IN
proto-oncogenes	NNS
.	.

Surprisingly	RB
,	,
while	IN
the	DT
addition	NN
of	IN
phytohemagglutinin	NN
further	RB
enhanced	VBD
the	DT
induction	NN
of	IN
AP1	NN
,	,
the	DT
addition	NN
of	IN
PMA	NN
inhibited	VBD
it	PRP
.	.

Okadaic	JJ
acid	NN
treatment	NN
was	VBD
found	VBN
to	TO
dramatically	RB
increase	VB
mRNA	NN
transcripts	NNS
of	IN
the	DT
jun	NN
family	NN
of	IN
proto-oncogenes	NNS
including	VBG
c-jun	NN
,	,
junD	NN
,	,
and	CC
junB	NN
and	CC
to	TO
a	DT
lesser	JJR
extent	NN
the	DT
fos	NN
family	NN
including	VBG
c-fos	NN
and	CC
fra-1	NN
.	.

By	IN
comparison	NN
,	,
PMA	NN
is	VBZ
a	DT
very	RB
inefficient	JJ
inducer	NN
of	IN
the	DT
jun	NN
gene	NN
family	NN
in	IN
Jurkat	NN
cells	NNS
.	.

Similar	JJ
to	TO
its	PRP$
effect	NN
on	IN
the	DT
induction	NN
of	IN
AP1	NN
by	IN
okadaic	JJ
acid	NN
,	,
PMA	NN
inhibits	VBZ
the	DT
induction	NN
of	IN
c-jun	NN
mRNA	NN
by	IN
okadaic	JJ
acid	NN
.	.

Transfection	NN
of	IN
c-jun	NN
promoter	NN
constructs	NNS
confirmed	VBD
the	DT
marked	JJ
difference	NN
between	IN
PMA	NN
and	CC
okadaic	JJ
acid	NN
in	IN
inducing	VBG
c-jun	NN
transcription	NN
.	.

The	DT
induction	NN
of	IN
AP1	NN
by	IN
okadaic	JJ
acid	NN
suggests	VBZ
that	IN
protein	NN
phosphatases	NNS
1	CD
and	CC
2A	NN
(	(
PP1	NN
and	CC
PP2A	NN
)	)
may	MD
be	VB
involved	VBN
in	IN
T	NN
cell	NN
activation	NN
as	IN
important	JJ
negative	JJ
regulators	NNS
of	IN
the	DT
transcription	NN
factor	NN
AP1	NN
.	.

